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Abstract 
ii Abstract 
Clostridium docile is a spore-forming anaerobic bacterium that is an emerging nosocomial 
threat; incidence in hospitals is increasing, both in frequency and severity, resulting in 
considerable morbidity and mortality. Recent outbreaks in Canada, the US and the UK have 
highlighted the severity of this disease. 
In order to adapt to the intestinal environment, C. difcile must react to the many stresses 
involved with colonisation. To investigate the responses of C. docile to various stresses, the 
C. dicile 630 (Cd630) microarray developed by the Bacterial Microarray Group at 
St. George's, University of London (BµG@S) was utilised. Cd630 was subjected to heat shock, 
oxidative shock, pH shock or antibiotic stress (subinhibitory amoxicillin, clindamycin or 
metronidazole); then RNA was extracted and gene expression was analysed. Significantly 
regulated genes and operons which are unique to or common between different stresses are 
identified. The general stress response is observed after heat shock and also after acid shock. 
Exposure to atmospheric oxygen induces a large number of electron transporters. Heat shock, 
clindamycin and amoxicillin regulate many biochemical pathways. Growth in the presence of 
antibiotics results in increased ribosomal protein transcripts. 
Proteins at the surface of the bacteria are likely to be involved in interactions with the intestinal 
environment, and perhaps adherence to the gut wall. cwpV `ell wall protein with varying 
repeats) is present in every strain examined, although its function is as yet uncharacterised. In 
addition to its cell wall binding domains, cwpV types I and II encode repeats of 120 as and 79 as 
respectively; these repeats are almost completely unrelated to one another. cwp V type III 
remains largely uncharacterised. cwpV is transcribed in representative strains of each type. 
With one exception, type I strains express CwpV at the surface of a subset of cells. This phase 
variation may be mediated by inverted repeats in the promoter region of cwp V 
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Chapter 1.1 - Introduction - Pathology 
1.1 The pathogenicity of C. difficile 
Historical aspects 
Clostridium difcile is a Gram-positive, spore forming anaerobic bacterium first isolated in 
1935 and initially named Bacillus difcilis. It was shown that C. difcile produces a soluble, 
heat labile toxin; and that C. diIcile infection could kill guinea pigs and rabbits. However at 
this time it was not thought to be associated with human disease due to its isolation as a 
commensal in neonates (Hall, 1935 #1121). 
During the late 1970s, several lines of research came together to show that C. difcile actually is 
a human pathogen. Clindamycin was known to cause lethal enteritis in hamsters, and it was 
shown that faecal filtrates were cytotoxic to tissue culture cells (Green 1974), due to a clostridial 
toxin that could be neutralised by Clostridium sordellii anti-toxin (Bartlett et at. 1977). 
Meanwhile, pseudomembranous colitis (PMC) had been shown to be caused by a bacterial toxin 
(Larson et al. 1977) that resembled the C. sordellii toxin in its in vivo and in vitro effects, and 
was neutralised by C. sordellii anti-toxin (Larson & Price 1977; Bartlett et at. 1978a). This 
toxin was shown to be heat labile, rapidly lethal for hamsters and cytotoxic for tissue-culture 
cells, and was noted to be similar to that responsible for clindamycin-induced colitis in hamsters 
(Rifkin et al. 1977). However, it was not until C. di lcile was isolated from PMC patients 
(Bartlett et al. 1978c; George et al. 1978) and from hamsters (Bartlett et al. 1978b) and shown 
to produce a toxin capable of causing enterocolitis in hamsters and neutralised by C. sordellii 
anti-toxin (Bartlett et al. 1978b; Chang et al. 1978b; Larson et al. 1978) that the two diseases 
were formally linked and C. dicile was identified as the cause of PMC in man. 
Clinical observations in C. difficile associated disease (CDAD) 
PMC was originally described in 1893 as a fatal complication of major abdominal surgery in a 
young woman, and was named for the diphtheric membrane observed at autopsy (Finney 1893). 
In the 1960s and 1970s, the incidence of PMC rose with the introduction of broad-spectrum 
antibiotics, and was noted to be particularly common (a rate of 10%) after treatment with 
clindamycin (Tedesco et al. 1974). 
C. dicile infection does not always cause disease: it may also be carried asymptomatically in 
adults transiently or persistently (Johnson et al. 1992b; Ozaki et al. 2004). In addition to PMC, 
C. diicile is now known to cause a disease spectrum in man ranging from mild, self-limiting 
diarrhoea to potentially fatal complications such as fulminant colitis and toxic megacolon (Cone 
& Wetzel 1982; George 1984; Kelly et al. 1994b). C. di/cile is associated with 96% to 100% 
of cases of pseudomembranous colitis, 60% to 75% of antibiotic-associated cases of colitis, and 
11% to 33% of antibiotic-associated cases of diarrhoea (George 1984; McFarland & Stamm 
16 
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1986). The severity of diarrhoea is linked to the concentration of C. difficile toxin (Tcd, 
Section 1.5) in the stool and a very high level of stool toxin is correlated with the development 
of PMC (Burdon et al. 1981; Chang 1984; Akerlund et al. 2006). A high leukocyte count and 
an elevated creatinine level are strongly associated with disease complications (Pepin et al. 
2004; Pepin et al. 2006). The attributable mortality associated with nosocomial CDAD is 0.8% 
to 2% (Loo et al. 2004). Age is a very strong factor in determining CDAD susceptibility and 
severity: in the UK in the period 2001 to 2004 there were 211.6 deaths per million population 
between ages 75 and 84, compared with 0.2 per million population in the under 45 age group 
(Office for National Statistics 2006). 
CDAD often presents as watery diarrhoea, which may be accompanied by lower abdominal 
cramping and tenderness, usually beginning 4-9 days after initiation of antibiotic therapy 
(reviewed in George 1984; Kelly et al. 1994b; and Kelly & LaMont 1998). More severe colitis 
is indicated by profuse, debilitating diarrhoea accompanied by abdominal pain and distention, 
nausea, anorexia, malaise and dehydration. Peripheral-blood polymorphonuclear leukocytosis 
and increased numbers of faecal leukocytes are common. Pseudomembranes may then form; 
endoscopic examination reveals raised adherent yellow plaques, ranging from 2mm to 10mm in 
diameter, scattered over the colorectal mucosa. Abdominal CT scans of patients may reveal a 
pronounced thickening of the colonic wall that may involve the entire colon. CDAD may 
present as acute abdomen and fulminant colitis in around 3% of patients, and may lead to 
serious and potentially fatal complications. This is often characterised by severe leukocytosis 
and hypoalbuminaemia. Diarrhoea may diminish or cease if paralytic ileus develops, and toxic 
megacolon may ensue due to the loss of muscle tone. In order to prevent the risk of bowel 
perforation, colectomy may be necessary in some cases (reviewed in George 1984; Kelly et al. 
1994b; and Kelly & LaMont 1998). 
The characteristic pseudomembranous plaques consist of an exudate of epithelial debris, fibrin, 
mucus, and inflammatory cells overlying groups of partially disrupted glands, and are separated 
by almost normal mucosa from adjacent plaques. These volcanic lesions may grow and 
coalesce, resulting in complete structural necrosis of the mucosa, with a thick covering of fibrin, 
mucus, and inflammatory debris (Price & Davies 1977). 
Extraintestinal infections with C. docile have been reported, although rarely. Most commonly 
bacteraemia, infra-abdominal infection, or extra-abdominal abscesses are found; although 
C. docile is often isolated as part of a mixed infection, and in these cases the role of C. difcile 
in pathogenicity is unclear (Feldman et al. 1995; Bedimo & Weinstein 2003). 
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Figure 1.1 Images of pseudomembranous colitis 
(A) Endoscopy image of the normal, healthy colon. (B) Endoscopic visualisation of 
pseudomembranous colitis. Classic pseudomembranes are visible as raised yellow plaques 
ranging from 2- 10 mm in diameter and scattered over the colorectal mucosa (Gronczewski & 
Katz 2006). (C) Histological imaging of the "volcanic lesion" surrounded by normal tissue 
after haematoxylin and eosin staining; the spray consists of fibrin, polymorphs and epithelial 
debris; a dilated capillary is indicated by the arrow (Price & Davies 1977). 
18 
Chapter 1.1 - Introduction - Pathology 
The impact of C. docile infection is severe, not only in terms of increased morbidity and 
mortality, but also due to the increased financial burden on health services. In 1996 the 
estimated cost of CDAD per patient was over £4000, due to their extended stay in hospital and 
additional tests and interventions (Wilcox et al. 1996); in 2002 CDAD was estimated to cost the 
USA over $1.1 billion per year (Kyne et al. 2002a). Hospital acquired infections in total lead to 
around 5000 deaths per year and cost the NHS about £1 billion annually (National Audit Office 
2000). 
CDAD recurrence 
In around 15% to 20% of successfully treated primary CDAD episodes, symptoms recur after 
withdrawal of treatment (Bartlett et al. 1980; Bartlett 1984; Wenisch et al. 1996). The 
continued detection of spores from the faeces of some patients after treatment implies that 
relapse of the original disease may be occurring (McFarland et al. 2002), however several 
studies have shown that up to 56% of recurrences are caused by a different strain of C. docile 
and must therefore be caused by reinfection (Johnson et al. 1989b; Wilcox & Spencer 1992; 
Wilcox et al. 1998). The exact proportion of relapse versus reinfection is not possible to 
calculate against the background of an endemic strain, as reinfection with the same strain cannot 
be distinguished from relapse (Kato et al. 1996; Wilcox et al. 1998). Following a secondary 
CDAD episode the likelihood of further episodes is increased (Fekety et al. 1997; McFarland et 
al. 2002), and as many as fourteen recurrences have been recorded (McFarland et al. 1999). 
Both metronidazole and vancomycin, the main agents used to treat CDAD, may themselves also 
precipitate CDAD (Fekety et al. 1980; Larson & Borriello 1990; Wight et al. 1998), which may 
contribute to the high level of recurrence of this disease. 
Asymptomatic carriage 
Clostridium spp. have been isolated throughout the stomach, small intestine and large intestine 
of healthy digestive tracts, and are one of the predominant genera in the stomach and duodenum 
(Zilberstein et al. 2007). Asymptomatic colonisation with C docile may be transient or 
persistent, and is detected in 3% to 6% of the general population (Viscidi et al. 1981; Ozaki et 
al. 2004). In the hospitalised population this may rise to almost one in five (Johnson et al. 
1990a; Clabots et al. 1992; McCoubrey et al. 2003), although antibiotic treatment to eradicate 
C. difcile from this population is not recommended as it is generally ineffective and overuse of 
antibiotics may encourage the emergence of resistant bacteria (Johnson et al. 1992b). 
Asymptomatic carriage may reduce the risk of subsequently developing diarrhoea (Shim et al. 
1998). 
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Paediatric C. difficile 
Asymptomatic carriage is common in young children, as was first noted in 1935 (Hall & 
OToole). C. docile cannot be detected in faeces of 3-day old infants, but can be found at 
day 6, implying rapid acquisition from the environment at this age (Park et al. 2005). In one 
study prevalence was 100% for babies of 6-12 months, falling progressively to around 25% in 
5-year olds (Matsuki et al. 2005). Other studies have found prevalence of 20-40% in infants, 
with decreased incidence of C. diffcile in breast-fed infants (Cooperstock et al. 1983; Tonooka 
et al. 2005; Penders et al. 2006). 
It is postulated that the high rate of carriage of C. difficile, in conjunction with a low rate of 
CDAD, is due to a lack of a toxin receptor in neonatal intestines. Foetal amnion and chorion 
cells and intestinal mucosa are resistant to toxin action (Chang et al. 1986), and the neonatal 
rabbit intestine, which is resistant to TcdA, lacks high affinity brush border TcdA receptors; 
these gradually appear between 5 and 90 days of age (Eglow et al. 1992). However, paediatric 
CDAD remains a contentious issue. C. dWiicile toxin could be detected in the stools of 20% of 
5 to 12 year old children with diarrhoea, although co-detection with other pathogens was also 
observed and the presence of the toxin may not be contributing to pathology in these cases 
(Gogate et al. 2005; Tang et al. 2005). Paediatric PMC has also been observed, although rarely 
(Zwiener et al. 1989; Brook 2005). 
Infection control 
CDAD is principally a nosocomial infection. Increased length of hospital stay is associated 
with increased CDAD incidence: the risk of contracting CDAD increases by 1% to 3% per day 
of hospitalisation (Harbarth et al. 2001; Modena et al. 2005; Asha et al. 2006). Around 9% of 
patients have a hospital acquired infection at a given time, of which almost 5% are 
gastrointestinal (Emmerson et al. 1996). C. diIcile is transmitted faecal-orally, and there is 
widespread C. docile contamination within the hospital environment (Fekety et al. 1981; Kaatz 
et al. 1988; Verity et al. 2001; McCoubrey et al. 2003; Fawley et al. 2005; Eckstein et al. 
2007). 
C. dicile is commonly found on the hands of hospital carers (Kim et al. 1981; McFarland et 
al. 1989; Fawley et al. 2005) and intensive education programs promoting the use of disposable 
gloves can significantly reduce CDAD incidence (Johnson et al. 1990b). Chlorhexidine in 
alcohol is as effective as soap and water at removing C. dicile spores from bare hands (Bettin 
et al. 1994). C. dicile spores are highly resistant to alcohol - alcohol shock is used to 
selectively isolate C. diicile spores - so it was feared that the widespread introduction of 
alcohol based hand rubs would increase the transmission of C. diJcile. Nevertheless, many 
studies have shown CDAD rates to remain static after alcohol hand rub introduction (Gopal Rao 
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et al. 2002; Gordin et al. 2005; Boyce et al. 2006) and it is thought that the mechanical action of 
the hand rub can be as effective as soap and water hand washing for removal of C. diJcile 
spores (The Medical Letter 2007). 
Wards containing symptomatic C. dicile patients are more highly contaminated by spores than 
those with asymptomatic carriers, and there is epidemiological evidence for patient-to-patient 
transmission (Mulligan et al. 1980; Kim et al. 1981; McFarland et al. 1989; Fawley & Wilcox 
2001; Dubberke et al. 2007a). There is evidence that the C. difficile colonisation pressure is 
linked to the CDAD rate (McFarland et al. 1989; Dubberke et al. 2007b; Lawrence et al. 2007), 
and physical proximity to a patient with CDAD significantly increases the risk of CDAD 
developing (Chang & Nelson 2000). The removal of C. diJcile from the hospital environment 
depends strongly on the cleaning and disinfection methods used. Routine cleaning with 
detergent is ineffective at removing C. docile from the environment (Fawley & Wilcox 2001); 
C. dicile inoculated onto a hospital ward floor persisted for five months (Kim et al. 1981). 
However, acidified bleach or high concentrations of bleach can inactivate all spores within 
15 minutes (Perez et al. 2005; Fawley et al. 2007). Hypochlorite disinfection can significantly 
reduce contamination levels over standard housekeeping cleaning (Eckstein et al. 2007) and 
reduce rates of CDAD (Wilcox et al. 2003; McMullen et al. 2007; Whitaker et al. 2007). 
However, hypochlorite is corrosive and the release of chlorine gas can be dangerous, so 
effective alternatives such as acidified nitrate and peracetyl ions should be considered (Wullt et 
al. 2003c; Dettenkofer et al. 2004). 
An increasing number of CDAD infections are unconnected to the hospital environment; this is 
known as community-acquired infection. The sources of these infections are generally 
unknown, but C. dicile can be isolated from both food animals and pets (discussed in 
Section 1.7), and C. dicile, including toxinogenic strains, can be cultured from some ground 
meat samples (Rodriguez-Palacios et al. 2007) and raw vegetables (al Saif & Brazier 1996). 
Environmental soils and waters are also commonly contaminated with C. diIcile (al Saif & 
Brazier 1996; Simango 2006). Although it is unlikely that these environmental isolates are 
capable of multiplying, they may act as a reservoir for community-acquired infection. Even in 
the healthcare setting, up to 10% of patients may be colonised by C. docile at the time of 
admission (McFarland et al. 1989; Clabots et al. 1992). 
1.2 Host factors affecting CDAD 
Iatrogenic risk factors 
CDAD may be viewed as collateral damage caused by conventional medical interventions. 
Patients with more severe underlying illness are more likely to develop CDAD (Kyne et al. 
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2002b), which may be linked to increased levels of treatment or to reduced immunological 
resistance in these individuals (discussed below). The link between CDAD incidence and 
length of hospital stay may be linked to increased medical treatments, prolonged exposure to an 
environment with high C. difficile colonisation pressure, or more severe underlying disease. 
Many hospitalised patients are prescribed antibiotics; these are known to be the primary 
instigators of CDAD. Other iatrogenic risk factors associated with development of CDAD 
include cancer cytotoxic drugs (methotrexate) (Silva et al. 1984), enemas and other gastro- 
intestinal procedures (tube-feeding, endoscopy, gastrointestinal surgery) (Pierce et al. 1982; 
Bliss et al. 1998; Kyne et al. 1999), and drugs affecting digestive processes (stool softeners, 
gastrointestinal stimulants, proton pump inhibitors) (McFarland et al. 1990; Dial et al. 2004). 
Taken together, these results imply any process that disrupts the normal colonic flora may result 
in a propensity to develop CDAD. 
Antibiotics 
The most common form of CDAD is antibiotic associated diarrhoea (AAD); C. difficile causes 
around one quarter of AAD cases (George 1984; Vasa & Glatt 2003). The risk of CDAD varies 
between antibiotics: those strongly implicated are the second and third generation 
cephalosporins (cefuroxime, cefaclor, cefotaxime), ampicillin, clindamycin, aminoglycosides, 
and administration of antibiotic combinations (Pierce et al. 1982; Hirschhorn et al. 1994; Chang 
& Nelson 2000; Harbarth et al. 2001; Starr et al. 2003; Thomas & Riley 2003). In a group of 
healthy volunteers receiving a single intravenous dose of antibiotic, cephalosporins, but not 
penicillins, were associated with the emergence of C. dicile (Ambrose et al. 1985). 
Antibiotics affect the normal gut flora in addition to the pathogen they are used to target, 
however the propensity of these antibiotics to precipitate CDAD is not purely due to their broad 
spectrum: change of antibiotic prescribing policy, for example restricting cephalosporins in 
favour of piperacillin-tazobactam, can reduce CDAD incidence (Settle et al. 1998; Thomas & 
Riley 2003; O'Connor et al. 2004; Fowler et al. 2007). In 2002 an unintentional experiment was 
carried out: a shortage of piperacillin-tazobactam forced an increase in cephalosporin use and 
CDAD incidence was seen to rise; return of normal supply reduced CDAD rate back to baseline 
levels (Alston & Ahern 2004; Wilcox et al. 2004). 
The propensity of fluoroquinolones to precipitate CDAD appears to have increased in recent 
years (Pepin et al. 2004); this may be linked to the increasing levels of antibiotic resistance 
found in isolates, particularly the emergence of a "hypervirulent" new strain (Loo et al. 2005; 
Warny et al. 2005), which is discussed in Section 1.4. 
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Proton pump inhibitors 
Recently gastric acid suppressors have been highlighted as risk factors for CDAD, particularly 
in the community setting. In the hospital environment, proton pump inhibitors (PPIs) have been 
found to increase the likelihood of CDAD development by 2.0- to 2.5-fold (Cunningham et al. 
2003; Dial et al. 2004; Akhtar & Shaheen 2007). In the community, the risk was increased 
3-fold with use of PPIs, and 2-fold by H2-receptor antagonists (Dial et al. 2005; Dial et al. 
2006). Meta-analysis of twelve studies reveals 1.96-fold increased CDAD risk with PPI use and 
1.40-fold with H2-receptor antagonists (Leonard et al. 2007). However, outpatients hospitalised 
for CDAD were found to be no more likely than controls to have taken PPIs in the preceding 90 
days (Lowe et al. 2006), and in some retrospective studies PPIs were not found to be associated 
with CDAD (Pepin et al. 2005b). C. dicile growth was inhibited more strongly in continuous- 
flow culture with a low-pH medium (Yamamoto-Osaki et al. 1994), and the vegetative form of 
C. dWIcile can persist in gastric contents with elevated pH (> pH 5), which may explain the 
propensity of gastric acid suppressants to cause C. docile colonisation (Gurian et al. 1982; 
Jump et al. 2007). 
Colonisation resistance 
As suggested by the identified iatrogenic risk factors, C. docile appears to only be able to 
infect the healthy gastrointestinal tract and cause disease after disruption of the normal flora, but 
the mechanism of colonisation resistance is not known. In the hamster model (Section 1.7), 
ingested C. dicile spores germinate in the small intestine but many bacteria rapidly die. The 
remaining C. dicile then multiply in antibiotic-treated animals, but this is completely inhibited 
in untreated hamsters (Wilson et al. 1985). The cecal flora of hamsters is capable of inhibiting 
the growth of C. dicile inoculated into gnotobiotic mice (Wilson & Freter 1986; Wilson et al. 
1986), and the administration of normal cecal contents after antibiotic challenge protects 
hamsters from cecitis and reduces viable C. difficile counts (Wilson et al. 1981). Normal human 
gut flora inhibits the growth of C. dicile in faecal emulsions; this is found to be less effective 
with infant or geriatric faeces, or with faeces from patients taking antibiotics (Borriello & 
Barclay 1986). In a model of the human gut, cefotaxime administration leads to proliferation of 
C. diJiicile and elevated toxin levels, and it was noted that the number of Bffidobacteria and 
Bacteroides decreased concurrently (Freeman et al. 2003). In fact, it has been previously noted 
that cephalosporin administration leads to appearance of C. di) cile and loss of E. coli and 
Bacteroides from the human stool (Ambrose et al. 1985). Administration of clindamycin, 
ceftriaxone or piperacillin-tazobactam to mice disrupts the anaerobic microflora and facilitates 
growth and toxin production of C. diJcile, but levofloxacin, cefepime or aztreonam, which 
cause minimal disruption, do not (Pultz & Donskey 2005). 
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Strains isolated from symptomatic patients are more likely to show antibiotic resistance 
(Shuttleworth et al. 1980), however the propensity of an antibiotic to cause CDAD can be 
linked to the extent and duration of flora disruption but not to C. docile resistance to the 
antibiotic (Larson & Borriello 1990; Freeman & Wilcox 2001). Continued administration of the 
predisposing antibiotic can in fact delay onset of symptoms in the hamster model (Ebright et al. 
1981). 
The principles of colonisation resistance have led to the theory that rebalancing the normal gut 
flora may be able to prevent recurrent CDAD. These probiotic approaches are discussed in 
Section 1.3. 
Immune defences 
Increased age and severe underlying disease are risk factors for CDAD (McFarland et al. 1990; 
Buchner & Sonnenberg 2001; Kyne et al. 2002b), implying that an effective immune system 
protects from disease. Antibodies (immunoglobulins, Ig) against C. docile may be protective: 
anti-C. dicile IgA, IgM and polyvalent immunoglobulins were found at higher levels in the 
sera of C. dicile asymptomatic carriers than in CDAD patients (Mulligan et al. 1993), as were 
antibodies to the flagellar proteins FliC and F1iD, the fibronectin binding protein (Fbp68), and a 
surface adhesin Cwp66 (Pechine et at. 2005a). Although anti-TcdA (C. dicile toxin A, 
Section 1.5) IgG titre did not affect colonisation incidence, a higher anti-TcdA IgG response 
was associated with asymptomatic infection (Kyne et al. 2000). Levels of anti-TcdA IgG were 
found to be higher in convalescent sera than in acute sera, carriers or controls (Johnson et al. 
1992a). Low levels of specific serum IgG and faecal IgA are also associated with prolonged 
symptoms (Warny et al. 1994). Transgenic mice expressing human anti-Tcd IgGI genes were 
protected from the effects of C. docile toxin, and these antibodies could reduce CDAD 
mortality in hamsters (Babcock et al. 2006). IgAl from convalescent sera can neutralise TcdA 
and have therefore been implicated in symptomatic disease resolution (Johnson et al. 1995). 
An effective immune response may also reduce the chance of recurrent CDAD: low serum anti- 
TcdA at 3 days of infection and low anti-TcdA IgG at 12 days are associated with recurrence 
(Kyne et al. 2001); as is low total serum IgG and faecal IgA (Warny et al. 1994). In one study 
overall levels of both total and anti-Tcd immunoglobulins of all subgroups were similar between 
patients with single occurrences and recurrent disease, except IgG2 and IgG3 where poor 
anti-TcdA responses were associated with recurrence (Katchar et al. 2007). Colonic biopsies 
reveal a decrease in the levels of B-cells, macrophages and IgA-producing cells in CDAD 
patients, and an increase in IgG-producing cells: very low levels of B-cells and IgA-producing 
cells were associated with recurrence (Johal et al. 2004b). 
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Antibodies to other C. di cile components may also affect CDAD progression. Immunisation 
of mice using F1iD can reduce toxigenic C. docile colonisation levels (Pechine et al. 2007), 
and low levels of anti-SLP (surface-layer protein, Section 3.1) IgM at day 3 are associated with 
recurrence (Drudy et al. 2004). 
The significance of a protective immune response is highlighted by the prevalence of CDAD in 
HIV patients. These patients may be over 100-fold more likely to develop bacterial diarrhoea 
than the general population, and whilst only a small proportion of cases have identified bacterial 
agents, over half of these are associated with C. dicile (Mathewson et al. 1998; Sanchez et al. 
2005). CDAD rates more than double with progression from HIV infection to clinical AIDS 
(Sanchez et al. 2005). However, a large part of the mechanism of CDAD pathology is 
immunopathology (Section 1.5), and therefore the clinical significance of the presence of 
C. di cile in these patients, and its contribution to pathogenesis, is not clear (Torre 2006). 
1.3 Treatment of CDAD 
Antibiotics 
Mild diarrhoea often resolves upon removal of the triggering antibiotic (Tedesco et al. 1985), 
and in cases where this is not possible or for more severe diarrhoea, primary CDAD can almost 
always be treated using either metronidazole or vancomycin (Keighley et al. 1978; Mogg et al. 
1980; Teasley et al. 1983). A first recurrence is often treatable in the same fashion as a primary 
episode. Tapered and pulsed vancomycin treatments may be effective at treating persistently 
relapsing CDAD by allowing spore germination and subsequent elimination (Tedesco et al. 
1985; McFarland et al. 2002), although many alternative interventions are also under 
investigation (see below). 
Metronidazole was originally thought to be equally effective as vancomycin despite being much 
less expensive (Teasley et al. 1983; Olson et al. 1994). Vancomycin is poorly absorbed through 
the gut, so concentrations remain high in the stool, whereas metronidazole reaches high 
concentrations in the stool when given orally or intravenously as it may pass through the gut 
walls (Bolton & Culshaw 1986). Vancomycin may result in more rapid resolution of symptoms 
(Wilcox & Howe 1995), but vancomycin use is restricted in hospitals to minimise selection for 
vancomycin-resistant enterococci (VRE). Recently, however, it has been asked whether 
metronidazole is associated with a higher rate of complicated disease courses (Pepin et al. 2004; 
Pepin et al. 2005a): very low serum albumin levels and intensive care unit treatment are 
predictors of failure of metronidazole treatment (Fernandez et al. 2004). It is suggested that 
metronidazole and vancomycin are as effective at treating mild CDAD, but that vancomycin is 
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superior for severe CDAD (Zar et al. 2007). Discontinuation of the precipitating antibiotic may 
be critical in metronidazole treatment success (Modena et al. 2006). 
Alternative treatment options are being sought, however C. difficile is naturally resistant to 
many antibiotics; the mechanisms of some of these antibiotic resistances are discussed in 
Section 1.6. Its resistance properties severely limit possible CDAD treatment options, however 
alternative antibiotics have been investigated. Agents with high in vitro activity against the 
majority of C. docile strains include tinidazole, rifaximin, rifalazil, tizoxanide, nitazoxanide, 
OPT-80, ramoplanin, doripenem, and meropenem (Hecht et al. 2007). Teicoplanin, fusidic 
acid, bacitracin and rifaximin were found to be as effective as metronidazole and vancomycin in 
treating CDAD (Wenisch et al. 1996; Wullt & Odenholt 2004; Bricker et al. 2005), and 
teicoplanin treatment may reduce recurrence rates (Wenisch et al. 1996; Bricker et al. 2005). 
Tigecycline has been shown to repress C. dicile germination in a chemostat human gut model, 
but not to eradicate spores (Baines et al. 2006). Rifaximin, administered after successful 
vancomycin therapy, can prevent further episodes of CDAD in patients with a history of 
multiple recurrences (Johnson et al. 2007). Nitazoxanide has been shown to be effective in 
treating patients for whom metronidazole treatment had failed (Musher et al. 2007). Rifalazil 
can treat CDAD in hamsters with reduced levels of relapse in comparison to vancomycin 
(Anton et al. 2004b). OPT-80 (PAR-101, difimycin), a narrow-spectrum macrocyclic antibiotic 
secreted by the actinomycete Dactylosporangium aurantiacum, shows high in vitro activity 
against all C. dicile strains tested (Ackermann et al. 2004), is only active against Gram- 
positive strains, especially Clostridium spp., minimising colonic flora disruption (Credito & 
Appelbaum 2004), and is currently in phase III clinical trials (Johnson 2007). 
Probiotics 
Probiotic approaches aim to rebalance the gut microflora. The Gram-positive bacteria 
Lactobacillus GG, L. plantarum and Bifidobacterium longum can ease the symptoms of CDAD 
and reduce rates of recurrence (Colombel et al. 1987; Gorbach et al. 1987; Pochapin 2000; 
Wullt et al. 2003b). Consumption of a probiotic drink containing L. casei, L. bulgaricus and 
Streptococcus thermophilus can reduce the incidence of antibiotic associated diarrhoea and 
CDAD (Hickson et al. 2007). The yeast Saccharomyces boulardii has been shown to reduce 
inflammation and increase survival in clindamycin-treated hamsters and gnotobiotic mice 
(Massot et aL 1984; Toothaker & Elmer 1984; Corthier et al. 1986), reduce the secretion from 
rat intestines in response to TcdA (Izadnia et al. 1998), and reduce the likelihood of AAD and 
CDAD in humans (Surawicz et al. 1989a; Cremonini et al. 2002). S. boulardii can protect 
hamsters in the CDAD relapse model (Elmer & McFarland 1987), and reduce the likelihood of 
recurrence in humans with a primary episode or with multiple previous recurrences (Surawicz et 
al. 1989b; McFarland et al. 1994; Elmer et al. 1999; Surawicz et al. 2000). 
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Several meta-analyses have concluded that probiotics are effective at preventing AAD and 
CDAD and also preventing CDAD recurrence (Cremonini et al. 2002; Guslandi 2006; 
McFarland 2006). The mechanisms by which probiotics are effective at promoting 
gastrointestinal health are not known, and are likely to be varied. Probiotics may be involved in 
immune modulation, antimicrobial secretion, competitive exclusion of pathogens, or breakdown 
of toxic substances or metabolic by-products (Hong et al. 2005). Bifidobacterium spp. can 
inhibit and displace C. docile binding to human intestinal mucus (Collado et al. 2005) and 
Lactobacillus GG induces mucin expression from intestinal cells which inhibits bacterial 
translocation (Marteau et al. 2002). Cell-free supernatants of Bifidobacterium spp. and L. casei 
rhamnosus inhibit the growth of C. docile and its adherence to Caco2 cells (Forestier et al. 
2001; Trejo et al. 2006), and a purified Bifidobacterium adolescentis adhesin inhibits binding 
of C. docile to Lovo epithelial cells (thong et al. 2004). S. boulardii inhibits binding of 
C. di/cile to Vero cells due to a PMSF- (phenyl-methyl-sulphonide-fluoride)-sensitive cell wall 
component, which is hypothesised to be a serine protease (Tasteyre et al. 2002). 
An alternative strategy, instead of introducing probiotics directly, is to use prebiotics that 
encourage growth of beneficial microbes in the gut. Dietary soy fibre can reduce disease and 
delay time of death in clindamycin-treated hamsters (Frankel et al. 1994). Dietary 
oligosaccharides can increase faecal Bifidobacteria and decrease C. docile prevalence in a 
chemostat gut model and in pre-term infants (Hopkins & Macfarlane 2003; Knol et al. 2005). 
Oligofructose does not protect from primary AAD or CDAD (Lewis et al. 2005b), but can 
increase faecal Bifidobacteria in CDAD convalescence and decrease rates of CDAD recurrence 
(Lewis et al. 2005a). An alternative approach to rebalancing gut microflora is stool replacement 
therapy from a healthy donor, thought to work by increasing the level of Bacteroides (Tvede & 
Rask-Madsen 1989). 
Competitive exclusion of toxigenic C. docile by non-toxigenic isolates has also been 
investigated. Inoculation with a non-toxigenic strain of C. dif cile protects clindamycin-treated 
hamsters subsequently exposed to toxigenic C. diJcile (Wilson & Sheagren 1983; Borriello & 
Barclay 1985; Sambol et al. 2002; Merrigan et al. 2003); prevents toxinogenic colonisation of 
piglets (Songer et al. 2007); and prevents CDAD recurrence in humans (Seal et al. 1987). 
Immunoglobulins 
Induction of the host's own immune response may help prevent or cure CDAD. Transcutaneous 
immunisation of mice with formalin treated TcdA induces a strong, toxin-neutralising IgG and 
IgA response in the serum and stool (Ghose et al. 2007), and purified inactivated toxins have 
been shown to prolong survival or prevent disease in hamsters (Fernie et al. 1983; Giannasca et 
at. 1999). A C. dicile toxoid vaccine has been shown to be effective in healthy volunteers 
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(Aboudola et al. 2003), and resultant anti-Tcd antibodies are associated with resolution of 
recurrent CDAD (Sougioultzis et al. 2005). 
However, vaccines are known to be less effective in those with suppressed immune systems, 
such as the elderly or very ill, who are most prone to succumbing to CDAD; anti-TcdA IgG, 
while present in 24% of the general population, was rarely found in those over 50 years old 
(Bacon & Fekety 1994). An alternative strategy, passive immunisation, was first shown to be 
effective in animal models: C. sordellii anti-toxin prevents death of clindamycin-treated 
hamsters and anti-TcdA protects axenic mice (Allo et al. 1979; Corthier et al. 1991). 
Intravenous pooled normal human IgG is capable of resolving the symptoms of children and 
adults with recurrent C. dicile colitis (Leung et al. 1991; Murphy et al. 2006), and has been 
effective in treatment of severe diarrhoea and PMC (Salcedo et al. 1997; Wilcox 2004; 
McPherson et al. 2006; Hassoun & Ibrahim 2007). Anti-Tcd antibodies have been shown to 
prolong survival in hamsters (Giannasca et al. 1999), and orally administered anti-SLP 
antibodies prolonged survival of challenged hamsters, proposed to be due to enhanced 
phagocytosis of C. dtcile (O'Brien et al. 2005). 
Orally administered concentrated colostrum from cows immunised with inactive Ted was 
capable of protecting hamsters from C. difcile challenge (Lyerly et al. 1991), as was 
concentrated whey from cows immunised with killed C. difficile and inactive Tcd (van Dissel et 
al. 2005). This whey contains high concentrations of anti-Ted antibodies which are toxin- 
neutralising (van Dissel et al. 2005). Both xylitol and bovine colostrum whey also inhibited 
adhesion of C. diIcile to Caco2 cells (Naaber et al. 1996). Whey treatment following standard 
antibiotic treatment may reduce the CDAD recurrence rate by half (van Dissel et al. 2005; 
Numan et al. 2007); recurrence was more frequent in patients with severe underlying disease or 
who were infected with C. dif cile ribotype 027 (Section 1.4) (Numan et al. 2007). 
Surgical 
In severe fulminant colitis, the only treatment option may be surgical removal of the affected 
parts of the gut. The indications for surgery are peritonitis, ileus with toxic megacolon, 
impending perforation, peritonitis, refractory sepsis, and the presence of shock or organ 
dysfunction (Malnick & Zimhony 2002; Koss et al. 2006). Even if surgery is performed, there 
is a high mortality rate of around 50% (Dallal et al. 2002; Longo et al. 2004; Lamontagne et al. 
2007), although patients undergoing emergency colectomy after admission to the intensive care 
unit were 4.5 times less likely to die than those treated medically (Lamontagne et al. 2007). 
Significant predictors of death after colectomy were preoperative vasopressor requirements, 
severe leukocytosis, raised lactate levels, immunosuppression and age (Dallal et al. 2002; 
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Lamontagne et a!. 2007), and therefore in patients with fulminant colitis, early colectomy before 
vasopressor therapy is required may improve survival (Adams & Mercer 2007). 
Other interventions 
Anionic binding resins have been proposed to relieve the symptoms of CDAD, as they are 
capable of binding Tcd. Cholestyramine may be effective in prolonging the survival of 
hamsters (Fekety et al. 1979; Taylor & Bartlett 1980) and treating CDAD and PMC in man 
(Kreutzer & Milligan 1978; Bartlett 1984) but cholestyramine also binds vancomycin and may 
therefore interfere with antibiotic therapy (Taylor & Bartlett 1980). Tolevamar is a Ted-binding 
polystyrene salt (Braunlin et al. 2004) that has been shown to resolve symptoms of CDAD 
almost as effectively and quickly as vancomycin, and was not associated with increased 
recurrence (Louie et al. 2006). Bismuth compounds, as found in Pepto-Bismole, may react with 
dietary components including thiol groups and vitamin C to create compounds with in vitro 
activity against C. dicile (Mahony et a!. 1999; Mahony et al. 2005). Tea phenolics repress 
growth of C. docile and other pathogens whilst commensal genera are relatively unaffected 
(Lee et al. 2006). The lantibiotic lacticin is capable of eliminating C. difcile from a model 
faecal environment whilst leaving many microflora unaffected, although Lactobacilli and 
Bifidobacteria were reduced (Rea et al. 2007). 
1.4 Detection of C. difficile 
Diagnosis 
There is no standardised method for the diagnosis of CDAD, as there is no test that is 
sufficiently rapid, specific and sensitive. Presence of either TcdA or TcdB in the stool is taken 
as diagnostic of CDAD, however toxin may also be detected in the stool of over half of 
asymptomatic carriers (McFarland et al. 1991); 14% of toxin-positive patients may remain 
asymptomatic (Scheurer et al. 2006). The most sensitive test for toxin is the cell culture 
cytotoxicity and neutralisation assay (CCNA) - where rounding of cells due to toxin is 
observed, and the protective property of C. sordellii anti-toxin is confirmed - and this is 
regarded a the "gold standard" in CDAD diagnosis. However, this test takes many days to carry 
out, is technically demanding and is not suited to the rapid diagnosis needed to initiate both 
treatment and isolation (Mohan et al. 2006; Ticehurst et al. 2006; van den Berg et al. 2007b). 
Toxigenic culture - isolation of C. dicile and subsequent colony immunoblot testing for toxin 
production - is reported to be more sensitive than faecal cytotoxin detection (Delmee et al. 
2005). However because of the possible carrier state of C. difjicile infection, culture of even 
toxigenic C. docile from stool is not sufficient for definitive diagnosis of CDAD: almost 90% 
of isolates from asymptomatic carriers were toxinogenic (McFarland et al. 1991). 
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A more rapid test is ELISA detection of one or both toxins; commercial tests have reported 
sensitivity and specificity rates of up to 97% and 95% in comparison to CCNA (van den Berg et 
al. 2007b). Both TcdA and TcdB should be tested for, due to the incidence of TcdA-negative 
pathogenic strains of C. docile (Section 1.5), which means that, in one study, screening for 
only TcdA would have missed almost one third of diagnoses (Snell et al. 2004). Enzyme 
immunoassay detecting TcdA and TcdB is the most commonly used method of CDAD 
diagnosis (Barbut et al. 2003). 
An alternative method proposed for rapid CDAD diagnosis is gas-liquid chromatography and 
mass spectroscopy of the gaseous compounds released from C. diJcile stool, as the volatile 
organic compound signature of CDAD is significantly different of that from healthy faeces or 
from other diarrhoea etiologies (Johnson et al. 1989a; Probert et al. 2004; Garner et al. 2007). 
Many nurses believe that the most reliable diagnosis of CDAD is by its characteristically 
unpleasant odour: nurses' judgement was significantly good at predicting CDAD by smell 
(Johansen et al. 2002; Burdette & Bernstein 2007). 
PMC is conclusively diagnosed by the appearance of the characteristic raised adherent yellow 
plaques upon colonic endoscopy (Seppala et al. 1981; Kawamoto et al. 1999); up to half of 
PMC cases may appear toxin-negative by CCNA (Johal et al. 2004a). However, endoscopy 
does carry the risk of gut perforation in severe cases of PMC (Kelly et al. 1994b). For diagnosis 
of atypical CDAD, PMC or severe colitis an abdominal radiograph, ultrasound or CT scan may 
be diagnostic, revealing diffuse thumbprinting or a pronounced thickening of the colonic wall 
that may involve the entire colon (Razzaq & Sukumar 2006). Interestingly, patients with cystic 
fibrosis often present with atypical CDAD and ultrasound diagnosis may be most appropriate in 
this condition (Binkovitz et al. 1999; Razzaq & Sukumar 2006; Sheridan et al. 2006). 
Characteristic CDAD symptoms such as severe leukocytosis and hypoalbuminaemia may also 
be useful in rapid diagnosis and may be indicative of the need for empiric metronidazole 
treatment (Bulusu et al. 2000; Wanahita et al. 2003; Peled et al. 2007), however empiric 
treatment of nosocomial diarrhoea is not recommended without strong CDAD indications as 
only 25% of AAD cases are caused by C. dijcile and diarrhoea of other etiologies will not 
benefit from metronidazole treatment (Vasa & Glatt 2003). 
Epidemiology and typing 
There have been many typing schemes set up to monitor the epidemiology of C. dif cile. 
Because each typing technique measures distinct properties of C. difficile strains, differing 
levels of agreement has been found between the methods. The most commonly used schemes 
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are serotyping, ribotyping, restriction-endonuclease analysis (REA) typing, pulse-field gel 
electrophoresis (PFGE) typing and toxinotyping. 
Serotyping distinguishes the surface antigenic properties of different strains, based on slide 
agglutination with rabbit antisera. It allows the differentiation of 10 serogroups designated A, B, 
C, D, F, G, H, I, K, and X (Delmee et al. 1986). Serogroup is determined by the surface 
immunogens of the isolates, and is strongly linked to the surface-layer proteins (SLPs, 
Section 3.1) and surface structures such as flagella (Section 1.6) (Delmee et al. 1990; 
Karjalainen et al. 2002). 
Typing by SDS-PAGE of EDTA extracted proteins was first demonstrated in the 1980s (Poxton 
et al. 1984), and has now been developed into S-typing. Each isolate is designated as an S-type 
represented by a four digit number representing the sizes of the major protein bands revealed, 
which are the high and low molecular weight SLPs (McCoubrey & Poxton 2001; McCoubrey et 
al. 2003), however this method relies only on the sizes of two proteins and is not likely to be 
very useful in epidemiological studies. Typing by sequencing of the slpA gene has also been 
proposed: this shows correlation with ribotyping (Karjalainen et al. 2002; Kato et al. 2005; 
Eidhin et al. 2006) but is again unlikely to be useful in large scale studies, and may not reflect 
the true phylogeny of the isolates (Lemee et al. 2005). 
DNA based typing schemes, for instance REA typing using an enzyme such as Hindlll, provide 
greater discrimination than serotyping, resulting in hundreds of strain classifications (Clabots et 
al. 1993; Samore et al. 1997). PFGE using a rare cutting enzyme such as Smal or NruI can also 
distinguish between isolates, but this is a difficult technique for the standard diagnostic 
laboratory as degradation of DNA is a common problem in C. dicile (Samore et al. 1997; 
Fawley & Wilcox 2002). 
PCR-ribotyping (ribotyping) involves PCR amplification of 16S-23S rRNA spacer regions 
(Gurtler 1993; ONeill et al. 1996). Although its discriminatory power is not as high as other 
typing schemes ribotyping is now one of the most commonly used typing systems, and a 
reference library of over 100 ribotypes has been set up at the Anaerobe Reference Unit (Stubbs 
et al. 1999). Ribotyping closely correlates with the serotype and toxinotype (see below) of the 
isolate (Stubbs et al. 1999; Rupnik et al. 2001). 
Other PCR-based typing systems include random-amplified polymorphic DNA (RAPD) 
(Chachaty et al. 1994); amplified fragment length polymorphism (AFLP) (Klaassen et al. 2002); 
arbitrary-primer PCR (AP-PCR) (Tang et al. 1995) although this technique may have an issue 
with reproducibility (Wullt et al. 2003a); repetitive extragenic palindromic PCR (REP-PCR) 
(Spigaglia & Mastrantonio 2003); and multi-locus variable-number tandem repeat analysis 
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(MLVA) (van den Berg et al. 2007a). 57% of UK hospital infection strains belong to ribotype 
group 001 (Brazier 1998), and it causes 93% of hospital outbreaks (Djuretic et al. 1999); 
however this endemic ribotype is not clonal, and REP-PCR can distinguish between strains of 
this group which may facilitate epidemiological studies in UK hospitals (Northey et al. 2005; 
Rahmati et al. 2005). 
Toxinotyping involves PCR amplification and RFLP analysis of the pathogenicity locus (PaLoc, 
Section 1.5), which encodes the large clostridial toxins and their regulators. This technique is 
particularly useful due to its functional significance and close correlation with serogroups and 
ribotypes. The majority of strains are toxinotype 0; variant toxinotypes are designated Ito XX 
(Rupnik et al. 1998; Rupnik et al. 2001; Rupnik et al. 2003b). 
Coexistence of multiple strains of C. dicile in faecal samples may potentially confound 
epidemiological studies where only one isolate per patient is characterised (van den Berg et al. 
2005). 
Increasing incidence and severity 
Recently, the rate of CDAD has been noted to be increasing. The number of death certificates 
mentioning C. docile has increased each year in England and Wales between 1999 and 2005: 
age-standardised rates for deaths involving C. dicile have increased 3.4-fold since 1999, from 
11.1 to 37.6 per million population (Office for National Statistics 2006; Office for National 
Statistics 2007) (Figure 1.2). The proportion of these deaths for which C difcile was the 
underlying cause as remains relatively constant at around 55% (Office for National Statistics 
2006). It is not only the UK that has noted increasing rates of CDAD. US hospital discharges 
for which CDAD was listed as any diagnosis doubled between 1996 and 2003 (McDonald et at 
2006). 
This increase in incidence is linked to the emergence of an epidemic of CDAD, first reported in 
Canada. In one hospital in Quebec, the incidence increased 3.7-fold from 2002 to 2003 after a 
fairly stable incidence from 1991 to 2002; among patients aged 65 years or more incidence 
increased more than 8-fold to 0.9% of the general population, and in patients aged 80 or more 
rates increased to 1.7% (Pepin et al. 2004). 4,860 cases of nosocomial CDAD were reported in 
Quebec in eight months of 2004-5 (Institut National de Sante Publique du Quebec 2005). 
At the same time as the incidence of CDAD is rising, the severity of disease is also increasing. 
In Quebec the proportion of complicated cases increased from 7.1% in 1991 to 18.2% in 2003 
(Pepin et al. 2004). The proportion of patients who die within 30 days of CDAD diagnosis has 
also increased, from 5% in 1991 to 20% in 2004 (Eggertson 2004; Pepin et al. 2004; Pepin et al. 
2005c). In Quebec in 2003-4 the increase in mortality attributable to CDAD was 16.7% 
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Figure 1.2 Increasing mortality due to C. difficile in the UK 
(A) Number of death certificates in England and Wales mentioning C. difficile, 2001 to 
2005. (B) For comparison, the number of death certificates mentioning Staphylococcus 
aureus, 2001 to 2005, is shown. Between 2001 and 2005, deaths directly attributed to 
methicillin-resistant Staphylococcus aureus (MRSA) have increased 1.8-fold to 467, 
whereas deaths directly attributed to C. difJIcile have tripled to 2,074 (Office for National 
Statistics 2007). 
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(Pepin et al. 2005c), although a prospective study of 12 hospitals over six months of 2004 
revealed a lower attributable mortality of 6.9% (Loo et al. 2005). Coincident with this, the rate 
of failure of metronidazole treatment was at 10% throughout 1991 to 2002 and has increased to 
26% in 2003-4 (Pepin et al. 2005a). The probability of recurrence also seems to be increasing: 
the 60-day probability of recurrence increased dramatically between 1991-2002 (20.8%) and 
2003-2004 (47.2%), particularly among the elderly (Pepin et al. 2005a); 11% of patients 
developed complications during the first recurrence, and of patients experiencing a first 
recurrence, one third experienced a second recurrence (Pepin et al. 2006). 
This epidemic was determined to be primarily caused by a single strain type, characterised as 
REA-type BI, toxinotype III, North American PFGE type 1 (NAP! ), and ribotype 027 
(BI/NAP1/027) (Warny et al. 2005) and of a single predominant REP-PCR type (Maccannell et 
A 2006). This strain had been previously isolated in the region at low prevalence (Maccannell 
et al. 2006); in general 2-3% of historical isolates are BUNAPI/027 (Rupnik et al. 1998; Rupnik 
et al. 2001; Geric et al. 2004). BI/NAP1/027 is known to produce binary toxin (Popoff et al. 
1988; Geric et al. 2004), although the contribution of this toxin to pathogenesis has not been 
determined (Section 1.5). 
In the US, REA-type BI was first isolated in 1984, although only 14 isolates were present in a 
historical (pre-2001) collection of over 6000 isolates. Outbreaks in eight healthcare facilities in 
the US in 2000 - 2003 were found to be caused by the BI/NAP1/027 strain, and both current 
and historic isolates were found to harbour binary toxin genes (McDonald et al. 2005). In one 
institution nosocomial C. di cile infections increased from 2.7 to 6.8 cases per 1000 
discharges, and colectomy and mortality rates rose to 10.3% and 7.1% respectively (Muto et al. 
2005). The first outbreak associated with BVNAPI/027 reported in the UK was at Stoke 
Mandeville Hospital: 174 cases and 19 attributable deaths occurred between October 2003 and 
June 2004. A second outbreak occurred between October 2004 and June 2005 with 160 new 
cases and 19 further deaths. In total, 498 patients contracted nosocomial CDAD at Stoke 
Mandeville Hospital between April 2003 and March 2006; 127 of these patients died, of which 
an estimated 41 - 65 were attributable to CDAD (Commission for Healthcare Audit and 
Inspection 2006). 
The overall pattern of ribotypes detected in the UK in the nosocomial setting appears to be 
shifting, although this is difficult to quantify due to a change in testing procedures. Previously, 
when testing was done only at the request of the healthcare facility (an approach likely to over- 
represent outbreak strains), ribotype 001 represented 57% of the isolates (Brazier 1998). A 
random sampling scheme has now been initiated, where hospitals have to submit a certain 
number of toxin-positive stools for culture and typing each year. There are now three dominant 
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ribotypes detected: 26% of isolates are ribotype 106,26% are ribotype 027 (BUNAPI), and 
only 25% are ribotype 001 (Health Protection Agency 2006). 
Isolation of BI/NAP1/027 has now been reported in South-East England (Smith 2005), The 
Netherlands (van Steenbergen et al. 2005), Belgium (Joseph et al. 2005), France (Coignard et 
al. 2006), Austria (Indra et al. 2006) and Japan (Kato et al. 2007); by October 2006, European 
outbreaks had been detected in seventy-five hospitals in England, sixteen hospitals in The 
Netherlands, thirteen healthcare facilities in Belgium and nine healthcare facilities in France 
(Kuijper et al. 2006a). It has been compulsory to test for CDAD in diarrhoea of the over-65s in 
the UK since 2004, and positive cases must be reported to the Communicable Disease 
Surveillance Centre (National Clostridium d ßIcile Standards Group 2004); in 2006 CDAD was 
recommended for addition to the Canadian Nationally Notifiable Disease List (Doherty 2006). 
The primary mediators of C. dicile pathogenesis are the large clostridial toxins (LCTs, TcdA 
and TcdB) (Section 1.5). BI/NAP1/027 have been found to produce greater levels of both LCTs 
in liquid culture than a group of toxinotype 0 strains (up to 23x), over a longer period of time, 
and to grow to a higher density (Warny et al. 2005). This strain was found to have an 18 bp 
deletion in tcdC, the negative regulator of the LCTs (Section 1.5) (Warny et al. 2005), which 
leads to a loss of a six amino acid repeated motif and was originally described in two (out of 26 
tested) toxinotype 0 strains (Spigaglia & Mastrantonio 2002b). Recently it has been shown that 
recombinant TcdC with the 18 bp deletion is as active as wild-type TcdC in repressing toxin 
expression both in vivo and in vitro (Matamouros et al. 2007). A further mutation in tcdC in 
BUNAPI/027 has now been discovered which is likely to fully explain the disruption of TcdC 
activity: a single base pair deletion at position 117 causes a frameshift mutation and introduces 
nonsense residues from residue 43, resulting in a truncated protein of only 65 as (Maccannell et 
al. 2006; Curry et al. 2007). 
An increasing proportion of CDAD cases are being triggered by fluoroquinolones (Pepin et al. 
2004). In community-acquired disease, CDAD risk increased 3-fold with use of any anti- 
microbial agent and 6-fold with use of fluoroquinolones (Delaney 2007). Nosocomial CDAD 
patients were more likely than matched controls to have received fluoroquinolones (3.9-fold) or 
cephalosporins (3.8-fold) (Loo et al. 2005). Fluoroquinolones are the antibiotics most strongly 
associated with CDAD, with a 3.44-fold increased risk of CDAD development: in this study it 
is calculated that 36% of CDAD could be attributed to fluoroquinolone use (Pepin et al. 2005b). 
The recent isolates of BUNAPI/027 are reported to be resistant to fluoroquinolones (Loo et al. 
2005). They may be more, susceptible to erythromycin and clindamycin (Spigaglia & 
Mastrantonio 2004; Bourgault et al. 2006), although other studies report no change in 
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incidence of clindamycin resistance (McDonald et al. 2005). A decrease in tetracycline and 
chloramphenicol MIC values was also observed in the recently isolated strains, associated with 
less frequent detection of the catD and tetM genes (Spigaglia & Mastrantonio 2004). 
The resistance of recent BI/NAP1/027 isolates is to all fluoroquinolones, including gatifloxacin 
and moxifloxacin, whereas historic isolates are susceptible to these newer fluoroquinolones 
(McDonald et al. 2005; Bourgault et al. 2006). Gatifloxacin or moxifloxacin promoted 
significantly more growth and toxin production than ciprofloxacin or levofloxacin when 
resistant C. dicile were inoculated into the cecal contents of antibiotic-treated mice. The 
inhibition of the growth of susceptible isolates was also greater using gatifloxacin or 
moxifloxacin. Thus, fluoroquinolones with enhanced antianaerobe activity (i. e., gatifloxacin 
and moxifloxacin) promoted C. difficile growth to a greater extent; these fluoroquinolones may 
exert selective pressure favouring emergence of epidemic, fluoroquinolone-resistant C. dicile 
(Adams et al. 2007). 
Analysis of the gyrA gene in recent BI NAPI/027 isolates reveals a single base pair mutation 
(C to T), resulting in the amino acid substitution Thr-82-Ile (Drudy et al. 2007c). Amino acid 
substitutions that occur at the equivalent serine residue in gyrA were first associated with 
fluoroquinolone resistance in E. coli (Hooper 1993) and have previously been found in 
C. dicile (Ackermann et al. 2001b; Dridi et al. 2002). 
In summary, the incidence and severity of CDAD is increasing, primarily due to the emergence 
of a toxinotype III, BIINAP1/027 strain that lacks negative regulator activity for toxin 
production and is highly resistant to fluoroquinolones. 
1.5 Toxins of C. diffccile 
Large clostridial toxins 
Many Clostridium species are pathogenic for humans and animals, and most of the resulting 
diseases, such as tetanus, botulism, gas gangrene 'and pseudomembranous colitis, are due to the 
production of potent extracellular toxins. Many of these diseases are mediated by the large 
clostridial toxins (LCTs): C. sordellii produces lethal toxin (TcsL) and haemorrhagic toxin 
(TcsH) (Arseculeratne et al. 1969); C. novyi produces alpha toxin (TcnA) (Novy 1894; Izumi et 
al. 1983); and C. perfringens produces TpeL (Amimoto et al. 2007). 
The pathogenesis of C. dicile is mediated by two LCTs, TcdA and TcdB (Taylor et al. 1981; 
Sullivan et al. 1982; Banno et al. 1984). These are single-chain polypeptides sharing 50% 
homology and with masses of 308 kDa and 270 kDa respectively (von Eichel-Streiber et al. 
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1992). TcdB is a potent cytotoxin and is primarily responsible for the effects seen on cultured 
cells, while TcdA has some cytotoxic activity but is also an enterotoxin causing fluid release in 
the gut and is principally responsible for intestinal damage (Donta et al. 1982; Lyerly et al. 
1982; Lima et al. 1988). Both TcdA and TcdB disrupt the actin cytoskeleton (Ottlinger & Lin 
1988; Kushnaryov et al. 1990) by glucosylating Rho family G-proteins (Just et al. 1994a; Just et 
al. 1995a) at Thr-37 using UDP-glucose as a cosubstrate (Just et al. 1995b; Just et al. 1995c). 
The observed difference in cytotoxic potency is because TcdB has 100-fold higher 
glucosyltransferase activity than TcdA and also binds more strongly to cell surfaces (Chaves- 
Olarte et al. 1997). The glucosylation of Rho results in inhibition of its GTPase activity, blocks 
interaction with protein kinase N and other downstream effectors (Sehr et al. 1998), and inhibits 
Rho cycling between cytoplasm and membrane (Genth et al. 1999). The resultant 
disorganisation of the cytoskeleton disrupts endothelial barrier function, allowing albumin 
leakage which could contribute to hypoalbuminaemia (Hippenstiel et al. 1997), and may lead to 
transmigration of gut bacteria across the epithelia (Feltis et al. 1999; Feltis et al. 2000). 
Both TcdA and TcdB consist of three domains. The N-terminal enzymatic domain contains the 
glucosyltransferase activity, the central domain is implicated in translocation, and the 
C-terminal domain consists of clostridial repetitive oligopeptides (CROPs) and is responsible 
for receptor binding (reviewed in Just & Gerhard 2004) (Figure 1.3b). 
The receptors for the large clostridial toxins are thought to be non-proteinaceous. TcdA binds 
branched saccharides with the core disaccharide Galß(1-º4)GIcNAc, including the I, X, and Y 
blood antigens which are present on a variety of cells including human intestinal epithelia in 
addition to other carbohydrate motifs not found in humans (Tucker & Wilkins 1991; Smith et 
al. 1997). The CROPs consist of thirty-one 20 - 21 amino acid (aa) motifs interspersed with 
seven 30 as motifs and are the binding site for this carbohydrate receptor (Dove et al. 1990; 
Greco et al. 2006): the CROPs bind to mammalian cells in the presence of Ca 2+ (Demarest et al. 
2005) and the entire C-terminal repetitive domain is critical for the uptake of Tcd into cells by a 
process of receptor-mediated endocytosis (Barth et al. 2001; Frisch et al. 2003). 
After uptake the LCTs then undergo structural changes in the acidified environment of the 
endosome which result in the exposure of hydrophobic regions and cause membrane insertion, 
creating pores in the lysosomal membrane (Qa'Dan et al. 2000; Barth et al. 2001); this insertion 
event is dependent upon the presence of cholesterol (Giesemann et al. 2006). TcdB is then 
cleaved and the enzymatic N-terminus is released into the cytoplasm whilst the central and 
C-terminal domains remain in the lysosome membrane (Pfeifer et al. 2003; Rupnik et al. 2005). 
This 543 amino acid fraction released into the cytoplasm shows RhoA glucosyltransferase 
activity (Hofmann et al. 1997; Wagenknecht-Wiesner et al. 1997). The crystal structure of this 
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Figure 1.3 The pathogenicity locus of C diffrcile 
A: The arrangement of genes in the pathogenicity locus of C. difficile reference strain 10463 is 
shown. The large clostridial toxin (LCT) genes are shown in dark grey and other genes in light 
grey (adapted from Hammond & Johnson 1995). B: Diagrammatic representation of the 
composition of toxinotype 0 Ted: amino acid residues are numbered according to TcdB. 
Catalytic motifs for glucosyltransferase activity and the proposed autocatalytic cysteine or 
aspartase protease autocleavage reaction are shown above; the autocleavage site is designated by 
an arrow (from Egerer et ul. 2007). 
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domain reveals that a DXD motif is involved in UDP, glucose and manganese complexation; 
and a tryptophan residue, previously shown to be necessary for catalytic activity, stabilises the 
UDP uracil ring by aromatic stacking (Busch et al. 2000; Reinert et al. 2005). 
The mechanism of toxin cleavage has recently been revealed to be autocleavage, dependent on 
cytosolic inositol hexaphosphate (InsP6); autocleavage is observed in all LCTs (Reineke et al. 
2007). This group proposes an aspartic protease activity in the central translocation domain, 
based upon inhibition by pepstatin A and labelling of the active site with EPNP (1,2-epoxy- 
3-(p-nitrophenoxy)propane). However, the proposed catalytic triad is not conserved in TcnA, 
which still shows autocleavage (Reineke et al. 2007). The aspartate catalytic site is C-terminal 
to the hydrophobic region predicted to form the transmembrane pore and would be expected to 
remain within the endosome: the mechanism by which the two sites are brought into close 
proximity is not known within this model. An alternative autocleavage catalysis has been 
concurrently proposed (Egerer et al. 2007). This involves a cysteine protease activity located 
between the glucosyltransferase domain and the hydrophobic region. Evidence for this includes 
activation by dithiothreitol (DTT) and inhibition by N-ethylmaleimide or iodoacetamide; in 
common with the study by Reineke et al. the cleavage activity is enhanced by InsP6. In support 
of this mechanism mutation of the proposed cysteine protease catalytic triad abrogated Tcd 
toxicity, and the toxin fragment 1-955 (which does not encompass the proposed site of aspartic 
acid activity) is capable of autocleavage (Egerer et al. 2007). 
The pathogenicity locus (PaLoc) 
The toxin genes are located on the C. dicile pathogenicity locus (PaLoc), a 19.6 kb genomic 
region incorporating five genes: tcdA and tcdB and also three small ORFs, tcdR, WE and tcdC 
(Figure 1.3a) (Hammond & Johnson 1995). tcdR, B, E and A are transcribed in the same 
direction and may be transcribed as both a single operon and as individual genes (Hammond et 
al. 1997). TcdE is structurally and functionally similar to holin proteins, and may be involved 
in toxin export, as these proteins do not have conventional signal sequences (Tan et al. 2001). 
TcdR (formerly TcdD) is a positive regulator of the toxin genes (Hundsberger et al. 1997; 
Moncrief et al. 1997), is a sigma factor belonging to a group of a70-family proteins including 
BotR, TetR and UviA, which are responsible for induction of toxin expression in C. botulinum, 
C. tetani, and C. perfringens respectively (Mani & Dupuy 2001; Raffestin et al. 2005; Dupuy & 
Matamouros 2006; Dupuy et al. 2006). tcdC is a regulated in an inverted fashion to the other 
PaLoc genes, and is proposed to be a negative regulator of the toxins (Hundsberger et al. 1997). 
It is now known that TcdC is a membrane associated protein (Govind et al. 2006) that 
destabilises the TcdR-RNA polymerase holoenzyme, acting as an anti-a-factor and preventing 
Tcd transcription (Matamouros et al. 2007). 
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Tcd expression is known to occur primarily after the end of the growth phase (Ketley et al. 
1984; Haslam et al. 1986; Osgood et al. 1993), and the tcdA and tcdB promoters drive 
transcription in C. perfringens in late stationary phase (Dupuy & Sonenshein 1998). Toxin 
expression is repressed by glucose or other fermentable carbon sources and therefore toxin 
production is delayed when glucose is present in the growth medium (Osgood et al. 1993; 
Dupuy & Sonenshein 1998). Toxin production is also mediated by the amino acid composition 
of the medium (Haslam et al. 1986; Osgood et al. 1993; Yamakawa et al. 1994). Toxin 
regulation is further discussed in Section 1.6. 
Toxin immune modulation 
Not all damage observed in CDAD is the direct result of Tcd glucosyltransferase activity: an 
immunopathology is also observed, resulting in excessive intestinal secretion and inflammatory 
injury. TcdA stimulates the release of the proinflammatory cytokines IL-8, IL-10 and TNF-a 
from various cell types (including monocytes and macrophages), which causes the influx of 
neutrophils into the peritoneal cavity. Neutrophil migration can be inhibited by blocking any of 
these cytokines or the leukocyte adhesion glycoproteins CD11/CD18, ICAM-1 or P-selectin; 
inhibition of neutrophil migration results in a reduction in intestinal secretion (Kelly et al. 
1994a; Kurose et al. 1994; Mahida et al. 1996; Linevsky et al. 1997; Melo Filho et al. 1997; 
Rocha et al. 1997; Rocha et al. 1998). A common single nucleotide polymorphism (SNP) in 
IL-8 is associated with increased susceptibility to CDAD, and with increased IL-8 levels in the 
diarrhoeal stool (Jiang et al. 2006). Transforming growth factor (TGF)-ß may act to protect 
cells from the effects of TcdA (Johal et al. 2004c). Inactivation of Rho also induces iNOS 
(inducible nitric oxide synthase) expression (Witteck et al. 2003) and blocks cyclooxygenase-2 
induction by proinflammatory mediators (Schmeck et al. 2003). 
Sensory afferent neurons are also implicated in the immunopathology of Tcd: the neuropeptides 
calcitonin gene related peptide (CGRP) and substance P are released which can activate lamina 
propria macrophages and intestinal mast cells to release inflammatory mediators (Kirkwood et 
al. 2001; Lamont 2002) possibly via the action of corticotropin-releasing hormone (Anton et al. 
2004a) or IL-1 ß action on vasoactive intestinal polypeptide (VIP)-positive neurons (Neunlist et 
al. 2003). Release of proteases from lamina propria leukocytes can activate the protease 
activated receptor 2 (PAR2), through the action of substance P, resulting in intestinal fluid 
secretion (Kelly 2007). 
Overall, blocking proinflammatory cytokines, neutrophil recruitment, neurogenic pathways, 
prostaglandin, leukotrienes or MAP-kinase activation can reduce toxin induced intestinal injury, 
despite having no direct effects on cytotoxicity (Kelly 2007). 
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In addition to the cytopathic effect of Tcd (actin skeleton reorganisation), Tcd also exhibits a 
cytotoxic effect. TcdA and TcdB can trigger apoptosis in epithelial cell lines and 
immunological cells including mast cells, monocytes, T-lymphocytes and eosinophils (Mahida 
et al. 1996; Calderon et al. 1998; Fiorentini et al. 1998; Mahida et al. 1998), although high 
levels of toxin may cause necrosis (Brito et al. 2002; Solomon et al. 2005). 
The extrinsic apoptotic pathway is triggered by an external ligand, for example TNF-a, or FasL, 
binding to its receptor which leads to activation of caspase 8. The intrinsic pathway involves 
cytochrome C release from the mitochondria, triggered by Bid, and resultant activation of 
caspase 9. Both pathways culminate in activation of the executioner caspases 3,6 and 7, and 
apoptosis then continues by the characteristic processes of DNA fragmentation and membrane 
blebbing (reviewed in Rupinder et al. 2007). 
Bid activation, cytochrome C release and caspase 9 activation have been observed after Tcd 
incubation, and caspase 9 inhibitors can partially prevent Tcd-induced apoptosis, implying an 
intrinsic pathway activation of apoptosis; inhibition of the executioner caspases 3 and 6 which 
are also observed to be activated may also prevent apoptosis (Brito et al. 2002). Bid cleavage is 
caspase independent, and may be mediated by calpain or cathepsin (Carneiro et al. 2006; 
Nottrott et al. 2007). The extrinsic pathway component caspase 8 is also activated and 
contributes to the process of apoptosis (Brito et al. 2002), although Tcd-induced apoptosis is 
TNF-a independent (Mahida et al. 1998; Brito et al. 2002). Caspase 8 may also be activated by 
caspase 3, and this may act as an amplification loop for Tcd-induced apoptosis (Nottrott et al. 
2007). Mitochondrial damage may occur through a pathway involving p38, p53 and p21 (Kim 
et al. 2005a), although other studies have reported Tcd-induced apoptosis to be p53 independent 
(Nottrott et al. 2007). TcdB may also cause damage to mitochondria directly (Matarrese et al. 
2007). Tcd-induced apoptosis may be prevented by elevation of cAMP levels (Hippenstiel et al. 
2002) or exogenous glutamine or alanyl-glutamine (Brito et al. 2005; Carneiro et al. 2006), 
although the protective mechanisms are not known. 
The induction of apoptosis by Tcd can be mimicked by GTP depletion (Li et al. 1998). The 
glucosylation of Rho (but not Rac or Cdc42) is necessary for the cytotoxic effect of Tcd (Brito 
et al. 2002; Rippenstiel et al. 2002; Huelsenbeck et al. 2007; Nottrott et al. 2007), however the 
cytopathic effect was linked to Racl glucosylation (Huelsenbeck et al. 2007). 
Tcd can also directly interfere with cellular immune defences. Rho is actively involved in the 
regulation of dendritic cell and T-lymphocyte morphology, motility and function (Kobayashi et 
al. 2001; Woodside et al. 2003), and inactivation of Rho also prevents both complement- 
(CR3-) and Fc7R-mediated phagocytosis (Hackara et al. 1997; Caron & Hall 1998). 
41 
Chapter 1.5 - Introduction - Toxins 
It is not only the action of the toxins that can modulate the immune reaction. Purified surface 
layer proteins (SLPs) induce the release of IL-lß and IL-6 from monocytes, enhance 
proliferation of T-cells, and induce maturation of monocyte-derived dendritic cells; these 
subsequently released high levels of IL-10 and IL-12 and induced a mixed ThliTh2 maturation 
of naive T-cells (Ausiello et al. 2006). 
Toxin A negative strains 
In recent years toxigenic C. docile strains that do not express TcdA (TcdK B+) have been 
isolated. The original assumption was that they could not be pathogenic as TcdB alone cannot 
cause disease in hamsters or gnotobiotic mice without previous damage to the intestine (Lyerly 
et al. 1985; Depitre et al. 1993). Most TcdA-B+ strains have variant TcdB (see below) and 
these strains have now been identified as agents of human disease (Alfa et al. 2000; Sambol et 
al. 2000; Johnson et al. 2001). TcdAB+ strains can cause severe disease including PMC 
(Limaye et al. 2000; Johnson et al. 2001; Toyokawa et al. 2003; Jakobsen & Tvede 2006). 
Isolation rates have been published as 3% in the UK (Brazier 1998), 6% to 11% in Japan (Pituch 
et al. 2001; Pituch et al. 2002a; Kikkawa et al. 2007) and up to 44% in Ireland (Drudy et al. 
2007b). TcdAB+ strains can be responsible for nosocomial outbreaks (al-Barrak et al. 1999; 
Alfa et al. 2000; Kuijper et al. 2001; Sato et al. 2004; Kuijper et al. 2006b). The largest 
outbreak yet described has been in Dublin, where 95% of isolates recovered from seventy-three 
consecutive patients over 6 months were found to be clonal fluoroquinolone-resistant TcdAB+ 
C. di cile; in this outbreak the recurrence rate was 36% (Drudy et al. 2007a). 
Although multiple strains have now been identified, only two TcdAB+ strains have been well 
characterised. C. dijJcile 8864 was the first TcdA-B+ strain reported (Borriello et al. 1992) and 
is now designated toxinotype X (Rupnik et al. 1997). Toxin B of C. docile 8864 (TcdB8864) is 
comparable in cytotoxic activity to the reference strain (TcdB1o463) but also weakly enterotoxic 
and therefore more lethal in the hamster model (Lyerly et al. 1992). The N-terminus of 
TcdB8864 deviates from the reference strain and this results in a small GTPase substrate 
specificity shifted to that of C. sordellii lethal toxin (Soehn et al. 1998). PaLoc8864 has two 
major changes compared to the reference strain: a large insertion between tcdA and tcdE; and a 
15.9kb deletion encompassing the 3' ends of both tcdA and tcdC. The resultant TcdA8SM does 
not have a translocation domain, so despite having in vitro glucosyltransferase activity when 
microinjected into cells, this protein exhibits no cellular toxicity (Soehn et al. 1998). C. dWIcile 
1470 contains the genes for both TcdA and TcdB, but a nonsense mutation introduces a stop 
codon at amino acid 47 of TcdA and, like TcdB88 , the N-terminus of TcdB1470 deviates from 
the reference strain (von Eichel-Streiber et al. 1999); this is now known as toxinotype VIII 
(Rupnik et al. 1997). Toxinotype VIII is the most commonly isolated TcdA"B' type, which also 
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correlates to serotype F, ribotype 017 and REA-type CF (Brazier 1998; Johnson et at. 2003); 
serogroup F strains were first documented to produce TcdB but not TcdA in 1993 (Depitre et 
al. ). Like TcdB8864, TcdB147o has a small GTPase substrate specificity shifted to that of 
C. sordellii lethal toxin, and the cytotoxic action of TcdB1470 is very similar to TcsL; this 
alternative cytopathic effect is characterised by cell clumping (von Eichel-Streiber et al. 1995; 
Chaves-Olarte et al. 1999). Two other toxinotypes, XVI and XVII, are also TcdAB+, although 
tcdA only has 3' deletions in the CROP region and therefore the molecular mechanism for the 
lack of TcdA expression in these strains is not known (Rupnik et al. 2003a). 
Variant TcdB with altered C. sordellii-like cytopathic effect can also be found in TcdAB+ 
strains: toxinotypes IX, XIV and XV exhibit characteristic cell clumping even after removal of 
TcdA (Blake et al. 2004). 
Binary toxin of C. difficile 
In addition to TcdA and TcdB, some strains are able to produce an actin-specific 
ADP-ribosylating binary toxin, CDT, similar to iota toxin of C. perfringens and the 
C. spiroforme toxin (Popoff et al. 1988). Binary toxins have two non-covalently bound types of 
subunit: the binding subunit and the catalytic subunit. CdtA (enzymatic) and CdtB (binding) 
have 81% and 84% identity with the iota toxin subunits (Perelle et al. 1997). 
The C-terminus of the binding subunit binds to a pronase-sensitive component at the cell 
surface, is then proteolytically cleaved and oligomerises in lipid rafts to form ion-permeable 
channels (Stiles et al. 2000; Blocker et al. 2001; Marvaud et al. 2001; Nagahama et al. 2002; 
Nagahama et al. 2004). The N-terminus of the binding component subsequently interacts with 
the enzymatic component, and the complex is endocytosed (Stiles et al. 2000; Marvaud et al. 
2001). Acidification of the endocytic compartment allows the enzymatic component access to 
the cytoplasm (Blocker et al. 2001), where its ribosylation of actin at Arg-177 results in 
complete disorganisation of actin filaments and consequent cell rounding (Vandekerckhove et 
al. 1987; Schering et al. 1988; Wegner & Aktories 1988). CDT-ribosylation (at Arg-177) and 
Tcd-glucosylation (at Thr-37) of actin are mutually exclusive events (Just et al. 1994a; Just et 
al. 1995a). 
Some TcdAB- C. dicile isolates are found to induce fluid accumulation in the rat small 
intestine (Gonzalez-Valencia et al. 1991); these TcdAB-CDT+ strains have been isolated from 
both symptomatic and asymptomatic patients and from the hospital environment and it is 
estimated that more than 2% of TcdAB- strains may produce binary toxin (Genic et al. 2003). 
Approximately 6.4% of toxigenic isolates from UK hospitals have both cdtA and cdtB, and the 
majority of these have variant Tcd toxinotypes (Stubbs et al. 2000; Genic et al. 2004; Goncalves 
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et al. 2004; Barbut et al. 2007). 79% of toxinotype 0 strains are found to have a truncated, non- 
functional cdt locus, as found in the C. docile 630 genome (Stare et al. 2007). The TcdAV+ 
strain 8864 has been shown to express CDT (Chang & Song 2001): TcdAB+ toxinotypes X, 
XVI and XVII express binary toxin whilst toxinotype VIII, the most commonly isolated 
TcdAB' type, does not (Rupnik et al. 2003 a). 
The production of binary toxin correlates with severity of diarrhoea and increased risk of 
mortality in CDAD (Barbut et al. 2005; Barbut et al. 2007); however no study has yet examined 
the patient immune response to CDT. Binary toxin strains are more often associated with 
community-acquired CDAD (Barbut et al. 2005) and CDT' CDAD appears to be becoming 
more common (Spigaglia & Mastrantonio 2004). However, challenge of clindamycin-treated 
hamsters with TcdAB-CDT+ strains resulted in asymptomatic colonisation (Geric et al. 2006). 
In one TcdAB+ hospital outbreak 65.3% of the strains carried the cdtA and cdtB genes. Strains 
that carried the binary toxin genes accounted for 87.5% of the cases of severe CDAD but only 
61.0% of the non-severe cases. REA types BI, BK and BR were found to be CDT* 
(McEllistrem et al. 2005). Whilst this outbreak was not clonal it may be linked to the 
"hypervirulent" BUNAPI/027 isolates, which are known to produce binary toxin (Warny et al. 
2005). 
1.6 Other virulence factors of C. difficite 
The surface of C. diffccile 
Processes such as binding of host tissues, interaction with specific immune system components, 
nutrient acquisition, manipulation of the external environment and interbacterial communication 
(such as aggregation for the conjugal transfer of DNA) must occur at the surface of the cell. 
The cell envelope separating the cytoplasm of C. dijJIcile from its external environment consists 
of three layers (Figure 1.4). (i) The cytoplasmic membrane, which is a phospholipid bilayer 
with integral proteins allowing communication and substance transfer with the external 
environment. (ii) A thick layer of peptidoglycan and secondary cell wall polymers such as 
teichoic acid, discussed below. (iii) A two-dimensional paracrystalline layer of two proteins, 
termed the S-layer, which is discussed in detail in Section 3.1. 
The Gram-positive cell wall 
The primary constituent of the Gram-positive cell wall is peptidoglycan (reviewed in Bhavsar & 
Brown 2006). This is a polymer with a repeating unit consisting of ß1--*4 linked N-acetyl- 
glucosamine and N-acetylmuramic acid with an amide-linked stem peptide: a pentapeptide side 
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Figure 1.4 The cell wall of C. difficile 
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The cytoplasm of C. (Iir. jicile is separated from its external environment by three layers. i) The 
cytoplasmic membrane is a phospholipid bilayer with integral proteins allowing communication 
and substance transfer with the external environment. ii) This is coated by a thick layer of 
peptidoglycan and secondary cell wall polymers such as teichoic acid. iii) The outer layer 
consists of a two-dimensional paracrystalline layer of two proteins, termed the S-layer 
(discussed in detail in Section 3.1). A hypothetical arrangement of these two proteins is shown, 
with the inner high-molecular weight (HMW) S-layer protein (SLP) interacting with the 
peptidoglycan layer (dark grey units), and a second, outermost layer consisting of the low- 
molecular weight (LMW) SLP (light grey units). We propose that these layers are sporadically 
interrupted with other cell wall proteins (striped units) that are homologous to the HMW-SLP 
and can therefore be incorporated without disrupting the regular pattern of interactions. 
Diagram reproduced courtesy of Prof. Neil Fairweather. 
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chain, usually of alternating L- and D-amino acids terminating in D-ala-D-ala, with a further 
pentapeptide branch attached to a tertiary L-lysine residue. These pentapeptide branches form 
amide linkage to the penultimate D-alanine residue of another stem peptide, resulting in 
pentapeptide crossbridges with other peptidoglycan molecules creating a complex 
three-dimensional structure. 
Secondary cell wall polymers may make up 10-60% of the cell wall (reviewed in Schaffer & 
Messner 2005; Bhavsar & Brown 2006), and are usually highly negatively charged polymers. 
The most common secondary cell wall polymers are teichoic acids, which consist of glycerol or 
ribitol linked by phosphodiester bridges, and teichuronic acids, which are polysaccharides 
incorporating residues such as rhamnose and glucuronic acid; these do not incorporate 
phosphate groups but are negatively charged due to carboxyl moieties and may be synthesised 
in times of phosphate starvation. A number of "non-classical" secondary cell wall polymers 
may also be present, and lipoteichoic acids may extend from the cytoplasmic membrane to the 
outer surface. 
There have been reports of a gap visualised between the lipid bilayer and the peptidoglycan, 
which has been postulated to be equivalent to the periplasmic space of Gram-negative bacteria 
(reviewed in Navarre & Schneewind 1999; Bhavsar & Brown 2006). Many proteins that are 
periplasmic in Gram-negative bacteria are predicted to be lipid-linked in Gram-positive bacteria, 
and would be present at the extracellular surface of the cytoplasmic membrane. It is likely that 
cell-wall synthesis also occurs in this lower density, inner `periplasmic' region of the cell wall. 
Surface-associated proteins 
In order to interact with the external environment without diffusing away, surface-exposed 
bacterial molecules must associate with the underlying cell wall. One mechanism employed for 
extracellular secretion is an N-terminal leader peptide, or signal sequence, which targets a 
protein to the general secretory pathway (reviewed in van Roosmalen et al. 2004; Scott & 
Zahner 2006). The signal peptide has a positively charged terminal, a region of hydrophobic 
residues and a series of small aliphatic residues. The Signal Recognition Particle recognises the 
signal sequence and relocates the complex to the membrane. The Sec machinery then passes the 
nascent polypeptide through a pore in the membrane, and integral membrane signal peptidases 
cleave the signal sequence from the mature protein. An alternative export strategy is the twin- 
arginine transport (TAT) pathway (reviewed in Bruser 2007), where previously folded proteins 
or protein complexes are transported outside the cell in response to the presence of two arginine 
residues in their N-terminal signal sequence, allowing prior intracellular quality control of 
protein folding and cofactor association; this mechanism has not been identified in C. dWicile. 
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The mature protein may then be secreted into the environment or may remain cell-associated by 
one of a number of mechanisms. For example the protein may be covalently transferred to a 
lipid molecule and remain associated with the cytoplasmic membrane. Both integral membrane 
proteins and lipoproteins may span the peptidoglycan cell wall and achieve surface association 
(reviewed in Desvaux et al. 2006). 
The most common mechanism of cell-wall association, present in almost all Gram-positive 
bacteria, is covalent anchoring to the underlying peptidoglycan (reviewed in Navarre & 
Schneewind 1999; Marraffini et al. 2006). This is signalled by the LPXTG amino acid motif, 
which is located close to the C-terminal of the protein and is followed by a hydrophobic region 
of amino acids and a positively charged tail. It is thought that this region halts the transit of the 
protein through the Sec machinery and allows recognition of the LPXTG motif by sortase which 
cleaves the protein and covalently attaches the threonine residue to an amino group at the end of 
an un-crosslinked peptidoglycan pentapeptide. 
The LPXTG motif is an example of a Pfam domain. These are conserved protein domains of 
known or unknown function, are often shared between proteins from diverse organisms, and are 
designated PF#####. Only one LPXTG motif is found in the proteins of C. dicile 630 
(Cd630) (Sebaihia et al. 2006), so alternative mechanisms have to be in place (although a 
protein incorporating the PF07170 sortase B domain is encoded). Binding affinity for cell wall 
components could also cause protein association with the cell wall (reviewed in Desvaux et al. 
2006). Lectin-like affinity for cell-wall components has been proposed for proteins 
incorporating the surface layer homology (SLH) domain; however no SLH domains are detected 
in Cd630. Similar carbohydrate binding properties may be conferred by other domains, and a 
family of twenty-nine Cd630 proteins incorporate the PF01422 cell wall binding domain 
(discussed in Section 3.1). The PF01473 cell wall binding domain, which has affinity for 
choline residues of teichoic acid, is found only in the large clostridial toxins and one protein 
which also incorporates the PF04122 cell wall binding domain. The PF01471 putative 
peptidoglycan binding domain is found in two putative peptidoglycan hydrolases. The LysM 
PF01476 peptidoglycan binding domain, which binds directly to peptidoglycan and is inhibited 
by secondary cell wall polymers, is found in three putative cell wall hydrolases, two of phage 
origin. There are, however, proteins encoded in the Cd630 genome with characteristic domains 
of cell surface proteins, such as extracellular matrix binding domains, for which no mechanism 
of attachment has yet been elucidated. Additional, as yet unidentified mechanisms of cell wall 
association are therefore likely to exist. 
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Motility 
Many strains of C. dicile are flagellated and motile; flagellar distribution may be peritrichous 
or primarily polar (Tasteyre et al. 2000a). Flagella were reported to be a determinant of the 
crossreaction between serogroups in serotyping (Delmee et al. 1990), however presence or 
absence of flagella did not strictly correlate with serogroup (Tasteyre et al. 2000b). fliC 
(flagellar subunit) and fliD (flagellar cap) are transcribed even in non flagellated strains, so 
surface expression cannot be ruled out under other growth conditions (Tasteyre et al. 2000b; 
Tasteyre et al. 2001b). Both fliC and fliD vary between strains as shown by PCR-RFLP 
analysis and by sequencing; sequence diversity may correlate with serogroup (Tasteyre et al. 
2000b; Tasteyre et al. 2001b). Variable flagellation was also observed among very closely 
related TcdKB strains with identicalliC RFLP patterns (Pituch et al. 2002b). 
In many bacteria, flagella are reported to be virulence factors involved in adhesion as well as 
motility (reviewed in Ramos et al. 2004). Anti-F1iC antibodies do not inhibit C. difficile 
adhesion to Vero cells (Tasteyre et al. 2000a), however flagella, F1iC & FliD adhere to axenic 
mouse cecal mucus, and flagellated strains bind to the caecum more strongly than non- 
flagellated strains (Tasteyre et al. 2001 a). Interestingly, flagella are not necessary for virulence, 
as comparative genomic analysis has revealed that a Glade of strains isolated from both humans 
and animals lack a large portion of the flagellar locus (Stabler et al. 2006). 
Type N pili, or fimbriae, have recently been identified on C. perfringens and are capable of 
producing gliding motility (Varga et al. 2006). Pili in Gram-positive bacteria are implicated in 
aggregation and biofilm formation, adhesion and invasion, and increased virulence (reviewed in 
Telford et al. 2006). Fimbriae were first identified on C. docile in 1988 (Borriello et al. 
1988a) although subsequent studies have failed to identify fimbriated strains (Baldassarri et al. 
1991; Taha et al. 2007). Type IV pilus genes have been identified in the genome of Cd630, 
primarily in two loci (Sebaihia et al. 2006). Recent work in our laboratory has revealed type N 
pili-like bundles at the surface of the BI/NAP1/027 strain Cd20352; provided evidence of 
twitching motility in both this strain and Cd630; and shown that a subset of pilus genes are 
transcribed (Xiaoyun Lee, unpublished data). Comparative genomic analysis has revealed that 
the majority of genes in the type N pilus loci are found in every strain investigated (Stabler et 
al. 2006). It is therefore possible that fimbrae play a critical role in the biology of C. dicile. 
Adhesion of C. difficile to the gut wall 
It is thought that C. diýcile must adhere to the gut wall in order to establish a stable 
colonisation. Adhesion of C. dicile to the human gut in disease was first shown by its 
recovery from a washed PMC biopsy specimen (Borriello 1979). All C. diffcile have 
hydrophobic surfaces, as shown by adherence to polystyrene, and also bind to cultured 
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mammalian cells: toxinogenic strains and CDAD isolates adhere more strongly (Wood-Helie et 
a!. 1986; Gonzalez-Valencia et a!. 1991; Drudy et al. 2001). Highly virulent strains adhere 
more strongly to clindamycin-treated hamster gut mucosa than avirulent strains, and this is 
enhanced by crude toxin preparations (Borriello et al. 1988b). C. difficile binds less strongly to 
postconfluent Caco2 monolayers and associates more strongly with the basolateral surface of 
differentiated cells (Cerquetti et al. 2002). Adherence of C. difcile to tissue culture cell lines is 
increased by high concentrations of sodium, calcium or protons in the culture medium, or iron 
starvation (Waligora et al. 1999). C. dif cile adheres to fibrinogen, vitronectin, fibronectin, and 
collagen types I, III, IV and V, but not laminin (Cerquetti et a!. 2002). 60°C heat shock of 
bacteria induces surface expression of GroEL, Cwp66 (cell wall protein of 66 kDa) and a 
27 kDa lectin; antibody blocking or recombinant protein competition to any of these proteins 
partially inhibited C. difficile binding to tissue culture cells (Eveillard et a!. 1993; Karjalainen et 
al. 1994; Hennequin et al. 2001; Waligora et al. 2001). Blocking of a 68 kDa fibronectin- 
binding protein inhibits C. dicile adherence to Vero cells (Hennequin et al. 2003), and the 
flagellar proteins FliC and F1iD are also implicated, as described above (Tasteyre et al. 2001a). 
Secreted enzymes 
Secreted enzymes may contribute to virulence by modulating the external environment for 
example by releasing nutrients from complex molecules, creating access to underlying 
molecules or cells, interfering with the host immune response, or exacerbating tissue damage. 
Inspection of the hydrolytic enzymes of one C. diIcile isolate revealed hyaluronidase, 
chondroitin sulphatase, gelatinase and collagenase activity, but not heparinase, fibrinolysin, 
lecithinase or lipase (Steffen & Hentges 1981). C. diIcile is known to be generally capable of 
degrading azocoll and gelatin, although activity varies between strains; the C. dicile secreted 
gelatinase is 35 kDa (Hafiz & Oakley 1976; Poilane et al. 1998). Hyaluronidase is also 
produced, but not deoxyribonuclease or neuraminidase (Hafiz & Oakley 1976; Popoff & Dodin 
1985). Addition of glucose, N-acetylglucosamine, or N-acetylneuraminic acid increased the 
growth rate of C. docile in an in vitro mixed flora gut model (Wilson & Perini 1988). 
However, C. difficile was not able to degrade mucin, and did not synthesise hydrolytic enzymes 
capable of releasing these monosaccharides from oligosaccharide side chains, and therefore 
must rely on scavenging to gain these sugars (Wilson & Perini 1988). Collagenase activity has 
also been reported, due to a 120 kDa collagenase, but this is generally weak (Seddon et al. 1990; 
Poilane et al. 1998). A study comparing chondroitin-4-sulphatase, hyaluronidase, heparinase, 
collagenase and protease revealed that all strains demonstrated some hydrolytic enzyme activity 
but there was no direct correlation between enzyme production and toxigenic status or 
virulence. However, combined high levels of hyaluronidase, chondroitin-4-sulphatase and 
collagenase activity were associated with virulence in toxinogenic strains (Seddon t all. 1990). 
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Protease activity is variably detected, and proteolytic activity is associated with more virulent 
strains (Seddon et al. 1990; Seddon & Borriello 1992; Poilane et al. 1998). C. dif cile may 
express a cell-associated clostripain-like cysteine peptidase (Seddon & Borriello 1992); Cwp84, 
an 84 kDa cell-wall protein, has also been shown to be a cysteine protease (see also Section 3.1) 
(Savariau-Lacomme et al. 2003). 
C. difficile persistence 
A major determinant of the incidence of CDAD is the persistence of the organism in the 
environment (Section 1.1). The vegetative form of C. docile is highly oxygen-sensitive, and 
the persistence of C. docile is achieved due to its ability to sporulate. Spores are highly 
resistant, dormant entities with extreme longevity and negligible metabolic activity that are 
capable of surviving extreme conditions and then germinating when favourable conditions 
recur. The UK-endemic ribotype 001 strains are particularly efficient at both sporulation and 
germination, which may explain their dominance in hospitals (and also its high isolation rate, 
particularly from stored samples) (Wilcox & Fawley 2000; Asha et al. 2005); in contrast, Cd630 
is reputed to be a very poor sporulator. The seven stages of sporulation - filamentation, 
asymmetric division, engulfment, cortex synthesis, coat synthesis, maturation, and lysis - were 
originally described in the 1960s (Ryter et al. 1966). The molecular mechanisms of sporulation 
in the Gram-positive bacteria, and particularly clostridia, have been recently reviewed (Piggot & 
Hilbert 2004; Paredes et al. 2005; Stephenson & Lewis 2005). Initiation of sporulation is 
triggered by a critical concentration of phosphorylated SpoOA reached (in B. subtilis) through 
the culmination of a tightly controlled phosphate transfer phosphorelay system involving SpoOF 
and SpoOB. However, no equivalent phosphorelay has yet been identified in the clostridia, and 
the possibility of direct enzymatic phosphorylation or phosphorylation by butyryl phosphate 
have been proposed as alternative mechanisms of SpoOA activation. Resultant asymmetrical 
division results in forespore formation, and a cascade of compartment-specific pro-a-factors, 
anti-a-factors, anti-anti-a-factors and their activators are then induced. These cause expression 
of a number of proteins which communicate back and forth between the mother cell and the 
forespore, resulting in the maturation of the spore and ultimately in lysis of the mother cell. 
The bile salts taurocholate, desoxycholate and cholate stimulate germination of C. docile 
spores (Wilson 1983), and other known triggers for germination of clostridia include the 
presence of certain L-amino acids, lactate and bicarbonate ions (Uehara & Frank 1965; from 
Gould 2006) (bicarbonate is secreted by duodenal epithelia to modulate lumen pH and protect 
from peptic acid damage): presence of these substances in the intestinal environment could 
therefore trigger germination of ingested C. dicile spores and trigger colonisation. 
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Very little investigation has been carried out into the specific sporulation mechanisms of 
C. dicile. It has been shown that the presence of a sigK-intervening element (skin) is 
necessary for efficient sporulation, as is the case for B. subtilis but not other species. This 
element is excised during the sporulation process, thereby allowing time-controlled activation of 
the sigK gene: dependence on the skin element for efficient sporulation may be due to a lack of 
an N-terminal "pro-" sequence in C. docile SigK which would otherwise prevent premature 
activity (Haraldsen & Sonenshein 2003). 
CodY is a ubiquitous negative regulator of stationary phase proteins in low %G+C Gram- 
positive bacteria (reviewed in Sonenshein 2005). In the presence of GTP and/or isoleucine it 
binds to DNA and represses translation of many genes, including those involved in virulence 
and sporulation. Reduction of cellular GTP concentrations, for example by the action of ReIA 
in the stringent response (Section 4.1), releases CodY repression of these genes. Indeed, in 
C. dicile CodY has been shown to bind to the promoter sequence of tcdR, and inactivation of 
codY resulted in derepression of the entire PaLoc in addition to a general growth defect (Dineen 
et al. 2007). CodY is found to be responsible for the branched-chain amino acid regulation of 
toxin expression, but glucose regulation is independent of CodY expression (Dineen et al. 
2007). 
Quorum sensing has also been recently described in C. dicile. A cell-free supernatant was 
found to contain an autoinducer 2 (AI-2) substance capable of inducing bioluminescence in 
Vibrio harveyi, which is maximally expressed during late exponential phase but not during 
stationary phase (Carter et al. 2005). A IuxS homologue has been identified, adjacent to a two- 
component system, rolA and ro1B, within the genome. rolAB is regulated in an inverse manner 
to IuxS and AI-2, and antisense RNA inhibition of rolA increases AI-2 release (Carter et al. 
2005). In this study exogenous AI-2 or its analogue did not affect the level or timing of Tcd 
production, however other studies have revealed that cell-free supernatants of late exponential 
phase C. d/Jcile cultures and E. coli expressing recombinant luxS were capable of inducing 
tcdA, tcdB and WE transcription from early-exponential phase cultures, and also TcdA 
production to a lesser extent (Lee & Song 2005). AgrB of C. docile, which in Staphylococcus 
aureus is responsible for quorum sensing, is upregulated by the two-component response 
regulator rgaR, which binds to the agrB promoter and can complement a virR mutant of 
C. perfringens; however tcd transcription is not affected in the rgaR mutant (O'Connor et al. 
2006). 
Antibiotic resistance 
In the early 1980s, C. dij icile was reported to be universally resistant to gentamycin, 
trimethoprim, nalidixic acid (ls` generation fluoroquinolone), 1$`, 2"d and 3rd generation 
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cephalosporins and aztreonam (a monobactam); variably resistant to erythromycin, clindamycin, 
tetracycline, chloramphenicol and 2nd generation fluoroquinolones; and almost universally 
susceptible to aminopenicillins, extended-spectrum penicillins, imipenem, fusidic acid, 
metronidazole and vancomycin (Dzink & Bartlett 1980; Nord & Olsson-Liljequist 1984a; Nord 
& Olsson-Liljequist 1984b; Chow et al. 1985). Similar patterns of resistance are reported in 
recent isolates, although widespread resistance to 2°d, 3`d and 40' generation fluoroquinolones 
and low levels of fusidic acid resistance are also detected (Aspevall et al. 2006; Samore et al. 
2006; Schmidt et al. 2007). However, resistance rates among the variable-resistance antibiotics 
is reported to be increasing (Wilcox et al. 2000; Schmidt et al. 2007). 
The modes of action of many of these antibiotics are detailed below, in addition to known 
mechanisms of resistance. Common mechanisms of antibiotic resistance are enzymatic 
modification of the antibiotic, mutation of the antibiotic target, efflux mechanisms, or increase 
in cellular impermeability. 
ß-lactam antibiotics (such as penicillins, cephalosporins, carbapenems and monobactams) 
disrupt the synthesis of the peptidoglycan layer because they show structural similarity to 
D-alanyl-D-alanine, the terminal amino acid residues of peptidoglycan stem peptides. Enzymes 
that normally interact with this moiety, such as D-alanine carboxypeptidase, peptidoglycan 
transpeptidase and peptidoglycan endopeptidase also bind to ß-lactams and are therefore known 
as penicillin-binding proteins (PBPs). The ß-lactam group can covalently attach to the PBPs, 
inactivating them and disrupting cell wall synthesis, eventually resulting in cell death. Common 
mechanisms of resistance to ß-lactams include secretion of ß-lactamases (which cleave the 
lactam ring of penicillins and cephalosporins), drug efflux, or PBP mutation (reviewed in 
Macheboeuf et al. 2006). 
Despite the presence of ß-lactamase genes in Cd630, no reports of ß-lactamase producing 
C. dicile have been made (Levett 1988; Ednie et al. 2007). Ampicillin and amoxicillin are 
aminopenicillins, members of the ß-lactam family of antibiotics; few strains are recorded to be 
resistant to aminopenicillins (Gianfrilli et al. 1984; Bendle et al. 2004; Goldstein et al. 2004). 
In contrast, for cephalosporins C. docile resistance is almost universal to even the 3`d and 4th 
generations (Chow et al. 1985; Okamoto et al. 1994; Ednie et al. 2007). Ampicillin or 
cephalosporin administration are high risk factors for the development of CDAD (Section 1.2). 
Most C. dicile strains remain relatively susceptible to carbapenems (Ednie et al. 2007), 
although imipenem-resistant strains have been isolated, with a metallo-enzyme implicated in 
this resistance (Goldstein et al. 2004; Zheng et al. 2007). 
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The glycopeptides vancomycin and teicoplanin also disrupt peptidoglycan synthesis, but by 
binding to the terminal D-ala-D-ala of the stem peptide and sterically hindering 
transglucosylation, the polymerisation of the peptidoglycan backbone (Reynolds 1989). Gram- 
positive vancomycin resistance by modification of the peptidoglycan stem peptide is discussed 
in Section 4.8vi; intermediate resistance may be conferred by thicker walls and less crosslinking 
leading to mopping up of the antibiotic by affinity trapping (reviewed in Appelbaum & 
Bozdogan 2004). The glycopeptide vancomycin is regarded as the last line of defence against 
C. dicile in the clinical setting and fortunately no functional resistance has been detected in 
C. dicile thus far, although intermediate-resistance isolates have been identified (Pelaez et al. 
2002). 
Inhibition of protein synthesis is an alternative mechanism of antibiotic action, commonly by 
binding to the ribosome and preventing translation. Chloramphenicol, lincosamides and 
macrolides all bind to the 23S ribosomal RNA (rRNA) at the peptidyl transferase cavity of the 
50S ribosome, although at distinct positions (Schlunzen et al. 2001). 
Chloramphenicol acetyltransferases (cat) may confer chloramphenicol resistance; the 
chloramphenicol resistance gene catD from C. dffficile was shown to be ' encoded on the 
mobilisable transposons Tn4453a and Tn4453b, and may be present in multiple copies (Wren et 
al. 1988; Lyras et al. 1998). This gene is not found in Cd630. 
Conjugatively transferable, chromosomally-located resistance to erythromycin (macrolide), 
clindamycin (lincosamide) and streptogramin B (MLSB) was first noted in C. docile in the 
early 1980s (Wust & Hardegger 1983) and was determined to be due to one or two copies of the 
erm(B) gene (Hachler et al. 1987a; Farrow et al. 2000; Spigaglia & Mastrantonio 2002a) on 
mobilisable non-conjugative element Tn5398 (Mullany et al. 1995; Farrow et al. 2001). erm(B) 
encodes an rRNA adenine N-6-methyltransferase, which methylates the 23S rRNA of the 50S 
ribosomal subunit and therefore disrupts the action of these antibiotics (Arthur et al. 1987). 
There must also be alternative mechanisms of resistance to these antibiotics in C. difcile, as not 
all resistant strains harbour erm genes (Ackermann et al. 2003). In other species, mutation of 
the 23S rRNA and enzymatic hydrolysis or modification of these antibiotics (for example by 
acetylation) have been described (Arthur et al. 1987). The 23S rRNA of six erythromycin 
resistant (but not clindamycin resistant) erm-negative isolates was recently found to harbour a 
nucleotide substitution (Schmidt et al. 2007). 
Streptogramin A is a macrolactone cyclic peptide that inhibits also ribosomal protein synthesis 
by binding to the 50S ribosomal subunit and inhibiting peptide elongation; streptogramin A may 
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be inactivated by acylation (Cocito et al. 1997). Cd630 encodes a streptogramin A 
acyltransferase (Sat, CD2226) within a putative conjugative transposon. 
Aminoglycosides (gentamicin, kanamycin, streptomycin) bind to the 16S rRNA of the 30S 
ribosomal subunits and cause conformational changes which interfere with the process of 
translation (Yoshizawa et al. 1998; Brodersen et al. 2000; Carter et al. 2000). Aminoglycoside 
resistance is often due to expression of aminoglycoside acetyltransferases, or to 16S rRNA 
mutations that interfere with antibiotic binding; no mechanisms of resistance have been reported 
in C. docile. 
Tetracycline binds to the aminoacyl-tRNA site of the 16S RNA of the 30S subunits and 
sterically blocks interaction of tRNA with the ribosome (Brodersen et al. 2000). Conjugatively 
transferable, chromosomally-located tetracycline resistance in C. docile was first noted in the 
early 1980s (Smith et al. 1981) and is located on a conjugative transposon similar to 
Enterococcusfaecalis Tn916, harbouring the tetM gene (Hachler et al. 1987b). TetM displays 
GTPase activity and shows homology to elongation factor G, and may therefore act as an 
alternative elongation factor, although it is not known how this confers tetracycline resistance 
(Burdett 1991). 
Fusidic acid disrupts translation by binding to elongation factor G (encoded by the fusA gene); 
in C. docile resistance may emerge during fusidic acid therapy and is linked to mutations 
within the fusA gene (Noren et al. 2006; Noren et al. 2007). 
An alternate method of antibiotic activity is to disrupt DNA replication or transcription. 
Fluoroquinolones inhibit DNA gyrase and topoisomerase IV, causing double-stranded DNA 
breaks during replication. Resistance to fluoroquinolones may involve mutations in DNA 
gyrase and topoisomerase IV genes, reduced permeability, or activation of efflux pumps (Jacoby 
2005). DNA gyrase consists of two GyrA and two GyrB subunits; mutations in each of these 
have been shown to confer fluoroquinolone resistance in C. diýcile (Ackermann et al. 2001b; 
Drudy et al. 2006; Drudy et al. 2007c). 
Trimethoprim is a bacteriostatic sulphonamide that inhibits dihydrofolate reductase, preventing 
synthesis of thymidine and uridine and therefore inhibiting DNA synthesis, resistance is usually 
conferred by target site mutation or acquisition of highly resistant enzymes (Sk6ld 2001); 
trimethoprim resistance has not been described in C. docile however this antibiotic may trigger 
CDAD (Scott 1982; Gordin et al. 1994). 
Metronidazole is the first line of clinical defence against C. docile. After chemical reduction 
in the cell by ferredoxin it interacts with DNA, causing double stranded breaks and disrupting 
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its helical structure (Edwards 1993). Decreased ferredoxin expression or pyruvate: ferredoxin 
oxidoreductase activity have been associated with metronidazole resistance (Quon et al. 1992; 
Samarawickrema et al. 1997). Metronidazole resistance has been occasionally reported in 
human C. difficile isolates (Barbut et al. 1999; Wong et al. 1999; Pelaez et al. 2002), however 
increased metronidazole resistance was found in 10% of equine isolates (Jang et al. 1997). 
Rather than specific antibiotic resistance mechanisms, there are also systems conferring 
multidrug resistance. The cdeA gene of C. dif cile 714, encoding a multidrug and toxic 
compound extrusion (MATE) family Na+-coupled efflux pump, confers resistance to ethidium 
bromide and acriflavin but not 2°d generation fluoroquinolones, gentamicin, erythromycin, 
tetracycline or chloramphenicol (Dridi et al. 2004). cme from Cd630 also confers ethidium 
bromide, safranin 0, and erythromycin resistance when expressed in Enterococcus faecalis 
(Lebel et al. 2004). 
1.7 Incidence of CDAD in other animals 
Natural incidence 
The most commonly reported natural incidence of CDAD in animals is in suckling piglets 
where, in contrast to other species, disease appears to be exclusive to neonates. Piglet 
typhlicolitis was first recognised in 1998 and has since been recognised as a major cause of 
neonatal diarrhoea, causing at least 34% of cases and resulting in considerable costs to the 
farming industry (Waters et al. 1998; reviewed in Songer & Anderson 2006). Neonatal 
diarrhoea has also been reported in hares, but not young rats, rabbits or mice, and may be 
prevented by early administration of healthy adult gut flora (Dabard et al. 1979; Dubos et al. 
1984). C. difcile or its toxin can be isolated from 65% of diarrhoeic foals (Jones et al. 1987) 
and has also been associated with typhlicolitis in an adult horses (Perrin et al. 1993b; Madewell 
et al. 1995), although asymptomatic carriage has been observed (Enrich et al. 1984). 
Household pets have been implicated as reservoirs of infection for human community-acquired 
CDAD (Borriello et al. 1983). The incidence of carriage of dogs has been reported as between 
9% and 58%, and for cats as 2% to 38% (Borriello et al. 1983; Weber et al. 1989; Riley et al. 
1991; Struble et al. 1994; al-Saif et al. 1997; Lefebvre et al. 2006), with rates increased during 
and after vetinary hospital stay, antibiotic administration, or visitation of human healthcare 
facilities (Riley et al. 1991; Martirossian et al. 1992; Struble et al. 1994; Lefebvre et al. 2006). 
20% to 71% of isolates may be toxinogenic (Weber et al. 1989; Riley et al. 1991; Arroyo et al. 
2005; Lefebvre et al. 2006), and these isolates are more often associated with diarrhoea in 
canines (Berry & Levett 1986; Struble et al. 1994). As in humans, no pathogenicity is observed 
in neonatal puppies despite high carriage rates (Perrin et al. 1993a). 
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Over 17% of healthy rural chickens may be colonised with C. dfcile, of which 55% of isolates 
were toxinogenic (Simango 2006); avian asymptomatic colonisation rates of up to 33% have 
been reported (Borriello et al. 1983). However, enteritis and enterotoxemia due to Clostridium 
dicile has been reported in captive ostriches (Struthio camelus) (Frazier et al. 1993). 
C. docile-associated disease has also been reported in a goat (Hunter et al. 1981), a brown bear 
(Orchard et al. 1983), and a colony of cotton-top tamarins (Saguinus oedipus) (Rolland et al. 
1997). 
Initial investigations into the possibility of zoonosis did not find a strong correlation between 
typing of human and pet isolates (ONeill et al. 1993), however recent studies have shown that 
although different C. dicile ribotypes appear to predominate in different mammalian species, 
25% of isolates from humans were indistinguishable from isolates from one or more animal 
species (Arroyo et al. 2005). The predominant human outbreak strain ribotypes 017 and 027 
have been isolated from meat samples and farm animals (Pirs et al. 2007; Rodriguez-Palacios et 
al. 2007; Rupnik 2007), and ribotype 078 is common in both piglets and calves (Keel et al. 
2007). Overall zoonosis may contribute to the prevalence of CDAD, particularly in the 
community setting. 
Model systems 
The tendency of many laboratory animals to spontaneously develop C. docile-associated 
diarrhoea or cecitis in response to antibiotic exposure is well established. The association 
between clindamycin treatment and C. difficile disease in hamsters helped lead to the discovery 
of C. dicile as a pathogen in man (Section 1.1). Like humans, neonatal hamsters may become 
asymptomatically colonised with C. docile (Rolfe & laconis 1983), and older hamsters are 
more susceptible to CDAD (Chang & Rohwer 1991). Guinea-pigs treated with-penicillin 
spontaneously develop a lethal C. dWcile-associated cecitis (Lowe et al. 1980; Rehg & Pakes 
1981; Rothman 1981) as do cefoxitin- or lincomycin-treated rabbits (Rehg & Pakes 1982; 
Chandrasekar et al. 1984). The isolation rate of C. docile from laboratory mice increased from 
19.4% to 63.6% after ampicillin treatment, although disease was not observed (Itoh et al. 1986). 
This propensity to acquire C. diJcile infection from the environment after antibiotic treatment 
has led to the development of these animals as model systems for human infection. 
Cli damycin-treated hamsters 
The use of hamsters as a model system for experimental PMC was first proposed as soon as the 
link between the two disease was made (Chang et al. 1978a), and two major derivatives have 
now been developed. In the hamster primary challenge model, a single dose of predisposing 
agent (i. e. antibiotic) is administered 5 to 24 hours or five days before challenge with 102 
C. di cile spores or 105 C. di cile CFU (Giannasca et al. 1999; Sambol et al. 2001; O'Brien et 
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A 2005; Babcock et al. 2006); alternatively oral challenge may precede predisposing agent 
administration by 24 hours (Freeman et al. 2005). In the hamster relapse model, infection is 
initiated in the same manner, but oral vancomycin treatment is initiated concomitantly with 
spore administration to prevent progress to symptomatic disease. Discontinuation of 
vancomycin treatment after 3 to 5 days will allow CDAD to develop between three days and 
three weeks later (Kink & Williams 1998; Anton et al. 2004b; Babcock et al. 2006). 
The hamster model has been used to investigate the propensity of antibiotics to predispose to 
infection (Ebright et al. 1981; Larson & Borriello 1990), and the effectiveness of agents to 
prevent CDAD (Fernie et al. 1983; Sambol et al. 2002), treat CDAD (Kink & Williams 1998), 
or reduce CDAD recurrence (Kink & Williams 1998; Babcock et al. 2006). 
Gnotobiotic rodents 
Axenic (germfree) rats or mice can be monoassociated with C. dicile, or may be associated 
with known other species before C. dif cile exposure in order to investigate the interaction 
between colonic bacteria. Monoassociation of axenic rats with toxinogenic C. docile resulted 
in mortality (17%) and in pathology to the small and large intestines, livers, and lungs, 
including colonic pseudomembrane formation (Czuprynski et al. 1983). Monoassociation of 
axenic mice leads to diarrhoea, cecitis, polymorphonuclear cell infiltration of the lamina propria 
and pseudomembrane formation (Onderdonk et al. 1980; Wilson et al. 1986). Vancomycin may 
abrogate symptoms and halt toxin detection in mice, but disease will relapse once treatment has 
ceased (Onderdonk et al. 1980). Disease may be prevented by introduction of normal hamster 
or mouse faeces (Wilson et al. 1986; Itoh et al. 1987), but defined collections of Lactobacillus, 
Bacteroides, or other Clostridium strains were not able to eliminate C. docile (Itoh et al. 
1987). Disease may be modulated by diet (Mahe et al. 1987). Gnotobiotic mice may also form 
the basis of experimental investigation of the effects of human faecal flora and its 
manipulations: erythromycin treatment of the donor human or the recipient mouse has been 
shown to reduce transferred colonisation resistance against C. difcile (Andremont et al. 1983). 
Other animal models 
Prairie dogs given cefoxitin develop C. dicile cecitis with pseudomembranes, and yet survive 
for up to 4 weeks. This chronic course, in comparison to that observed in other animals, may be 
useful in the study of less severe CDAD (Muller et al. 1987). 
Closed ileal loops of the larger rodents (rabbit, rat and occasionally mice) have been used to 
investigate the immunomodulatory properties of the Tcds, their hypersecretory mechanism and 
their effects on morphology (Pothoulalcis et al. 1993; Kelly et al. 1994a; Alcantara et al. 2001; 
Kirkwood et al. 2001; Alcantara et al. 2005; Cottrell et al. 2007). 
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The inactivation of Rho by TcdB was elucidated in Xenopus laevis oocytes (Just et al. 1994b). 
Similarly, Zebrafish embryos have been utilised, due to their transparency, to study the effects 
of systemic TcdB. TcdB was found to localise to the pericardial region, and to cause 
cardiovascular damage mediated by apoptosis; this effect could be reproduced in primary rat 
cardiomyocytes. As multiple organ failure and cardiac arrest have been associated with CDAD 
death, it is possible that the toxin can escape from the gut to cause systemic toxicity; this 
demonstrates that CDAD is not purely an intestinal disorder (Hamm et al. 2006). 
In vitro model systems 
Study of C. dicile based on the in vitro growth in faecal emulsions was first used in the mid- 
1980s, and was used to demonstrate inhibition of C. dicile growth by faecal emulsions from 
healthy adults, but less growth inhibition by those from infants, geriatrics, or antibiotic-treated 
patients (Borriello & Barclay 1986). A continuous flow culture system (Freter et al. 1983) was 
also used to demonstrate the suppression of pathogens including C. difficile by normal hamster 
flora (Wilson & Freter 1986), possibly by competition for carbohydrate or amino acid nutrients 
(Wilson & Perini 1988; Yamamoto-Osaki et al. 1994). This system has now been developed 
into a three stage compound continuous flow model, or triple stage chemostat model, 
(Macfarlane et al. 1998) that has been used to investigate the effects of dietary input such as 
prebiotic non-digestible oligosaccharides (Hopkins & Macfarlane 2003); the elimination of 
spores by antibiotic administration (Baines et al. 2005); and the effects of antibiotic 
administration on gut microflora composition and on C. di cile proliferation and toxin 
production (Freeman et al. 2003; Baines et al. 2005; Freeman et al. 2005) including C. dif cile 
strain comparisons (Baines et al. 2006; Freeman et al. 2007). Overall this in vitro model system 
allows designed experimentation into the interactions of complex ecosystems under a controlled 
environment. 
1.8 Genetic techniques 
The genome sequence of C. difficile 630 
The C. dfjJIcile 630 (Cd630) genome has been completely sequenced (Sebaihia et al. 2006). It 
consists of a circular chromosome of 4,290 kb and a 7.9 kb plasmid; the genome has 3,679 
annotated genes and contains only 27% G+C. Surprisingly 11% of the genome consists of 
mobile elements, including two complete prophages, two putative prophages, seven conjugative 
transposons and a conjugative transposon remnant. Encoded within the genome are the 
expected housekeeping genes and metabolic pathway enzymes, which are often grouped 
together in gene clusters that represent potential operons. Selected metabolic pathways are 
illustrated in Appendix 3 (Chapter 9). Transcriptional polymerases and some sigma factors can 
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be identified, as can the ribosomal protein translation apparatus. As discussed above, in 
addition to the toxins, C. dijlcile also encodes multiple drug- and chemical-resistance genes. 
The standard sec secretion apparatus is observed, as are two potential type N pilus clusters and 
a large region encoding flagellar genes. Genes encoding enzymes responsible for the synthesis 
of the external peptidoglycan layer are present, as are genes encoding other external proteins 
including those forming the S-layer and several putative extracellular matrix binding proteins. 
Numerous two-component system constituents can be identified, and a profusion of the 
ubiquitous ABC transporters and phosphotransferase systems are present. 
Although the annotation of the genome is fairly advanced, it is not completed. In order to gain a 
fuller picture of the encoded proteins, in this study all of the predicted proteins within the 
genome were subjected to a Pfam domain search, so as to identify conserved domains and 
predict putative functions (see Supplemental Data CD). 
C. dicile is closely related to the well-studied model organism Bacillus subtilis, which like 
C. dfJcile is a firmicute (low %G+C Gram-positive bacterium), has a cell wall and is capable 
of sporulating. B. subtilis is considered a soil organism for which endospore formation provides 
a means to ensure long-term survival in the environment. However, the related organism 
B. cereus has been proposed as a probiotic; it is capable of replicating in the mouse gut and can 
persist for over two weeks (Hoa et al. 2001; Duc le et al. 2004). B. subtilis spores have recently 
been shown to be capable of germination, replication and resporulation in a mouse model, 
suggesting that B. subtilis is capable of an intestinal life cycle (Tam et al. 2006). The B. subtilis 
genome has also been sequenced (Kunst et al. 1997) and shows similar metabolic pathways and 
basic cellular structures to C. dicile. 
The availability of the genome sequence of Cd630 (Sebaihia et al. 2006) will also allow the 
identification of other potential virulence factors of C. difficile. Based on this sequence and its 
preliminary annotation, a Cd630 microarray has been developed by the Bacterial Microarray 
Group at St. George's Hospital, Tooting (BAG@S) (Section 4.1). This will facilitate 
epidemiological characterisation of strains. Comparative genomic analysis of 75 C. difficile 
strains using the C. dicile 630 microarray has demonstrated four major clades (Stabler et al. 
2006): one Glade of primarily TcdA"B+ strains, one Glade containing the "hypervirulent" and 
historic BUNAPI/027 strains, and two clades (HAI and HA2) encompassing all other human 
and animal TcdA+B+ and TcdAKB- strains. 
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Genetic manipulation 
Introduction of foreign DNA 
Conjugative transfer of genomic elements between C. docile strains was first demonstrated in 
the early 1980s (Smith et al. 1981; Wust & Hardegger 1983), and transfer from C. docile to 
Staphylococcus aureus was shown a few years later (Hachler et al. 1987a). The conjugative 
transposon Tn916 can be transferred from B. subtilis into C. d fJicile CD37 by filter mating; 
Tn916 shows a strong integration site preference (Mullany et al. 1991). This property was used 
to design an integrative plasmid vector capable of shuttling cloned genes into B. subtilis and 
then to C. dicile (Mullany et al. 1994), however this approach could not be used for 
mutagenesis due to the site-specific insertion. Interestingly, in some instances Tn916 has been 
reported to integrate via homologous recombination rather than transposition (Haraldsen & 
Sonenshein 2003), however without characterisation of the necessary insertion properties this 
could not be used for general targeted insertion. 
Tn5397 can also reversibly shuttle between B. subtilis and C. dfjflcile, and transposition may be 
enhanced by high expression of the plasmid gene TndX (Lyras & Rood 2000; Wang & Mullany 
2000); Tn5397 has high preference for the attB site for integration (Wang et al. 2006). Tn5398, 
encoding the Erm(B) erythromycin resistance determinant, can also shuttle between C. dicile 
and the rumen commensal Butyrivibriofibrisolvens (Spigaglia et al. 2005), although it does not 
carry any transposase or site-specific recombinase genes, nor any genes likely to be involved in 
conjugation, and must therefore be exogenously mobilised (Farrow et al. 2001). 
Electroporation of plasmids incapable of replication in C. dWIcile has resulted in the transfer of 
tcdB into a non-toxigenic strain, which is proposed by the authors to occur via genomic 
incorporation (Ackermann et al. 2001 a). However the neither the longitudinal stability nor the 
integration site have been characterised. 
A plasmid transfer system has been developed that utilises the E. coli encoded RP4 plasmid to 
mobilise a clostridial plasmid incorporating the RP4 oriT and a C. perfringens replicon, and 
results in integration by homologous recombination (Sloan et al. 1992; Lyras & Rood 1998). 
This system was used to investigate the effects of TcdR gene activation in C. dicile Cd37 
(Mani et al. 2002). However this system was not found to work with other C. docile strains, 
and as Cd37 is non-toxigenic it has limited utility in investigations of C. dWicile pathogenicity. 
An alternative plasmid transfer system has been developed that incorporates both the pCD6 (an 
endogenous plasmid found in C. dif vile Cd6) and oriT replicons into a single plasmid with 
erythromycin selection. This plasmid may be introduced into C. docile Cd3 or Cd6 via an 
E. coli strain which methylates sites that are sensitive to C. difficile restriction endonucleases 
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(Purdy et al. 2002). Cd37 appears to lack the restriction activity present in CO, Cd6 and other 
strains, which explains why previous techniques had only worked in this strain (Purdy et al. 
2002). This plasmid may be transferred successfully to Cd630 with no modification except for 
plasmid selection (the addition of catP, conferring chloramphenicol resistance, due to the 
natural resistance of Cd630 to erythromycin) (Herbert et al. 2003). 
Gene inactivation 
Tn916 was used as a vector to introduce into C. docile a sequence encoding antisense RNA for 
cwp66, although no consequent reduction in protein expression was observed (Roberts et al. 
2003). The authors also note that in C. dicile 79-685 Tn916 does not integrate into a preferred 
site and its utilisation for random mutagenesis is proposed. Both rolA and luxS have been 
targeted by antisense RNA technology using the technique of Purdy et al. (2002), and rolA has 
been implicated in quorum sensing in C. difcile (Carter et al. 2005). The knockdown of virR 
using antisense RNA results in a transient growth impairment, but upon subculture the 
production of antisense RNA was not maintained (Minton et al. 2004). Antisense RNA is rarely 
seen to completely abrogate expression of any protein, and RNAi technology as applied to 
eukaryotes does not function in bacteria. Therefore true gene knockouts are more desirable for 
functional investigations of non-essential proteins of C. docile. 
A non-replicative suicide vector with erythromycin selection has been used to inactivate the 
gidA gene of C. di cite in a targeted fashion using homologous recombination; unfortunately 
this gene proved to be essential and therefore longitudinal stability could not be established, 
however genomic integration was demonstrated in the pinprick, non-replicating colonies 
obtained (Liyanage et al. 2001). Regrettably this technique did not prove to be repeatable for 
other genes in other laboratories (Carter et al. 2005; O'Connor et al. 2006). 
The relatively unstable E. coli-C. perfringens shuttle vector (Sloan et al. 1992; Lyras & Rood 
1998) has been seen to integrate into the genome by homologous recombination under 
continued chloramphenicol selection, and this was used to characterise the function of rgaR and 
rgbR in quorum sensing (O'Connor et al. 2006). 
Overall, the sporadic success with gene transfer demonstrates that recombination is highly 
inefficient in C. difficile. In order to circumvent this, a system of clostridial gene knock-out 
utilising the mechanism of group II intron insertion have been developed' (Minton et al. 2006). 
The rules governing integration site specificity of mobile group II introns has been elucidated 
The Minton laboratory (2006). Protocol for clostridial gene knockout using pMTL007. Centre for 
Biomolecular Sciences, University of Nottingham. 
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and a system of retargeting to any gene of interest has been developed; these constructs are 
referred to as Targetrons (Mohr et al. 2000; Perutka et al. 2004). A retrotranscription activiated 
marker (RAM) is used for positive selection of genomic integrants: a resistance gene is carried 
by the group II intron, itself interrupted by a group I intron. Upon transcription of the group II 
intron the group I intron will excise itself, leaving a functional selectable marker remaining in 
the group II intron which inserts itself into the genome (Karberg et al. 2001; Zhong et al. 2003). 
The Minton group have adapted this system to incorporate a promoter and erm(B) selectable 
marker that function in the clostridia: the ClosTron system (Minton et al. 2006; The Minton 
laboratory 2006). In proof of principle studies, ClosTron constructs were used to knock out 
pyrF and spoOA genes in C. diffIcile, C. acetobutylicum and C. sporogenes (Heap et al. 2006). 
As there are no resultant flanking homologous sequences using this technique, the insertion 
cannot be lost by homologous recombination, and the mutants are incredibly stable. 
The isolation of an erythromycin-sensitive derivative of Cd630 (Hussain et al. 2005) will allow 
use of the ClosTron selective knockout system in this genome-sequenced, highly antibiotic- 
resistant strain. However the method of derivation of this mutant, namely serial subculture, 
does not guarantee that the loss of erm(B)2 is the only genetic alteration in this erythromycin 
sensitive strain. 
The Minton laboratory (2006). Protocol for clostridial gene knockout using pMTL007. Centre for 
Biomolecular Sciences, University of Nottingham. 
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1.9 Project aims 
Despite major developments in the understanding of C. dicile disease and biology, many 
aspects of its pathogenicity remain to be elucidated. Further understanding of the survival 
mechanisms of C. diIcile both within the gut and in environmental persistence may allow the 
development of better control strategies and disease interventions. In this context, a global 
approach was taken to elucidate the strategies C. diJcile 630 employs to tolerate suboptimal 
conditions. A microarray based on the published genome sequence of C. docile 630 was used 
to determine the differential expression of C. dicile genes in response to various stresses. 
These were chosen to mimic the possible conditions within the gut in CDAD infection, namely 
heat shock, pH shock, aerobic exposure, and exposure to antibiotics. Statistically regulated 
genes were identified, and the responses of functional gene sets are also addressed. 
In addition to this global approach, a specific investigation was also performed. The surface of 
C. dfýcile will determine its interaction with its environment. A family of proteins 
incorporating a putative cell-wall binding domain were studied, with particular focus on one 
member of the family, designated CwpV (cell all protein with _varying repeats). 
The cwpV 
gene and its expression are compared between strains, and three types of cwpV are identified; 
cwpV is conserved in every strain examined. The function of CwpV has not been determined, 
however this protein remains of interest. The expression of CwpV is phase-variable, and a 
putative mechanism for this switching is described; we believe this to be the first phase-variable 
protein described in C. docile. 
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2.1 Bacterial strains and culture 
C. difficile strains 
C. dicile 630 (Cd630) (Wust & Hardegger 1983) was provided by Dr Peter Mullany, Eastman 
Dental Institute, London, and has been fully sequenced by the Wellcome Trust Sanger Institute 
(Sebaihia et al. 2006). Cdl, Cd17 (Stubbs et al. 1999), and CdY (Heard et al. 1986) were 
obtained from St. Bartholomew's Hospital, London. Cd101, Cd167, Cd291, Cd371 and Cd959 
are clinical isolates that were provided by Professor C. P. Kelly, Harvard Medical School, 
Boston, USA. Cd167 was isolated from a patient with a single episode of diarrhoea that 
responded well to metronidazole treatment; Cd101 was obtained from a patient who died during 
the illness; Cd371 was obtained from a patient who suffered multiple (three) relapses of CDAD. 
Cd291 and Cd959 were obtained from asymptomatic carriers. CdM9 was obtained from 
Dr. Denise Drudy, Dublin, Ireland and was isolated from a symptomatic patient in a TcdAB+ 
outbreak. R20291, R20352 and R20928 were obtained from Prof. Brendan Wren and were 
isolated from patients from "hypervirulent" outbreaks in Stoke Mandeville (UK), Quebec 
(Canada) and the USA respectively. Cd12087 was obtained from Dr. Jon Brazier, but originally 
isolated by Dr. Michel Popoff from a PMC patient in Paris (Popoff et al. 1988). Cd12628 and 
Cd16760 were obtained from Jon Brazier and were chosen from isolates sent to the Anaerobe 
Reference Laboratory for typing (Table 2.1). 
C. difficile culture conditions 
C. dicile was routinely cultured either on blood agar base II (Oxoid Ltd, Basingstoke, UK) 
supplemented with 7% horse blood (TCS Biosciences, Botolph Claydon, UK); or in brain-heart 
infusion (BHI) broth (Oxoid). Culture was undertaken in an anaerobic cabinet (Don Whitley 
Scientific, Shipley, UK) at 37°C (or 30°C for heat shock experiments) in a reducing anaerobic 
atmosphere (10% C02,10% H2,80% N2). Long-term C. difficile stocks were kept at room 
temperature in Robertson's double cooked meat medium (Southern Group Laboratory, Corby, 
UK). Rescue from these stocks was performed first onto blood plates containing C. diJcile 
selective supplement (Oxoid) giving final concentrations of 25µg/ml D-cycloserine and 8µg/ml 
cefoxitin. 
To obtain cells during exponential phase, an overnight liquid culture was inoculated 1/20 into 
BHI that had been pre-equilibrated to the temperature and atmosphere of the anaerobic cabinet, 
and the culture was shaken to mix thoroughly. In order to monitor the growth of C. docile, the 
culture was periodically mixed and the OD600 of a sample was determined using either a 
SpectronicTM HeXiosTM C spectrometer (Thermo Scientific, Waltham, MA) or a WPA biowave 
CD8000 cell density meter (Isogen Life Science, IJsselstein, The Netherlands). 
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OD600 was found to be approximately proportional to the viable cell count for OD600 values 
between 0.2 and 0.9 (Figure 2.2). To determine the viable cell count - during growth and after 
stress -a 100µl sample of culture was serially diluted 1/10 in pre-equilibrated BHl and then 
50µI of the appropriate dilutions were spread onto non-selective blood agar plates. Colonies 
were counted after 24 hours. 
10 
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fy=1.677x + 8.5262 
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0.1 0.16 0.25 0.40 0.63 1.00 1.58 
OD600 
Figure 2.1 Relationship between optical density and viable cell density 
Cd630 was grown in BHI and samples were periodically taken. OD600 was 
determined, and culture dilutions were plated to ascertain viable cell counts. Both 
values are plotted above on logarithmic scales. Blue, green and red diamonds 
represent independent cultures. 
E. coli strains and culture 
E. coli strains (Table 2.2) were routinely grown at 37°C on LB-agar plates or in LB liquid 
culture in the presence of selective antibiotics where appropriate to any transformed plasmid 
(50µg/ml ampicillin (Amp) and/or 50gg/ml kanamycin (Km)) (Table 2.3), and in the additional 
presence of 30gg/ml chloramphenicol (Cm) for Rosetta TM cells (Novagen, Merck, Darmstadt, 
Germany). For storage, E. coli strains were grown overnight in LB, then made up to 20% 
glycerol and frozen at -80°C. 
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Strain Genotype 
TOP 10 F' mcrA A(mrr-hsdRMS-mcrBG) (D801acZZM15 AlacX74 recAl 
araD139 A(ara-leu)7697 galUgalKrpsL (StrR) endAl nupG 
BL21(DE3) F ompT hsdSB (r8, mB) gal dem (DE3) 
RosettaTM FompT hsdSB (rB , mB) gal dem (DE3) pRARE (CmR) 
Table 2.2 E. coli host strains used in this study 
Commercial TOP 10 cells were always used for initial transformation after cloning and 
were used for plasmid maintenance. Protein expression was carried out in either 
BL21(DE3) or RosettaTM . 
(Novagen) cells. RosettaTM are BL21(DE3) cells carrying a 
plasmid encoding tRNAs specific to codons that are rare in E. coli but common in other 
organisms. 
Chemical transformation of E. coli 
Preparation of chemically competent E. coli cells 
lml overnight culture of Rosetta or BL21(DE3) E. cola was inoculated into 50m1 LB ± 30Rg/ml 
Cm and grown at 37°C with shaking until OD600 reached 0.5. The bacterial suspension was then 
chilled on ice for 10 minutes before being harvested by centrifugation at 4,000 rpm, 4°C for 
10 minutes. The cell pellet was resuspended in 20m1 RF1 buffer (100mM RbCI, 50mM MnCl, 
30mM KAc, 10mM CaC12,15% w/v glycerol, pH 5.8) and incubated on ice for 10 minutes. 
Bacteria were pelleted at 4,000 rpm, 4°C for 10 minutes and then the pellet was resuspended in 
2ml RF2 buffer (10mM MOPS, 10mM RbCl, 75mM CaC12,15% w/v glycerol, pH 6.5). 50µ1 
aliquots were flash-frozen in a dry-ice/isopropanol bath before storage at -80°C. 
Chemical transformation 
Either O. 511 purified plasmid or an entire cloning reaction was added to an aliquot of chemically 
competent cells and incubated on ice for 10 minutes. The aliquots were then plunged into a 
42°C water bath for 30 - 45 seconds before returning to ice. 250µl room-temperature SOC 
medium (Invitrogen, Paisley, UK) was then added to the cells and the tubes incubated with 
shaking at 37°C for 1 hour before spreading 0.1 volumes and 0.9 volumes onto selective agar 
plates. 
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2.2 Bioinformatics and computer programs 
Genome visualisation 
The genome of Cd630 and its annotation were obtained from The Sanger Institute website 
(Sebaihia et al. 2006, http: //www. sanger. ac. uk/Projects/C difficile/), as were the contigs of the 
genome of Cd20291. The contigs of Cd20352 were obtained from Washington University 
(http: //www. ncbi. nlm. nih. gov/entrezquery. fcgi? db=genomeprj &cmd=retrieve&adopt=overview 
&list_uids=16328). Artemis Release 8 (The Sanger Institute, http: //www. sanger. ac. uk/ 
Software/Artemis/) DNA sequence viewer and annotation tool was used to visualise the genome 
sequences and annotation. Screen shots of this were used to generate scale gene-cluster 
diagrams. Further information about annotated products was ascertained using the BRENDA 
enzyme database (Schomburg et al. 2004, http: //www. brenda. uni-koeln. de/) and KEGG 
PATHWAY information (Kanehisa et al. 2006, http: //www. genome. jp/kegg/). 
DNA sequencing, alignments and homology 
Primer3® vO. 3.0 (Rozen & Skaletsky 2000, http: //frodo. wi. mit. edu/cgi-bin/primer3/ 
primer3_www. cgi) was used to design primers used for PCR (Table 2.4). Sequencing traces 
were visualised and manually corrected using Chromas Lite® v2.0 (Technelysium Pty Ltd, 
http: //www. technelysium. com. au/chromas_lite. html). BioEdit° v7.0.1 sequence alignment 
editor (http: //www. mbio. ncsu. edu/BioEdit/bioedit. html), and its accessory application ClustalW 
multiple alignment tool (Thompson et al. 1994, http: //www. ebi. ac. uk/clustalw/), were used to 
align and compare resultant sequences. GeneDoc® v2.6.003 multiple sequence alignment editor 
and shading utility (Nicholas et al. 1997, http: //www. psc. edu/biomed/genedoc) was used to 
visualise similarity between sequences. 
Homology searches were carried out using BLAST (basic local alignment search tool) (Altschul 
et al. 1990). Searches against all known protein or nucleotide sequences were carried out using 
BLASTP and BLASTN respectively (http: //www. ncbi. nlm. nih. govBLAST/). Searches against 
C. di cile 630 and 820291 sequences were carried out on the website of The Sanger Institute 
(http: //www. sanger. ac. uk/cgi-bin/blast/submitblastlc-difficile) and those against C. difficile 
R20532 were performed using NCBI Entrez Genome (http: //www. ncbi. nlm. nih. gov/genomes/ 
geblast. cgi? gi=5410). 
Gene and protein property predictions 
Softberry BPROM (prediction of bacterial promoters) was used to predict the site of initiation 
of transcription (http: //www. softberry. com/berry. phtml? topic=bprom&group=programs& 
subgroup=gfindb). Inverted repeats were discovered by visual inspection, and confirmed using 
EINVERTED (http: //bioweb. pasteur. fr/seganal/interfaces/einverted-simple. html). 
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Rudimentary properties of proteins, such as molecular weight and pI, were predicted using the 
Protein Calculator (http: //www. scripps. edu/-cdputnam/protcale. html). SignalP 3.0 (Bendtsen et 
al. 2004, http: //www. cbs. dtu. dk/services/SignaIP/) was used to predict the presence and length 
of signal sequences within protein sequences. PHYRE® vO. 2 (protein homology/analogy 
recognition engine) (Kelley et al. 2000, http: //www. sbg. bio. ic. ac. uk/phyre/) and PSIPRED 
(Jones 1999; McGuffin et al. 2000; Bryson et al. 2005, http: //bioinf. cs. ucl. ac. uk/psipred/) were 
used to predict the secondary structure of protein sequences. Pfam v21 (Finn et al. 2006, 
http: //www. sanger. ac. uk/Software/Pfam/search. shtml) was used to find protein family 
conserved domains within protein sequences. The entire predicted proteome of U630 was 
subjected to large batch Pfam searching, and descriptions of the detected domains were also 
annotated from this website (http: //www. sanger. ac. uk/Software/Pfam/tsearch. shtml). 
Image and data processing 
Digital records of Coomassie-stained SDS-PAGE gels, Ponceau-S-stained membranes and 
96-well plate reactions was obtained using a Powerlook 2100XL scanner (Umax, Milton 
Keynes, UK) and MagicScan DA v4.5 (Umax). For all images, Microsoft Photo Editor® v3.01 
was used for basic cropping and resizing purposes. 'Adobe® Photoshop® CS v8.0 was used for 
adjusting colour balance and contrast and for overlay of images, for example light and 
chemiluminescent images of a membrane. For quantification and sizing of protein or DNA gels, 
AIDA Image Analyser v4.18 ID evaluation (http: //www. raytest. com/bio_imaging/products/ 
aids/biopackage/products_aida_biopackage. html) was used. 
Numerical data generated by all methods, excepting Microarray analysis, was manipulated and 
analysed using Microsoft® Excel 2000. 
2.3 DNA manipulation 
Extraction of DNA from C. difficile 
A 25m1 overnight culture was pelleted and resuspended in 0.4m1 200mM NaCl, 50mM 
Na2EDTA, 20mM Tris-HC1 pH 8.0 containing at least 1mg/mi hen egg lysozyme (Roche 
Diagnostics, Lewes, UK) and incubated at 37°C for 1 hour. 40111 10% SDS and 4111 
proteinase K (20mg/ml in H20) were added and the samples incubated at 50°C for 1 hour. After 
cooling to room temperature the sample was extracted once with an equal volume of phenol 
pre-equilibrated with 1M Tris-CI pH 8.0 (USB corporation, Cleveland, Ohio). The DNA was 
precipitated by the addition of 0.25m1 isopropanol, washed in 70% ethanol, air dried and 
resuspended in 400µ1 TE (1mM EDTA, IOmM Tris-Cl pH 8.0). This was treated with 
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0. lmg/ml RNaseA for 30 minutes at 37°C, then made up to 0.25M NaCl and extracted again 
with one volume of pre-equilibrated phenol. DNA was precipitated with two volumes of 
ethanol and resuspended in l00µ1 TE. 
DNA concentration and purity was determined by measuring A2SA280 using a Cary 50 Scan 
UV-visible spectrophotometer (Varian, Palo Alto, CA) and Cary WinUV Simple Reads 
Application v3.00. 
Polymerase chain reaction (PCR) and agarose gels 
For general DNA amplification, a 501i1 reaction incorporating lx reaction buffer and either 
5U Taq (SIGMA, Sigma-Aldrich, Gillingham, UK) + 25mM MgC12, or 5U Fast Start Taq 
(Roche Diagnostics); 100pmol each primer (Table 2.4) and 20µM dNTPs (SIGMA) combined 
with 1µl template DNA. Thermal cycler parameters were 95°C, 5 minutes; thirty cycles of 
denaturation (95°C, 30 s), annealing (25 s) and extension (72°C, 1 minute per kb of the desired 
PCR product); and a final 10 minute 72°C incubation. Annealing temperature was generally 
5°C lower than the melting temperature (T,,, ) of the primers (Table 2.4). 
For long PCR products, or for cloning reactions, a proofreading polymerase was used. For 50µ1 
reactions 2.6U Expand Hi-Fidelity Polymerase or Expand Long-Range Polymerase (Roche 
Diagnostics), lx reaction buffer, 100pmol each primer and 30µM dNTPs were combined on ice 
with 1µl template DNA. Thermal cycler parameters were 95°C 2 minutes; then thirty cycles of 
denaturation (95°C 30 s), annealing (Tm- 5°C, 30 s), extension (68°C 20 s to 6 minutes 
depending on the length of the desired PCR product); followed by a final 10 minutes 68°C 
incubation. 
PCR reactions were run on 0.8 - 1.2% TAE-agarose gels (TAE: 40mM Tris, 20mM acetic acid, 
1mM EDTA) containing 0.05% ethidium bromide solution (SIGMA) using the Hyperladder I 
(Bioline) size standard. Images were captured using a Uvitec UV illuminator and UviPhoto 
v99. O ls (UVI, Cambridge, UK). Where appropriate, sizing and quantification were carried out 
using AIDA Image Analyser v4.18 or manually using Microsoft® Excel 2000. 
PCR Cleanup 
For amplifications generating multiple products, a QIAquick® Gel. Extraction Kit (QIAGEN, 
Crawley, UK) was used according to the manufacturer's instructions. Briefly, the entire 
reaction was run on a TAE-agarose gel and the required band excised using a scalpel. This was 
solubilised in three volumes Buffer QG at 50°C. One volume of isopropanol was added and the 
solution applied to a QlAquick® spin column. The column was washed 500µ1 Buffer QG, 500µ1 
Buffer PE and 25Oµ1 Buffer PE, and was then centrifuged for a further 2 minutes to ensure 
complete removal of ethanol. 30µ1 H2O or 3O11 EB (10mM Tris-Cl pH 8.5) was added to the 
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Primer CD# a Gene 
Position 
in Cd630b 
genome 
Sequence Features T. 
NF376 - pGEX GGGCTGGCAAGCCACGTTTGGTG - 67.8 
NF377 - pGEX - CCGGGAGCTGCATGTGTCAGAGG - 67.8 
NF404 - T3 - pCR4 - ATTAACCCTCACTAAAGGGA 45.0 
NF405 T7 - pCR4 - TAATACGACTCACTATAGGG - 38.8 
NF408 - 16S rRNA 25480* U TCTTGAATATCAAAGGTGAGCCAGTACA - 58.4 
NF409 16S rRNA 26016* L TACAGCGTGGACTACCAGGGTATCTAAT 58.6 
NF486 CD0184 pyrB 242794 U GCTTTTCAGAGCCAAATTCATCCTC - 61.3 
NF487 CD0184 pyrB 243044 L AACCAAAGAATGCACAGTTCTTCCA - 59.7 
NF488 CD0185 pyrK 243833 U GTAGGAGGAGGAATCGGTGTAGCTC - 66.3 
NF489 cD0185 pyrK 244157 L CCCAGAACACTGGACCATCTTTACA - 63.0 
NF490 CD0186 pyrD 244658 U GGCAAGAGAAGTTGTTCGTGAGGTA 63.0 
NF491 cD0186 pyrD 244961 L TTGGATACAAGTAGCTCCTGCCATT - 61.3 
NF492 CD0187 pyrE 245328 U AGATTCCCAGAATATGCTGCTGAGG - 63.0 
NF493 co0187 pyrE 245585 L TGCAACACCTACAACTTCTCCACCT 63.0 
NF400 CD0513 606586 U AATTTAGATAATCTGGAGAGGGAAT - 50.4 
NF749 - 607191 U AATATCGCAATTATTTGTTTTTC - 54.6 
NF750 - 607321 L GGTAAGTTTGATTTTTATGTTAATG 53.6 
NF751 - 607345 U CATTAACATAAAAATCAAACTTACC - 53.6 
NF384 CD0514 cwpV 607512 U GCCGGATCCCCTTTAGAATTAGAACGGGAACAA BamHI 70.5 
NF401 co0514 cwpV 607563 L TGCAGCAATCTTCTTTGGTATTTTC - 58.1 
NF664 CD0514 cwpV 607664 U CACCCAAACTGTGGCAACAAATTTAAC CACC 61.9 
NF654 CD0514 cwpV 608065 U TGGTGAAAAAGGACTTGCAG - 55.2 
NF655 000514 cwpV 608724 L CATCACCATTAGGCATGTTG - 55.2 
NF665 CD0514 cwpV 609002 L TTACTAAGAATTATCTCCCTTAACAC stop 56.9 
NF372 000514 cwpV 609093 U TCAAGTGGAGGTTCTTCAGGA - 57.9 
NF385 CD0514 cwpV 609126 L CCGCTCGAGCTATGTTGCACTAAATTTTATTTGACCT stop, Xhol 69.0 
NF666 cD0514 cwpV 609134 U CACCTCATCAAAGGTAGGTCAAAT CACC 59.3 
NF345 CD0514 cwpV 609135 U GCCGGATCCTCATCAAAGGTAGGTCAAATA BamHI 74.0 
NF658 CD0514 cwpV" 609317* U" ACAAATCTGGTGTAACACAAAAAGA - 56.4 
NF346 000514 cwpV 609809* L CCGCTCGAGCTACACATATTTTTTAACTTCAAATGTTG stop, hol 65.8 
NF667 CD0514 cwpV 609812' L TTACACATATTTTTTAACTTCAAATG stop 52.2 
NF701 CD0514 cwpV" 610464* U" GCCGGAT CGGATCAAAAGCAACGTATAAAAC amHI 68.2 
NF375 CD0514 cwpV 610579* U GCCGGATCCGCACCAGCAATAGGTCAAT BamHI 69.5 
NF702 000514 cwpVM 610701* L" CCGCTCGAGTACAGCATAGTTTCCTTCTGCTGTTC Xhol 71.8 
NF386 CD0514 cwpV 612296 U GCCGGATCCATAAGTGTGTTAGTTAAAGCAGGAGC BamHI 69.1 
NF703 CD0514 cwpV" 612360 L" AATGCAATTGTAGTAGGTACTTTCC - 58.1 
NF373 CD0514 cwpV 612382 L TGATAGCCCAGAAGATATTTTTCC - 57.6 
NF659 CD0514 cwp'/ 612976 L" GAAGGATAAGATTAAGATTAAGGTTGC - 58.9 
NF414 CD0515 613411 L TACAGATAATGCTGGATATTGCCTTGC - 58.3 
NF415 CD0515 613437 U GCAAGGCAATATCCAGCATTATCTGTA - 58.7 
NF416 Co0515 614151 L ATATGAAATGGAGGACGAGATTTTG - 54.6 
NF478 CD0888 speA 1070376 U TATAACGAATGGCACAACTCAAGCA - 59.7 
NF479 CD0888 speA 1070611 L CTCTCAAGGTCTGCACAAACTCCAT - 63.0 
NF480 CD0889 speD 1071777 U GCGACAATTGTGGATTCTGTATTCC - 61.3 
NF481 CD0889 speD 1071946 L TCTTGGAATTTCTGTAGACTCGCTTC - 61.6 
NF482 cD0890 speE 1072589 U GGTGAAGGGCTTTTCTCAACTGATT - 61.3 
NF483 CDO890 speE 1072765 L AATCCAAACAACCAGTGACCAGATG - 61.3 
NF484 CD0891 speB 1073044 U CTAACAGACCTGGGGCTAGATTTGC - 64.6 
NF485 CD0891 speB 1073312 L CCTCAAATCAGTATGGGCATCAAAA - 59.7 
NF494 cD1023 1195265 U GAACAGAAAAACAACTGACCCAGGA - 61.3 
Table 2.4 Primers used in this study... 
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Primer CD#4 Gene 
Position 
In Cd630e 
genome 
SequenLe Features Tm 
NF495 CD1023 1195564 L ATCCAAATTCTTCACCTTCATGTGG - 59.7 
NF496 CD1024 potA 1196431 U ATTCAACAAATGGGAACACCACAAG - 59.7 
NF497 CD1024 potA 1196730 L TTCAGTCCCAACCTCAGCATTTTTA - 59.7 
NF498 co1025 potB 1197407 U TTTCCTTTGAGTTTGCCAGGTGTAA - 59.7 
NF499 CD1025 potB 1197620 L ATAGTAACCCACCGCCTTCTTTGTC - 63.0 
NF500 CD1026 potC 1197775 U TCAATGGCAAGATGGAATGGATTTA - 58.1 
NF501 CD1026 potC 1198121 L CCCAAGTCCATAGCTGCATCTTCTA - 63.0 
NF502 cD1027 potD 1198843 U TTGCATATATGTGGGGAACTCTTGG 61.3 
NF503 Co1027 potD 1199196 L CTCCAGAATACAGCATACCCATTGC - 63.0 
NF512 cD1682 iunH 1957043 U GGATTCATGGAAATTGCTCTCCAGT - 61.3 
NF513 CD1682 iunH 1957250 L ATCACACAGCCAATTATTCCCTCCT - 61.3 
NF514 co1683 1957706 U GCTGTTGTTACAGGTGTGTTTGGAA 61.3 
NF515 CD1683 1957939 L AACATCCCCCAGTCCTAACACTTTC - 63.0 
NF516 cD1684 1958192 U ATGGGGAAAGTGTTCTTTTTGTGAT - 58.1 
NF517 CD1684 1958455 L TCATTGTCAAAGGTTTCAACTCCAA - 58.1 
NF518 cD1685 1959145 L TTGCCAATTACCATACCTTGTAGCC 61.3 
NF598 cD2781 3233021 U CATTGGCGTTTTTGTATCTGAA 54.7 
NF597 c02781 3233777 L AGGATTTAGAAACGACCCTGCT - 58.4 
NF600 CD2782 cwp7 3234495 U TTTCTTTTGCTGATACTACTCCCA - 57.6 
NF599 cD2782 cwp7 3235217 L AGATGCAAATCCCAAAAGAGAG - 56.5 
NF602 Co2783 3235430 U ATCTAGCTCCGTCTCCTGTCAA - 60.3 
NF601 CD2783 3236035 L AAATTAAAAGCTATCCAGGGGC - 56.5 
NF603 CD2784 cwp6 3237563 L TCAGTTTCACAAAAGGCAGTGT 56.5 
NF605 cD2784 cwp6 3237890 U CTGCTTTTGTTGAATTTGCATC - 54.7 
NF604 CD2784 cwp6 3238306 L CAACAAAATTATTGGCAACAGG - 54.7 
NF607 co2785 3239166 U CTGGCTTGTACAAATGTCCCTT 58.4 
NF606 CD2785 3239913 L TTGAATAAGCTTTGGGGAGGTA - 56.5 
NF608 CD2786 cwp5 3240652 L AATGAAGAAGCTTTTGATGAAATTA 53.1 
NF610 CD2786 cwp5 3240698 U TCCATTTCCACCTACCTGTGTT - 58.4 
NF609 CD2786 cwp5 3241409 L AGCTGATGCACTTTCAGCTACA - 58.4 
NF611 CD2787 cwp84 3242828 L CAAAAACATCTTCTGGACAAGC 56.5 
NF613 co2787 cwp84 3243479 U ACCATGCTCCATTTGATTCTG - 55.9 
NF612 cD2787 cwp84 3244232 L TACCTGTCTCAGCAGAAAACCA - 58.4 
NF614 CD2788 3244619 U TTCTTTGGAGCATTTACTACTCTTG - 58.1 
NF615 C02788 3244809 L AACATTTCAACGACACCAGAAA - 54.7 
NF663 CD2789 cwp66 3245029 U TTAAAATCCATCATCTGTAGCGTTAG stop 58.5 
NF616 CD2789 cwp66 3245792 L TGCTGCTATAAAAAGAGCAGATG - 57.1 
NF662 cD2789 cwp66 3245883 L CACCGGTGGCTTAGGTAATGAAAAT CACC 61.3 
NF661 CD2789 cwp66 3245924 U TTACTAACCAATTTGAGTAACTTTATCTAT stop 57.2 
NF618 CD2789 cwp66 3246020 U TAGCTGCTAATACACCCACTGC - 60.3 
NF660 CD2789 cwp66 3246711 L CACCGGAAGATGGGAAACAGCA CACC 62.1 
NF617 CD2789 cwp66 3246721 L CATTAACGGGTTCTGGAAGATG - 58.4 
NF620 CD2790 3246899 U GCATGTACATACTGTATTTTATTT 52.5 
NF619 CD2790 3247554 L GTGGTAGATGCAACTTTATTTTT - 53.5 
NF621 cD2791 cwp2 3248534 L AACTGCAGTGGCTATAGCAAAAC - 58.9 
NF623 co2791 cwp2 3248729 U TTTCCTGTTTCTGAATCTTTTGC 55.3 
NF622 c02791 cwp2 3249482 L TCAGTAGCTCCAGTTTTTGCTG - 58.4 
NF625 cD2792 secA 3250007 U AGTATTGCACTGTTGCTTCCCT - 58.4 
NF624 cD2792 secA 3250722 L TGATAATCAGCTTAGAGGGCGT - 58.4 
NF626 cD2792 secA 3252092 U TGACGCATTCCCAATTTTCT - 53.2 
NF627 CD2793 s/pA 3253400 L GTCTTGTTGCATCACCATTAGC - 58.4 
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Primer CD? Gene 
Position 
in Cd6306 
genome 
SequenLe Features Tm 
NF629 CD2793 slpA 3253875 U GCTGATGTATATGAGCTTGCATC 58.9 
NF628 co2793 s/pA 3254628 L GCTGCAACTACTGGAACACAAG - 60.3 
NF630 cD2794 cwpl2 3255633 L AGGAGGAATAGATGAAAAGACGC - 58.9 
NF632 cD2794 cwpl2 3255759 U ATAGAAGAACCAGCAACTGCATC - 58.9 
NF631 CD2794 cwpl2 3256450 L ATTAATAATGGCAGGAGCACCA - 56.5 
NF633 CD2795 Cwpll 3257421 L AAATGCTTCAAAGTCAAATGGA 52.8 
NF635 cD2795 cwpll 3257578 U GTAAGTGGTGCAGCTGCTATTG - 60.3 
NF634 cD2795 cwpll 3258251 L TCAAAAGTGTAAATGCATCATCAG - 55.9 
NF636 cD2796 cwp10 3259499 L GATAAAAGTATGGTGGATGGGC - 58.4 
NF638 CD2796 cwp10 3259718 U CTCCACCATTATTTCCACCACT - 58.4 
NF637 cD2796 cwp10 3260473 L GCTCCAGTTTTACAAGGAACAAA - 57.1 
NF639 CD2797 3261504 L GTTGGTGGAGGAAAAGACCA - 57.3 
NF641 CD2797 3265819 U GCTGGAGCAGTACCTTCTGG - 61.4 
NF640 CD2797 3266654 L GGAAGCTAAGGGCAGTTGAA - 57.3 
NF642 CD2798 cwp9 3267321 L CAAGCTTCACCAAATCAACAAG 56.5 
NF644 cD2798 cwp9 3267782 U GCTATTGTAGAGGCAGCCAAAG - 60.3 
NF643 cD2798 cwp9 3268456 L TCCTATGGTAAGTGCGTTGACA - 58.4 
NF645 c02799 cwp8 3269859 L GATTCAAAGATGGAGAAGCAGAA - 57.1 
NF647 co2799 cwp8 3270083 U TCAAAGCTTGATTTTTCTGGTTT - 53.5 
NF646 CD2799 cwp8 3270839 L ATGGCAGGTGCTACAGTTATGA - 58.4 
NF649 CD2800 3271754 U TTTAAAGTTGACACCCAATACGC - 57.1 
NF648 C02800 3272029 L TGCATATATAATAACTTTGGCTGTT - 54.8 
NF505 CD2851 d/tC 3333712 U TTCTCTCTAAATCAGTTGGTTGAAGCTC - 62.2 
NF504 cD2851 dltC 3333811 L TTTGAAGATGTATTAGGGACTGATGAGA - 60.7 
NF507 cD2852 d/tB 3333960 U ATGAAAATCTGCACTCTCTCGAACC - 61.3 
NF506 co2852 d/tB 3334111 L AAAAGGACTACTGCTGCTCATGTGG 63.0 
NF509 CD2853 d/tA 3335837 U GCAAAAGAAGGAGTTGACACCCATA - 61.3 
NF508 co2853 dltA 3336055 L GCCAAAAGGGGTTCAAATAAGTTCA - 59.7 
NF511 CD2854 dltD 3337257 U AAAGCACCTTTTCAGCTTTTTCAGG - 59.7 
NF510 cD2854 dltD 3337427 L AAAAAGACGGAGTCACAAGTCACCA - 61.3 
NF467 co3215 3760672 U AATTCTGATGGGTAACGCACTTTCA 59.7 
NF466 c03215 3760932 L CTGTAATTGGTTCGTCTGGTTCTGG - 63.0 
NF469 cD3216 3761790 U TTCCCCCTCCTACACCTTGTGTAAT - 63.0 
NF468 co3216 3762118 L TGCATTAGCTGGTATCGCTTCATTT - 59.7 
Table 2.4 Primers used in this study 
The sequences of oligonucleotide primers are shown in the 5' to 3' direction. Relevant features 
and the predicted Tm are shown. Primers were designed using Primer3® vO. 3.0 (Rozen & 
Skaletsky 2000, http: //frodo. wi. mit. edu/cgi-bin/primer3/ primer3 www. cgi). Primers were 
obtained from Thermo Hybaid (Thermo Scientific) or MWG Biotech (Ebersberg, Germany). 
' CD# refers to the gene numbering in the genome of Cd630 (Sebaihia et aL 2006). b The 
position in the genome indicates the last nucleotide of the primer; U, uppermost strand; L, lower 
strand, as published. # indicates that the sequence is only found in Cd20532, and the equivalent 
position in Cd630 is shown. * indicates multiple binding sites. 
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centre of the membrane, allowed to stand for 1 minute, and then eluted at 15,000 rpm for 
1 minute. For amplifications generating a single product, a QIAquick® PCR Cleanup Kit was 
used according to the manufacturer's instructions. Briefly, the reaction was mixed with five 
volumes of Buffer PB before application to a QIAquick® spin column. The column was washed 
with 500µ1 and then 250µ1 Buffer PE. The column was then centrifuged for a further 2 minutes 
to ensure complete removal of ethanol. 30µl H2O or 30µ1 EB was added to the centre of the 
membrane, allowed to stand for 1 minute, and then eluted at 15,000 rpm for 1 minute. 
Southern blotting 
10µg genomic DNA was digested in a 4Oµ1 reaction containing lx BSA and either Ipi Asel 
(NEB) and 1x NEBuffer 3, or 1 µl SpeI (NEB) and 1x NEBuffer 2, which was then incubated at 
37°C overnight. Entire reactions were then run on a 1% TAE agarose gel at 60V for 4 hours. 
The gel was imaged, and then agitated in depurination solution (250mM HCl) for 12 minutes 
until the bromophenol blue loading dye had become yellow. The gel was rinsed and then 
agitated in denaturation solution (1.5M NaCl, 0.5M NaOH) until the bromophenol blue returned 
to blue, and for a further 25 minutes. The gel was rinsed, and then agitated in neutralising 
solution (1.5M NaCl, 0.5M Tris-Cl, pH 7.5) for 30 minutes and then a further 15 minutes in 
fresh neutralising solution. 
Capillary transfer was set up, with a reservoir of 20x SSC (0.3M Na3 citrate, 3M NaCl, pH 7.0) 
(Invitrogen) and three Whatman 3MM paper wicks, and the gel was placed on top. A 
Hybond-N+ membrane (Amersham Biosciences, GE Healthcare, Little Chalfont, UK) 
presoaked in lox SSC was placed on top, and then covered with three sheets of Whatman 3MM 
paper presoaked with lOx SSC and then a stack of paper towels before a weight was placed on 
top and the stack was left overnight. In the morning the stack was dismantled, the membrane 
was cut to the size of the gel, and the lane positions were marked. The membrane was rinsed 
with 6x SSC for 1 minute and then allowed to dry. A UV Stratalinker 1800 was used to 
crosslink the DNA to the membrane. 
The ECL Direct Nucleic Acid Labelling and Detection System (Amersham Biosciences) was 
used to probe the membrane. Hybridisation buffer (30m1 gold buffer, 1.5g blocking agent, 
877mg NaCl) was prepared and heated to 42°C. The membrane was transferred to a cylinder 
then the hybridisation buffer was added and rotated at 42°C for 1 hour. 
The probe used was one Cd630 repeat amplified by PCR (using NF375 and NF346, with an 
annealing temperature of 60°C and a 20 s extension time) and cleaned (QIAquick® PCR 
Cleanup Kit). lOng probe in l0µl was boiled for 5 minutes in a water bath and then plunged 
into ice for 5 minutes. 10µl labelling buffer and 10µ1 glutaraldehyde solution were added; the 
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solutions were mixed and then incubated at 37°C for 10 minutes. The labelled probe was added 
to the hybridisation buffer, returned to the membrane and rotated overnight at 42°C. 
The membrane was washed with 5x SSC for 5 minutes at 42°C, and then with preheated 
primary wash buffer (6M urea, 0.4% SDS, 0.5x SSC, 42°C) for 20 minutes and then twice for 
10 minutes at 42°C. The membrane was removed from the cylinder and washed twice with 
secondary wash buffer (2x SSC) for 5 minutes at room temperature. The membrane was 
exposed to ECL detection reagents (Amersham Biosciences) and signal was detected using a 
LAS-3000 Image Reader (Fujifilm, Bedford, UK). 
Cloning 
General Cloning 
A TOPO TA Cloning® Kit, which clones the insert using topoisomerase bound to the ends of 
the open vector, was used for primary cloning and also cloning for sequencing. After PCR 
amplification with a proofreading polymerase, O. 2µ1 Taq (SIGMA) was added and the reaction 
incubated at 72°C for 10 minutes to add A-overhangs. The required PCR product was then 
subjected to either QlAquick® PCR Purification or QlAquick® Gel Extraction. 
2µl cleaned amplification product was then mixed with O. 5µ1 salt solution and 0.5gl 
pCR®4-TOPO® vector (Invitrogen) and incubated at room temperature for 10 minutes before 
immediate transformation into One Shot® TOP 10 cells (Invitrogen). 
For subcloning, insert was excised using appropriate enzymes and gel purified. The digested 
insert and vector were mixed in a 3: 1 molar ratio in 101l volume. 101il 2x Quick Ligation'M 
Buffer and then 1 µl Quick T4 DNA ligase (New England Biolabs (NEB), Hitchin, UK) were 
added and the solutions were thoroughly mixed before being briefly centrifuged. The reaction 
was incubated at room temperature for 5 minutes before being returned to ice. The reaction was 
either immediately transformed into One Shot® TOP 10 cells (Invitrogen) or frozen at -20°C 
until needed. 
Cloning using the Gateway® system 
The Gateway® system uses att recombination sites to allow easy transfer of insert between 
vectors (Invitrogen). For entry into the system, in-frame primers were designed with a CACC 
extension to the forward primer, to allow directional cloning. After PCR amplification, IOng 
amplification product was mixed with 0.5µ1 salt solution and O. 5µ1 pENTR'"-TEV-TOPO® entry 
vector for directional cloning (Invitrogen) and incubated at room temperature for 10 minutes 
before immediate transformation into One Shot® TOP 10 cells (Invitrogen). Plasmid was 
extracted and purified from positive clones and the DNA sequenced. 50ng pENTR7-TEV clone 
was then mixed with 75ng pDEST'"15 (Invitrogen) (for N-terminal GST-tagged protein 
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expression) in 41l TE and 1 µl LR ClonaseT" II Enzyme Mix (Invitrogen) was added and 
thoroughly mixed. The reaction was incubated at 25°C for 1 hour, and then 0.511 proteinase K 
solution was added and the reaction was incubated at 37°C for 10 minutes. The reaction was 
immediately transformed into One Shot® TOP 10 cells (Invitrogen). Plasmid was extracted from 
positive colonies and then chemically transformed into Rosetta cells. 
Plasmid extraction 
Plasmids were extracted from positive colonies using Wizard® Plus SV miniprep DNA 
purification system (Promega, Southampton, UK) according to the manufacturer's instructions. 
Briefly, the colony was grown overnight in lOml LB. The cells were harvested by 
centrifugation at 15,000 rpm and then the pellet was resuspended in 250gl Cell Resuspension 
Solution. 250gl Cell Lysis Solution and l0µ1 Alkaline Protease Solution were added, and then 
the solutions were gently mixed by inversion and incubated at room temperature for 5 minutes. 
350µl Neutralisation Solution was added, the solutions were gently mixed by inversion and 
were then centrifuged for at least 20 minutes at 15,000 rpm. The cleared lysate was applied to a 
Wizard® SV minicolumn, washed with 50011 and then 250gl Wash Buffer, and then centrifuged 
for a further 2 minutes to ensure complete removal of ethanol. 3011 H2O or EB was applied to 
the membrane and allowed to sit for 1 minute before elution, and this process was repeated once 
more. Quality and quantity of the resultant plasmid was confirmed by measuring the A2601A280 
and by running an agarose gel. 
DNA Sequencing 
12.8pmol oligonucleotide primer and either 1µg plasmid or 300 - 600µg PCR product were 
made up to 12µl total volume and were sent to the Advanced Biotechnology Centre (ABC) at 
Imperial College London where the samples were subjected to dideoxy chain terminator DNA 
sequencing using BigDyeTM technology. Chromas Lite® v2.0 was used to visualise and edit the 
interpretation of resultant sequencing traces. 
2.4 Protein manipulation 
Protein expression and purification 
Expression and purification of CwpVrptl 
For induction of GST-tagged CwpVrptl, an overnight culture of E. coli BL21(DE3) 
transformed with plasmid pGEX-cwpVrptl (previously constructed in the laboratory by J-C 
Zhang, Figure 2.2) was diluted 1: 100 - 1: 50 into pre-warmed LB and incubated at 37°C with 
shaking. Once ODD had reached 0.4,1mM IPTG was added and the culture incubated for a 
further 3 hours. 
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T7 promoter 
GST tag 
GST-CwpVrpt 1 
Thrombin cleavage site 
BamHI 
CwpVrptl 
pGEX-4T-1: CwpVrptl 
5314 bp 
Z VT 
pBR322 origin 
Amp(R) 
Figure 2.2 Map of pGEX-cwpVrptl 
Diagrammatic map of pGEX: CwpVrptl, the pGEX-4T-1 (Amersham Biosciences) 
derived plasmid containing DNA encoding the first repeat of CwpV from Cd630 
fused to a GST expression tag. Resistance markers are shown. 
Cells were harvested by centrifugation and resuspended in phosphate buffered saline (PBS) 
pH 7.3, disrupted by sonication on ice for 10 minutes (10 s on / 10 s off) and the lysate was 
filtered and passed through a GSTrapTM FF column (Amersham Biosciences) using an ÄKTATM 
Prime setup (Amersham Biosciences) according to the manufacturer's instructions. 
To cleave the fusion protein, IOU thrombin (SIGMA) was added per milligram of protein and 
the mixture incubated at room temperature for 8 hours. Buffer exchange to PBS was 
accomplished using a HiTrapTM desalting column (Amersham Biosciences) or by two dialysis 
steps. The solution was passed in series through Benzamidine and GSTrapTM FF columns 
(Amersham Biosciences) to remove thrombin and cleaved GST respectively. 
Alternatively, after cleavage the solution was passed through a SuperdexTM 75 HiLoadT"' 26-60 
size exclusion column (Amersham Biosciences) to separate CwpVrptl from all other proteins. 
Peak fractions were pooled and concentrated using an Amicon Centriprep YM-3 (Millipore, 
Watford, UK) at 3,000xg. 
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Expression and purification of GST-tagged N- and C- termini of Cwp66 and CwpV 
The N-terminal cell-wall-binding domains of both Cwp66 and CwpV, the C-terminal domain of 
Cwp66 and two repeats of CwpV-Cd630 were cloned into pDEST15 as described above 
(Figure 2.3). The resultant plasmids were transformed into E. coli RosettaTM cells (Novagen). 
Transformants were selected on LB-Amp-Cm agar plates and inoculated into 2m1 Overnight 
Express (Novagen) + 50gg/ml ampicillin + 15gg/ml chloramphenicol and grown at 37°C for 
3 hours. These were then added to 120m1 Overnight Express (Novagen) + 50µg/ml ampicillin + 
I5gg/ml chloramphenicol in 21 baffled flasks and incubated at 25°C with 200rpm shaking for a 
further 23 hours until the OD had ceased increasing (at OD600 17.2-18.0). Cells were pelleted at 
10,000 rpm for 20 minutes at 4°C and frozen at -20°C. 
r-NterCwpV 
ROD 
pDEST15-N' 
6807 6 
pBR322 origin 
/ 
bla 
Amp(R) 
Figure 2.3 Map of pDEST15-cwpVN 
promoter 
N-ter CwpV 
attB2 
Diagrammatic map of pDESTl5-cwpVN, the pDEST15 derived plasmid 
containing DNA encoding the first repeat of CwpV from Cd630 fused to a GST 
expression tag. These are separated by pENTRTM-TEV derived DNA encoding a 
TEV cleavage site. Resistance markers are shown. All other pDEST-derived 
constructed plasmids show similar composition. 
Each pellet was then defrosted and resuspended in 30ml binding buffer (20mM NaPO4,150mM 
NaCl, pH 7.3) +2 Complete Mini EDTA-free Protease Inhibitor Cocktail tablets (Roche 
Diagnostics) + 5mg lysozyme (SIGMA) + 0.2mg DNase (SIGMA). The suspension was 
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sonicated on ice for 12 minutes in 1 minute bursts. Cell debris was pelleted at 4,200 rpm for 
20 minutes at 4°C. 5m1 Glutathione SepharoseTM 4 Fast Flow GST-affinity beads (GE 
Healthcare) in a 50m1 Falcon were washed twice with 30ml H2O, allowed to settle and the 
excess liquid removed. The cell lysate was poured onto the beads and the tube was rotated for 
4-5 hours at 4°C. The beads were pelleted at 600 rpm for 5 minutes and the supernatant 
removed. This was repeated for four 40ml binding buffer washes before the beads were poured 
into a Bio-Spin polypropylene chromatography column (Bio-Rad Laboratories, Hemel 
Hempstead, UK). Two further 10ml binding buffer washes were carried out until A28o returned 
to baseline. 3ml elution buffer (50mM Tris-Cl, 100mM reduced L-glutathione (SIGMA)) was 
added, the column was sealed and rotated for 10 minutes, and the eluate was drained and 
collected. Thiswas repeated 3-5 times until A280 returned to baseline. 
Elutions were pooled and centrifuged at 4,200 rpm, 4°C for 10 minutes. A SuperloopTM 
(Amersham Biosciences) was used to load the eluate onto a SuperdexTM 75 HiLoadTM 26-60 
size exclusion column (Amersham Biosciences), which was pre-equilibrated with 
10mM Tris-Cl, 150mM NaCl, pH 7.4 and attached to an ÄKTATM Fast Protein Liquid 
Chromatography (FPLCTM) setup. 2m1 fractions were collected, and those with substantial A280 
were visualised using SDS-PAGE. Fractions corresponding to the full-length protein were 
pooled, and the protein quantified by BCA assay. 
SDS-PAGE 
Standard SDS-PAGE gels at 10%, 12.5% or 15% acrylamide were prepared using mini-protean 
kits (Bio-Rad Laboratories). The separating gel (10-15% 39: 1 acrylamide: bisacrylamide, 
375mM Tris pH 8.8,0.1% SDS, 0.5% APS, 0.07% TEMED) was poured and isopropanol 
carefully layered on top. Once the gel was set, the isopropanol was discarded, the separating gel 
was rinsed with H2O and the stacking gel (5% 39: 1 acrylamide: bisacrylamide, 62.5mM Tris 
pH 6.8,0.1 % SDS, 0.1 % APS, 0.24% TEMED, trace bromophenol blue) was poured and the 
comb put in place to form the wells. Once set, the comb was removed and the gel was 
immersed in electrophoresis buffer (25mM Tris, 192mM glycine, 0.1% SDS). Protein samples 
were diluted in sample buffer (final concentration 45mM Tris pH 6.8,0.7% SDS, 0.7mg/ml 
sucrose, 3.5% ß-mercaptoethanol, trace bromophenol blue). These, along with a 101l aliquot of 
Prestained Broad Range Protein Marker (NEB), were heated to 100°C for 5 minutes and then 
briefly centrifuged. Samples were loaded into the wells of the gel and a constant voltage of 
100 - 160V applied. 
For visualisation of proteins, gels were stained in Coomassie blue (45% methanol, 10% glacial 
acetic acid, lmg/ml Coomassie blue stain) for 4- 16 hours, followed by destaining using 45% 
methanol, 10% glacial acetic acid. Gels were image scanned and then rehydrated in 10% 
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glycerol and dried between two cellulose membranes. Alternatively, gels were transferred to 
nitrocellulose membrane for immunoblotting. 
Determination of protein concentration 
Protein concentration was estimated by measuring OD280 using a Cary 50 Scan UV-visible 
spectrophotometer (Varian) and Cary WinUV Simple Reads Application v3.00. 
Protein concentration was then determined using a BCA assay (Pierce, Perbio Science, 
Cramlington, UK) carried out according to the manufacturer's instructions. Briefly, standards 
(BSA) and samples were serially diluted in PBS. Reagents A and B were mixed in a 50: 1 ratio, 
then 180µI reagent was added to 20µl sample. The reaction was incubated for 30 minutes at 
37°C, then the absorbance at 595nm determined using a Benchmark microplate reader (Bio-Rad 
Laboratories). 
2.5 Immunodetection 
Raising rabbit a-CwpVrptl antibodies 
Purified CwpVrptl, at 1.4mg/ml as determined by BCA assay, was sent to Eurogentec (Seraing, 
Belgium) for raising of antiserum using their FAST Rabbit Polyclonal Antibody protocol. 
400µg protein plus 500µ1 adjuvant was administered to two New Zealand White rabbits on days 
0,14,28 and 50. Rabbits were bled out on day 65 and anti-CwpVrptl serum was obtained. 
Rabbit 899 showed a stronger response, as serum demonstrated dramatically higher affinity for 
CwpVrptl as determined by ELISA, so this serum was subsequently used. 
Affinity purification 
An Affi-gel 10 (Bio-Rad Laboratories) column was prepared and used according to the 
manufacturer's instructions. Briefly, 3ml Affi-gel 10 was applied to Bio-Spin polypropylene 
chromatography column (Bio-Rad Laboratories) and washed with three times with 3m1 distilled 
water. 100mg FPLC-purified CwpVrptl protein was concentrated to 6m1 and rotated with the 
column overnight at 4°C. The column was washed with 20mM HEPES pH 7.5 until OD280 
returned to base levels. The column was then washed with 9m1 each of TBS (20mM Tris 
pH 7.5,150mM NaCl); TBS-salt (20mM Tris pH 7.7,500mM NaCl); 100mM glycine pH 2.5; 
50mM Tris pH 8.8; 100mM ethanolamine pH 11.5; and TBS again. No elution of CwpVrptl 
was seen with any solution, as monitored by OD280 (data not shown). 
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2m1 rabbit anti-CwpVrptl serum was diluted to 4m1 with TBS, added to the column and rotated 
overnight at 4°C. The column was washed with 9m1 each of TBS and TBS-salt. 100mM glycine 
pH 2.5 was added in lml aliquots and fractions were collected into tubes containing 84µl 1M 
Tris base and 80µl 5mg/ml BSA. The column was washed with 10ml 50mM Tris pH 8.8. 
100mM ethanolamine pH 11.5 was added in lml aliquots and fractions were collected into tubes 
containing 100µl 1M Tris pH 7.5 and 8011 5mg/ml BSA. The column was washed with 16m1 
TBS. Fractions were assayed by ELISA against immobilised purified CwpVrptl (Figure 2.2), 
and glycine elutions 4-7 were pooled as affinity-purified rabbit anti-CwpVrptl (a-CwpVrptl). 
Antibody specificity was verified by absence of detection of any proteins by Western 
immunoblotting of an E. cola strain not harbouring pGEX-cwpVrptl. 
ELISA 
96-well MaxiSorp PS Immuno F96 plates (Nunc, Roskilde, Denmark) were coated overnight at 
4°C with 50µ1 antigen at lµg/ml. After three washes with PBS + 0.1% Tween-20 (PBS-T) the 
plates were blocked with 100µ1 PBS-T + 2.5% dried skimmed milk (milk) at 37°C for 1 hour. 
Plates were washed three times with PBS-T. Sera were serially diluted in PBS-T + 2.5% milk, 
and 50µl incubated on the plate for 2 hours at 37°C. Plates were washed three times with PBS-T 
then 5011 1/2000 HRP-conjugated secondary antibody diluted in PBS-T + 2.5% milk was added 
and incubated in the wells for 1 hour at 37°C. After three washes with PBS-T, 50gl OPD 
substrate was added and incubated on the plate for 15 minutes at room temperature. The 
reaction was stopped using 15µ1 3M H2SO4 and the optical density at 492nm was determined 
using a Benchmark microplate reader (Bio-Rad Laboratories). 
Western immunoblotting 
SDS-polyacrylamide gels were transferred to Trans-blotTM transfer medium (Bio-Rad 
Laboratories) nitrocellulose membrane using a semi-dry protocol. Membrane, gel and filter 
paper were pre-soaked in transfer buffer (25mM Tris, 192mM glycine, 20% methanol). A 
Trans-blotTM SD semi-dry transfer cell was run at 0.08V for 0.5 - 1.5 hours. Transferred 
proteins were visualised by staining with Ponceau S solution (SIGMA) for 1 minute, destained 
using H2O and the membrane was image scanned. Stain was then removed by immersion of the 
membrane in PBS-T. 
The membrane was blocked for at least 1 hour in PBS-T + 10% milk. After one wash in PBS-T, 
primary antibody diluted in PBS-T + 2.5% milk was added for at least 1 hour as detailed in 
Table 2.6. The membrane was washed four times in PBS-T, then incubated for at least 30 
minutes in secondary antibody (Dako Cytomation, Ely, UK) diluted in PBS-T + 2.5% milk. 
The membrane was washed four times in PBS-T. Signal was detected using ECL reagents 
(Amersham Biosciences) or SuperSignal® West Pico Chemiluminescent Substrate (Pierce) 
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followed by image capture using a LAS-3000 Image Reader (Fujifilm). Where appropriate, 
sizing and quantification were carried out using AIDA Image Analyser v4.18. 
Immunostaining 
200µl C. docile cells from liquid culture at an optical density (OD600) of 0.6 were washed in 
twice with PBS then fixed in 8% formaldehyde at room temperature for 15 minutes. After two 
PBS washes the cells were incubated in 500m120mM NH4C1 for 15 minutes. After two further 
PBS washes, cells were resuspended in 20µ1 PBS and then lOµ1 cell suspension was spotted 
onto a glass slide and allowed to dry. The slide was washed by running PBS over the spot and 
the slide was then drained. 15µl PBS containing rabbit a-CwpVrptl (final dilution 1/10) 
together with rat a-LMW-SLP (1/20 dilution) was dropped onto the spot and the slide was 
incubated covered on a moist tissue for 45 minutes. The slide was washed by running PBS over 
the spots before immersion in a PBS bath for 1 minute and the slide was then drained. 151il 
PBS containing a-rabbit-FITC (1/10 dilution) (Dako Cytomation) and a-rat-rhodamine red (1/40 
dilution) (Jackson ImmunoResearch Laboratories, West Grove, PA) was dropped onto the spot 
and the slide was incubated in the dark on a moist tissue for 45 minutes. The slide was washed 
by running PBS over the spots before immersion in a bath containing PBS for 1 minute and a 
bath containing H2O for 1 minute. The slide was then drained and allowed to dry before 10µl 
Mowiol mount was dropped over the spot, a glass cover slip was placed on top, and the 
mountant was allowed to dry in the dark at room temperature overnight. Images were captured 
using an Axio Imager. M1 microscope and AxioVision v4.6 (Carl Zeiss Ltd., Welwyn Garden 
City, UK), with the help of Andy Whale. High but consistent background glow was adjusted 
using Adobe® Photoshop CS v8.0. 
Flow cytometry 
l0µ1 overnight liquid culture of C. dWIcile was washed in PBS then the cells resuspended in 
25gl a-CwpVrptl (1/10 dilution in PBS) and incubated on ice for 1 hour. lml PBS was added; 
the cells were pelleted and then washed with lml PBS. The cells were resuspended in 25µl 
a-rabbit-FITC (1/10 dilution in PBS) and incubated on ice in the dark for 30 minutes. lml PBS 
was added; the cells were pelleted and then washed with lml PBS. Cells were resuspended in 
200µl PBS, transferred to FACS tubes and analysed with the help of Aaron Rae or Sachintha 
Jayasinghe using a Becton Dickinson FACS Calibur that was calibrated according the 
manufacturer's instructions. The cells were run through the flow cytometer and excited with a 
488nm laser and the FITC fluorescence was measured in the FL1 channel with a 530/30 band 
pass filter. The data was analysed using BD CellQuestTM Pro (BD Biosciences, San Jose, CA). 
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Immunogold electron microscopy 
Colonies were scraped from blood agar plates and resuspended in cold 4% paraformaldehyde 
(PFA) and 0.2% glutaraldehyde in PBS, and were fixed on ice for 10 minutes. The cells were 
pelleted at 3,000 rpm, the supernatant was discarded and the pellet was fixed with 4% PFA and 
0.2% glutaraldehyde for a further hour. The pellet was washed three times in PBS and then 
infiltrated with 2.3M sucrose in PBS overnight at 4°C; attached to a specimin stub; and plunge- 
frozen in liquid nitrogen. 65nm ultrathin cryosections were cut on a Leica UCT ultramicrotome 
with EM FCS cryoattachment. Sections were mounted on grids with formvar support and 
blocked with 0.02M glycine in PBS followed by 10% FCS in PBS; this was the diluent for all 
subsequent steps. Sections were incubated in a-CwpVrptl for 1 hour followed by three 
5-minute PBS rinses. Sections were incubated in l5nm Protein A gold for 30 minutes followed 
by three 5-minute PBS rinses. Sections were rinsed in double distilled H2O six times over 
5 minutes. The sections were then contrasted with uranyl acetate in methyl cellulose on ice for 
10 minutes. The sections were air dried and viewed in a CM100 transmission cryo-electron 
microscope (Philips, Guildford, UK) at 16,000x - 32,000x magnification. Immunogold staining 
and electron microscopy were carried out by David Goulding. 
2.6 Mammalian cell culture 
Tissue culture 
Vero cells (ATCC® number: CCL-81TM) are adherent epithelial cells derived from normal 
African green monkey kidney cells, and were obtained courtesy of Yash Bhasin, St Mary's 
Hospital, Paddington. HEp2 cells (ATCC® number: CCL-23TM) are adherent epithelial cells 
that were originally thought to be derived from an epidermoid carcinoma of the larynx, but are 
actually a HeLa contaminant. HeLa cells are derived from an adenocarcinoma of the cervix. 
Both cell lines were routinely cultured in DMEM, 4500mg/l glucose (SIGMA) plus 10% FCS 
plus 10mM L-glutamine (DMEM) in a Heraeus® HERAcell® 150 incubator (Kendro, Thermo 
Scientific) set to 37°C, 5% CO2. Cells were split by washing the flask twice with 0.02% EDTA 
followed by incubation with 0.02% EDTA plus 2% trypsin for 10 minutes at 37°C, before 
sharply knocking the flask and adding of five volumes of media. Cells were pelleted at 
1,500 rpm for 4 minutes at room temperature, then the supernatant was discarded and 10ml 
fresh media was added. A haemocytometer was utilised to determine the concentration of cells 
in suspension, then the suspension was adjusted to 105 cells/ml with DMEM+. Cells were 
replated at a density of 1/6 to 1/30 and replaced at 37°C, 5% CO2. 
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For subsequent use in binding assays, l00µ1 cell suspension (104 cells), or IOOµ1 DMEM+, were 
plated into each well of a tissue-culture-treated 96-well Cell Culture Cluster (Coming Inc., 
Lowell, MA) and the plates were incubated for 16 - 24 hours at 37°C 5% C02- 
Binding assays 
Binding of purified protein to mammalian cells 
GST-tagged proteins were adjusted to the required concentrations in 20% Tris-NaCI (IOmM 
Tris 150mM NaCl pH 7.4) / 80% DMEM+. 96-well plates of HEp2 or Vero cells were drained 
and 50µ1 protein solution was added to each well and incubated at 37°C, 5% CO2 for 
20 minutes. Wells were drained and washed three times with l00µ1 Dulbecco's PBS (dPBS) + 
0.1% Tween-20 (dPBS-T). 50µl 4% formaldehyde was incubated in each well for at least 
20 minutes, followed by 60µl IOmM NH4Cl for at least 20 minutes. Wells were washed once 
with l00µ1 dPBS-T and 50µl a-GST (SIGMA) (diluted 1/5000 in dPBS-T + 2.5% milk) was 
added and incubated at 37°C for at least 1 hour. Wells were washed three times with 100µ1 
dPBS-T. 50µl a-rabbit-HRP (Dako Cytomation) (diluted 1/2000 in dPBS-T + 2.5% milk) was 
added to each well and the plate was incubated at 37°C for at least 1 hour. Wells were washed 
three times with 100µl dPBS-T and once with l00µ1 dPBS. 50µl lmg/ml OPD in citrate buffer 
(50mM citric acid, 100mM Na2HPO4, pH 5.0,0.1% hydrogen peroxide) was incubated in each 
well at room temperature until sufficient signal was observed, then the reaction stopped by 
addition of 20gl 3M H2SO4 to each well and the absorbance at 492nm was determined using a 
Benchmark microplate reader (Bio-Rad Laboratories). For each condition, the data was 
averaged and signal from the two empty wells (no mammalian cells) was subtracted from the 
signal in the six experimental wells, before also subtracting the signal generated in the absence 
of added experimental protein. 
Haemagglutination 
GST-tagged test proteins and concanavalin A were serially diluted to the required 
concentrations using 40% 10mM Tris, 150mM NaCl, pH 7.4 / 60% PBS. 25µ1 was transferred 
to a round-bottomed 96-well NunclonTM A surface tissue culture plate (Nunc). Freshly collected 
human blood was washed three times with PBS and resuspended at 1/20 in PBS. 25111 blood 
suspension was added to each well, the plate was gently agitated and then incubated without 
disturbance for 1.5 hours at either 4°C, 22°C (room temperature) or 37°C. The plates were then 
scanned using a Powerlook 2 100XL scanner (Umax) and MagicScan DA v4.5 (Umax). 
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2.7 RNA and Microarray analysis 
Stress and harvest of C. difficile cultures 
For antibiotic exposure experiments, Cd630 was grown in triplicate in the presence of maximal 
concentrations of antibiotic allowing relatively normal growth rates, which were determined 
to be lµg/ml amoxicillin, 50gg/ml clindamycin or 0.15µg/ml metronidazole (Section4.6). 
Cultures with each antibiotic or no antibiotic were set up from the same overnight starter 
culture. Cells were harvested at late logarithmic phase (0.6 - 0.8 OD600). 
For heat shock experiments, Cd630 cultures grown to late logarithmic phase (0.6 ODD) at 
30°C. These were split into 15m1 aliquots and then sealed into 50m1 Falcon tubes and incubated 
in a water bath at either 30°C (control) or 42°C (heat) for 5,15,30 or 60 minutes before harvest. 
For pH shock experiments, 50m1 Falcon tubes were prepared containing 0.5m1 BHI containing 
either 63µl IOM sodium hydroxide (designed to alter the final pH to pH 8.5), 24µl concentrated 
hydrochloric acid + 39µl water (to pH 4.5) or 63µl water. Triplicate cultures of Cd630 were 
grown to late logarithmic phase (0.5 - 0.6 OD600) and then 16.5m1 culture was added to the 
prepared tubes. These aliquots were incubated anaerobically for 15 minutes before harvest. 
For oxygen exposure experiments, late logarithmic phase (0.5 - 0.7 ODD) Cd630 cultures were 
separated into 17m1 aliquots, sealed into 50m1 Falcon tubes and removed from the anaerobic 
cabinet. Half of the aliquots were exposed to the atmosphere and then resealed and shaken, 
three times. Control aliquots remained sealed with parafilm and were shaken but not exposed to 
the atmosphere. All aliquots were parafilm sealed and returned to the 37°C anaerobic cabinet 
for 10 minutes. 
In each case, cells were harvested by immediate addition of two volumes of RNAprotect® 
Bacteria Reagent (Qiagen) to a volume of up to 17m1 stressed Cd630 culture. This was mixed 
thoroughly and incubated at room temperature for 5 minutes before pelleting at 4,000 rpm, 4°C 
for 10 minutes. The pellet was stored at -80°C before proceeding to RNA extraction. 
C. difficile RNA extraction 
For all situations which involved handling RNA, surfaces, gloves and pipettes were wiped with 
RNaseZap® RNase decontamination solution (Ambion, Austin, TX). 
After bacterial cell harvest (see Stress and harvest of C. di/cile cultures), RNA was extracted 
using the TRIzol® Max'm Bacterial RNA Isolation kit (Invitrogen) according to the 
manufacturer's instructions. Briefly, the stabilised pellet from 5m1 to 12m1 culture was 
resuspended in 2O0µ1 hot Max 
TM Bacterial Enhancement Reagent and incubated at 95°C for 
6 minutes. 1 ml TRIzol® reagent was added, mixed well, and incubated for 5 minutes at room 
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temperature. 2O0µ1 ice-cold chloroform was added, shaken vigorously for 15 seconds and 
incubated for 3 minutes at room temperature, before centrifuging at 15,000 rpm, 4°C for 20 
minutes to separate the phases. 600µl of the clear upper phase was removed into a fresh tube 
and 75Oµ1 ice-cold isopropanol was added to precipitate the RNA. This was incubated at room 
temperature for 10 minutes before pelleting the RNA at 15,000 rpm, 4°C for 10 minutes. The 
pellet was washed with 75% ethanol and then allowed to air dry. The pellet was resuspended in 
water and then treated with DNA-free*' or Turbo DNA-free'" (Ambion) according to the 
manufacturer's instructions in order to remove DNA contamination. The A260/A280 ratio was 
determined and samples were run on an agarose gel in order to determine RNA quality, quantity 
and purity. A 16S rRNA PCR amplification was carried out using O. 5µ1 RNA as template to 
ensure there was no residual DNA. 
Reverse transcription (RT)-PCR 
RNA was reverse transcribed using a RETROscript® First Strand Synthesis Kit (Ambion) 
according to the manufacturer's instructions. Briefly, 2µl (100pmol) Random Decamers were 
added to 1µg RNA in 12µ1 total volume and heated to 85°C for 3 minutes. The tubes were 
returned to ice and 2µl lOx RT buffer, 4p1(lOnmol each) dNTPs, lµl (10 units) RNase inhibitor 
and lµl (100 units) MMLV-RT (Moloney murine leukaemia virus reverse transcriptase) were 
added and mixed thoroughly. The reaction was incubated at 44°C for 1 hour, and then the 
enzyme was heat-inactivated at 92°C for 10 minutes. 
0.1 - 2µl cDNA (depending on the prevalence of the target gene), derived from 5- lOOng RNA, 
was used as template in a standard 12µl or 20µ1 PCR reaction. 
Real-time qPCR 
RNA was reverse transcribed using a High-Capacity cDNA Archive Kit (Applied Biosystems, 
Foster City, CA) according to the manufacturer's instructions. 0.25µg RNA was placed in a 
l001il reaction containing Ix RT buffer, 1x dNTP mixture, Ix Random Primers, and 250U 
MultiScribe RT. This was incubated at 25°C for 10 minutes and then at 37°C for 2 hours before 
storage on ice. Real-time quantitative PCR (qPCR) assays were designed by Applied 
Biosystems using their Custom TagMan® Gene Expression Assay Service (Table 2.5) and 
carried out according to the manufacturer's instructions. 
Briefly, 2µl cDNA template was added to each well of a Fast Optical 96-well Plate (Applied 
Biosystems) and spun down. 12.5µl Master Mix (Applied Biosystems) was combined with 
1.25µ1 assay and 9.25 µ1 H2O per well and then 23µl was added to the opposite wall of each well 
and spun down. The plate was sealed with an Optical Adhesive Cover (Applied Biosystems) 
and loaded into an ABI PRISMTM 7700 sequence detector (Applied Biosystems). The plate was 
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heated to 50°C for 2 minutes then 95°C for 10 minutes, and then cycled 95°C 15 s, 60°C 60 s, 
forty times. Data was analysed using Sequence Detection Systems (SDS) v1.9.1. CT values 
were determined using cycles 3 -11 as background and a 0.55 cutoff (samples which never 
reached this threshold were given a CT value of 40), and were exported to Excel for 
manipulation. Each reaction was normalised to the Cr determined by the slpA assay OCT) and 
then converted into arbitrary units of RNA. 
Assay Forward Reverse Probe 
16S TGAGACACGGTCCAAACTCCTA GCTTTCGCCCATTGTGCAATAT CCCACTGCTGCCTCC 
CD2263 CTGAAGAAATACTTAAAAAAGCCCAAGCT GATTCCACCATCTGACCTTTACCAA TCTCCACCTGATTCTGC 
Co3215 GCCAAATGATATGAAAGTGCGTTACC CTTGCAATCCCTACACGTTGTTG CCACCTGACAATTCT 
cwp66 GGACAAAGTCTGAAAGTGCTGTCTT GGCGCATCTTTTGCTTTAGCA CCATAGCAGATGCTTTATCA 
groEL AAGTGCTTTACAAAATGCTGCATCA CTGGCATTCCTGCATCTTCTTTT CAGCAACAGCAGCTTCAGT 
cwpV GCAGGAGCAGTATCTGAAACAACT TGTTGATATTGGATCTGACGCATGT TCAGCAGCAAATGCA 
potC TTTGCCAAAAATGAAGCAATTACCTGAT CGTATATAGGTGTTGCTCCCAAGT CCATAGCTGCATCTTCT 
sIpA GCTGCAACAAAGGCACTTAAAGTTA CAACATATCCAGTATCTTCGCTTCCA CCAGACTTCAAACCAAATGT 
speE GTGAAGGGCTTTTCTCAACTGATTTTTAT GTCAAAATACGGACTTTCACTTTGATTTACT ACTGATGATGGAATTTT 
Table 2.6 TagMan® Gene Expression Assay component sequences 
Nucleic acid sequences of the components of the Custom TagMan® Gene Expression 
Assays obtained from Amersham biosciences. The probe (reporter oligo) is labelled 
with FAM dye and NFQ quencher. These are released as the polymerase reads 
through the probe, and the dye ceases to be quenched. The increase in fluorescence is 
continuously measured, and the CT determined as the cycle in which the fluorescence 
rises above a cutoff value. 
Microarray 
Concentration of RNA 
RNA was concentrated using an RNeasy® MinElute'M Cleanup kit (QIAGEN) according to the 
manufacturer's instructions. Briefly, RNA volume was adjusted to 200µl and 700µ1 Buffer RLT 
was added and thoroughly mixed. 500µ1 97% ethanol was added, mixed, and the solution 
applied to a RNeasy® MinEluteT" spin column. This was then washed with 500µ1 Buffer RPE 
and then 500µl 80% ethanol before a further 2 minute spin to dry the silica-gel membrane. 
RNA was eluted twice using 12µl RNase-free water, and adjusted to 1.25µg/µ1. 
Microarrays were then carried out and analysed according to the BµG@S Microarray Group 
Hybridisation Protocol, which is described below. 
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Cy5 Labelling of RNA 
10µg of total RNA sample was placed in a microfuge tube (0.5m1) with 3µg random hexamers 
(1µl) (Invitrogen) and made up to a final volume of 11µl with nuclease-free H2O (Ambion). 
The RNA was then heated to 95°C for 5 minutes, snap-cooled on ice and briefly centrifuged. 
5µl 5x First Strand Buffer, 2.5µ1 100mM DTT, 2.3µl dNTPs (5mM dA/G/ITP, 2mM dCTP), 
L7µ1 1mM Cy5 dCTP (Amersham Biosciences) and 2.5µ1 SuperScript II (200U/µl) (Invitrogen) 
were added to make a final volume of 25µl. The solution was incubated in the dark at 25°C for 
10 minutes and then at 42°C for 90 minutes. 
Cy3 labelling of DNA 
3µg of C. dilcile genomic DNA was placed in a microfuge tube (0.5ml) with 3µg of random 
hexamers (lµl) (Invitrogen) made up to a final volume of 42.5p1 with nuclease-free H2O 
(Ambion). This was then heated to 95°C, snap-cooled on ice and briefly centrifuged. 5µl lOx 
REact Buffer 2, lµl dNTPs (5mM dA/G/TTP, 2mM dCTP), 1.511 1mM Cy3 dCTP (Amersham 
Biosciences) and lµ1 Klenow fragment (3.9U/µl) (Invitrogen) were added to make a final 
volume of 50µl. The solution was incubated in the dark at 37°C for 90 minutes. 
Hybridisation 
Excess Cy3- and Cy5-dCTP was removed from labelled DNA and cDNA samples using the 
MinEluteTM Reaction Cleanup Kit (QIAGEN). Briefly, Cy3-labelled DNA and Cy5-labelled 
cDNA samples were combined in a single tube (1.5ml) and five volumes (375µl) of Buffer PB 
was added. The solution was applied to a MinEluteT" column and centrifuged at 13,000 rpm for 
1 minute. The column was washed with 500µ1 of Buffer PE and then 250µ1 of Buffer PE. The 
MinEluteTM column was placed into a fresh 1.5m1 tube, and then 30.2µl nuclease-free H2O was 
added to the. centre of the membrane and allowed to stand for 1 minute before being centrifuged 
at 13,000 rpm for 1 minute. 
50m1 of prehybridisation solution (3.5x SSC, 0.1% SDS, 10mg/ml BSA) was placed in Coplin 
jar and incubated at 65°C to preheat for at least 90 minutes. The microarray slide was placed in 
the pre-hybridisation solution and incubated at 65°C for 20 minutes. The slide was then rinsed 
in 400m1 water for 1 minute and then 400m1 isopropanol for 1 minute. The slide was placed in 
a 50m1 centrifuge tube and centrifuged at 1,500 rpm for 5 minutes to dry. Each slide was stored 
in a dark, dust free box until hybridisation (<1 hour). 
The prehybridised microarray slide was placed in the hybridisation cassette and two 15gl 
aliquots of water added to the wells of the cassette. A 4x SSC, 0.3% SDS hybridisation solution 
containing the Cy3/Cy5 labelled samples with a final volume of 45µl was prepared. The 
hybridisation solution was heated at 95°C for 2 minutes, allowed to cool slightly at room 
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temperature and briefly centrifuged. Two 22x22mm LifterSlips (Erie Scientific, Thermo 
Scientific) were placed carefully over the arrayed area of the slide, avoiding scratching its 
surface. The hybridisation solution was pipetted under one corner of the LifterSlip, allowing the 
solution to be drawn completely across the array by capillary action. Any excess hybridisation 
solution was pipetted under the opposite corner of the LifterSlip. The hybridisation cassette was 
sealed and submerged in a water bath at 65°C in the dark for 16 - 20h. 
Wash A (1 x SSC, 0.05% SDS) was preheated to 65°C and placed in a staining trough pre-heated 
to 65°C. The microarray slide was removed from the hybridisation cassette and carefully 
washed in the staining trough of Wash A at 65°C to remove the LifterSlip. The slide was then 
placed in a slide rack and agitated in Wash A for a further 2 minutes. Slides were then agitated 
in a trough of 400m1 of Wash B (0.06x SSC) at room temperature for 2 minutes, twice. Slides 
were then dried by centrifugation at 1,500 rpm for 5 minutes in a 50m1 centrifuge tube. 
Scanning and Quantification 
The standard BµG@S Affymetrix 428 scanning protocol was used. Fluorescence intensity was 
scanned in each channel at the lowest sensitivity resulting in partial saturation of the brightest 
spot (excluding positive control spots); this was usually the s1pA spots. Where possible, scans at 
increasing sensitivity increments were also obtained, up to the maximum sensitivity of 100. 
All images of a single slide were uploaded together into ImaGene® v5.5 (BioDiscovery, El 
Segundo, CA), and manually aligned where necessary. A4x8x (17 x 18) grid was overlaid 
and roughly aligned to the grid of spots, and then automated spot finding and adjustment was 
carried out using auto-segmentation settings. Manual modifications were then made where 
necessary and "Poor" spot labels used to discount artefacts (for example dust or scratches in the 
slide resulting in defects on the image). The intensity of each spot in each image relative to its 
local background was then calculated and spot confidence labels (Present, Marginal, Absent) 
were assigned according to the spot's shape, intensity and uniformity. Only spots labelled 
Present or Marginal were used in subsequent GeneSpringTM analysis; Absent or Poor spot data 
was discarded. 
For antibiotic experiments, scans at multiple intensity were obtained and MAVI Pro v2.6.0 
(MWG Biotech) was used to collate the intensity data into a single data set with larger dynamic 
range than is possible to determine from a single image. 
Data analysis 
Paired data sets for Cy5 (RNA) and Cy3 (DNA) spot fluorescence intensity quantifications were 
then uploaded to GeneSpringTM GX v7.2 (Agilent Technologies, Wokingham, UK). Values 
below 0.01 were set to 0.01, to allow logarithmic interpretation of the data. The logt ratio of the 
93 
Chapter 2- Materials and methods 
intensity in the RNA channel (Cy5) to that in the control DNA channel (Cy3) was calculated. 
Data was then normalised to each slide's median intensity ratio (of Present and Marginal spots). 
Each gene in each experiment was then normalised to the median of the ratios obtained under its 
"control" condition. 
Quality control testing consisted of comparison of the overall hybridisation intensity profile of 
each slide using box plots; principal component analysis to identify outliers; and phylogenetic 
tree construction to determine clustering. Abnormal, weak slides were removed from the data 
set and the normalisations carried out once again. 
The default interpretation mode was set to "Log of Ratio" (of Present and Marginal spots) to 
allow correct statistical analysis; this is essential for parametric tests. Each stress was then 
tested separately for statistical differences between stress and control conditions using ANOVA. 
A 1% or 5% confidence level was used, in conjunction with Benjamini-Hochberg, Bonferroni or 
no multiple testing correction. 
GeneSpringTM also contains a number of gene lists related to gene properties. Some gene list 
sets were automatically generated using the genome annotation or downloaded information 
(gene product; EC number; KEGG pathway (B. subtilis); GO (gene ontology) classification; 
Pfam domains'), and some were compiled manually using keyword searches, shared gene 
names, or closely contiguous genes within the genome that may represent operonic structures. 
Each statistically derived list of genes whose expression was changed by stress was compared to 
these gene lists to identify significant overlap. Expression data was also inspected manually for 
trends of change below statistically significant levels. 
Fully annotated microarray data has been deposited in BuG@Sbase: shock experiments with 
accession number E-BUGS-55 (http: //bugs. sgul. ac. uk/E-BUGS-55) and antibiotic experiments 
with accession number E-BUGS-56 (http: //bugs. sgul. ac. uk/E-BUGS-56). The BuG@S 
CDv1.0.0 array design is also available in BuG@Sbase with accession number A-BUGS-20 
(http: //bugs. sgul. ac. uk/A-BUGS-20). Data is also deposited in ArrayExpress with the same 
accession numbers (http: //www. ebi. ac. uk/arrayexpress/). 
1 data generated in this study 
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3.1 Introduction 
Bacterial surface-layers 
Surface-layers, or S-layers, are paracrystalline two-dimensional arrays of a single protein 
forming a complete monolayer covering at the outermost surface of bacteria (reviewed in Sleytr 
& Beveridge 1999; and Sara & Sleytr 2000). S-layers have been identified in both Gram- 
positive and Gram-negative Eubacteria and are present on almost all Archaea from many 
different habitats. The S-layer protein subunits, SLPs, create a regular lattice that may have 
square, oblique or hexagonal symmetry, with uniform pores of 2-8 nm comprising up to 70% 
of the surface area. Many purified SLPs retain the ability to form regular arrays; these 
spontaneously re-form upon removal of the disrupting agent used for their isolation. SLPs are 
usually 40 - 170 kDa in size and are weakly acidic with a high proportion of acidic amino acids, 
low levels of histidine and methionine, and little or no cysteine; although little sequence 
homology is seen even between individual strains of some species. S-layers of Gram-positive 
bacteria are commonly glycosylated, although the glycosylation bears little resemblance to that 
seen in eukaryotes (Messner et al. 1997). Many SLPs have been shown to contain one or more 
S-layer homology (SLH) domains at their N-terminus. This is a complex motif thought to 
anchor the protein to the underlying cell wall. The SLH domain has also been found at the 
C-terminal of cell-associated exoenzymes (Lupas et al. 1994; Sara 2001). 
S-layers are a huge metabolic investment: it has been estimated that in bacteria replicating every 
20 minutes, over four hundred SLP subunits must be produced and translocated every second 
(Sleytr & Messner 1983). This, together with the ubiquitous nature of S-layers, suggests that 
they serve an important purpose, although no consistent function has been characterised for all 
S-layers. The regular arrangement of precisely-sized pores may allow the S-layer to serve as a 
molecular sieve; indeed the S-layer of Bacillus stearothermophilus has been shown to 
demonstrate a sharp cutoff in permeability to molecules above 30 - 45 kDa (Sara & Sleytr 
1987). The S-layer can also serve as a binding site for extracellular enzymes: the S-layer of 
Staphylothermus marinus associates stoichiometrically with a globular subtilisin enzyme; and 
the B. stearothermophilus S-layer functions as an adhesion site for a high molecular weight 
amylase (Egelseer et al. 1995; Mayr et al. 1996). In Synechococcus strain GL24 the S-layer 
precipitates and sheds fine-grain minerals in order to prevent build up on the bacteria (Schultze- 
Lam et al. 1992). 
97 
Chapter 3.1 - CwpV - Introduction 
S-layers have been shown to be virulence factors of Bacteroides forsythus and Aeromonas 
salmonicida (Gustafson et al. 1994; Sabet et al. 2003), to have insecticidal activity in Bacillus 
thuringiensis (Pena et al. 2006), and to protect bacteria from Bdellovibrio bacteriovorus attack 
(Koval & Hynes 1991). In Aeromonas salmonicida the S-layer binds IgG and provides 
resistance to the bactericidal activity of complement (Munn et al. 1982; Phipps & Kay 1988); 
and the Campylobacter rectus S-layer protects against complement-mediated and phagocytic 
killing in the absence of specific antibody (Okuda et al. 1997). The Campylobacter fetus 
S-layer is responsible for immune evasion in two different ways: presence of the S-layer inhibits 
complement C3b binding (Blaser et al. 1988), and the bacteria are also able to switch which of 
their multiple SLP genes is expressed, providing antigenic variation thereby delaying the 
development of specific antibodies in an ovine model (Dubreuil et al. 1990; Grogono-Thomas et 
al. 2003). This switching is accomplished by inversion of genomic DNA to place one of eight 
SLP genes in close proximity to the SLP promoter (Dworkin & Blaser 1996). 
The S-layer of Clostridium difficile 
The S-layer of C. dicile has been studied by a number of groups. Treatment of cells with 
urea, guanidine hydrochloride or low pH glycine results in the extraction of two proteins from 
the cell wall. The sizes of these proteins vary between strains, with the vast majority having a 
-32 kDa low molecular weight (LMW) SLP and -45 kDa high molecular weight (HMW) SLP. 
These proteins can be induced to self-assemble in the presence of divalent cations into a regular 
array with tetragonal symmetry with an inter-subunit spacing of 8.1 nm, visible under the 
electron microscope by negative staining (Kawata et al. 1984; Takumi et al. 1992). When 
C. dfJIcile cells are subjected to freeze etch electron microscopy, a square lattice is seen on the 
surface of the cells (Cerquetti et al. 2000). However, when cell wall fragments were prepared, 
or a urea extract was dialysed and the proteins induced to self assemble, a hexagonal lattice was 
seen upon negative staining (Cerquetti et al. 2000). As it is difficult to reconcile the presence of 
one S-layer on the cell which results in both a square lattice and a hexagonal lattice, Cerquetti et 
al. proposed that C. diJcile contains two S-layers, the inner one forming a hexagonal lattice and 
the outer one composed of a square lattice. Whilst it is not a common phenomenon, double 
S-layers have also been reported in Aquispirillum serpens and Brevibacillus brevis (Yamada et 
al. 1981; Kist & Murray 1984). 
The C. difficile SLPs have amino acid compositions characteristic of S-layer proteins from other 
bacteria and show typical pls of 3.7 - 3.9 (LMW-SLP) and 3.3 (HMW-SLP). They are 
antigenically unrelated to one another and are both exposed evenly over the entire cell surface 
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(Takeoka et al. 1991). The size of the SLPs diverges considerably between strains, with the 
LMW-SLP varying from 32 kDa to 45 kDa and the HMW-SLP from 45 kDa to 56 kDa (Kawata 
et al. 1984; Poxton et al. 1999). A protein of -70 kDa was consistently co-purified in all strains 
(Sharp & Poxton 1988; McCoubrey & Poxton 2001) and is now recognised to be Cwp2 (Calabi 
& Fairweather 2002) (see below). In general, anti-LMW-SLP antisera do not cross-react with 
the LMW-SLP of other strains, whereas the HMW-SLPs are more antigenically conserved 
(Sharp & Poxton 1988; Takeoka et al. 1991; Cerquetti et al. 2000; Calabi et al. 2001). 
Antibodies to the LMW-SLP are found in the sera of CDAD patients whereas the HMW-SLP 
seems to be poorly immunogenic in C. dicile infections (Pantosti et al. 1989; Cerquetti et al. 
1992; Poxton et al. 1999). This, together with the difference in antigenic variation, suggests 
that the LMW-SLP may form the external, surface-exposed S-layer and the HMW-SLP the 
more protected inner S-layer (Figure 1.3). 
The LMW-SLP and HMW-SLP are proteolytically derived from a common precursor 
transcribed from the slpA gene (Figure 3.1B). Sequencing shows that the HMW-SLP is highly 
conserved between strains, whereas the LMW-SLP is more divergent, reflecting the previous 
immunological observations (Calabi et al. 2001; Calabi & Fairweather 2002). The slpA gene is 
strongly transcribed during the entire growth phase (Savariau-Lacomme et al. 2003). The 
HMW-SLP shows weak homology to the cell wall binding region of the N-acetyl muramoyl- 
L-alanine amidase from Bacillus subtilis; both native SLP and recombinant HMW-SLP show 
amidase activity by zymography (Calabi et al. 2001). The HMW-SLP incorporates two 
complete copies and one partial copy of the Pfam domain PF04122 cell_wall_binding_2. This 
domain is thought to mediate binding to the underlying bacterial cell wall, possibly through an 
affinity for teichoic acids, resulting in the anchoring of the protein to the exterior of the 
bacterium (Herbold & Glaser 1975; Kuroda & Sekiguchi 1991; Waligora et al. 2001). PF04122 
has so far been identified in multiple (typically three) copies in several species of Gram-positive 
bacteria: C. tetani (19 proteins) (Bruggemann et al. 2003); Desulfitobacterium hafniense 
(20-24); Kineococcus radiotolerans (9); Acidothermus cellulolyticus (4); B. subtilis (CwIB and 
CwbA); and B. licheniformis (LytB and LytC). PF04122 is also found in single copy in proteins 
of the Archaea Methanocaldococcus jannaschii (1), Thermococcus kodakarensis (1) and 
Pyrococcus (in 3 proteins in each of three species) (http: //www. sanger. ac. uk//cgi-bin/Pfam/ 
getacc? PF04122). 
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C. difficile cell wall proteins (CWPs) 
A family of 28 genes has been identified in C. dicile 630 (Cd630) that show homology to the 
HMW-SLP (Calabi et al. 2001) - all are found to contain three copies of the PF04122 
cell wall_binding 2 domain (see Figure 3.2 and Supplemental Data CD). These cell wall 
anchoring regions are predicted to share a common secondary structural pattern'. It is proposed 
that this will result in a three-dimensional structure shared with the HMW-SLP that would allow 
these proteins to incorporate into the S-layer without disruption of the paracrystalline array 
(Figure 1.4). 
In this thesis these proteins are termed Cell Wall Proteins (CWPs) and are named using the 
prefix "Cwp". Eleven CWP genes are found clustered around the slpA locus (Calabi et al. 2001; 
Karjalainen et al. 2001) (Figure 3.1A) and the remainder are scattered throughout the genome. 
The six CWP genes located closely downstream of slpA, termed cwp2 to cwp7, are conserved 
between strains and have been shown to be transcribed in C. dicile in liquid culture (Calabi et 
al. 2001; Calabi & Fairweather 2002). 
In addition to the cell wall anchoring domains, all CWPs are found to have an N-terminal signal 
sequence for Sec-mediated export from the cell. Each CWP also contains a unique region of 
varying size. It is interesting to note that when a phylogenetic tree was constructed using only 
the amino acid alignment of the PF04122 domains, those with similar "unique" regions tended 
to cluster together (Figure 3.2). cwp84 (cwp4) and cwp13 encode proteins incorporating 
PRO 112 peptidase_C1 domains; Cwp84 has been shown to be a cysteine protease, possibly 
involved in maturation of secreted bacterial proteins (Savariau-Lacomme et al. 2003). The 
PF00188 SCP domain (putative calcium-chelating serine protease) is encoded by cwp9, cwpll 
and cwp12; cwp12 also encodes a PF07523 Big_3 (bacterial immunoglobulin-like 3) domain. 
cwp16 and cwpl7 are found adjacent in the genome, and together with cwp6 encode proteins 
incorporating the PF01520 amidase_3 domain. Cwp20 features a PF00144 ß-lactamase domain, 
and Cwp19 features a PF02638 DUF187 (conserved domain of unknown function) domain. 
cwp22 encodes a protein with one PF03734 ErkK_YbiS YhnG domain (conserved bacterial 
domain - possibly enzymatic) in addition to seven copies of PF01473 cell wall binding_1 
domain, which is also found in the repeat region of the large clostridial toxins. Cwp14 
incorporates two PF08239 SH3_3 domains; and Cwp21 features three PF03413 PepSY 
(putative protease inhibitory function) domains. 
R. Fagan, personal communication. 
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Both the cell wall anchoring region and the "unique" region of Cwp66 (Cwp3) have been shown 
to be involved in adhesion of C. difficile to the gut wall (Waligora et al. 2001; Janoir et al. 
2004). The HMW-SLP also shows strong binding to intestinal epithelium of both human and 
mouse; and a-HMW-SLP antibodies partially block adherence of C. difficile to HEp2 cells 
(Calabi et a!. 2002). SLPs have also been shown to mediate adherence to the gut wall in other 
organisms; the S-layers of Lactobacillus acidophilus and L. brevis are necessary for intestinal 
adhesion and survival in the gastrointestinal tract (Schneitz et a!. 1993; Hynonen et al. 2002; 
Kos et al. 2003; Frece et al. 2005). 
Cwpl5 contains three copies of the PF04122 cell wall anchoring domain, but does not feature 
any other Pfam domains. It is the largest CWP in Cd630, and its unique domain consists of 
multiple repeats. It has previously been found in a proteomic analysis of cell wall extracts of 
Cd630 (Wright et al. 2005). Investigations into the conservation, expression and function of 
this protein are the primary focus of this chapter: in view of the results presented here we have 
termed its gene cwpV (cell wall protein with varying repeats) to reflect its considerable 
variability in form and expression. 
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Figure 3.1 Map of the genome region containing slpA 
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A: Arrangement of the cluster of related open reading frames around slpA. The region of 
each CWP gene encoding the cell wall anchoring region is shown in blue and the unique 
region is shown in white. Unrelated genes are depicted in grey. B: Diagrammatic 
representation of SIpA protein from C. dffficile 630. Signal sequence is depicted in black, 
LMW-SLP in white, and HMW-SLP in light blue, with PF04122 cell wall anchoring 
domains indicated in royal blue. The sites of cleavage to generate the mature proteins are 
indicated by red triangles. Amino acid residues are numbered. 
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Signal sequence 
CW_binding_2 Pfam04122 ý 
Peptidase_C 1 Pfam00112 
ä-lactamase PfamO0144 ý 
SH3 3 Pfam08239 ý 
PepSY Pfarn03413 
Amidasc 3 Pfarn01520 
DUF 187 Pfam02638 ý 
ErkK YbiS YhnG Pfam03734 ý 
CW binding_I Pfarn01473 ý 
SCP Ptam001 KK ý 
Big_3 Pfam07523 
Figure 3.2 PF01422 cell wall proteins in Cd630 
ClustalW was used to align the amino acid sequence of the PF04122 cell 
wall anchoring domains of each CWP encoded in the Cd630 genome. 
A phylogenetic tree was constructed from this alignment, depicted to the left, 
where the CD# of each CWP gene is indicated. Each CWP is then represented 
by a scale diagram to the right of the figure, numbers represent amino acid 
residues. PF04122 domains are shown in royal blue, and other conserved 
domains are coloured according to the Key shown above. 
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3.2 Results: Operonic transcription within the slpA gene cluster 
In order to investigate the transcription of genes within the sipA cluster (see Figure 3.1 A), 
primers were designed to amplify each gene alone, and from each gene to its neighbour. RNA 
was extracted from mid-exponential and from early stationary phase cultures of U630 and 
reverse transcribed using random decamer primers. The resultant cDNA was amplified using 
PCR to investigate the transcription of these genes (Figure 3.3). 
Transcripts were detected for each individual gene within the cluster, with the exception of 
cwp84 (cwp4). Detection levels ranged from extremely strong in the case of sipA to extremely 
weak in the cases of CD2797, CD2792, CD2785, cwp5 and cwp7. Both cwp12 and CD2788 show 
stronger amplification from exponential phase cDNA than from early stationary phase cDNA, 
whilst conversely cwp10, CD2790, and cwp66 appear to have higher transcript levels during 
stationary phase. secA2 appears to give a stronger signal from the first biological replicate for 
both exponential and stationary phase cDNA, whereas cwp8 can only be detected from the 
second biological replicate in each case. 
Amplification (increased to 35 PCR cycles) was then attempted between each gene and its 
neighbours. No signal is seen for the majority of reactions, implying that most of the genes in 
this cluster are independently transcribed as monocistronic messages. cDNA is detected 
spanning from cwp2 to CD2790 and from CD2790 to cwp66, implying that these three genes are 
co-transcribed as an operon. This is consistent with previously reported investigations 
(Savariau-Lacomme et al. 2003). The only other evidence of co-transcription within the gene 
cluster was the observation of a single faint positive band in one exponential cDNA reaction 
amplifying from CD2783 to cwp7. 
No evidence of other co-transcription within the gene cluster was generated in this study, but 
evidence of coupled transcription of cwp12 and slpA has been previously presented (Savariau- 
Lacomme et al. 2003). They show that slpA was detected as a 3.2 kb transcript whereas the 
gene is only 2459 bp long, and that transcript spanning from cwpl2 to slpA was detected using 
RT-PCR. However, the cwp12 and slpA genes occupy 4.25 kb in the genome and therefore a 
3.2 kb transcript is not sufficient to allow co-transcription of these genes. The fragment 
amplified by RT-PCR by Savariau- Lacomme et al. only overlaps the cwp12 gene by 42 bp, 
merely 253 bp upstream of the sipA translational start site, so it is perhaps possible that this was 
a false positive result due to amplification of the sipA transcript alone. 
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Figure 3.3 Transcriptional 
__ analysis of the genes of the 
cell surface cluster in Cd630 
k' 
RNA was extracted from three 
" biological replicate cultures at 
" " Exp mid-exponential phase ( , 
OD600 = 0.5) and in early 
stationary phase ("Stat"). This 
was reverse transcribed and 
PCRs were carried out to 
amplify each individual gene 
within the cluster and also to 
®®, 
amplify from each gene to the 
next. See Table 2.4 (Methods) 
for primer sequences and 
binding sites. Vertical lines 
adjacent to the genetic diagram 
represent co-transcription of 
genes demonstrated by this 
study (orange), Savariau- 
L l acomme et a . 
(green), or 
both (red). Genomic DNA 
controls were positive for each 
ý® PCR reaction (data not 
_®ý 
shown). 
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3.3 Conservation of the cwpV gene between strains of C. difficile 
Analysis of cwpV from strain Cd630 
CwpV (CDO514, Cwpl5) is a paralogue of the HMW-SLP that it is not sited in the s/pA gene 
cluster (Calabi et al. 2001). An N-terminal signal sequence is predicted by SignalP 3.0 
(Bendtsen et al. 2004). The mature protein consists of three distinct domains: (1) an N-terminal 
HMW-SLP homology region incorporating three copies of the PF04122 cell wall binding_2 
domain; (2) a region of unknown function terminating in a serine-glycine-rich flexible linker; 
and (3) nine repeats of 120 amino acids (Calabi 2002) (Figure 3.4). These repeats are almost 
perfect copies of one another with the exception of the first repeat, which is more divergent. 
The CwpV protein has been previously detected in the cell wall of Cd630 (Wright et al. 2005), 
and is annotated as a cell surface putative haemagglutinin/adhesin protein (Sebaihia et al. 2006). 
BLASTP (Altschul et al. 1990) searching of the repeat domains (data not shown) reveals some 
homology to a haemolysin-type calcium-binding region of Trichodesmium erythraeum 
(Expect = 2e' 13); and also low levels of similarity to putative outer membrane adhesin-like 
proteins of Shewanella amazonensis and Prosthecochloris vibrioformis; a probable RTX (repeat 
in structural toxin) protein of Chromobacterium violaceum; a putative autotransporter/adhesin 
of E. coli; a putative adhesin MadA of Mesorhizobium sp.; a COG3210 protein (large 
exoprotein involved in heure utilisation or adhesion) of E. coli; and a cell wall associated 
biofilm protein of Algoriphagus sp. No conserved domains are revealed within the repeats by a 
Pfam database search (Finn et al. 2006) (see Supplemental Data CD). 
Conservation of cwpVbetween C. difficile strains as shown by PCR 
In order to investigate the presence of cwpV in strains of C. dicile, primers were designed 
(designated NF#, Table 2.4: Methods) to bind various regions of the cwpV gene from the Cd630 
genome and were used to amplify the gene from other strains (Figure 3.5). The 5' region of 
cwpV (NF384-NF655) encoding the cell wall anchoring region was amplified from all strains, 
however the 3' repeat region was not. 
All primer pairs were able to amplify the expected product from strains Cdl, CdlOl, Cd291, 
Cd371, Cd959, Cd630 and CdY. An exception is seen with the primers NF372-3, addressed 
below, which result in products showing size variability. These results indicate that cwpV is 
present in these strains and is substantially akin to that of Cd630. This form of cwpV will 
subsequently be referred to as type I. 
In contrast to the region encoding the PF04122 cell wall anchoring domains the repeat region 
was not detected in any other strain. Neither the 5' flanking region of cwpV (NF400-1) nor the 
immediate 3' region (NF386-414) is amplified from the hypervirulent ribotype 027 strains 
Cd20352, Cd20291 and Cd20928, whereas the distal 3' region (NF415-6) is amplified as 
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expected. This form of cwpV will subsequently be referred to as type II, and is further 
investigated below. In order to investigate whether the change in cwpV type is linked to the 
acquisition of the hypervirulent phenotype, three historic ribotype 027 strains were also 
investigated; these strains date back to 1988 (see Table 2.1: Methods). The pattern of PCR 
amplification for these strains is identical to that of the hypervirulent strains, and therefore these 
historic isolates are also found to be cwp V type II (Figure 3.5). 
In Cd167 (ribotype 016), Cd17 and CdM9 (both ribotype 017, TcdA"B4) the region encoding the 
PF04122 cell wall anchoring domains (NF384-655) and the regions flanking either side of the 
gene (NF400-1 and NF386-414) could be amplified, whereas no downstream part of the gene 
itself could be detected. NF654 is known to bind in these strains as a PCR product is formed in 
conjunction with NF655 (data not shown). Amplification was attempted between NF654 and 
all downstream reverse primers. NF654 and NF387 produced a product of 1.8 kb in all three 
strains, but only under low stringency conditions. Unfortunately upon sequencing this product 
it was revealed to originate from a completely different region of the genome, spanning from 
cwp84 (cwp4, CD2787) to cwp5 (CD2786) and not to represent cwpV (CD0514) (data not shown). 
Currently, therefore, these strains are only characterised by the presence of the 5' region of 
cwpV encoding the cell wall anchoring repeats, and no other sequence information is known. 
Although the cwp V of this grouping is highly uncharacterised, and may therefore represent more 
than one form of cwpV, these strains will subsequently be referred to as cwp V type III. 
Sequence conservation of type I cwpV 
Amplification of the repeat region of cwpV using primers NF372 and NF373 results in a product 
from only type I strains (Figure 3.5 panel 3). As predicted, amplification from Cd630 genomic 
DNA results in a major product of 3.3 kb. A ladder of minor products is also visualised, which 
is consistent in size with amplification of lower numbers of repeats. This was unexpected as the 
primers were designed to bind just outside the repeated sequence. This phenomenon may be 
explained if partial transcripts were created during the amplification reaction. These may then 
anneal to one another in a subsequent cycle, due to the homology of the repeats, and 
polymerisation would continue using the other partial product as template. This would result in 
a product differing in size to that of the original template by a whole number of repeats. 
Although this process could result in the elongation of the number of repeats, shorter products 
would be preferentially amplified resulting in a ladder of smaller bands. This is, however, likely 
to be a relatively rare process and the major band elicited is probably representative of the 
length of the original template. 
A ladder of products is observed in all strains, however the major product from all other strains 
is smaller than that amplified from Cd630. The observed ladder of bands, in addition to 
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conventional band sizing, was used to show that in comparison to the nine repeats present in 
Cd630, cwpV from Cdl, CdlOl, Cd291, Cd959 and CdY incorporates four repeats, whereas 
cwpV from Cd371 contains six repeats. Southern blotting using genomic DNA cut with either 
AseI or Spel and probed with the NF375-NF346 PCR product (representing one repeat of cwpV 
type I) was then carried out (Figure 3.6). The pattern of band sizes observed is consistent with 
that predicted from the PCR results, confirming that the major PCR band is representative of the 
length of the original template and that the number of repeats varies between strains. This 
Southern blot also confirms that the cwpV type I repeats are absent from Cd17 and Cd167. 
The cwpV gene was sequenced from all type I strains as fully as possible given the highly 
repetitive nature of the sequence, using a combination of sequencing of cloned fragments and 
direct sequencing of PCR products (Figure 3.7). The sequences obtained were very similar to 
the published Cd630 genome sequence: the 5' region (extending to the sequence encoding the 
flexible linker) was almost completely identical in each case. This region is 99.73% conserved 
at the DNA level: there are an average of only 4.2 base pair changes per strain (range 0 bp to 10 
bp), resulting in only one amino acid alteration observed across all the strains examined. In the 
repeat region, a number of differences were observed from the published Cd630 genome 
sequence. However, many of these differences are present in other cwp V repeats in Cd630. 
Excluding the divergent first repeat, there are only nineteen sites that vary within the 121 amino 
acids of the repeat. Only forty-one amino acid differences from the consensus repeat sequence 
are observed in total in all strains including Cd630 (average 1.5 per repeat, range 2 as to 12 as 
total per strain), of which twenty-one changes are conservative substitutions. In total, only 
sixty-eight base pair alterations compared to the Cd630 repeats were detected across the six 
strains sequenced (range 4 bp to 26 bp per strain): cwp V repeats show on average 99.26% DNA 
sequence identity between strains, discounting the variable number of repeats. cwpV of Cd1, 
Cd371 (both ribotype 001) and CdY are most divergent compared to cwpV from Cd630 and are 
very similar to one another in the changes observed, except in the number of repeats present. 
Cloning and sequencing of type II cwpV 
Towards the end of this study, the genome of the hypervirulent C. docile strain isolated in 
Quebec, Canada (Cd20352) had been partially sequenced and was at that time presented in 
sixty-four contigs. The 5' region of cwpV, encoding the PF04122 cell wall anchoring region, 
was found at the 3' end of contig 011: homology to the Cd630 genome extends 445 bp upstream 
of the translational start site of CwpV (Figure 3.8A). The close relationship between the two 
sequences is lost 405 bp before the 3' end of contig 011, just after the region encoding the 
flexible linker of CwpV. The downstream flanking CDOSJS gene was detected at the start of 
contig 012 (Figure 3.8B), and close homology to the Cd630 genome continues 74 kb to the end 
of the contig. The genome of the hypervirulent strain Cd20291 isolated at Stoke Mandeville 
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Hospital, UK, has also been partially sequenced and is presented in 546 contigs . The 5' region 
of cwpV, encoding the cell wall anchoring region, can be found at the 3' end of contig 00089, 
although the contig terminates at the sequence encoding the flexible linker and does not extend 
as far as the loss of homology between Cd20352 and Cd630 (Figure 3.8A). The downstream 
gene CD0S1 S is found at the 3' end of contig 00057 (Figure 3.8B), which when reverse 
complimented aligns almost perfectly to Cd20352 contig 012 throughout its length. 
Primers were designed in close proximity to the ends of the Cd20352 contigs (NF658 and 
NF659) and then PCR amplification spanning the divide was attempted in order to determine 
whether these contigs are adjacent in the genomes of these strains. In both Cd20352 and 
Cd20291 a ladder of products increasing in size by 238 ± 15 bp was observed culminating in a 
major band at -2.3 kb (see Figure 3. MOB panel 2). This was only observed using a long-range 
proofreading polymerase, whereas using standard polymerase an alternative product of -1.5 kb 
was observed (data not shown). Both of these bands were excised, cloned into pCR4-TOPO®, 
and their DNA sequences determined from the plasmid. For the large insert, a further primer 
(NF703) was designed to allow complete sequencing of the insert. Sequencing reveals that 
although the almost perfect homology of cwpV from Cd20352 and Cd20291 to that of Cd630 
extends to the region encoding the serine-glycine-rich flexible linker, after that similarity is 
completely disrupted (Figure 3.9). Reminiscent of type I cwp V, the type II cwp V gene continues 
as eight highly conserved repeats. However these repeats have very little DNA or amino acid 
sequence homology to type I repeats (Figure 3.11). As is seen in type I CwpV, a very short 
amino acid sequence is observed after the end of the repeats prior to a stop codon. The 
divergent DNA sequence then continues for a further 200 bp before. abruptly becoming 
equivalent to the Cd630 sequence once more, 254 bp beyond the stop codon of CWpV in U630 
and just prior to the beginning of Cd20352 contig 012 and Cd20291 contig 00057. 
The 1.5 kb product amplified by standard polymerases corresponds exactly to the last one and a 
half repeats of cwp V (from the location equivalent to that in the first repeat where NF65 8 binds) 
followed by the terminus of the gene and its 3' flanking sequence (data not shown). When the 
Cd20352 genome sequence was later updated it showed this, incorrectly, to represent the 
genomic sequence. 
Primers were designed to amplify a single type II repeat (NF701-2), and all strains were 
screened using both these and NF658-9 (which amplify the entire 3' cwpV type II region) 
(Figure 3.10). No PCR product was generated from any type I or type III strain, but the 
expected bands were produced by all type II strains: both recent hypervirulent outbreak strains 
and historical ribotype 027 isolates. 
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Comparison of type I and type II repeats 
Whilst the type I repeats are predominantly 360 bp (120 aa) long, the type II cwpV repeats are 
smaller, being 234 or 237 bp (78 or 79 aa) long (Figure 3.11B). Like type I cwpV, the first 
repeat of type II CwpV is the most divergent, being only 70.8% identical (75.9% similar) to the 
consensus sequence. Of the seven remaining type II repeats in both Cd20291 and Cd20352, two 
sequence similarity groups are observed, showing 86.1% identity and 93.7% similarity to one 
another. Repeats two to four are representative of one group and repeats six to eight are 
representative of the other, whilst repeat five represents a hybrid. 
Each type II repeat shows weak homology to the PF07554 FIVAR `found in various 
architectures) domain, which is often found in cell wall associated proteins and may be 
repeated. It is particularly highly repeated (forty-four to sixty-two times) in a family of 
Staphylococcus cell wall associated fibronectin-binding proteins including EbhA (Clarke et al. 
2002; Williams et al. 2002). These high molecular weight proteins consist of a YSIRK signal 
peptide, followed by seven or twenty-three tandem FIVAR repeats, thirty-seven to fifty-three 
pairs of alternating GA (protein-G-related albumin-binding, PF01468) and FIVAR domains, 
and then four to eight DUF1542 (domain of unknown function, PF07564) domains. 
The FIVAR domain is a putative sugar-binding domain, possibly with fibronectin, hyaluronan 
or N-acetylglucosamine specificity (http: //www. sanger. ac. uklcgi-bin/PfanVgetacc? PF07554). 
There are no sequences in Cd630 with similarity to the type II repeats, and the FIVAR domain 
is not found. Given the proposed specificity of this domain, it is no surprise that BLASTP 
searching of the type II repeats reveals closest homology to a fibronectin type III domain 
glycosyl hydrolase (Expect = 7e 24) and a polysaccharide lyase (E=2e''$) from Enterococcus 
faecalis and an a-N-acetylglucosaminidase family protein from C. perfringens (E=8e-14). The 
repeats also show weaker similarity to a glycoside hydrolase of C. beijerincki, a gellan lyase of 
Bacillus sp., and to hyaluronidase (Mu toxin) from C. perfringens. Interestingly, like the type I 
cwpV repeats, type II repeats also show weak homology to a COG3210 protein (large 
exoprotein involved in heme utilisation or adhesion), but from Bifidobacterium longum. 
Type II repeats share a similar amino acid composition to the type I repeats, with both showing 
particularly elevated proportions of alanine and threonine and reduced levels of isoleucine, 
arginine, methionine, tryptophan and phenylalanine in comparison to the proteome as a whole. 
Type I repeats also have high levels of glutamate and serine, and low histidine and aspartate, 
whereas type II have low levels of serine and proline. Neither type has any cysteine residues. 
Both repeats are charged and acidic: the consensus type I repeat is composed of 21.6% charged 
residues and has a calculated pI of 4.57, whereas consensus type II repeats have 24.2% charged 
0 
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residues and a calculated pI of 4.71. In both cases the more divergent first repeat actually 
carries a positive charge, with calculated pl in each case of 9.20. 
Despite the similar overall properties, the two types of repeats have very dissimilar sequences. 
It is not possible to align them to any degree (Figure 3.9), and the longest shared motifs are five 
amino acids long: TAEG(N/D) and TATD(S/T). The repeats also show completely different 
predicted secondary structures. Both PHYRE (Kelley et al. 2000) (data not shown) and PsiPred 
(Bryson et al. 2005) were used to predict the secondary structure and possible folds of each type 
of repeat (Figure 3.11iii). Both type II consensus repeats are predicted to have 68% a-helix as 
three large helices per repeat, and the divergent first repeat to have these plus a small additional 
a-helix, resulting in 76% a-helix. In contrast, the type I consensus repeat is predicted to have 
3.4% a-helix and 38% ß-sheet in eight short strands per repeat, with the divergent first repeat 
having an extra two short ß-strands resulting in 3.4% a-helix and 44% ß-sheet. For both types 
of repeat, attempted alignment to known folds did not find any good matches (data not shown). 
Purified CwpVrptl from Cd630 was analysed using circular dichroism (with the help of Ben 
Moore; Figure 3.12). The deduced structure contains 5% a-helix, 38% ß-strand and 25% ß-turn. 
The relative consistency of this with the secondary structure composition predicted by both 
PHYRE and PsiPred increases confidence in the prediction that type I and type II repeats will 
form highly unrelated structures. 
In summary, cwpV takes one of three major forms in each of the strains examined (Figure 3.13). 
Type I cwpV is found in Cd630, Cd101, Cd291, Cd371, Cd959, CdY and Cdl and may have 
four, six or nine -360 bp repeats. Type II is found in all six ribotype 027 strains investigated, 
both recent hypervirulent outbreak strains and historic isolates, and has eight -237 bp repeats. 
Type III cwp V is found in Cd 17, Cd 167 and CdM9 but is currently highly uncharacterised and 
may therefore represent multiple cwp V types. 
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A 
100aa 
B 20 * 40 * 60 
rptl : SSKVGQIKFSATDKQIKMASGDKTVDPSDNTYILKLTNGTVKDGDVKANVKVAGLPSGLD 
rpt2 : APAIGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVTGLPSGLD 
rpt3 : AAPAVGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDIKANVEVTGLPSGLD 
rpt4 : AAPAVGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVTGLPSGLD 
rpt5 : APAIGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVTGLPSGLD 
rpt6 : APAIGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVTGLPSGLD 
rpt7 : APAIGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVTGLPSGLD 
rpt8 : APAIGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVIGLPSGLD 
rpt9 : APAIGQLTFDATDKQIKMASGDKTVDPSDDTYVLTLTKGTAKDGDVKANVEVIGLPSGLD 
* 80 * 100 * 120 
rpt1 : YTAVGNRSANTITITVSGTASQSIQNDLNNVSVLVKAGAVSGTGATDSIANTTFEIKKYV 
rpt2 : YTAEGDSSTNTITITVSRTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt3 : YTAEGDSSANTITITVSGTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt4 YTAEGDSSANTITITVSGTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt5 : YTAEGDSSANTITITVSGTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt6 : YTAEGDSSANTITITVSGTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt7 : YTAEGDSSANTITITVSGTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt8 : YTAEGDSSANTITITVSGTASQAVQTDLDNVSVLVKAGAVSETTATDSAANATFEVKKYV 
rpt9 : YTAEGDSSANTITITVSGTASQAVQTDLDNISVLVKAGAVSETTATDSAANATFEVKKHA 
Figure 3.4 The composition of CwpV from Cd630 
A: Diagrammatic representation of CwpV from Cd630. Signal sequence is depicted in black, 
PF04122 cell wall anchoring domains in blue, and repeats in green. 1 mm represents 10 amino 
acids. B: Amino acid alignment of the nine repeats as predicted from the published Cd630 
genomic sequence. Differences from the consensus sequence (not shown) are shown in red text 
and similarity in blue text. 
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Figure 3.5 PCR amplification of cwpV in C. difficile strains 
Regions around the cwpV gene were amplified by PCR from various strains. A diagrammatic 
representation of cwpV situated within the Cd630 genome is depicted to the left, and the region 
amplified by each primer pair used is indicated. The 5' region of cwpV is located towards the 
bottom of the diagram. Each strain tested is indicated at the top, and the sizes of amplified 
bands are shown to the right. Derived cwpVtype (I, II or III) is labelled below. 
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Figure 3.6 Type I cwpV is absent or present in single copy in all strains tested 
A: Diagrammatic representation of the locations of Asel and Spel restriction enzyme sites 
around cwpV in the Cd630 genome. B: Predicted sizes of cwpV-positive fragments in different 
strains. C: 10µg genomic DNA from alI strains was digested using (i) Asel or (ii) Spel and then 
run on a 0.8% agarose gel, Southern blotted, and probed using a PCR product generated using 
primers NF375 and NF346 (one type I repeat). Red arrows indicate positive bands. The images 
have been manipulated to reorganise the lane order. Cd630 lanes were taken from a separate 
blot. 
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Cd20291 : ........................................................................................................................ . 360 
Cd630 : ........................................................................................................................ 360 
+ 380 400 420 440 460 480 
Cd20352: EVKEAFTIQTDKAITVNLNGTYTKTVTINMPNGDVNNYAKVDDVVIDDVKDGTFVNYGKITNLKVNDKNGAKIENNSKGEIGSLTVASGASQVKVTNGGKITTVTNNSKGTTIUNKGTIS 480 
Cd20291 : ........................................................................................................................ 480 
Cd630 : ............. V .......................................................................................................... : 480 
" 500 " 520 540 560 ' 580 + 600 
Cd20352: SVKGDNSPTISGNSPSSNSSGGSSSSGGSSHG--GGSSSSKVDKVVLKN------------TITAANKLYNEAIEGTNVGEYKVGS--------KAIYKTAIDKAQAILDKSGVTQKEVN 578 
Cd20291: ................................ ....:..,.,.,:,:.:.,..,. ..,.:...:.;,..... s..:...:,. ---- _. _" --... 1., . .. 
578 
Cd630 : ...............................:. s s. ....... 
GQIK F: ýFlT; KpiKNA: 9GDKTVDPSDNTYILKLTNGT. KDG0. KnNVKVAGLP>GLD'i.. VNF. T:: VS 600 
' 620 " 640 " 660 " 680 " 700 " 720 
Cd20352: DAVTALNTATDTFKAGKVVAVDKT---------------- ALQDAVTAATALHAKATEG---------------------------------------- TAEGNYAVG--SKATYKTAID 640 
Cd20291: ------------------------------------------------------------------------------------------------------------------------ 640 
Cd630 .,.. t,: 
sS,: , ---` .. ý,. !AN`FTr; Y nt. ... r ..: r,,. hv,... °: '=KDGUVKANVE, T,; I, l JGI CY . -. . ... DS NT_ TI.... : R. .: J : 720 
+ 740 " 760 " 780 800 " 820 " 840 
Cd20352: EAQAILDKSDATQKE--VNDALSALNTATETFEAGKVVAV-------------------- DKAALQDAVTAATALHNGATEG------------------ TAEGNYAVG--SKATYKTAI 718 
Cd20291: ... .......... . . -- ....................... ------------------- ... ..................... ------------------ ......................................................... 718 
AV. h:,.. NT: VL7. AGA.:; r:. A. NA... VK. i.. Al rý,,;. 1 I:, ATL K,? IKMA ,. . 'IVI F3Ii. f. I K. TAYI ITIKAN Cd630 r: T, [. IP, t. oY.... D: iANT[T; ":.. . .: 
840 
" 860 880 900 920 940 " 960 
Cd20352: DEAQAILDKSDATQKE--VNDALSALNTATETFEAGKVVAV-------------------- DKTALQDAVTAATALHNGATEG------------------ TAEGEYAVG--SKATYKTA 796 
Cd20291: .... .... ....... . -. .............. ... . ... .. ------------------ ...................... ------------------......... --........ 796 
Cd630 : QAV. TV.. NVTVLV. A , A.: 'Ei TA'I'I1 IA. NA... VK. Y.. AI VAVGQI. TFI iATDKQIKM5S ,... VDPSI I .11, . 
TK. TAKPý; I'V KANVEVTý; 1.1 (1 LD Y... I: ýSANTITIT:... 960 
+ 980 " 1000 " 1020 " 1040 " 1060 " 1080 
Cd20352: IDEAQAILDKSDATQKE--VNDALTALNTATETFEAGKVVA------------------- VDKTALQDAVTAATALHNGATEG------------------ TAEGN-------------- - 863 
Cd20291: -- ...................... ________________-__....................... - ____..... - 863 
Cd630 : SQAV. '1'l1.. NVSVLV. ' .L:.:... ý. 
L.. PAIG, 1I. '1'FI, AII, KQIKMFl. 
_:,,..... 
k:. Iii. ...... TK. "'. At, ; 'I'A : 1080 
" 1100 + 1120 " 1140 + 1160 ' 1180 " 1200 
Cd20352: -YAVGSKATYKTAIDEAQAILDKTG------------------------- ATQKEIDDALS----------- ALNTATDTFKAG------------------------------------ " 910 
Cd20291: - ........................ -------------------------........... -----------............ ------------------------------------ : 910 
Cd630 SG.. VTIý:. IN'S'LVK, rV: ýET, A'I'hSAANAT F'F; VY. K'fVAI A1::., ý;, ': 'h'hI, Q. 0M... ýG Uh: 'I'VGPFý1 ý1 ý'1'YV, TLTKG. A,: ý, ITV KANV F; V'I'GLf':: GL D'i 'I'AF. GIýS SANTITITVS1: TA : 1200 
" 1220 " 1240 + 1260 " 1280 " 1300 " 1320 
Cd20352: ---------- KVVLNKTALQDAVTAATSLHAG------------------------------------------------ ATEG----------------- TAEGN-------------- : 941 
Cd20291: -_________ ...................... _______________- ___-___________________________.... ____________-___..... - 941 _____________ 
Cd630 : SQAVQTDLINVS.. V. AGAVSET.. TU, MNA'I'Ph: VKKYVAIA1I, A'I'I'KQI EMS(; I'KTVDPS UUTYVL'I'LTKGT, KD. I, VKANVEVT[; I, PG, ; LUY .... Dt; SANTITITVSGTA : 1320 
" 1340 " 1360 " 1380 " 1400 " 1420 " 1440 
Cd20352: -YAVGSKATYKTAIDEAQAILDKTG-------------------------ATQKEIDDALS-----------ALNTATDTFKAGKVVLNKTAL---------------QDAVTAATSLHA : 1009 
_________________________........... ___________. .......... ......... . _______________............ : 1009 
Cd630 ..,:. Il VKKYVAPAIGVI. TFC.. I 11 1ý.,. : 1440 
" 1460 " 1480 " 1500 1520 " 1540 " 1560 
Cd20352: GATEGTAEGNYAVGSKATYKTAIDEAQAILDKTGATQKEIDDALSALNTATDTFKAGKVVLNKTALQDAVTAATSLHAGATEG------------------TAEGNYAVG--SKATYKTA : 1109 
Cd20291 : ................................................................................... ------------------......... --........ : 1109 G J. , "l I AANA. Cd630 . TVAF. IGI-L: L: L: '1: 1 ., i'I, T. TF. TAKI,, I'VKANVPb IGLE JGLDf .... D..: T:: `' .. : 1560 
" 1580 " 1600 " 1620 
cd20352: IDEAQAILDKADATQKE--IDDAVTALNTATATFEAGKVPTT------- IALMLSRILGFMK" : 1163 
.............................................................. * : 1163 
Cd630 ß'1'. T:... "1 LSVLV. A , AVFFTTATDSA. N ...... . 1'p.... I. :..... .,, BEET. "L. " : 1623 
Figure 3.9 Alignment of Cd20352, Cd20291 and Cd630 CwpV amino acid sequences 
ClustalW alignment of CwpV sequences of Cd20291 and Cd20352 as published (Washington University; 
Wellcome Trust Sanger Institute) and as sequenced in this study with that of CwpV from Cd630 (Sebaihia et 
at 2006). Identity to the sequence of CwpV from Cd20352 is represented by ". " whereas similar residues 
are shown in blue text and differences are shown in red text. 
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Figure 3.10 Conservation of cwpV type II 
A. Diagrammatic representation of cwpV type I (Cd630) and type II 
(Cd20352) as situated within the genome. Green shading joins regions of 
homology. B. PCR conservation of cwpV type II motifs across all strains. 
The regions amplified by each primer pair are depicted on the left. Each 
strain tested is indicated at the top and the sizes of amplified bands are 
shown to the right. ctiw/pV type is labelled below. 
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Figure 3.12 Structural analysis of CwpVrptl by circular dichroism 
Purified CwpVrptl was analysed by circular dichroism and the traces were analysed using the 
CDSSTR program. A: PsiPred prediction of secondary structure. Arrows represent ß-sheet 
(44%) and barrels represent a-helix (3.4%). The confidence in the prediction for each amino 
acid is given above. B: Circular dichroism spectrum of Cd630 CwpVrptl as determined 
experimentally. C: Fitting of experimental data (green) to the predicted spectrum of best fit 
(blue) that represents 5% a-helix, 38% ß-sheet and 25% ß-turn. This analysis was done with the 
help of Ben Moore. 
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Type I 
Cd630 
100aa 
Cd371 
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Figure 3.13 Diagrammatic representation of CwpV from all strains 
The deduced genomic sequence of cwpV from each strain was translated in silico, and a 
diagrammatic representation of the resultant CwpV is shown above. Signal sequence is shown 
in black, PF04122 cell wall anchoring domains in blue, type I repeats in green and type II 
repeats in purple. The sequence of all strains is almost identical for the N-terminal region, 
extending beyond the cell wall anchoring region to the serine-glycine-rich flexible linker 
sequence just prior to the start of the repeats. As the cwpV of type III strains is highly 
uncharacterised, this type may actually represent more than one form of cwpV. 
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3.4 CwpV expression patterns 
Raising antibodies to type I CwpV 
In order to analyse expression of cwpV, antibodies were raised against recombinant CwpV. In 
order to be sure to prevent any cross-reaction with other CWPs, it was decided to raise 
antibodies to the repeat region of the protein. This process was carried out before the genomic 
sequence of the ribotype 027 strains were available, and at the time it was not realised that the 
region of cwp V encoding the cell wall anchoring domains was conserved across all strains. We 
have therefore raised antiserum that is specific to type I CwpV and will not recognise type II or 
type III CwpV. 
The first repeat of cwp V from Cd630 (cwpVrptl) had previously been cloned as a GST-tagged 
fusion. This was expressed in E. coli and was purified by GST affinity chromatography, 
followed by excision of the GST tag and separation of the proteins by size exclusion 
chromatography. The purified protein was inoculated into rabbits to raise antisera recognising 
CwpVrptl. This was then affinity purified using a column of CwpVrptl-coated agarose gel 
beads, resulting in highly specific antisera, a-CwpVrpt1. 
CwpV is expressed throughout growth in Cd630 
Cd630 was grown in liquid culture and samples were periodically harvested using 
RNAprotect®. RNA was extracted and reverse transcribed, and then cwpV transcript was 
detected by PCR amplification of a single repeat (Figure 3.14A). Transcription of cwpV appears 
similar at all points of the growth curve. A slight rise in mRNA levels towards the later stages 
of exponential phase and into early stationary phase can be seen, then levels fall again after 
overnight culture (late stationary phase). 
Cd630 was grown in liquid culture and periodically samples were taken, pelleted and frozen. 
Total bacterial lysates were prepared and Western immunoblotted using a-CwpVrptl 
(Figure 3.14B). As was observed for mRNA levels, expression of CwpV is relatively constant 
at all points of the growth curve. A slight rise in protein expression towards the later stages of 
exponential phase and into early stationary phase can be seen, and then prevalence falls again 
after overnight culture (late stationary phase). 
A pattern of bands was exposed by the a-CwpVrptl immunoblot, as opposed to the single band 
predicted. A pair of major bands was observed in all samples, with estimated sizes of 125 kDa 
and 100 kDa. The predicted molecular mass for mature CwpV from Cd630 is 164 kDa, around 
40 kDa larger than the largest band observed. There were also a series of fainter, lower 
molecular weight protein moieties detected in every sample, with, an average spacing of 
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10.3 ± 1.6 kDa. Purified recombinant CwpVrptl is seen to run faster than expected on 
SDS-PAGE gels (data not shown), so it is possible that the repeat unit has a particularly 
compact fold resulting in aberrant migration. The smaller protein moieties could therefore 
represent the successive loss of individual repeat domains, which have a predicted molecular 
mass of 13.4 kDa. The repeat sequence incorporates an Asp-Pro amino acid motif, which has 
previously been reported to be acid labile and to cause the formation of a ladder pattern of 
breakdown products for a repeating protein (Wastfelt et al. 1996). However, aberrant migration 
cannot fully explain the pattern of proteins observed. The N-terminal cell wall anchoring region 
of CwpV (extending to the serine-glycine-rich flexible linker) has a predicted molecular weight 
of 50 kDa, so at least the smallest protein moieties must also be lacking at least part of this 
region. Two additional bands are detected from stationary phase cultures, each -4.5 kDa 
smaller than a bands also present in logarithmic phase cultures. 
In Chapter 4, the global expression profile of Cd630 after various stresses is examined using 
microarray hybridisations. The results obtained for cwp V are shown in Figure 3.15A: the two 
lines on each panel of the graph represent data for the probes representing the 5' cell wall 
anchoring region and the 3' repeat region. cwpV is observed to remain at constant levels after 
every stress tested - heat, acid, alkali and oxygen shocks and growth in the presence of 
amoxicillin, clindamycin and metronidazole - presenting at maximum only a 0.87- to 1.08-fold 
change. Lest a transient effect is occurring after heat shock that is not observed at the 15-minute 
time point, a time-course of expression was examined. RNA was extracted at 5,15,30 and 
60 minutes after the start of heat shock. This was reverse transcribed and subjected to real-time 
quantitative PCR (qPCR) analysis (Figure 3.158). Although the data are not tightly correlated 
between biological replicates, qPCR reveals that cwpV is essentially unchanging, being 
expressed on average at 1.08-fold over the control after 5 minutes of heat shock (not significant, 
NS), 1.48-fold after 15 minutes (P=0.04), 1.47-fold after 30 minutes (NS) and 0.90-fold after 
60 minutes (NS). 
In summary, no condition has been found that causes the expression of cwpV to change 
substantially, and it appears to be basally expressed at a low but consistent level under all 
conditions investigated. 
CwpV is expressed at the surface of a subset of C. difficile 
In order to determine the cellular localisation of CwpV, cell surface staining using a-CwpVrptl 
was carried out. Cd630 cells in stationary growth phase were immobilised onto a glass slide 
and immunofluorescently stained with a-CwpVrptl visualised using a-rabbit-FITC (green), and 
co-stained with rat a-LMW-SLP visualised using a-rat-rhodamine red (Figure 3.21). In 
comparison to DIC bright field images, it is clear that LMW-SLP can be detected uniformly on 
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every bacterium. In contrast, only a small subset of bacteria were positive for surface CwpV, 
implying that expression of CwpV is limited to a subset of cells. This staining, where present, 
was strong and uniform. 
In order to determine whether cells with no surface-exposed CwpV are completely deficient of 
CwpV or whether the protein is present with an alternative localisation, transmission electron 
microscopy (TEM) was utilised. Cd630 was scraped from plates, cryosectioned and then 
immunogold labelled and negatively stained. Once again, only a small proportion of bacteria 
are positively labelled by a-CwpVrptl, and where present labelling is spread over the entire 
surface of the bacterium, with almost no CwpV detected intracellularly (Figure 3.23; 
Supplemental Data CD). This demonstrates that apparent CwpV-negative cells within a CwpV- 
positive culture of Cd630 are not due to a defect in CwpV localisation. No labelling was seen in 
the Cd 17, Cd167 and C. tetani negative controls (Supplemental Data CD). CwpV is therefore a 
phase variable protein in Cd630. 
CwpV is expressed in all cwpV type I strains with the exception of Cdl 
Expression of CwpV in various strains was examined by Western immunoblotting of total 
lysates of overnight cultures using a-CwpVrptl (Figure 3.16). As expected, the a-CwpVrptl 
antibody was not able to detect any protein in type II or type III strains, confirming the 
specificity of the antibody for type I CwpV. Expression of CwpV is detected in type I strains 
Cd101, Cd291, Cd371, Cd630, Cd959 and CdY. The differences in the sizes of the major 
detected bands are consistent with the differing number of repeats detected by PCR 
amplification of the cwpV gene from these strains (compare to Figure 3.5 line 3). Interestingly, 
as was observed in Cd630, two major bands are observed in each strain, plus a third in Cd371. 
The size of the largest observed band is around 42 kDa smaller than predicted for the mature 
protein in every strain, and the lower major band is -6.5 kDa smaller than the higher. As was 
seen in Cd630, a ladder of smaller proteins is also visualised, which is approximately consistent 
with the successive loss of single repeat units. 
C. diicile cells of all strains were then scraped from plates. These were immunofluorescently 
labelled using a-CwpVrptl and a-rabbit-FITC and subsequently FACScan analysed 
(Figure 3.22). As expected, the antibody did not label any strain harbouring type II or type III 
cwpV. Staining was observed for all type I strains where CwpV could be detected in total cell 
lysates, and as expected no staining of Cd1 was detected. The fluorescence plots reveal that for 
each CwpV type I-positive strain only a sub-population of between 1% and 7% of bacteria are 
labelled, which is consistent with the previous immunofluorescence microscopy data obtained 
for Cd630. CwpV is therefore a phase variable protein in all cwp V-type I strains in which it is 
expressed. 
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FACS analysis of individual Cd630 colonies scraped from plates showed a range from 0.4% to 
1.9% CwpV positive cells in each colony (data not shown). The presence of some positive cells 
in each colony implies that the switch regulating expression is not stably heritable, meaning that 
it is not possible to simply isolate CwpV-expressing cells. 
No CwpV expression is detected in type I strain Cdl. This was confirmed by analysing total 
lysates obtained over the entire course of growth, where no bands are seen, other than a very 
faint signal after overnight culture (Figure 3.17). Inspection of the previously determined amino 
acid sequence of cwpV in all strains shows there is only one amino acid alteration, Ala-606-Thr, 
in the sequence of the first repeat in Cdl in comparison to that of Cd630. As the antibody is 
polyvalent it is unlikely that a single amino acid change could prevent recognition of the CwpV 
from Cdl by a-CwpVrptl. 
To further investigate the expression of cwpV in Cdl and also in representative type II and 
type III strains, RNA was extracted from mid-exponential phase and early stationary phase 
cultures of Cd630 (type I control), Cdl (type I non-expressing), Cd20352 (type II) and Cd167 
(type III). After reverse transcription, PCR amplification of 16S rRNA resulted in strong signal 
from all strains. PCR was then carried out to detect transcription of cwp V in these strains under 
these conditions (Figure 3.18). The 5' conserved region, encoding the cell wall anchoring 
domains, could be amplified from cDNA of both Cd20352 and Cd167 at a level similar to that 
observed in Cd630, and in addition the type II repeat could be amplified from Cd20352 cDNA. 
This shows that although a-CwpVrptl is not able to demonstrate the presence of CwpV in 
type II and type III strains, the gene is at least transcribed in representative strains of each cwpV 
type. No signal from Cdl was detected for either region of the gene, implying that the cause of 
the lack of expression detected by a-CwpVrptl is not an issue of translation or of protein 
stability, but a deficiency of transcription. As a further control, transcription of cwp66 was also 
examined in all strains, and was detected in Cd630, Cdl and Cd20352 but not in Cd167, despite 
amplification from genomic DNA of this strain. Amplification reactions were repeated where 
negative RT-PCR results were found, with the number of PCR cycles extended from 30 to 35 in 
order to increase the sensitivity of detection. After this modification, a faint signal could be 
seen for cwpV in Cdl, implying that transcription is not completely abolished but is severely 
attenuated in this strain. Even after this more sensitive test, no transcription of cwp66 was 
observed in Cd 167; the significance of this is not known. 
To quantify the relative levels of transcript, real-time quantitative PCR (qPCR) was utilised. 
Unfortunately the assays were designed using the published Cd630 genome, and the assays for 
both s1pA (used for normalisation) and cwp66 did not work on the genomic DNA of either Cdl 
or Cd167, so it was not possible to determine whether cwp66 transcription is completely 
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abolished in Cd167 (Figure 3.19A). In Cd630, it can be seen that cwpV is detected in both 
growth phases tested, and it is present at 3.5-fold higher levels in early stationary phase cultures 
than in mid-exponential cultures (Figure 3.19B), confirming earlier observations using RT-PCR 
and Western blotting. qPCR produced intriguing results concerning the transcription of cwpV in 
Cdl. Absolute mRNA levels appear reduced in comparison to Cd630, but only 2.2-fold in 
exponential phase cultures and 5.1-fold in stationary phase cultures, which is not enough of a 
difference to explain the previous observations by PCR. However, equivalent amounts of 
genomic DNA produced a much stronger qPCR signal from Cdl than Cd630, implying that 
possibly the assay is much more efficient in Cdl. This is perhaps due to the reduced number of 
alternative binding sites for the assay components (which are located in the repeat region of 
cwpk) in this strain. Normalisation to the genomic DNA signal results in detection of a lower 
level of cwpV mRNA in Cdl compared to Cd630 by 122-fold in mid-exponential stage cultures 
and by 287-fold in early stationary phase cultures. cwpV transcription is severely attenuated in 
Cd l. 
Inverted repeat sequences in the promoter region of cwpV 
In search of an explanation for this phenomenon, the genome upstream of cwp V was sequenced 
(Figure 3.23). In type I and III strains, the genome sequences are almost identical from beyond 
the start of the upstream gene CD0513. In type II strains the observed homology only extends 
445 bp upstream of the translational initiation codon of CwpV (the ATG site), and a different 
gene is found upstream. As cwpV is transcribed in all cwpV types, it is likely that the promoter 
will be situated in this region of homology between all strains, and this is henceforth referred to 
as the promoter region. The only difference from consensus seen in the promoter region of Cdl 
that is not also observed in Cd371 (a strain of the same ribotype as Cdl that is capable of 
expressing CwpV) is the deletion of two nucleotides 291 bp upstream of the ATG site. 
Visual inspection of the sequences revealed that a 21 bp sequence observed in other strains at 
the location of the 2 bp deletion in Cdl is repeated in the inverted orientation 216 bp 
downstream; this observation was confirmed using the inverted repeat prediction program 
EINVERTED (EMBOSS software) (Figure 3.25A). A perfect 12 bp repeat is flanked either 
side by 2 bp and 5 bp extensions separated by single nucleotide mismatches, resulting in a 21 bp 
imperfect repeat (sequence identity 12/12,17/18 or 19/21). The 2 bp deletion observed in Cdl 
reduces the region of homology to a 10 bp perfect repeat flanked either side by 1 bp and 5 bp 
extensions separated by single nucleotide mismatches, resulting in a 18 bp imperfect repeat 
(sequence identity 10/10,15/16 or 16/18). 
The intervening DNA sequence was inverted in silico assuming a recombination within the 
central perfect 12 bp repeat (Figure 3.24). Analysis of this predicted DNA sequence after 
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inversion using Softberry BPROM reveals a predicted transcriptional start site 93 bp upstream 
of the ATG site, with strong predicted -10 and -35 boxes. Both the -10 box, TATAAA, and 
the -35 box, TTGATT, deviate at only the last residue from the B. subtilis and C. perfringens 
consensus sequences; a -14 TG dinucleotide is also observed (Rood & Cole 1991; Helmann 
1995). Both the gdh and rRNA genes of C. dii facile are transcribed from promoters that also 
deviate from the consensus sequence (Mani et al. 2006), so it is possible that these predictions 
are correct and that these sequences could promote transcription. The Shine-Dalgarno ribosome 
binding site is dictated by complementarity to the anti-Shine-Dalgarno sequence located near 
the 3' end of 16S rRNA (Shine & Dalgarno 1975). In C. difficile this is CCUCCU, and a close- 
to-consensus Shine-Dalgarno binding site can be observed just before the translational start site 
of CwpV (AGGGGG). 
In order to determine whether the observed inverted repeats actually result in a DNA inversion, 
complementary primers were designed between the two repeats (Figure 3.25B). In the genomic 
sequence as published, NF750 will produce a 177 bp product with an upstream external primer, 
whereas its complementary primer NF751 will produce a 270 bp product if the DNA is inverted 
between the repeats. Products of the expected size were amplified from genomic DNA using 
both primers (Figure 3.25C), indicating that the purified genomic DNA consists of a mix of 
sequence orientations and demonstrating that inversion does occur. Although the products were 
of the predicted size for the majority of strains, a second, larger band of approximately 500 bp is 
faintly visible in the "inverted" PCR of many strains, and a smaller band is also amplified from 
Cd630. A larger band is also observed in the published, "off' orientation of U2029 1. 
If the 2 bp deletion in Cdl disrupts DNA inversion, no product would be expected from the 
inverted, "on" PCR in this strain. A product is amplified, although it is not of the predicted 
length and appears to be the same size as the non-specific band observed in other strains. 
Sequencing of this product will be necessary to determine its origin. 
Sequencing of PCR products from all combinations of NF749 or NF770 and NF750 or NF751 
reveals that the DNA inversion does occur within the 12 bp region initially assumed, as the 
inner C-T mismatch is seen to invert, but this is not observed for the outer G-T mismatch (data 
not shown). 
An attempt was made to verify the transcriptional start site for this gene in Cd630 using 
fluorescent oligonucleotide primer extension, but technical problems were encountered and 
there was not time to optimise the technique within the context of this study (data not shown). 
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CwpV immunogenicity and antigenic cross-recognition 
As the cell wall anchoring domains of the CWPs are clearly related, it is possible that 
immunological cross-reaction could occur. To test this, a-HMW-SLP was used to immunoblot 
purified recombinant proteins. The N-terminal cell wall anchoring regions of CwpV and 
Cwp66, the C-terminal region of Cwp66, and two CwpV repeats were cloned from Cd630 as 
GST-tagged fusions, which were then expressed in E. coli and purified. These recombinant 
proteins, together with purified recombinant His-tagged Cwp2', were separated by SDS-PAGE 
and Western immunoblotted using a-HMW-SLP (Figure 3.26A). A C. docile cell wall 
extract', prepared using low-pH glycine, was used as a positive control for antibody recognition. 
As expected, HMW-SLP was detected in the glycine cell wall extract. No recombinant protein 
was detected by a-HMW-SLP. This result implies that the cell wall anchoring regions are not 
closely related enough to be immunologically cross-recognised. This is not unexpected, as 
while the proteins all contain three copies of the PF04122 cell wall anchoring domain, the 
sequences are quite divergent. 
As CwpV appears to be expressed at the surface of the bacterium and to be accessible to the 
external environment, it is possible that it could be immunogenic in C. diIcile infection. In 
order to investigate this, an antibody raised against formaldehyde-fixed whole Cd630 
(a-Cd630), which is assumed to recognise surface exposed proteins, was used as a crude 
model system. a-Cd630 was used to immunoblot purified recombinant proteins as above 
(Figure 3.268). As expected, three major bands are detected in the glycine cell wall extract, 
corresponding to Cwp2, HMW-SLP and LMW-SLP (Calabi & Fairweather 2002), which are all 
known to be highly expressed in the cell wall (Wright et al. 2005). Unsurprisingly, purified 
recombinant His-tagged Cwp2 is recognised by a-Cd630. In contrast neither Cwp66 nor CwpV 
are recognised by this antibody. It is possible that the proteins were not present on the surface 
of the C. docile culture inoculated to raise this antibody. However, this appears unlikely for 
CwpV as we have shown here that its expression is relatively constant. Cwp66 has previously 
been found to be expressed at the cell surface, although it may be differentially expressed as it is 
detected much more strongly after intense heat shock (Waligora et al. 2001). Alternatively, the 
proteins may be either expressed at a comparatively low level in the cell wall or may be poorly 
immunogenic, resulting in a very weak specific antibody response. For Cwp66 this would 
contrast with reports that antibodies against Cwp66 may be detected in the serum of patients 
with CDAD (Pechine et al. 2005a; Pechine et al. 2005b). Although CwpV is only expressed on 
the surface of a subset of cells, CwpV protein fragments have been detected in two-dimensional 
electrophoresis gels of cell wall extracts (Wright et al. 2005), implying that CwpV is present at 
a relatively high level in those cells where expression occurs. 
Provided by Nan Zhang 
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Figure 3.14 CwpV is expressed by Cd630 throughout the growth cycle 
A. Cd630 was grown in BHI and bacteria were periodically harvested using RNAprotect®. 
RNA was extracted and reverse transcribed, and then cwpV (one repeat) was PCR-amplified 
using primers NF375 and NF346. Optical density at harvest is indicated above the lanes. 
B. Cd630 was grown in BHI and bacteria were periodically harvested and frozen. Total lysates 
were then separated by SDS-PAGE and were Western immunoblotted using a-CwpVrptl. 
Optical density at harvest is indicated above the lanes and calculated band molecular weights are 
shown to the right. 
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Figure 3.15 Expression of cwpV in response to stress 
A: Microarray analysis of the effect of various stresses on the transcript levels of cwpV (see 
Section 4.2 for an explanation of the graph). The two lines in each panel represent intensity 
levels of two probes, representing the 5' cell wall anchoring region and the 3' repeat region, 
normalised to the control condition for each stress. B: Real-time quantitative PCR (qPCR) 
analysis of cwpV expression after heat shock. RNA was extracted from three biological 
replicates of mid-exponential phase C. difficile after incubation at 30°C (control, blue) or 42°C 
(heat shock, red) for 5,15,30 and 60 minutes. Reverse transcription and qPCR were carried 
out. CT values were normalised against . slpA signal and converted to 
fold change compared to 
the signal for each replicate after 5 minutes at 30°C. Biological replicates are represented by 
dark coloured diamonds, bright triangles and light coloured circles. 
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Figure 3.16 Immunofluorescence staining of cultured C. difficile 630 
A dense liquid culture of Cd630 was fixed onto a glass slide and immunofluorescently stained 
using a-CwpVrptl and rat a-LMW-SLP. i: a-rabbit-FITC labelled a-CwpVrptl staining. 
ii: a-rat-rhodamine-red labelled a-LMW-SLP staining. iii: Merged FITC and rhodamine-red 
images. iv: Bright field DIC image. v: DIC-fluorescence overlay. Scale bars represent 20µm. 
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Figure 3.17 Surface staining of C. difficile with a-CwpVrptl visualised by TEM. 
Cd630 were scraped from blood plates, cryosectioned, and then immunogold labelled 
using a-CwpVrptl. These sections were negatively stained and then transmission 
electron microscopy (TEM) images were obtained. Staining and microscopy were carried 
out by Dave Goulding. Scale bars represent 200nm. Further images are presented on the 
Supplemental Data CD. 
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Figure 3.18 Expression of CwpV type I by various C. difficile strains 
All strains of C. difficile were grown overnight on blood plates. Total lysates were 
prepared, separated by SDS-PAGE and then Western immunoblotted using a-CwpVrptI. 
Cd630 was repeated on the second blot as a positive control. 
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Figure 3.20 Cdl does not express CwpV during any growth phase 
Cdl was grown in BHI and bacteria were periodically harvested and frozen. Total lysates 
were then separated by SDS-PAGE and Western immunoblotted using a-CwpVrptl. 
Optical density (OD600) at harvest is indicated above the lanes: "M" signifies the marker 
lane, "S" signifies the starter culture, and "o/n" signifies the culture after overnight 
incubation. 
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Figure 3.21 RT-I'CR analysis of transcription of cwpV in representative strains 
RNA was extracted from cultures of strains Cd l, Cd l 67, C d20352 and Cd630 during 
mid-exponential phase (OD()() = -0.5, "Exp") or early stationary phase ("Stat") and reverse 
transcribed. A. PCR amplification was carried out using 30 cycles, and genomic DNA was used 
as a strain specific positive control for each reaction. B. Where product was obtained from 
genomic DNA but not cDNA, PCR amplification was repeated using 35 cycles. 
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Figure 3.22 (1PCR analysis of transcription of ewpV in representative strains 
RNA was extracted from cultures of strains Cd l, ('d]67 and Cd630 during mid-exponential 
phase ("Ex") or early stationary phase ("St") and reverse transcribed. Real-time quantitative 
PCR (qPCR) was carried out using an Aß17700. A. Amplification of genomic DNA using the 
(i) slpA or (ii) cwp66 qP('R assays, converted to arbitrary units of RNA where I represents the 
signal generated in the 11.0 negative control. B. i: cttpV qPCR signal converted to arbitrary 
units of RNA. ii: cwpV cl)NA qPCR signal expressed as a percentage of genomic DNA signal. 
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Figure 3.25 Evidence of DNA inversion upstream of cwpV 
A: Alignment of the inverted repeat sequences of (i) the consensus sequence, or (H)Cd I; 
numbering is relative to the translational start site of cwpV, identical residues are highlighted, 
and the site of the 2 bp deletion is marked. B: Diagram of the genome of Cd630 between 
CD0513 and cwpV showing the location of primers on (i) the sequence of Cd630 as published, 
where NF749 and NF750 would be expected to amplify a 177 bp product, and (ii) the sequence 
after predicted DNA inversion, where NF749 and NF751 would be expected to amplify a 
270 bp product. Inverted repeat sequences are shown as yellow boxes. C: Amplification of 
genomic DNA using PCR with NF749 and either (i) NF750 or (ü) NF751. Band sizes are 
indicated to the right. 
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Figure 3.26 a-Cd630 does not recognise CwpV 
The N- and C- terminal regions of both CwpV and Cwp66 were purified as GST-tagged fusions, 
and Cwp2 was purified as a His-tagged fusion. 0.2µg of each of these recombinant proteins, 
together with 0.2µI of a Cd630 cell-wall glycine extract, were separated by SDS-PAGE and 
Western immunoblotted using either a-HMW-SLP (A) or a-Cd630 (B). The chemiluminescent 
image was overlaid onto a light image of the membrane to allow visualisation of the protein size 
markers. 
' Provided by Nan Zhang 
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3.5 Adherence of type I CwpV 
CwpV is located at the surface of C. docile, and may therefore be involved in interactions with 
its external environment. As CwpV in Cd630 is annotated as a possible adhesin or 
haemagglutinin, and shows homology to other proteins with these properties, an investigation 
into its interaction with mammalian cells was carried out. 
Cloning, expression and purification of GST-tagged CWP fragments 
Cwp66 has been previously reported to bind to mammalian cells (Waligora et al. 2001), so this 
was utilised as a positive control for adherence studies. Using the Gateway® system 
(Invitrogen), the 5' regions of cwp V and cwp66 from Cd630, encoding the cell wall anchoring 
regions, were cloned into pDESTT. M15, as were two repeats of type I cwp V and the 3' region of 
cwp66. These N-terminally GST-tagged fusions were expressed in E. coli and purified by 
GST-affinity column and size-exclusion chromatography. Each protein comprises a known 
proportion of its molecular weight as GST. In subsequent experiments, the amount of these 
proteins is quoted as jig GST present, as this measurement is proportional to molar values in 
comparison between proteins. 
Binding to cultured mammalian cells 
The mammalian cell line that Cwp66 has previously been reported to bind is Vero cells 
(Waligora et al. 2001), so these were chosen for preliminary binding studies. Purified 
recombinant GST-tagged proteins were incubated for 40 minutes on Vero cells in 96-well plates 
that had been seeded 16 hours previously. Unbound protein was then washed away, and the 
cells were fixed. Protein was then detected using a-GST and a-goat-HRP ELISA. After 
subtracting background (from wells with no added protein), signal was converted into a 
percentage figure relative to positive control wells containing 20µg/ml N-terminal Cwp66 (cell 
wall anchoring region). Purified GST was used as a negative control. 
As expected, both N- and C-terminal domains of Cwp66 show adhesion to Vero cells, with the 
C-terminal region binding around 2-fold more weakly than the N-terminal cell wall anchoring 
region (Figure 3.27A). The bacterial cell wall anchoring region of CwpV also binds to Vero 
cells, to around 150% of the level of the cell wall anchoring region of Cwp66. No evidence of 
binding to Vero cells was seen for the type I repeats of CwpV. 
The experiment was repeated using HEp2 cells, and a similar pattern of adhesion was observed 
(Figure 3.27B). Once more, the N-terminal cell wall anchoring region of CwpV bound more 
strongly (around 1.9-fold) than the cell wall anchoring region of Cwp66, and the C-terminal 
domain of Cwp66 shows some binding but only to around 20% of the level of the cell wall 
anchoring region. Again no adhesion of CwpV type I repeats was observed. 
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Haemagglutination 
In the absence of haemagglutination, suspended blood cells in round-bottomed 96-well plates 
will slowly sink to the bottom and roll down the sloping base of the wells to form a tight pellet. 
If haemagglutination occurs, the clumped cells are no longer able to roll and therefore remain 
where they fall, creating a lawn across the entire base of the well. 
To investigate whether CwpV is capable of causing haemagglutination, dilution series of the 
purified GST-tagged CwpV and Cwp66 proteins were prepared in round-bottomed 96-well 
plates before addition of human blood cells and incubation at 4°C, 22°C or 37°C (Figure 3.28). 
A lectin, concanavalin A, was used as a positive control for haemagglutination and purified 
GST was used as a negative control. Over the range of concentrations used, concanavalin A is 
diluted out of effectiveness. Although the concentrations of concanavalin A used were much 
lower than for the test proteins, investigations have shown that haemagglutination occurs up to 
the highest concentration tested (50µg/ml, data not shown). At lower temperatures, 
concanavalin A seems to haemagglutinate more efficiently, as greater levels of 
haemagglutination are seen with equal amounts of protein. No haemagglutination is seen with 
any other protein investigated at any temperature tested. This was also the case when equine 
blood was used (data not shown). At all temperatures, the highest protein concentration of 
C-terminal Cwp66 and the N-terminal cell wall anchoring regions of both CwpV and Cwp66 
caused the remaining liquid in the wells to appear clearer than in wells with lower or no protein 
levels. The explanation for this phenomenon is not known. 
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Figure 3.27 Binding of Cwp66 and CwpV to mammalian cell lines 
Vero (A) or HEp2 (B) cells were seeded into 96-well plates and grown overnight. Dilution 
series of purified recombinant GST-tagged proteins were resuspended in mammalian cell 
growth media and incubated on cells for 40 minutes ("GST" = 20gg/ml GST tag alone). After 
formaldehyde-fixing, ELISA was carried out using a-GST antibody and then HRP-labelled 
secondary antibody. OPD reagent was incubated in the wells and signal measured as A492. The 
signal above background (media alone) is expressed as a percentage of that in control wells with 
20µg/ml N-terminal Cwp66. Cwp66 is shown in black and CwpV in red. The N-terminal cell 
wall anchoring regions are shown as filled diamonds and the C-terminal regions as open 
diamonds. Error bars represent the standard deviation of the six test wells. 
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Figure 3.28 Neither Cwp66 nor CwpV haemagglutinate human blood cells 
Purified recombinant GST-tagged proteins were resuspended in Dulbecco's PBS at 
2x concentration and then serially diluted I in 2.25µI was added to rounded-bottomed 96-well 
plates and then 25µI 1: 10 human blood in Dulbecco's PBS was added to each well and the plate 
was gently agitated to mix the solutions. The plates were then covered and incubated for one 
hour at 4°C (A), 22°C (B) or 37°C (C). Plates were carefully transferred into a scanner for 
image capture. I Buffer only (no protein) added to "GST" wells. 
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3.6 Discussion 
cwpV appears to be a highly conserved, and yet highly variable, gene of C. docile. The 
5' region, encoding three PF04122 bacterial cell wall binding domains, was found in every 
strain examined in this study, and was very highly conserved at the DNA sequence level. The 
3' region of the gene has at least three possible forms, designated types Ito III. Type III has not 
been characterised, and may therefore represent more than one form of cwpV. Both type I and 
type II cwp V 3' regions display a highly repetitive nature. The gene sequences, both between 
the repeats and the strains of the same type, are highly conserved. However these two types of 
repeat, despite sharing similar amino acid compositions and predicted pls, are otherwise very 
different. Type I repeats are 50% larger than type II repeats, and are predicted to form primarily 
ß-sheet secondary structure, whereas type II repeats are predicted to be highly a-helical. In both 
cases, however, the first repeat is divergent from the others and has a much higher proportion of 
basic amino acids. Type II repeats show homology to a proposed sugar-binding domain, 
although it has not been possible to begin characterisation of the significance of this 
resemblance within the context of this study. The significance of this variation of cwpV type 
between strains is not known. 
The presence of a highly conserved 5' region and a variable 3' region of cwpV is consistent with 
microarray studies into the comparative phylogenomics of C. dWIcile (Stabler et al. 2006). The 
microarray used in this study contains two reporters designed against the cwpV present in 
Cd630. One cwpV probe, hybridising to the 5' region of cwpV encoding the cell wall anchoring 
domains, positively hybridised against every strain tested. The other cwp V probe, hybridising to 
type I repeats, was identified as absent in all REA type BI strains (designated as hypervirulent) 
and all TcdA-B+ strains. Of the other strains, this probe was variously detected as present, 
absent or divergent. Cdl was investigated in this study, and was labelled as divergent. This 
implies that the reduced number of repeats in comparison to Cd630 genomic DNA is reducing 
the ability of Cdl genomic DNA to compete for hybridisation, reducing the signal. This effect 
may result in false "absent" labels in type I strains with lower numbers of repeats; a number of 
strains where the 3' region of cwpV has been labelled as "absent" do show some degree of 
hybridisation to this probe in the microarray, but at lower levels than that necessary for 
"present" or "divergent" classification. In contrast, other strains in which the 3' region of cwpV 
has been labelled as "absent" (including Cd20352, Cd20291 and Cd20928) exhibited essentially 
no hybridisation to the cwpV type I repeat probe, and these are likely to represent type II or 
type III strains. 
Aside from the conjugative transposon 1.5 kb upstream, there are no obvious genomic 
rearrangement sequences surrounding cwpV, so it is not known how the phenomenon of 
completely different gene types came about. This is also true of the PaLoc, and yet numerous 
toxinotypes have been described. The significance of the correlation between cwpV type and 
virulence, with all "hypervirulent" strains examined having type II cwpV and all TcdAB+ 
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strains having cwpV type III, is not known. However, as not all cwpV type II strains are 
hypervirulent, and not all type III strains are TcdAB+, then the link with virulence attributes 
cannot be strong or causal, at least not independently, although a synergistic effect cannot be 
excluded. 
CwpV has been shown to be expressed at the surface of all type I strains examined, with the 
exception of Cdl. This appears to be the case for only a subset of cells, in all strains, under all 
growth conditions tested. It is not possible to determine from the FACS data alone whether the 
"non-expressing" subset has no CwpV expression at all or just no surface CwpV expression. 
For Cd630, the transmission electron microscopy images support the hypothesis that there is 
actually no CwpV expressed in these cells at all, as immunogold staining is only seen at the 
surface of a subset of cells, and almost no CwpV was detected intracellularly in any cell. It 
would be reasonable to assume therefore that this is the case for all CwpV type I expressing 
strains. The significance of this phase variation of CwpV is not known. It would be very 
interesting to be able to separate the CwpV-expressing subset and determine whether any 
phenotype is apparent. However, the mechanism of phase variation must be rapid, as the 
expression of CwpV does not appear to be stably heritable. 
The phase variation of CwpV expression may be explained by "switching" of the orientation of 
the promoter region, mediated by the inverted repeats identified upstream of cwpV. Phase 
variation of fimbriae controlled by DNA inversion has been reported in E. coli, Salmonella 
typhimurium and Proteus mirabilis (Scott & Simon 1982; Abraham et al. 1985; Zhao et al. 
1997). In E. coli, this is mediated by two tyrosine site-specific recombinases, FimB and FimE, 
which bind to the inverted repeats and surrounding region and catalyse inversion of the 
promoter region; the region directly surrounding the inverted repeats is designated as four half- 
sites - the internal and external, left and right half-sites (Gally et al. 1996). Whilst FimB 
catalyses the inversion in either direction, FimE specifically inverts the DNA to the "off' 
orientation because it only exhibits affinity for the combination of half sites in the "on" 
orientation (Gaily et al. 1996; Kulasekara & Blomfield 1999). It is not only fimbriae that are 
known to be controlled by promoter DNA inversion: phase variable families of caspsular 
polysaccharide synthesis proteins and glycoproteins in Bacteroides are regulated by inversion of 
the upstream DNA by serine site-specific recombinases Mpi and Gfi (Krinos et al. 2001; Coyne 
et al. 2003; Fletcher et al. 2007). 
A similar system can be envisaged in C. docile. The "off' switching must happen more 
rapidly than "on" switching, as only a small proportion of cells actually express CwpV. This 
higher abundance of "off' orientation would explain the detection of this orientation by the 
Cd630 genome sequencing project. A simpler system to generate predominantly "off" promoter 
regions than is seen in E. cola is possible, needing only one recombinase, if the recombinase 
merely had higher affinity for the half-site combination present in the "on" orientation, resulting 
in more frequent `°off ' switching. However this would not allow regulation of the process). 
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Investigation of those proteins in C. docile that show homology to site-specific recombinases 
and determination of their affinity for the inverted repeat regions of cwp V will be necessary to 
elucidate the precise mechanism of DNA inversion. 
In C. docile it is predicted that an inversion of the published sequence would bring the 
promoter sequences into the correct orientation, allowing cwpV transcription to occur. 
Sequencing across the promoter region in the inverted orientation will be necessary to define the 
site of recombination. It has not been possible to experimentally locate the start site of 
transcription within the context of this study. Amplification of mRNA containing the inverted 
intervening sequence would prove that transcription does occur after switching, although the 
distance between the repeat sequence and the predicted start of transcription is quite small, and a 
specific reaction may be hard to design. Sequencing of cDNA products could also confirm that 
transcription occurs from the reverse orientation. 
Alternatively, isolation of the promoter region DNA in each orientation and expression of a 
reporter protein under its control would prove that expression occurs from the inverse 
orientation as predicted. It may be possible to use PpFbFP, a recently published protein that is 
capable of fluorescing under anaerobic conditions (Drepper et al. 2007), as a reporter under the 
control of the cwp V promoter region. It would also be very interesting to determine whether 
cwp V switching and expression are affected in vivo, as this will primarily dictate the potential 
contribution of CwpV to virulence. 
Whilst we have not been able to demonstrate expression of CwpV in type II or type III strains, 
we have demonstrated that the cwp V gene is transcribed in representative strains of each type. 
As in type I strains, inverted repeats can be identified in the promoter region of type II and 
type III strains. Genomic DNA inversion of the promoter region is detected, implying that 
expression of type II and type III CwpV is also likely to be phase variable. 
The largest protein detected in each type I strain by immunoblotting using a-CwpVrptl is 
around 40 kDa smaller than would be predicted for the mature protein. This size difference is 
consistent with the truncation of the entire cell wall anchoring region. Proteomic analysis of the 
cell wall has shown CwpV to be present in several different forms, ranging from 47 - 85 kDa in 
glycine extracts and -63 to -100 kDa in lysozyme extracts (Wright et al. 2005). The majority 
of the CwpV spots were identified only by peptides derived from the repeats, with only the 
largest protein moieties generating peptides matching the extreme C-terminus. The only spot 
generating peptides from the cell wall anchoring region was a 47 kDa basic fragment isolated 
using glycine extraction, consistent with an absolute N-terminal fragment. If the cell wall- 
anchoring region of CwpV is indeed cleaved from the repeats, there must be an alternative 
mechanism by which the detected CwpV type I repeats associate with the C. docile cell 
surface. 
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In this study, cwp V has revealed a relatively constant expression level under every condition of 
growth and stress tested. This is in contrast, however, to proteomic investigations into the 
changes in cell-wall composition after stress (Wright 2006). CwpV is detected at decreased 
levels after 20 minutes of heat shock at 60°C, and cannot be detected at all after 30 minutes of 
heat shock. The disparity between the microarray and real-time PCR analysis of cwpV 
expression and the results of proteomic studies may suggest that CwpV is also regulated at a 
later stage than transcription, for example by translational efficiency or by protein modifications 
affecting the stability of the protein. Alternatively, the difference in the temperature of the heat 
shock used may have resulted in differential regulation of cwpV. 
It is very interesting to note that Cdl is the only strain in which we have not been able to 
demonstrate significant cwpV or CwpV expression. cwp V transcription is severely attenuated in 
this strain, which may be due to the disruption by a2 bp deletion of the inverted repeats 
putatively responsible for phase variation. Ribotype 001 represents the UK endemic strain, 
prior to the recent hypervirulent epidemic. If Cdl is representative of ribotype 001 as a group, 
then it is unlikely that the loss of CwpV expression could severely affect virulence. However, 
lack of expression cannot be a conserved trait among all ribotype 001 strains as Cd371 is also 
ribotype 001 and has been shown to express CwpV. 
The significance of the presence of three PF04122 cell wall anchoring domains in all CWPs is 
not known. This domain is postulated to mediate binding to the underlying bacterial cell wall, 
so it is possible that these domains are merely necessary for retention of the CWPs at the surface 
of the bacterium. It is also possible that the shared predicted fold pattern actually allows the 
CWPs to incorporate into the S-layer in the place of HMW-SLP without disrupting the 
crystalline array, thereby conferring localisation at the outermost surface of the cell. Thus far, 
every CWP examined has shown binding to mammalian cells (Cwp66: Waligora et al. 2001; 
HMW-SLP: Calabi et al. 2002, and CwpV: this study). This may be a conserved property of 
the PF04122 bacterial cell wall anchoring domains of all the CWPs of C. diJcile. It is possible 
that this adherence may play a functional role, although it is also possible that the domain's 
intrinsic bacterial cell wall binding properties coincidentally confer the ability to adhere to a 
carbohydrate (or other) moiety on the surface of cultured mammalian cells and that this 
phenomenon is not relevant to clinical infections. 
In summary, we have shown that cwpV is present in every strain examined, and that there are at 
least three major forms. Types I and II have been characterised to encode repeats of 120 as and 
79 as respectively, which are almost completely unrelated to one another, cwp V is transcribed 
in representative strains of each cwpV type. All type I strains examined, with the exception of 
Cdl, express CwpV at the surface of a small subset of cells. This phase variation may be 
mediated by two imperfect 21 bp inverted repeats in the promoter region of cwpV. Although the 
exposure of type I CwpV repeats to the external environment has been demonstrated, we have 
not yet been able to characterise any function of these repeats. 
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4.1 Introduction 
Bacterial responses to stress 
Heat-shock response 
The general mechanism of the heat-shock response is conserved in all organisms (Boorstein et 
al. 1994; Gupta 1995), and in Gram-positive bacteria it consists of three major regulons: HrcA, 
CtsR and SigB (reviewed in Rosen & Ron 2002; Schumann 2003). These responses are not 
solely regulated by heat shock, and may be induced by any stress producing damaged or 
denatured proteins, for example ethanol shock, acid shock or salt shock. 
The major heat-shock chaperone systems GroESL and DnaJ/K are regulated by HrcA, which 
normally represses expression by binding to a CIRCE (controlling inverted repeat of chaperone 
expression) element (Zuber & Schumann 1994; Schulz & Schumann 1996). The monomeric 
DnaK (Hsp70) chaperone is aided by the DnaJ (Hsp40) cofactor in binding to the exposed 
hydrophobic regions of unfolded or nascent polypeptides. This complex is involved in both the 
correct folding of large proteins under normal growth conditions and for the refolding and 
disaggregation of proteins after a denaturing stress such as heat shock. GrpE, a nucleotide 
exchange factor, is necessary for dissociation of the DnaJ/K complex (reviewed in Houry 2001; 
Bukau et al. 2006). In contrast, the GroEL (Hsp60) tetradecamer forms two opposing cavities 
that can bind to the hydrophobic regions of nascent or denatured proteins. The GroES (Hsp10) 
heptamer then acts as a "cap", sealing the cavity. The bound ATP is hydrolysed and the 
complex disassembles to release the now natively folded protein, although the mechanism of 
this refolding is under debate (reviewed in Houry 2001; Lin & Rye 2006). 
In C. diicile, groEL has been shown to be strongly induced at both mRNA and protein levels 
after heat shock from 30°C to 43°C, and also to be secreted into the supernatant, but no change 
is observed after heat shock from 30°C to 48°C (Hennequin et al. 2001). groEL RNA is also 
strongly induced after exposure to ampicillin, however GroEL protein levels are affected at a 
much slower rate and to a far lesser degree. Acidic conditions and high osmolarity also strongly 
induced groEL RNA but this was not accompanied by a large relative increase in protein levels 
(Hennequin et al. 2001). 
CtsR controls expression of the Clp proteases by binding to a heptanucleic repeat motif in the 
promoter region, repressing transcription. Upon a protein unfolding stress, CtsR binding is 
prevented and expression of previously repressed genes may occur. The protease subunit CIpP 
forms tetradecamers that must bind to Hsp 100 family ATPase hexamers - CIpA, CIpC or C1pX 
- in order to function. These motors drive unfolded proteins into the proteolytic central core of 
the C1pP complex, where the unfolded protein is degraded. C1pB, whilst a member of the 
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Hsp 100 family, does not associate with the protease C1pP and can therefore act as a chaperone, 
extending denatured proteins to allow refolding without degrading them. In association with 
DnaK it is thought to be particularly involved in the extraction of proteins from aggregates 
(reviewed in Houry 2001; Weibezahn et al. 2005; Frees et al. 2007). 
There are also chaperones in B. subtilis that are not heat-shock regulated. Trigger factor (tig) is 
a peptidyl-prolyl isomerase involved in the protection of nascent polypeptides at ribosome 
(Hoffmann et al. 2006) and is induced by cold shock. The clpX ATPase subunit is also not 
regulated by heat shock, and in C. difficile is found in a gene cluster with c1pP1. 
The largest grouping of heat shock responsive genes fall under the control of sigma B (SigB, 
0B). This sigma factor is tightly regulated by the anti-sigma-factor RsbW and its antagonist 
RsbV, which in B. subtilis and in C. difficile are situated in the same gene cluster as sigB itself. 
In B. subtilis, these are in turn controlled by the RsbST two-component system (from Rosen & 
Ron 2002), which is not identified in C. difficile. ßß is strongly induced immediately after stress 
but then rapidly returns to pre-stimulus levels, in contrast to HrcA and CtsR which show much 
slower kinetics (Helmann et al. 2001). 
The aB regulon varies between different organisms, and can incorporate as many as two hundred 
genes (Hoper et al. 2005; Pane-Farre et al. 2006; van Schaik et al. 2007). It can be induced by 
heat, salt, acid or ethanol shock. In B. subtilis, rsbVW and sigB; app and opu ABC transporters; 
arginine biosynthesis enzymes and transporters; 3-oxoacyl-(acyl-carrier-protein) reductase; 
thioredoxin and ferredoxin genes; and cardiolipin synthase were all found to be upregulated by 
heat shock (Helmann et al. 2001). In response to ethanol or exogenous aB expression ribosomal 
proteins, RNA polymerase, cell-wall synthesis enzymes and iron binding proteins were 
downregulated, implying a reduction in growth rate (Price et al. 2001). Carbon metabolism 
genes (cellular redox, fatty acid metabolism), envelope function genes (teichoic acid synthases, 
exopolysaccharides, sugar transferases and cardiolipin synthase) and turnover (damaged or 
surplus macromolecule recycling) genes were all upregulated, together with multidrug 
resistance genes and opuB (osmoprotectant ABC transporter) (Price et al. 2001). Comparison 
of induction between wild-type and sigB-null bacteria after treatment with heat, salt or ethanol 
shock, together with promoter inspection, identifies 127 genes as belonging to the aB regulon in 
B. subtilis. These include sigB, rsbV, rsbW and rsbX; ctsR, clpP and clpC; multidrug, tellurium 
and tellurite resistance proteins; cardiolipin synthetase and thioredoxin (Petersohn et al. 2001). 
From this it can be seen that some genes (for example c/pP and clpC) are regulated by multiple 
mechanisms. aB-independent genes induced by one or more stresses include the HrcA regulon, 
the aW regulon (see below), NADH oxidoreductases and cell-wall synthesis and modification 
proteins (Petersohn et al. 2001). 
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Systematic knockout of B. subtilis a8-regulated genes reveals that eighty of the ninety-four 
constructed mutants have reduced culturability after heat-, cold-, salt- or ethanol-shock (Hoper 
et al. 2005), revealing that many do not have redundant functions. 
In contrast, after cold shock, B. subtilis upregulates ribosomal proteins and cold shock proteins 
that facilitate translation by blocking mRNA secondary structure formation. Manganese ABC 
transporters are upregulated whilst opu osmoprotectant ABC transporters (glycine/betaine/ 
carnitine/choline specific) and purine synthesis genes (except purA) are downregulated (Kaan et 
al. 2002). 
General Stress response 
In E. coli whenever growth is arrested, either by an induced stress or by reaching stationary 
phase, RpoS (as) is induced. This causes production of a gene set which prevents damage 
within the cell and therefore confers general resistance to many stresses. RpoS has thus far only 
been identified in Gram-negative bacteria (reviewed in Hengge-Aronis 2002). The induced 
resistance to multiple stresses may be equated to the aB induced stress responses in Gram- 
positive bacteria; this system is not known to be induced at entry to stationary phase but may be 
induced by starvation (Hecker & Volker 2001). 
Stringent Response 
In response to carbon, nitrogen or phosphorus starvation (p)ppGpp accumulates. ReIA is 
induced to catalyse the synthesis of (p)ppGpp upon the binding of uncharged tRNAs to the 
ribosome, resulting in the formation of stalled ribosome complexes. (p)ppGpp then binds 
directly to RNA polymerase and results in the repression of rRNA and tRNA transcription and 
the production of metabolic enzymes, particularly those involved in amino acid biosynthesis. In 
Gram-negative bacteria, SpoT is. responsible for the breakdown of (p)ppGpp. The stringent 
response may be necessary for bacterial persistence, quorum sensing or virulence (reviewed in 
Chatterji & Ojha 2001; Jain et al. 2006). 
SOS response 
Upon DNA damage, for example by UV light or genotoxic agent exposure the SOS response is 
triggered. The LexA repressor is constitutively expressed and binds to DNA, repressing the 
transcription of a set of genes. RecA binds to the single-stranded DNA resulting from damage 
and induces the autocleavage of LexA, releasing repression of the gene set. These genes 
include DNA repair enzymes, recombinase machinery and error-prone DNA polymerases that 
are capable of functioning over DNA lesions. Mobile element expression is increased, as is 
horizontal transfer, potentially resulting in the increased transfer of antibiotic resistance genes 
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within the population. The SOS response can also be triggered by many antibiotics (reviewed in 
Foster 2005; Kelley 2006). Quinolones disrupt DNA topoisomerase activity, resulting in double 
stranded breaks that are then processed to single stranded DNA by RecBC (Newmark et al. 
2005). ß-lactam antibiotics can also induce the SOS response in E. coli, possibly through 
sensing by a two-component system of the inactivation of a penicillin-binding protein PBP3 
(ftsl) (Perez-Capilla et al. 2005), and ciprofloxacin can induce the SOS response in 
Staphylococcus aureus (Cirz et al. 2007). 
Sigma W 
Sigma W (a') of B. subtilis has been shown to be induced by alkaline conditions and phage 
infection but not acid, ethanol, cold or osmotic shocks; it is proposed that the underlying 
induction trigger may be membrane leakiness (Wiegert et al. 2001). aW controls expression of 
app oligopeptide ABC transporter, phosphate ABC transporters, his histidine synthesis genes, 
sodium/hydrogen antiporters, tellurite and toxic anion resistance proteins and multidrug efflux 
pumps (Wiegert et al. 2001). After salt shock aW induces itself and an anti-a' factor, opu 
osmoprotectant ABC transporters (glycine/betaine/carnitine/choline specific), proline synthesis 
genes, alkyl hydroperoxide reductase and tellurite and toxic anion resistance proteins (Petersohn 
et al. 2001). In B. licheniformis the observed effect on phosphate uptake and the shift from 
phosphate teichoic acid synthesis to polyglycerate teichoic acid synthesis after alkali shock is 
proposed to be due to phosphate starvation caused by precipitation of phosphate with calcium 
and magnesium in the high pH conditions (Hornbaek et al. 2004). However, there is no aW 
homologue found in Cd630. 
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The C. difficile 630 microarray 
In 2004, the Bacterial Microarray Group at St. Georges, University of London (BgG@S) 
designed a microarray based on the preliminary C. diIcile 630 (Cd630) genome sequence and 
annotation available at the time (Sebaihia et al. 2006). At least one unique PCR probe was 
designed for each gene in the genome, and the C. dif cile microarray consists of these PCR 
products printed onto a coated glass slide. There are two spots of each PCR product probe 
printed on the slide to allow internal quality control. There are thirty-two (4 x 8) blocks of three 
hundred and six (17 x 18) spots; each block consists of both control spots and experimental 
spots (Figure 4.1). Cy3 and Cy5 labelled oligonucleotides ("landing lights") are printed in the 
corners of each block to allow easy alignment of images; dilution series of C. docile 16S rRNA 
(top left) and 23S rRNA (bottom right) PCR products act as positive controls for hybridisation; 
and negative control spots consist of human gapDH and ß-actin gene dilution series, DMSO or 
nothing spotted onto the slide, and include the distinctive "St. George's Cross" pattern at the 
centre of each block. 
The C. dii ficile microarray is designed as a two-colour array for competitive hybridisation 
between two different species of nucleic acid. For transcriptional comparison studies there are 
two major experimental approaches. RNA-RNA hybridisation can be carried out, with direct 
competition between experimental and control RNA for each condition. This approach allows 
direct comparison between samples, removing much experimental variation, and can therefore 
easily identify changed genes. However, the results are not comparable between microarray 
slides so for comparison between multiple samples a separate hybridisation must be carried out 
for each. The number of hybridisations necessary is proportional to the square of the number of 
samples to compare', resulting in very large numbers of slides being needed for large projects 
using direct comparisons. An alternative is to perform hybridisations against a constant control 
preparation, using either pooled RNA or genomic DNA as a control in each slide. By 
normalising the RNA signal to this constant background, comparisons can be made between 
different hybridisations and therefore larger studies are possible. I chose the DNA-RNA 
hybridisation approach to use for this study, so that multiple different stresses could be 
compared. 
'Number of hybridisation necessary = (n 
2- n)/2, where n is the number of samples to compare. 
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A 
Figure 4.1 The C. difficile microarray 
B 
C 
Cy3-labelled C. docile genomic DNA and Cy5-labelled RNA were competitively hybridised to 
microarray slides, the fluorescence was scanned and the images were overlaid. DNA signal is 
shown in green and RNA in red. A: The C. difcile microarray consists of thirty-two (4 x 8) 
blocks of three hundred and six (17 x 18) spots. B&C: One block is enlarged to show the 
negative control "St George's Cross" (white cross), positive control 16S and 23S dilution series 
at the top and bottom (white rectangles), and "landing lights" in the corners (white diamonds). 
RNA was extracted from control (B) or heat-shocked (C) cultures. Note the consistent DNA 
signal (green) between B and C, which is used as a control for hybridisation efficiency. Spots 
representing groEL, a known heat shock gene, are circled to demonstrate change in RNA signal 
intensity (red) after stress. 
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4.2 Microarray data generation and presentation 
In this chapter the C. dicile microarray has been used to investigate the responses of 
C. difficile 630 (Cd630) to stresses. During the early stages of infection, when C. difficile is in 
the spore form, it will encounter many stresses. However, by definition, spores have very low 
metabolic activity and are very difficult to study at the RNA level. In comparison to 
exponential phase cells, even vegetative cultures grown overnight to stationary phase show a 
very low mRNA expression profile (data not shown). It was therefore decided to focus on the 
responses of the vegetative cell to try to identify any genes that respond to stress and therefore 
may contribute to survival or adaptation during infection. Four categories of stress were 
studied. 1) Heat shock was chosen as a model for the general stress response. 2) Acid and 
alkali shocks were applied to C. difficile to model its response to altered pH. 3) Although 
C. difficile is a strict anaerobe, its response to exposure to atmospheric oxygen was studied. 
4) Antibiotics often elicit CDAD, so the reaction of C. difficile to growth in the presence of 
sub-inhibitory antibiotics was also investigated. The general methodology used is summarised 
below, although the detailed procedures are described in Chapter 2 (Methods). 
Triplicate actively growing, logarithmic phase cultures of C. difficile were stressed and then 
bacteria were harvested and their RNA was extracted and concentrated (biological replicates). 
Duplicate competitive RNA/DNA hybridisations were then carried out on C. difficile microarray 
slides (technical replicates) at the London School of Hygiene and Tropical Medicine in 
collaboration with Prof. Brendan Wren and Dr. Richard Stabler. Up to six measurements were 
therefore determined for each gene in each condition, plus the internal spot duplicates within 
each slide. However, quality control, which is detailed below, meant that some measurements 
were discarded and therefore there is not a full set of twelve measurements for each probe. 
Hybridised microarray slides were then scanned and the images uploaded to ImaGene® v5.5 and 
overlaid. A grid was superimposed to locate each spot, automated spot finding and adjustment 
was applied, and then manual amendments were carried out to identify and label artefacts and 
erroneously detected spots. The intensity of signal for each spot in comparison to the local 
background was quantified and the quality of each spot in terms of shape and consistency of 
signal was determined by ImaGene®. 
Data for each microarray slide was then uploaded to GeneSpringTnl GX v6.1 for analysis. Spots 
were filtered by quality: only those spots labelled as present or marginal were used, and absent 
or poor quality spots were discarded. The logt ratio of the intensity in the RNA channel (CyS) 
to that in the control DNA channel (Cy3) was calculated. The data for each slide was 
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normalised to its median, to account for changes in hybridisation efficiency, and then each gene 
was normalised to its average ratio in the experimental control hybridisations for each condition. 
The data set as a whole was then subjected to quality control testing. , 
Box plots, principal 
component analysis and phylogenetic tree construction for all genes were used to check for 
outlying hybridisations. Abnormal slides -a few that had very weak hybridisations and were 
giving unusual results - were removed from the data set and then normalisations were carried 
out afresh. Even after this pruning, both clustering techniques revealed that the hybridisations 
were clustered by the print run of the slides used. This has been proposed to be due to the 
highly variable very low intensity signals given by, for example, poorly printed spots, and 
ideally the entire experiment would have been carried out on a single print run'. This is, 
however, unlikely to have lent any bias to the results as entire stress experiments were carried 
out on individual print runs where possible (heat shock and antibiotic exposure), or otherwise 
paired control and stress hybridisations were carried out (pH and atmospheric shocks). 
Repeating these clustering techniques at a later date using a partial gene set of only genes that 
were significantly regulated in at least one stress condition (which tend to be the higher 
intensity, more robust hybridisation probes) substantially reduced the level of print run 
clustering. 
The data was interpreted by analysing the reliability of the changes in gene expression observed, 
rather than inspecting solely the magnitude of the change. Although the majority of artefacts 
were identified and excluded from the analysis during ImaGene® inspection, a few may have 
been missed. Individual ANOVA tests for each stress were therefore used to compare 
expression of each gene in control and stressed cultures and identify genes with statistically 
altered expression, where possible using multiple testing corrections. For illustrative purposes, 
the fold change between control and stress conditions is quoted in the text in a number of cases. 
The statistical lists generated for each stress are shown in Tables 7.1 to 7.12 in Appendix 1, and 
are collated on the Supplemental Data CD. Due to the complexity of the larger lists it is not 
feasible to examine each gene in the text. Interesting genes and gene sets within each list have 
been selected and are detailed in the following sections, while other genes in the lists are 
discussed in Appendix 2 (Chapter 8). For clarity C. difficile gene numbers (CD####) have been 
omitted from the text in the majority of cases. Often genes encoding related proteins all linked 
to a biochemical pathway are co-regulated; those pathways identified within the results as 
'J. Hinds, personal communication. 
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potentially co-regulated are diagrammed. In addition to the statistically generated lists, the 
behaviour of selected functional gene groupings is also examined (Section 4.8). 
Only selected gene sets are illustrated in figures. Each figure incorporates an expression graph 
exported from GeneSpringTM and, where appropriate, a diagrammatic representation of the 
genes situated within the genome. Each panel of a GeneSpringTM graph represents one 
experimental stress, with expression under control conditions (normalised to 1) shown on the 
left and expression after stress at the right. As each gene in each experiment is normalised to 
the level of expression under the control conditions it has a loge ratio of I under control 
conditions and the intercept of the line at the right of each panel is indicative of the fold change 
induced by that stress. Each line represents one probe (gene), which is coloured the same in all 
experiments within one graph. Colouring (Figure 4.2C) is relative to the fold change after a 
chosen stress (which is underlined in each figure): upregulation is shown in red, downregulation 
in blue, and no change in purple; where there is no data point for the chosen. stress the gene is 
coloured grey in other panels. The depth of colour indicates the level of trust in the expression 
level, which is also indicated by the error bars on each data point that demonstrate the standard 
error of the normalised spot intensities. 
To demonstrate this graphic presentation, the same three genes are shown twice in Figure 4.2, 
where part A is coloured by expression after heat shock and part B by expression after growth in 
the presence of amoxicillin (see underlining). In these complex diagrams it is not feasible to 
label each line as representing a specific gene. 
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Figure 4.2 Interpretation of GeneSpringTM graphs 
Amox 
A and B: GeneSpringTM graphs. Each panel of the graph represents one 
experimental stress, with expression under control conditions (normalised to 1) 
shown on the left and expression after stress at the right. As each gene in each 
experiment is normalised to the level of expression under the control conditions it 
has a logt ratio of I under control conditions and the intercept of the line at the 
right of each panel is indicative of the fold change induced by that stress. Each line 
represents averaged data for one microarray reporter (gene). Colouring (C) is 
relative to the fold change after a chosen stress (which is underlined in each 
figure): upregulation is shown in red, downregulation in blue, and no change in 
purple. The depth of colour indicates the level of trust in the expression level, 
which is also indicated by the error bars on each data point that demonstrate the 
standard error of the normalised spot intensities. 
Each line (reporter) is coloured the same in all experiments (graph panels); where 
there is no data point for the chosen stress the gene is coloured grey in other panels. 
For example, A is coloured by expression after heat shock and B is the same data 
coloured by expression after growth in the presence of amoxicillin. 
C 
In these complex diagrams it is not feasible to label each line as representing a specific gene. 
In all other figures, all seven tested stresses are shown on the GeneSpringTM graphs: Heat, heat 
shock; Acid, acid shock; Alkali, alkali shock; Aero, atmospheric oxygen shock; Amox, growth 
in the presence of amoxicillin; Clind, growth in the presence of clindamycin; Metro, growth in 
the presence of metronidazole. 
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4.3 Results: Responses of C. difficile to heat shock 
Microarray analysis of the responses of C. difficile 630 to heat shock 
In order to investigate the responses of C. difficile to heat shock, late logarithmic phase cultures 
of Cd630 grown at 30°C were sealed into Falcon tubes in an anaerobic atmosphere and were 
incubated at 42°C (or 30°C as a control) for 15 minutes. Plating revealed that the number of 
surviving C. difficile was not affected by this treatment (data not shown). RNA was extracted 
and analysed using the C. difcile 630 microarray. Genes with statistically altered expression 
between control and heat shocked cultures were then identified using ANOVA tests with a 5% 
confidence level and multiple testing corrections. One hundred and fourteen genes were 
determined to be upregulated and ninety-eight determined to be downregulated after heat shock 
using the Benjamini-Hochburg multiple testing correction. In contrast only sixty-four 
upregulated genes and thirty-one downregulated genes were identified using the stricter 
Bonferroni correction (Figure 4.3; Tables 7.1 and 7.2). 
The genes identified as being altered by heat shock using the Benjamini-Hochburg multiple 
testing correction will be examined further. The magnitude of change of the statistically 
upregulated genes ranged from 1.37-fold to 11.17-fold (mean 2.71-, median 2.10-fold), and the 
fold-change of downregulated genes ranged from 1.34- to 18.17-fold (mean 1.71-, median 
1.75-fold). Selected genes will be described in this chapter; others are discussed in Section 8.2. 
For clarity all CD gene numbers have been omitted in the text, but all genes are detailed in 
Tables 7.1 and 7.2. Selected gene sets are illustrated in Figures 4.4 to 4.13. 
As expected, genes homologous to known E. cola heat shock operons are seen to be highly 
upregulated, and all are also present in the more stringent Bonferroni list. The known HrcA 
regulated gene cluster containing dnaJ, dnaK, grpE, hrcA and hemN (oxygen-independent 
coproporphyrinogen III oxidase) appears to be co-ordinately upregulated in response to heat 
(Figure 4.4A), as are groES and groEL (Figure 4.4B). The CtsR regulated c1pC is situated in a 
gene cluster with cstR$ itself, a DNA repair protein and an ATP: guanido phosphotransferase that 
appear to be co-ordinately controlled (Figure 4.5A). c1pB is located with two hypothetical 
proteins, which are also significantly upregulated (Figure 4.5B). htpG, a heat shock chaperone 
protein, is also upregulated. All three annotated cold shock proteins, cspA$, cspBs and cspD, are 
downregulated (Figure 4.6A). 
Many clusters of genes within the genome that encode enzyme complexes or biochemical 
pathways appear to be co-ordinately regulated after heat shock. The components of the acetoin 
dehydrogenase enzyme system multimeric complex are all located in one gene cluster - acoA 
$ not significantly regulated 
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and acoB (E1 component, acetoin: 2,6-dichlorophenolindophenol oxidoreductase a and ß 
subunits), acoC (E2 component, dihydrolipoamide acetyltransferase) and acoL (E3 component, 
dihydrolipoyl dehydrogenase) - preceded by a transcriptional regulators. These five genes are 
all co-ordinately upregulated by an average of 1.47-fold (Figure 4.6B). 
The conversion of L-glutamine to 5'-uridine monophosphate (UMP) involves a chain of 
enzymes (Figure 4.8): pyrAal, pyrAa2, pyrAbl and pyrAb2 (carbamoyl-phosphate synthase), 
pyrB (aspartate carbamoyltransferase), pyrCC (dihydroorotase), pyrD and pyrK (dihydroorotate 
dehydrogenase), pyrE (orotate phosphoribosyltransferase) and pyrFa (orotidine-5'-phosphate 
decarboxylase). These can all be identified in the C. difficile genome, and are primarily located 
in two gene clusters (Figure 4.7). All the genes in these potential operons, together with the 
pyrR bifunctional regulatory gene located elsewhere in the genome, are upregulated in response 
to heat shock (by 1.88-fold on average), whereas pyrC, pyrH and a second copy of pyrD are not. 
plsX (fatty acid/phospholipid synthesis protein) is situated in the genome with a large cluster of 
fatty acid biosynthesis genes (Figure 4.10): fapRS (DeoR-family fatty acid and phospholipid 
biosynthesis transcriptional regulator), fabl- (3-oxoacyl-ACP synthase III), fabK$ (trans-2- 
enoyl-ACP reductase), fabDs (malonyl CoA-ACP transacylase), fabG$ (3-oxoacyl-ACP 
reductase), acpP$ (acyl-carrier protein, ACP) and fabF' (ffabJ, 3-oxoacyl-ACP synthase II). 
Also necessary for this pathway is the gene cluster of accA$, accD$ (acetyl-CoA carboxylase 
carboxyl transferase a and ß subunits), accC$ (biotin carboxylase) and accB$ (biotin carboxyl 
carrier protein). This entire pathway appears to be co-ordinately downregulated by at least 
1.27-fold (average 1.78-fold) (Figure 4.9). 
Genes encoding four enzymes of the spermidine synthesis pathway (Figure 4.12) - speA 
(arginine decarboxylase), speDs (S-adenosylmethionine decarboxylase proenzyme), speE 
(spermidine synthase), and speB (putative agmatinase) - are situated in a cluster within the 
genome. All four genes are upregulated on average 2.34-fold in response to heat shock 
(Figure 4.11A). Additionally, genes encoding the four components of the spermidine/putrescine 
ABC transporter - potA (ATP-binding protein), potB (permease protein), potC (putative 
permease protein) and potD (substrate-binding lipoprotein) - are located in a cluster with a 
putative transcriptional regulator, and all five genes are co-ordinately upregulated 
(Figure 4.11B). 
All the components of an oligopeptide ABC transporter necessary for B. subtilis sporulation 
(Perego et al. 1991) - oppAs (substrate-binding lipoprotein), oppB, oppC (permease proteins), 
oppDS (ATP-binding protein) and oppF$ (ATP-binding protein, pseudogene) - are present in the 
genome as a gene cluster. These are all downregulated after heat shock, by an average of 
s not significantly regulated 
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1.51-fold, and so represent a potential operon in C. dicile as in B. subtilis (Figure 4.13A). 
Genes encoding both the ATP-binding protein and substrate-binding/permease protein of a 
putative osmoprotectant acid ABC transporter are also closely adjacent to one another in the 
genome and are strongly downregulated, by an average of 4.04-fold (Figure 4.13B). 
For a detailed analysis of the other genes with statistically altered expression levels after heat 
shock, see Section 8.2. 
Operon structural analysis 
The microarray results have suggested that a number of the related adjacent genes within the 
genome are co-ordinately regulated and therefore may be transcribed as operons. A number of 
the co-regulated gene clusters identified using microarray analysis of heat-shocked RNA were 
selected for further investigation. Reverse transcription and PCR (RT-PCR) were used to 
amplify mRNA transcripts spanning adjacent genes in order to identify genes that are 
co-transcribed (Figure 4.14). 
CD3215 and CD3216, the components of a putative osmoprotectant acid ABC transporter, appear 
to be co-ordinately transcribed. RT-PCR product of the expected size was amplified from RNA 
extracted after incubation at 30°C, demonstrating that these genes are transcribed as one unit 
(Figure 4.14A). No product could be detected at 42°C, but this is consistent with the strong 
downregulation of these genes after heat shock. 
Microarray analysis reveals that the gene cluster CD1682-4 containing iunli$ (inosine-uridine 
preferring nucleoside hydrolase) and genes encoding a putative membrane proteins and a radical 
SAM-superfamily proteins is downregulated by heat by an average of 1.71-fold (Figure 8.13B: 
Amoxicillin, Appendix 2). Product could be amplified between each gene of this cluster 
(Figure 4.14B). RT-PCR signal is lower, as expected, after heat shock. As predicted, no 
product could be amplified from CD1684 to CD1685, which is closely situated but divergently 
regulated. This demonstrates that iunHto CD1684 is transcribed as an operon. 
One of the two gene clusters encoding pyrimidine synthesis genes, pyrBKED (CD0814-5), 
which both seem to be co-ordinately upregulated after heat shock (Figure 4.7), was examined. 
Products of the expected sizes are amplified between both pyrB-pyrK, and pyrK-pyrE after both 
30°C and 42°C incubation, but no product could be amplified from pyrE-pyrD (Figure 4.14C), 
demonstrating that pyrB, pyrK, and pyrD are transcribed as an operon under these conditions, 
but that pyrE is transcribed separately. 
not significantly regulated 
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The CD2854-1 gene cluster, consisting of dltDs (putative D-alanine transferase), dltB (D-alanyl 
transferase), dltA$ and dltO (D-alanine-poly(phosphoribitol) ligase subunits 1 and 2), is 
co-ordinately upregulated after heat shock by an average of 1.98-fold (Figure 8.1B: Heat, 
Appendix 2). Products could be amplified between dltD and ditA, and dutB and dltC, but no 
product was detected between dltA and dltB despite the overlapping coding regions of these 
genes (Figure 4.14D). CD2854 to CD2851 may therefore be transcribed as two two-gene 
operons. 
The spermidine synthesis gene cluster speADEB (CD0888-91, Figure 4.11 A) is co-ordinately 
upregulated after heat shock. RT-PCR products of the expected size are detected after 
amplification from RNA extracted after 30°C incubation and more strongly after 42°C 
incubation between speD and speE (Figure 4.14E). No product is detectable between speE and 
speB, despite overlapping coding sequences, nor between speA and speD, after either treatment; 
demonstrating that the entire gene cluster is not transcribed as an operon under these conditions, 
but speD-speE may be. 
The spermidine/putrescine ABC transporter potABCD (CD1023-7, Figure 4.11B) also appears to 
be co-ordinately regulated. RT-PCR products of the expected sizes can be amplified between 
each gene pair in this cluster: CD1023 to potA; potA to potB; potB to potC; and potC to potD. 
Signal is generally stronger from RNA extracted after heat shock, consistent with the microarray 
results previously generated. This demonstrates that CD1023-7 is transcribed as an operon 
under these conditions (Figure 4.14F). 
Real-time quantitative PCR analysis 
In order to confirm the validity of the microarray results, quantitative real-time PCR (qPCR) 
was carried out on a few selected genes. Triplicate logarithmic phase cultures were heat 
shocked from 30°C to 42°C, and samples were removed at 5,15,30 and 60 minute intervals. 
Extracted RNA was reverse transcribed and TagMan® custom assays were used to determine the 
relative levels of each gene transcript (Figure 4.15). The HMW- and LMW-SLPs, encoded by 
slpA, are the most abundant proteins at the surface of C. difficile, and their expression is 
determined to be relatively constant under microarray analysis (1.18-fold decreases, 
Figure 4.65A: Section 4.8xi). slpA was therefore used to normalise the signal from the other 
assays. Each biological replicate was then normalised to 1 after five minutes at 30°C. In the 
text, results are presented as fold-changes for the average of the biological replicates relative to 
the control signal at each time point, and the probability of each value happening by chance is 
given in brackets. 
$ not significantly regulated 
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groEL is a known heat shock gene that was used as a positive control for this method. It was 
observed by microarray to be highly upregulated (6.8-fold) after heat shock of C. diJcile 630 
for 15 minutes at 42°C (Figure 4.4B). qPCR reveals that groEL is induced 3.04-fold after 
5 minutes of heat shock (P<10"3), rising to 13.74-fold after 15 minutes (P<10'5), then falling 
again to a 6.96-fold induction over control after 30 minutes (P<10"5) and 6.14-fold after 
60 minutes (P<10-5) (Figure 4.15A). 
cwp66 has previously been reported to be upregulated in response to 20 minutes of heat shock 
at 60°C in C. difficile 79-685 (Waligora et al. 2001). cwp66 was not observed to change 
expression after heat shock of Cd630 at 42°C for 15 minutes in the microarray studies (1.12-fold 
reductions; Figure 4.65C: Section 4.8xi). qPCR also reveals steady cwp66 transcript levels over 
the time-course of 42°C heat shock in Cd630, with a maximum observed change of 1.15-fold 
increase after 30 minutes, and no significant difference at any time point (Figure 4.15B). 
CD2263 is a putative protein export chaperone that is induced 3.64-fold in the microarray 
results$ (data not shown). qPCR quantifies this gene as being induced 1.86-fold after 5 minutes 
of heat shock (P<0.03), peaking at 3.93-fold after 15 minutes (P<10-3), and slightly falling again 
to an induction of 3.23-fold after 30 minutes (P<10-3) and 3.27-fold after 60 minutes (P<104) 
(Figure 4.15C). 
CD3215, part of an osmoprotectant ABC transporter operon, is downregulated 5.09-fold in the 
microarray results (Figure 4.13B). qPCR quantifies this as being is downregulated in 
comparison to the control samples by 6.25-fold after 5 minutes of heat shock (P<10"6), 6.38-fold 
after 15 minutes (P<10-3), 4.40-fold after 30 minutes (P<10"3) and 3.71-fold after 60 minutes 
(P<10"2) (Figure 4.15D). In this example, in contrast to all other genes examined by qPCR, the 
level of signal from the control samples varies dramatically over time, decreasing almost 
10-fold over the course of the experiment. However, CD3215 expression levels fall even further 
in the heat-shocked bacteria, so it is unlikely that the observed comparative downregulation is 
an artefact. This phenomenon was also observed by semi-quantitative PCR (data not shown). 
potC and speE are constituents of the spermidine-related operons, and are induced 3.83- and 
3.35-fold after 15 minutes of heat shock as measured by the microarray (Figure 4.11). As 
measured by qPCR, speE expression is induced 4.11-fold after 5 minutes of heat shock 
(P<10"3), peaks at 5.01-fold after 15 minutes (P<104), and then returns close to basal levels at 
only 1.16-fold induction after 30 minutess and 1.39-fold after 60 minutes (P<10'2) 
(Figure 4.15E). potC shows a similar time-course of induction, and is increased 7.24-fold 
after 5 minutes of heat shock (P<10-5), and 5.60-fold after 15 minutes (P<10'3) but falls to 
only a 1.32-fold induction after 30 minutest and 0.93-fold after 60 minutest (Figure 4.15F). 
$ not significant 
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Figure 4.3 Cd630 genes with significantly altered expression after heat shock 
Late logarithmic cultures of Cd630 grown at 30°C were subjected to a 15 minute incubation at 
either 30°C (control) or 42°C ("Heat"). RNA was extracted from triplicate cultures and 
competitive DNA/RNA hybridisations were carried out. Spot intensities were determined and 
the resultant gene ratios were filtered by ANOVA using 5% confidence level and Benjamini- 
Hochberg (A) or Bonferroni (B) multiple testing correction. The behaviour of these gene sets 
after all tested stresses is shown. For an explanation of GeneSpringTM graph interpretation, see 
Figure 4.2. 
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Figure 4.4 Responses of the HrcA-regulated heat shock gene clusters 
GeneSpringTM graphs illustrating the change in expression of the dnaJ/K (A) and groESL (B) 
gene clusters after stress. The lines are coloured by the relative level of gene expression after 
heat shock. Diagrammatic representations of each gene cluster within the genome are depicted 
below the graphs with significantly regulated genes shown in bold; the dnaJ/K gene cluster is 
shown at 80% scale. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
169 
Heat Acid Alkali Aero Amox Clind Metro 
Chapter 4.3 - Microarray - Heat shock 
A 
o. 
i; j 
  Mat l1a. ýu ýaaaawu t1a. ýv raýwv. ý t. uýýu 1ýacaýu 
ctsR Cv0024 CD0025 cIpC 
B 
o. 
Heat Acid Alkali Aero Amox Clind Metro 
clpB CD2021 CD2022 
Figure 4.5 Responses of the CtsR-regulated heat shock gene clusters 
GeneSpringTM graphs illustrating the change in expression after stress of the gene clusters 
encoding CtsR and CIpC (A) and ClpB (B). The lines are coloured by the relative level of gene 
expression after heat shock. Diagrammatic representations of each gene cluster within the 
genome are depicted below the graphs with significantly regulated genes shown in bold. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.6 Responses of genes encoding cold shock proteins and the acetoin 
dehydrogenase enzyme complex 
GeneSpringTM graphs illustrating the change in expression after stress of the csp genes, 
encoding cold shock proteins, (A) and the acoABCL gene cluster, encoding the acetoin 
dehydrogenase enzyme complex (B). The lines are coloured by the relative level of gene 
expression after heat shock. A diagrammatic representation of the aco gene cluster within the 
genome is depicted below its graph with significantly regulated genes shown in bold, whereas 
the cold shock protein genes do not lie in a cluster. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 4.7 Responses of genes encoding the pyrimidine synthesis pathway 
GeneSpringTM graphs illustrating the change in expression of the pyrA (A) and pyrBKED (B) 
gene clusters after stress. These gene clusters encode the pyrimidine synthesis pathway 
(Figure 4.8). The lines are coloured by the relative level of gene expression after heat shock. 
Diagrammatic representations of these gene clusters within the genome are depicted below the 
graphs with significantly regulated genes shown in bold; the pyrA gene cluster is shown at 60% 
scale. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.8 Pyrimidine synthesis pathway 
Reactions in the pyrimidine (A) synthesis pathway forming uridine 5'-monophosphate from 
i, -glutamine are detailed (B). Protein names are shown in green and their enzyme descriptions 
are shown in blue; cofactors are shown in ire\. Enzymes with significantly upregulated 
transcripts are boxed in red; those with over 1.5-fold but statistically insignificant upregulation 
are boxed in orange. 
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Figure 4.9 Responses of genes encoding the fatty acid synthesis pathway 
GeneSpringTM graphs illustrating the change in expression of the acc (A) and fab (B) gene 
clusters after stress. These gene clusters encode the fatty acid synthesis pathway (Figure 4.10). 
The lines are coloured by the relative level of gene expression after heat shock. Diagrammatic 
representations of these gene clusters within the genome are depicted below the graphs with 
significantly regulated genes shown in bold; the fah gene cluster is shown at 80% scale. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.10 Fatty acid synthesis pathway 
Reactions in the straight chain fatty acid synthesis pathway are detailed. Protein names are 
shown in green and their enzyme descriptions are shown in dark blue; cofactors are shown in 
gre}. Enzymes with over 1.5-fold but statistically insignificant downregulation are boxed in 
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Figure 4.11 Responses of spermidine related gene clusters 
GeneSpringTM graphs illustrating the change in expression of the spe (A) and pot (B) gene 
clusters after stress. The spe gene cluster encodes the spermidine synthesis pathway 
(Figure 4.12), and the pot gene cluster encodes a sperm id ine/putresci ne-specific ABC 
transporter. The lines are coloured by the relative level of gene expression after heat shock. 
Diagrammatic representations of these gene clusters within the genome are depicted below the 
graphs with significantly regulated genes shown in bold. For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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Figure 4.12 Spermidine synthesis pathway 
Spermidine (A) is a polyamine involved in basic metabolic processes and can bind to the DNA 
backbone. (B&C) Reactions synthesising spermidine from S-adenosylmethionine and L-arginine 
are detailed. Protein names are shown in green and their enzyme descriptions are shown in 
blue; cofactors are shown in ; gre . 
Enzymes with significantly upregulated transcripts are boxed 
in red; those with over 1.5-fold but statistically insignificant upregulation are boxed in orange 
according to data after heat shock (B) or alkali shock (C). 
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Figure 4.13 Responses of gene clusters encoding oligopeptide and osmoprotectant ABC 
transporters 
GeneSpringTM graphs illustrating the change in expression of the opp oligopeptide (A) and 
CD3215-6 osmoprotectant (B) ABC transporter gene clusters after stress. The lines are coloured 
by the relative level of gene expression after heat shock. Diagrammatic representations of these 
gene clusters within the genome are depicted below the graphs with significantly regulated 
genes shown in bold; the oppBCADF gene cluster is shown at 80% scale. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.14 Detection of operonic transcription in C. difficile 
Cd630 was grown to late logarithmic phase at 30°C, then incubated at either 30°C or 42°C for 
15 minutes before RNA extraction. RT-PCR, with a genomic DNA (gDNA) positive control, 
was used to amplify RNA stretching from each gene in a potential gene cluster to the adjacent 
gene. Each set of panels represents results for one potential operon; diagrammatic 
representations of each gene cluster within the Cd630 genome are shown beneath each set of 
panels. The first panel presents amplification from the first gene to the second; the second panel 
from the second gene to the third etc. 
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Figure 4.15 Results of real-time quantitative PCR analysis 
Cd630 was grown to late logarithmic phase at 30°C, then incubated at either 30°C (control) or 
42°C (heat shock) for 5,15,30 and 60 minutes. RNA was extracted from three biological 
replicates, then reverse transcription and real-time quantitative PCR (qPCR) custom TagMan® 
assays, as labelled above, were carried out. CT values were normalised against . s1pA signal and 
converted to fold change compared to the signal for each replicate after 5 minutes at 30°C. 
Biological replicates are shown as dark coloured diamonds, bright triangles and pale squares. 
Control data is shown in shades of blue, and heat shock data is shown in shades of red. 
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4.4 Responses of C. difficile to pH shock 
Survival of C. difficile 630 under extreme pH 
In order to investigate the responses of C. difficile to pH stress, it was first necessary to 
determine the tolerance of Cd630 to extremes of pH. Calibration curves of the resultant pH of 
BHI after addition of HCl or NaOH were determined (data not shown). Cd630 was grown in 
BHI with the addition of either HCl or NaOH calculated to alter pH by 1-unit intervals. It was 
determined that Cd630 can grow in BHI media adjusted to between pH 5.4 and pH 9.2 
(Figure 4.16A). However, it was observed that the conditions in the anaerobic cabinet caused 
the pH of the media to shift towards approximately pH 5 over time, particularly from alkaline 
conditions (Figure 4.16B). As pH during growth could not be adequately controlled, an 
alternative strategy was used. Logarithmic cultures of C. dicile were subjected to pH shock. 
Cd630 was grown to an OD600of 0.6 and then HCl or NaOH was added to alter the pH of the 
media, in approximately 1-unit pH intervals. Plating of cultures after 15 minutes of incubation 
revealed that Cd630 is able to substantially survive shock to pH 4.8 or to pH 8.3 (Figure 4.16C). 
It was therefore decided to test the responses of C. dicile to these extremes. 
Microarray analysis of the responses of C. difficile 630 to acid shock 
C. dicile 630 was grown to late logarithmic phase and then hydrochloric acid was added, 
altering the acidity from pH 6.2 to pH 4.32, pH 5.29, pH 5.35 in the three biological replicates; 
water was added to control cultures. After a 15 minute incubation, bacterial RNA was extracted 
and then subjected to microarray analysis. ANOVA tests using a 1% confidence level (but no 
multiple testing correction) were then used to identify genes with statistically altered expression 
after acidic pH shock: twenty-four genes were determined to be upregulated and five 
downregulated (Figure 4.17, Table 7.3). ANOVA testing using a 5% confidence level in 
combination with Benjamini-Hochberg multiple testing correction identified four genes as 
significantly upregulated after acid shock. 
The genes identified as changing using ANOVA with no multiple testing correction will be 
examined further. The magnitude of change of the statistically upregulated genes ranges from 
1.41-fold to 7.33-fold (mean 3.59-, median 2.67-fold), and the fold-change of downregulated 
genes ranges from 1.27- to 100-fold (mean 41.0-, median 2.17-fold). These genes are detailed 
below. For clarity CD numbers have been omitted, but all genes are detailed in Table 7.3. 
Selected gene sets are illustrated in previous figures in addition to Figure 4.18. 
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The genes statistically upregulated by acid shock exposure include known E. coli heat-shock 
proteins. This is not unexpected, as the heat shock response is also activated by general stresses 
resulting in protein denaturation or misfolding, including acid shock. The gene clusters 
encoding ClpB and two adjacent hypothetical proteins; ClpC and its adjacent putative DNA 
repair protein and putative ATP: guanido phosphotransferase; and GroES/GroEL are all 
significantly upregulated; whereas all genes in the dnaJ/K gene clusters are upregulated, but 
only dnaK and grpE significantly so (Figures 4.4 and 4.5: Heat). 
A putative transcriptional regulator gene and IicT (putative transcription antiterminator) are 
downregulated and an ArsR-family transcriptional regulator gene is upregulated. A gene 
encoding a DNA repair protein, radA, is also upregulated. 
bcp (putative thiol peroxidase, bacterioferritin comigratory protein), a putative nitrite and 
sulphite reductase subunit gene and rbr (rubrerythrin) are all upregulated. A gene cluster 
involved in the fermention of phenyllactate, consisting of ldA$ (hadA; E-cinnamoyl- 
CoA: R-phenyllactate CoA transferase large subunit), fldls, ldB$ and fldC (hadl, hadB, hadC: 
R-phenyllactate dehydratase activator, medium subunit, small subunit), bcdl$ (acdB; acyl-CoA 
dehydrogenase, short-chain specific) and etfAl $ and eJ1 (electron transfer flavoprotein a- and 
ß-subunits), is upregulated (Figure 4.18). 
Cardiolipin (bisphosphatidyl glycerol) stabilises the activity of protein complexes important to 
the electron transport chain and serves as an insulator; cls (cardiolipin synthetase) is upregulated 
after acid shock. A putative membrane protein is upregulated, whilst a putative surface- 
anchored membrane protein gene is downregulated. All genes of the fatty acid synthesis gene 
cluster are slightly upregulated, by an average of 1.27-fold, but only fabF (3-oxoacyl-ACP 
synthase II) significantly so (Figure 4.9B: Heat). 
Genes encoding an ABC transporter ATP-binding protein (pseudogene) and an ABC transporter 
substrate-binding lipoprotein are downregulated. thrS (threonyl-tRNA synthetase) and genes 
encoding a putative glyoxalase, a probable protease, and a conserved hypothetical protein are 
upregulated. 
$ not significantly regulated 
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Figure 4.16 Tolerance of C. difficile to extremes of pH 
A: Growth of Cd630 in BHI with altered pH; determined pH of the media at the start is shown 
in the figure legend. B: Change over time of the pH of sterile BHI media left unsealed in the 
anaerobic cabinet. C: HCl or NaOH was added to late logarithmic cultures of Cd630 and 
incubated for 15 minutes. Survival after 15 minutes of pH shock was revealed by plating and 
enumeration. Colouring is consistent between the panels, with yellow signifying no pH 
alteration, red intensity signifying acidification by addition of HCI and blue intensity signifying 
increasing alkalinity by addition of NaOH. 
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Figure 4.17 Cd630 genes with significantly altered expression after acid shock 
Late logarithmic cultures of Cd630 were subjected to a 15 minute incubation after addition of 
water (control) or l7mM HCI (pH shift -1.5) ("Acid"). RNA was extracted from triplicate 
cultures and competitive DNA/RNA hybridisations were carried out. Spot intensities were 
determined and the resultant gene ratios were filtered by ANOVA using 1% confidence 
level (A) or 5% confidence level and Benjamini-Hochberg multiple testing correction (B). The 
behaviour of these gene sets after all tested stresses is shown. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.18 Responses of the fld-etf electron transport gene cluster 
GeneSpringTM graph illustrating the change in expression of the fld-etf gene cluster after stress. 
The fd-etf gene cluster encodes a phenyllactate dehydrogenase and an electron transfer 
flavoprotein. The lines are coloured by the relative level of gene expression after acid shock. A 
diagrammatic representation of this gene cluster within the genome is depicted below the graph, 
at 60% scale, with significantly regulated genes shown in bold. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Microarray analysis of the responses of C. difficile 630 to alkali shock 
Cd630 was grown to late logarithmic phase and then sodium hydroxide (or water) was added, 
changing the alkalinity of the medium from pH 6.2 to pH 8.56, pH 7.37 and pH 7.35 in the three 
biological replicates. After a 15 minute incubation, bacterial RNA was extracted and then 
subjected to microarray analysis. ANOVA tests using a 1% confidence level (but no multiple 
testing correction) were then used to identify genes with statistically altered expression after 
alkaline pH shock; thirty-three genes are significantly upregulated and ten downregulated 
(Figure 4.19, Tables 7.4 and 7.5). 
The magnitude of change of the statistically upregulated genes ranges from 1.35-fold to 
12.1-fold (mean 2.73-, median 1.94-fold), and the fold-change of downregulated genes ranges 
from 1.37- to 94.4-fold (mean 18.5-, median 2.18-fold). These genes are detailed below, and 
although CD numbers have been omitted for clarity all genes are detailed in Tables 7.4 and 7.5. 
Selected gene sets are illustrated in previous and subsequent figures in addition to Figure 4.20. 
Sudden exposure to an alkaline environment induces ssb (single-strand binding protein) but 
reduces the levels of a probable ATP-dependent helicase gene. xy1R (xylose repressor) and a 
putative transcriptional regulator gene are also downregulated. A putative protein translocase 
subunit is upregulated, and both 30S and 50S ribosomal-protein genes show an upwards trend; 
rp1L, rplU and rpsT significantly so (Figure 4.47: Section 4.8i). erm(B)1 (rRNA adenine N-6- 
methyltransferase, erythromycin resistance protein) is upregulated, and genes encoding a 
conjugative transposon protein, two hypothetical phage proteins and a putative phage tail fibre 
protein are downregulated after alkaline shock Foreign DNA as a whole shows no consistent 
trend (Figures 4.58 and 4.59: Section 4.8vii). 
Genes encoding the enzymes of the biochemical pathway converting 5-phospho-a-D-ribose 
1-diphosphate (PRPP) to histidinol in the histidine synthesis pathway are primarily located in a 
single gene cluster (Figure 4.21). hisla (bifunctional: phosphoribosyl-AMP cyclohydrolase and 
phosphoribosyl-ATP pyrophosphatase), hisF4, hislis (putative imidazole glycerol phosphate 
synthase subunits), hisA$ (putative phosphoribosyl formimino-AICAR phosphate isomerase), 
hisB (imidazoleglycerol-phosphate dehydratase), his C4 (putative histidinol-phosphate 
aminotransferase), hisG (putative ATP phosphoribosyltransferase), and his2 s (putative ATP 
phosphoribosyltransferase regulatory subunit), together with hisK (putative histidinol 
phosphatase), situated elsewhere in the genome, are all upregulated (Figure 4.20A). 
f not significantly regulated 
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The gene clusters consisting of fldAIBC, bcdl and etfA1B1 is upregulated by an average of 
1.51-fold, but only eftBi (electron transfer flavoprotein ß-subunit) significantly so (Figure 4.18: 
Acid). The speAs, speD, speE and speB spermidine synthesis operon and the potA$, potBS, 
potC$ and potD spermidine/putrescine ABC transporter operon are co-ordinately upregulated in 
response to alkali shock by 2.13- and 2.20-fold respectively (Figures 4.11 and 4.12: Heat). 
A gene cluster encoding a putative peptidase and the components of a probable amino acid ABC 
transporter (two permease proteins$, an ATP-binding protein and two substrate-binding 
proteins") is co-ordinately upregulated by an average of 1.85-fold (Figure 4.20B). Elsewhere in 
the genome, genes encoding another ABC transporter ATP-binding protein, a putative permease 
and a proton-dependent oligopeptide transporter and are also upregulated. 
IspA (lipoprotein signal peptidase) and a putative peptidase gene are downregulated, whilst 
cwp13, cwpl9 and cwp24 (PF04122 putative cell surface proteins, Figure 4.67: Section 4.8xi), 
and genes encoding a probable protease and a putative peptidase are upregulated. 
Genes encoding a putative glycosyltransferase, a putative mannosyl-glycoprotein endo- 
p-N-acetylglucosamidase, GuaA (GMP synthase), a putative chorismate biosynthesis-related 
protein and AroK (shikimate kinase) are upregulated, whereas a gene encoding a putative nitrite 
and sulphite reductase subunit is downregulated. Genes encoding two conserved hypothetical 
proteins and a hypothetical protein are also upregulated. 
$ not significantly regulated " only one probe/gene significant 
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Figure 4.19 Cd630 genes with significantly altered expression after alkali shock 
Late logarithmic cultures of Cd630 were subjected to a 15 minute incubation after addition of 
water (control) or 37mM HCI (pH shift --1.5) ("Alkali"). RNA was extracted from triplicate 
cultures and competitive DNA/RNA hybridisations were carried out. Spot intensities were 
determined and the resultant gene ratios were filtered by ANOVA using 1% confidence level. 
The behaviour of this gene set after all tested stresses is shown. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.20 Responses of gene clusters encoding the histidine synthesis pathway and an 
amino acid ABC transporter 
GeneSpringTM graphs illustrating the change in expression of the his (A) and CD2177-2 (B) gene 
clusters after stress. The his genes lie primarily in one cluster and encode the histidine synthesis 
pathway (Figure 4.21); and cD2177-2 encodes components of a probable amino acid ABC 
transporter. The lines are coloured by the relative level of gene expression after alkali shock. 
Diagrammatic representations of these gene clusters within the genome are depicted below the 
graphs with significantly regulated genes shown in bold. For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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4.5 Responses of C. difficile to exposure to an aerobic atmosphere 
Microarray analysis of the responses of C. difficile 630 to atmospheric exposure 
Plating of Cd630 from a logarithmic phase liquid culture revealed that viability fell dramatically 
to below 1% after fifteen minutes of exposure to the atmosphere, whereas after ten minutes over 
15% of cells were still immediately culturable, with more recovering if the plates were 
incubated for extended periods of time (data not shown). In order to investigate the responses 
of C. docile to exposure to oxygen, late logarithmic phase cultures of Cd630 were sealed into 
Falcon tubes in an anaerobic atmosphere and removed from the cabinet. All cultures were then 
shaken three times, with half being unsealed and opened between each treatment. Falcons were 
resealed and returned to 37°C for 10 mins. RNA was extracted and subjected to microarray 
analysis. ANOVA tests using a 1% confidence level (but no multiple testing correction) were 
then used to identify genes with statistically altered expression after exposure to atmospheric 
oxygen (Figure 4.22, Tables 7.6 and 7.7). Ninety-eight genes are determined to be upregulated 
and twenty-six downregulated after oxygen shock. ANOVA testing using Benjamini-Hochberg 
multiple testing correction and a 5% confidence level determined nineteen genes to be 
upregulated after exposure to atmospheric oxygen. 
The gene set identified using no multiple testing correction will be described in further detail. 
The magnitude of change of the statistically upregulated genes ranges from 1.36-fold to 
1507-fold (mean 25.7-, median 1.90-fold), and the fold-change of downregulated genes ranges 
from 1.20- to 2.27-fold (mean 1.69-, median 1.61-fold). Selected genes are discussed below, 
whilst the remainder are detailed in Section 8.3. CD gene numbers have been omitted from the 
text for clarity, but all genes are detailed in Tables 7.6 and 7.7. Selected gene sets are illustrated 
in figures in preceding and subsequent sections, in addition to Figures 4.23 to 4.26. 
C. docile does appear to respond specifically to the oxidative stress of atmospheric exposure. 
7.6% (18/238) of genes annotated as encoding proteins involved in electron transport are 
significantly upregulated£. A gene cluster encoding a putative oxidoreductase NAD/FAD 
binding subunit, electron transfer subunit and acetyl-CoA synthase subunits is co-ordinately 
upregulated (Figure 4.23A), as are etfE2 (electron transfer flavoprotein ß-subunit) and cls 
(cardiolipin synthetase: cardiolipin in membranes is important for the electron transport chain). 
Genes encoding a putative nitric oxide reductase flavoprotein and NorV (a putative anaerobic 
nitric oxide reductase flavorubredoxin), which may be involved in protection against nitric 
oxide, are upregulated (Figure 4.23B). A putative flavodoxin gene is also upregulated whereas 
ribA (riboflavin biosynthesis protein) is downregulated. 
Because the superoxide dismutase / catalase oxidative stress protection system results in the 
production of molecular oxygen, it is proposed that an alternative oxidative stress protection 
f statistically significant overlap 
f not significantly regulated 
191 
Chapter 4.5 - Microarray - Oxygen shock 
system may occur in anaerobic bacteria (Lumppio et al. 2001). Superoxide (02) may be 
converted to hydrogen peroxide (H202) by a superoxide reductase (rubredoxin oxidoreductase 
or desulphoferredoxin) followed by reduction of H202 to water by rubrerythrin, an NADH 
peroxidase. Cd630 has one desulphoferredoxin and four (two putative) rubrerythrins. After 
exposure to an aerobic atmosphere, genes encoding all of these genes" except one rubrerythrin 
genes are upregulated by an average of 1.93-fold (Figure 4.24A). 
The components of the ATP synthase complex lie in a single gene cluster in, the genome. All 
ten genes are upregulated, by an average of 1.44-fold, but only atpC (partial e chain) and atpE 
(C chain) are significantly increased (Figure 4.24B). 
The protein disulphide oxidoreductase genes trxAl/trxBl (thioredoxin / thioredoxin reductase) 
and trxB2 are upregulated, however trxA2a/trxB3s are downregulated (Figure 4.25). feoAI 
(putative ferrous iron transport protein A), a ferritin gene, and bcp (putative thiol peroxidase, 
bacterioferritin comigratory protein) are upregulated, whereas genes encoding a putative 
bacterioferritin, a putative iron-sulfur cluster-binding protein and a putative oxidoreductase are 
downregulated. 
All components of the putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex 
are situated in a cluster in the genome. Genes encoding the small subunits, a-subunit, 
methyltransferase subunits and ß-subunits are upregulated by an average of 1.36-fold, whilst the 
3'-situated dihydrolipoyl dehydrogenase subunits and nickel-inserting subunits genes are 
downregulated (Figure 4.26A). Interestingly the immediately adjacent upstream gene cluster of 
Jhss (formate-tetrahydrofolate ligase), fchA5 (methenyltetrahydrofolate cyclohydrolase), fo1D$ 
(bifunctional: methylenetetrahydrofolate dehydrogenase; methenyltetrahydrofolate cyclo- 
hydrolase), a conserved hypothetical protein genes, and a putative methylenetetrahydrofolate 
reductase genes is also downregulated, by an average of 1.42-fold (Figure 4.26B); whereas the 
further upstream genes cooC$ (putative carbon monoxide dehydrogenase-related protein) and 
adjacent cooSs (putative bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase) are 
relatively unchanging (Figure 4.26C). 
All three genes encoding cold shock proteins are upregulated, but only cspD significantly so 
(Figure 4.6A: Heat). This may however be an artifact due to exposure to air at room 
temperature. 
Interestingly, much of the response of Cd630 to atmospheric exposure is the regulation of 
proteins of as yet unknown function: of the 341 conserved hypothetical proteins in the genome 
eighteen are significantly upregulated, as are seven of the 164 hypothetical proteins represented 
on the microarray. 
# only one probe/gene significant 
$ not significantly regulated 
£ statistically significant overlap 
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Figure 4.22 Cd630 genes with significantly altered expression after oxygen shock 
Late logarithmic cultures of Cd630 were subjected to a 10 minute incubation after shaking in 
either anaerobic (control) or atmospheric ("Aero") conditions. RNA was extracted from 
triplicate cultures and competitive DNA/RNA hybridisations were carried out. Spot intensities 
were determined and the resultant gene ratios were filtered by ANOVA using 1% confidence 
level (A), or 5% confidence level and Benjamini-Hochberg multiple testing correction (B). The 
behaviour of these gene sets after all tested stresses is shown. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.23 Responses of gene clusters encoding an oxidoreductase complex and nitric 
oxide reductase flavoproteins 
GeneSpringTM graphs illustrating the change in expression after stress of the CDO174-6 gene 
cluster (A) and genes encoding nitric oxide reductase flavoproteins (B). The CD0174-6 gene 
cluster encodes components of a putative oxidoreductase. The lines are coloured by the relative 
level of gene expression after oxygen shock. A diagrammatic representation of the CDO174-6 
gene cluster within the genome is depicted below its graph with significantly regulated genes 
shown in bold, whereas the nitric oxide reductase flavoprotein genes do not lie in a cluster in the 
genome. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.24 Responses of genes encoding rubredoxins and the ATP synthase complex 
GeneSpringTM graphs illustrating the change in expression after stress of the genes encoding 
rubredoxins (A) and the atp gene cluster (B). The alp gene cluster encodes components of the ATP 
synthase complex, as shown in the diagram to the right. The lines are coloured by the relative level of 
gene expression after oxygen shock. A diagrammatic representation of the atp gene cluster within the 
genome is depicted below its graph, at 80% scale, with significantly regulated genes shown in bold; 
whereas the rubredoxin genes do not lie in a cluster in the genome. For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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Figure 4.25 Responses of genes encoding thioredoxins and their reductases 
GeneSpringTM graphs illustrating the change in expression after stress of the trxAIB1 and 
trxB2 (A) and the trxA2B3 (B) gene clusters. trxA genes encode thioredoxins and trxB genes 
encode thioredoxin reductases. The lines are coloured by the relative level of gene expression 
after oxygen shock. Diagrammatic representations of the trx gene clusters within the genome 
are depicted below each graph with significantly regulated genes shown in bold. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.26 Responses of genes clusters encoding carbon monoxide-related proteins 
GeneSpringTM graphs illustrating the change in expression after stress of the CD0723-8 (A), 
cD0718-22 (B) and CDI716-7 (C) gene clusters. These encode the putative carbon monoxide 
dehydrogenase/acetyl-CoA synthase complex; many tetrahydrofolate modifying proteins; and 
two putative carbon monoxide dehydrogenase-related proteins respectively. The lines are 
coloured by the relative level of gene expression after oxygen shock. Diagrammatic 
representations of the gene clusters are depicted below each graph (CD0723-8 at 70% scale) with 
significantly regulated genes shown in bold. 
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4.6 Responses of C. difficile to antibiotic exposure 
Resistance of C. difficile to antibiotics 
Disk Inhibition assays 
In order to determine the resistance patterns of C. dicile to various antibiotics, growth 
inhibition assays were carried out. C. difcile strains were grown overnight on blood agar at 
37°C, scraped from plates and resuspended in BHI before spreading onto fresh plates. Disks 
impregnated with antibiotic were then placed on top. After 24 hours' growth, the annular radius 
of the zone of inhibition around the disk was measured, and compared to published cut-off 
measurements for definition of resistance (Antibiotic Susceptibility Test Discs, Fluka) 
(Table 4.1). Antibiotic modes of action and bacterial mechanisms of resistance are reviewed in 
Sections 1.6 and 4.8vi. 
One mode of action of antibiotics, such as the penicillins and glycosides, is to disrupt cell wall 
synthesis. All C. difficile strains tested are resistant to ampicillin, and all strains are susceptible 
to amoxicillin with the exception of strains Cd17, Cd167 and Cd20928 that are intermediately 
resistant. All strains are susceptible to piperacillin, an extended-spectrum penicillin. However, 
as expected cephalosporins, also of the ß-lactam family, are less effective against C. d/Jcile in 
this test: all strains are resistant to both cefuroxime (second generation) and cefotaxime (third 
generation). The glycopeptide vancomycin is the last line of defence against C. dffcile in the 
clinical setting; reassuringly all strains are highly susceptible. 
Another common mode of activity of antibiotics is to bind to the bacterial ribosome and thereby 
inhibit protein synthesis. Clindamycin (a lincosamide) and erythromycin (a macrolide) bind to 
the 50S ribosomal subunits; all strains tested are resistant to all these antibiotics, except that 
Cd167 is susceptible to erythromycin. In Cd630, macrolide, lincosamide and streptogramin B 
(MLS) resistance is conferred by erm(B), present on Tn5398, the erythromycin resistance 
mobilisable non-conjugative element. Gentamycin (an aminoglycoside) and tetracycline bind to 
the 30S ribosomal subunits. All strains are resistant to gentamycin except U291 and U959, 
which are only intermediately resistant; and all strains are susceptible to tetracycline except for 
Cd17, Cd630 and CdM9 that are resistant. In Cd630 tetracycline resistance is known to be due 
to the presence of tetM on Tn5397 (conjugative transposon 3). 
An alternate method of antibiotic activity is to disrupt DNA replication and translation. 
Fluoroquinolones inhibit DNA gyrase; all strains tested are resistant to both nalidixic acid and 
ofloxacin, a second-generation quinolone. Trimethoprim is a bacteriostatic sulphonamide that 
prevents DNA synthesis; all strains are resistant to this antibiotic using the disk inhibition assay. 
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Metronidazole is the first line of clinical defence against C. docile and works by disrupting the 
helical structure of DNA. As expected, all strains are susceptible to metronidazole. 
C. di icile 630 growth in liquid culture 
Amoxicillin was chosen for further study as it is a commonly prescribed drug that can cause 
C. dicile associated disease. Clindamycin was chosen due to its historic significance in the 
disease; and metronidazole because it is the first line for treatment of C. dicile associated 
disease. These antibiotics show different methods of action: cell wall disruption; inhibition of 
protein synthesis; and inhibition of polynucleic acid synthesis - and also differing resistance 
patterns: C. difficile 630 is resistant to clindamycin but susceptible to amoxicillin and 
metronidazole. 
In order to determine the tolerance of C. difficile 630 to the presence of each antibiotic in the 
growth medium, cultures with increasing levels of antibiotic were set up and growth monitored 
at OD600 (Figure 4.27). Clindamycin and metronidazole are both observed to cause partial 
growth inhibition at certain concentrations, slowing bacterial growth without completely 
preventing it, whereas amoxicillin was either permissive to growth or completely prohibitive 
within the timescale examined. 
The maximal concentrations of antibiotic that allow relatively normal growth rates were chosen 
for utilisation with microarray analysis: 1 µg/ml amoxicillin, 50µg/ml clindamycin and 150ng/ml 
metronidazole. 
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Figure 4.27 Growth of C difficile 630 in the presence of selected antibiotics 
C. difficile 630 cultures were set up in the presence of increasing amounts of antibiotic in the 
growth medium. Growth was monitored 
by optical density at 600nm; OD(, 00 values below 0.03 
are set as 0.03. Growth 
in the absence of antibiotic is shown as black crosses. Growth in the 
presence of 2x antibiotic 
is shown as black diamonds, Ix antibiotic as grey diamonds and 
0.5x antibiotic as white diamonds. A: lx = 14g/ml amoxicillin. B: lx = 50µg/ml clindamycin. 
C: 1x= 150ng/ml metronidazole. 
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Microarray analysis of the responses of C. difficile 630 to the presence of amoxicillin 
In order to investigate the responses of C. docile to antibiotic exposure, Cd630 was grown to 
late logarithmic phase in the presence of lgg/ml amoxicillin, the maximal concentration of 
antibiotic that allows an essentially normal growth rate. RNA was then extracted and subjected to 
microarray analysis. ANOVA tests using a 1% confidence level in combination with multiple 
testing corrections were then used to identify genes with statistically altered expression in 
response to the presence of amoxicillin. Two hundred and thirty genes are determined to be 
upregulated and twenty-four are downregulated using Benjamini-Hochberg multiple testing 
correction; whilst eleven genes were determined to be upregulated and one downregulated using 
Bonferroni (Figure 4.28; Tables 7.8 and 7.9). ANOVA testing at 5% cut-off using Benjamini- 
Hochburg multiple testing correction resulted in 1090 genes being identified as statistically 
changed during growth in the presence of subinhibitory levels of amoxicillin: 443 downregulated 
and 647 upregulated (data not shown). 
The genes identified using the Benjamini-Hochburg multiple testing correction with a 1% 
confidence level will be further detailed. The magnitude of change of the statistically upregulated 
genes ranges from 1.39-fold to 11.7-fold (mean 2.85-, median 2.62-fold), and the fold-change of 
downregulated genes ranges from 1.50- to 5.03-fold (mean 2.68-, median 2.56-fold). Selected 
genes are detailed below, and others are examined in Section 8.4. CD gene numbers have been 
omitted in the text for clarity, but all genes are detailed in Tables 7.8 and 7.9. Selected gene sets 
are illustrated in figures in preceding and subsequent sections, in addition to Figures 4.29 to 4.39. 
The gene region CD0059-CD0099 appears to be co-ordinately upregulated (with the exception of 
CDO065, which in unchanged) by an average of 4.36-fold (range 2.18- to 6.01-fold), including 
significant upregulation of genes including rpoB, rpoC and rpoA (DNA-directed RNA 
polymerase ß, ß' and a chains), twenty-five ribosomal protein genes (plus four situated 
elsewhere), secE and secY (and secA2 situated elsewhere) (preprotein translocase subunits). 
Overall, 30S and 50S ribosomal protein genes are induced by 3.69- and 3.80-fold respectively 
(Section 4.8i, Figure 4.47). Five tRNA synthetases are significantly upregulated, and genes 
encoding tRNA-associated proteins are on average upregulated 1.81-fold (Section 4.8i, 
Figure 4.45). These significantly regulated genes are detailed in Section 8.4. Taken together 
these results imply that a general increase in transcription, translation and possibly secretion may 
be taking place in the presence of amoxicillin. 
Given the mode of action of amoxicillin, it is not surprising to see cell wall biosynthesis related 
proteins being affected. ditA (D-alanine-poly(phosphoribitol) ligase subunit 1: D-alanine- 
activating enzyme) and dacF (D-alanyl-D-alanine carboxypeptidase: penicillin-binding protein) 
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are upregulated; as is a gene cluster incorporating murD (UDP-N-acetylmuramoyl- 
alanine-D-glutamate ligase), mraY (phospho-N-acetylmuramoyl-pentapeptide-transferase) and 
murF (UDP-N-acetylmuramoyl-tripeptide-D-alanyl-D-alanine ligase) (Figure 4.29A). All of the 
mur genes, which are involved in the peptidoglycan synthesis pathway, are upregulated at least 
1.17-fold (average 1.92-fold) (Section 4.8x). Genes encoding a penicillin-binding protein and a 
putative ß-lactamase are induced; as is a gene cluster encoding a penicillin-binding protein and a 
penicillin-binding protein repressor. Overall, all annotated penicillin-binding proteins are either 
up- or downregulated by an average of 1.72-fold; none remain unaffected (Figure 4.29B). 
The region of the genome from CD2767-CD2801 encodes many surface associated proteins, 
including cell wall biosynthesis and modification genes, and thirteen PF04122-domain 
incorporating cell wall binding proteins (CWPs). Thirty-four of the forty-seven genes are over 
1.30-fold upregulated - six significantly so - and the cluster as a whole is on average 2.30-fold 
increased (Section 4.8xi). Statistically upregulated genes in this region are mviN (putative 
transmembrane virulence factor), cwp84" (cwp4, putative PF04122 cell surface-associated 
cysteine protease), cwp2, cwp6# (putative PF04122 cell surface proteins) and those encoding two 
putative glycosyltransferases. Elsewhere in the genome, a gene cluster containing cwp22 
(PF04122 cell surface protein), galE$ (UDP-glucose 4-epimerase) and gtaB (UTP-glucose- 
1-phosphate uridylyltransferase) is co-ordinately upregulated (Figure 8.7B: Amoxicillin, 
Appendix 2). 
A gene cluster containing maf (septum formation protein), radC (DNA repair protein), mreB2 
(rod shape-determining protein), mreCC (putative rod shape-determining protein putative 
membrane protein), a putative penicillin-binding protein gene, minCC (septum site-determining 
protein), minD$ (divIVB, septum site-determining protein, cell division inhibitor), minE (cell 
division topological specificity factor), mrdB (rodA, spoVE, rod shape-determining protein) and 
mgsA (methylglyoxal synthase) is strongly upregulated, by an average of 3.77-fold 
(Figure 4.32A). mreBl (rod shape-determining protein), ftsHJs, ftsH2, ftsZZ (cell division 
proteins), ftsW 
(spoVE, cell division/stage V sporulation protein), ftsY (putative signal 
recognition particle) and ftsK5 (spoIIIE, putative DNA translocase) that are located elsewhere in 
the genome are all upregulated; whereas cotJCJ (putative spore-coat protein) is downregulated. 
Overall, cell division and cell shape associated genes are upregulated by an average of 2.05-fold 
(Figure 4.32B). 
"' only one probe/gene significant 
$ not significantly regulated 
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Most foreign DNA is downregulated during exposure to amoxicillin: conjugative transposon 
genes by an average of 1.26-fold and phage genes by 1.53-fold (Section 4.8vii). However, the 
genes in the erythromycin-resistance mobilisable non-conjugative element Tn5398a are 
upregulated by an average of 2.27-fold, including significant upregulation of genes encoding 
EffR (hypothetical protein), a conserved plasmid hypothetical protein and a plasmid replication 
protein. 
A putative chemotaxis protein is significantly upregulated, and chemotaxis proteins in general are 
upregulated, by 1.20-fold on average (Figure 4.33A). Also, all genes in the region of the genome 
from CD0226-CD0272, which contains primarily flagellar genes, are co-ordinately upregulated by 
at least 1.56-fold and on average 2.90-fold, of which thirteen genes are significant (Sections 8.4 . 
and 4.8viii). 
A gene cluster encoding three tellurium resistance proteins (only two significant), a conserved 
hypothetical proteins, a tellurite resistance protein and a putative calcium-transporting ATPase is 
co-ordinately upregulated (Figure 4.33B), as is another tellurium resistance protein gene - all ten 
tellurium resistance proteins in the Cd630 genome are upregulated, by an average of 2.34-fold 
(Section 4.8vi). 
All ten ATP-synthase subunits are encoded in a single gene cluster in the genome; all these genes 
are co-ordinately upregulated by an average of 2.86-fold, although only atpH (subunit S) and atpF 
(B chain) significantly so (Figure 4.24B: Oxygen). 
The app oligopeptide ABC transporter resides in two adjacent but opposing gene clusters that 
appear to be co-ordinately upregulated - genes encoding two ATP-binding proteins in one, and 
two permease proteins" and a substrate-binding proteins in the other (Figure 4.34A); in B. subtilis 
this transporter may be involved in sporulation (Koide & Hoch 1994). Co-ordinately upregulated, 
by an average of 2.22-fold, is a gene cluster encoding three hypothetical proteins (two 
significant); a putative aliphatic sulphonate ABC transporter ATP-binding proteins, permease 
protein (pseudogene) and solute-binding lipoproteins; a putative membrane proteins; a putative 
exported protein; a putative permease; and a conserved hypothetical proteins (Figure 4.34B). The 
potABCD$ operon is upregulated (but only potC significantly), as is speADEBs (Figure 4.11: 
Heat) and metK (metE, S-adenosylmethionine synthetase). 
The fatty acid biosynthesis pathway is encoded in a single gene cluster, CD1177-CD1184. Of 
these genes acpP, fabD, fabF, fabK and fapR are significantly upregulated, while the cluster as a 
S not significantly regulated 
0 only one probe/gene significant 
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whole is upregulated 2.80- to 4.15-fold (average 3.73-fold). The related gene cluster accBCDA$ 
is also upregulated 2.34-fold, but only accB and accC significantly (Figures 4.9: Heat and 4.35). 
A gene cluster incorporating cggR$ (central glycolytic genes regulator), gapB (glyceraldehyde-3- 
phosphate dehydrogenase 2), gpml (pgm, 2,3-bisphosphoglycerate-independent phosphoglycerate 
mutase), tpiA (triosephosphate isomerase) and pgK (phosphoglycerate kinase) is co-ordinately 
upregulated (Figure 4.36A), as are tkt and tkt's (transketolases), and adjacent rpe (putative 
ribulose-phosphate 3-epimerase) and rpiBls (ribose-5-phosphate isomerase 1) (Figure 4.36B). 
These clusters, together with Jbp (putative fructose-l, 6-bisphosphatase), Jba (putative fructose- 
bisphosphate aldolase), pf7r-45 (6-phosphofructokinase), and eno (enolase) that are all also 
upregulated, encode proteins that are involved in the glycolytic pathway and pentose phosphate 
pathway, resulting in the production of both phosphoenolpyruvate and D-erythrose-4-phosphate 
(Figure 4.37). 
The enzymes that convert these precursors to phenylpyruvate (Figure 4.39) lie together in a single 
cluster within the genome, except aroDs which lies elsewhere and is downregulated in response 
to amoxicillin exposure. With the exception of tyrC (which has no data at any point) and 
cD1832, the genes in this cluster are upregulated by an average of 4.11-fold. aroB 
(3-dehydroquinate synthase), pheA (P-protein: chorismate mutase; prephenate dehydratase), aroE 
(shikimate dehydrogenase) and aroK (shikimate kinase) are significantly upregulated 
(Figure 4.38). 
$ not significantly regulated 
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Figure 4.28 Cd630 genes with significantly altered expression during growth in the 
presence of amoxicillin 
Cultures of Cd630 were grown to late logarithmic phase in the presence ("Amox") or absence 
(control) of lµg/ml amoxicillin. RNA was extracted from triplicate cultures and competitive 
DNA/RNA hybridisations were carried out. Spot intensities were determined and the resultant 
gene ratios were filtered by ANOVA using a 1% confidence level and Benjamini-Hochberg (A) 
or Bonferroni (B) multiple testing correction. The behaviour of these gene sets after all tested 
stresses is shown. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.29 Responses of a mur gene cluster and genes encoding penicillin-binding 
proteins (PBPs) 
GeneSpringTM graphs illustrating the change in expression after stress of a mur-mra gene cluster 
(A) and genes encoding penicillin-binding proteins (B). The mur-mra gene cluster encodes 
components of the peptidoglycan synthesis pathway. The lines are coloured by the relative level 
of gene expression after growth in the presence of amoxicillin. A diagrammatic representation of 
the mur gene cluster within the genome is depicted below its graph with significantly regulated 
genes shown in bold; whereas the penicillin-binding protein genes do not lie in a cluster in the 
genome. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.30 D-alanine and D-glutamine pathways 
D-alanine (A) and D-glutamine (B) conversion pathways are detailed. Protein names are 
shown in red and their enzyme descriptions are shown in blue; cofactors are shown in 
grey. Both D-alanyl-D-alanine and D-glutamate feed into the peptidoglycan synthesis 
pathway. Protein names are shown in green and their enzyme descriptions are shown in 
blue; cofactors are shown in Enzymes with significantly upregulated transcripts 
are boxed in red; those with over 1.5-fold but statistically insignificant upregulation are 
boxed in oi. ing, (,. 
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Figure 4.32 Responses of a gene cluster encoding cell-shape related proteins, and all 
genes encoding cell shape and cell division proteins 
GeneSpringTM graphs illustrating the change in expression after stress of CD1143-53 (A) and 
genes encoding cell division and cell shape determining proteins (B). The CD1143-53 gene 
cluster encodes many cell shape related proteins. The lines are coloured by the relative level of 
gene expression after growth in the presence of amoxicillin. A diagrammatic representation of 
the CD1143-53 gene cluster within the genome is depicted below its graph (at 75% scale) with 
significantly regulated genes shown in bold, whereas cell division genes do not lie in a cluster in 
the genome. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.33 Responses of genes encoding chemotaxis proteins, and a tellurium/tellurite 
resistance gene cluster 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding 
chemotaxis related proteins (A) and CD1634-9, a gene cluster encoding multiple tellurium and 
tellurite resistance proteins (B). The lines are coloured by the relative level of gene expression 
after growth in the presence of amoxicillin. Diagrammatic representations of relevant gene 
clusters within the genome are depicted below the graphs with significantly regulated genes 
shown in bold; the CD1634-9 gene cluster is shown at 70% scale. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.34 Responses of gene clusters encoding App and sulphonate ABC transporters 
GeneSpringTM graphs illustrating the change in expression after stress of the app gene cluster (A) 
and a gene cluster encoding a sulphonate ABC transporter (B). The app gene cluster encodes an 
amino-acid ABC transporter necessary for sporulation in B. subtilis (Koide & Hoch 1994). The 
lines are coloured by the relative level of gene expression after growth in the presence of 
amoxicillin. Diagrammatic representations of these gene clusters within the genome are depicted 
below the graphs (CD2360-69 at 80% scale) with significantly regulated genes shown in bold. For 
an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.35 Fatty acid synthesis pathway 
Reactions in the straight chain fatty acid synthesis pathway are detailed. Protein names are shown 
in green and their enzyme descriptions are shown in dark blue; cofactors are shown in 
Enzymes with significantly upregulated transcripts are boxed in red; those with over 1.5-fold but 
statistically insignificant upregulation are boxed in orange. 
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Figure 4.36 Responses of selected gene clusters encoding glycolytic and pentose 
phosphate pathway components 
GeneSpringTM graphs illustrating the change in expression after stress of the CD3171-3 (A) and 
CD2319-22 (B) gene clusters. These gene clusters encode components of the glycolytic and 
pentose phosphate pathways (Figure 4.37). The lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. Diagrammatic representations of these 
gene clusters within the genome are depicted below the graphs with significantly regulated genes 
shown in bold. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.37 Glycolytic and phosphosugar pathways 
Reactions in the glycolytic and phosphosugar pathways forming phosphoenolpyruvate and 
D-erythrose-4-phosphate (phenylalanine precursors) from D-glyceraldehyde-3-phosphate. Protein 
names are shown in green and their enzyme descriptions are shown in blue; cofactors are shown 
in L! rc\. Enzymes with significantly upregulated transcripts are boxed in red; those with over I. 5- 
fold but statistically insignificant upregulation are boxed in ormiue. 
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Figure 4.38 Responses of the aro gene cluster 
GeneSpringTM graph illustrating the change in expression after stress of the aro gene cluster. 
This gene cluster encodes components of the aromatic amino acid synthesis pathway 
(Figure 4.39). The lines are coloured by the relative level of gene expression after growth in the 
presence of amoxicillin. A diagrammatic representation of this gene cluster within the genome 
is depicted below the graph, at 70% scale, with significantly regulated genes shown in bold. For 
an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.39 Phenylalanine synthesis pathway 
Reactions in the phenylalanine synthesis pathway are detailed. Protein names are shown in green 
and their enzyme descriptions are shown in blue; cofactors are shown in Enzymes with 
significantly upregulated transcripts are boxed in rcd; those with over 1.5-fold 
but statistically 
insignificant upregulation are boxed in orange; and those with over 1.5-fold but statistically 
insignificant downregulation are boxed in 
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Microarray analysis of the responses of C. difficile 630 to the presence of 
clindamycin 
In order to investigate the responses of C. docile to antibiotic exposure, Cd630 was grown to 
late logarithmic phase in the presence of 50gg/m1 clindamycin, the maximal concentration of 
antibiotic that allows an approximately normal growth rate. RNA was then extracted and 
subjected to microarray analysis. ANOVA tests using a 1% confidence level but no multiple 
testing correction were then used to identify genes with statistically altered expression 
(Figure 4.40; Tables 7.10 and 7.11). Seventy-four genes were determined to be upregulated and 
sixty-nine were downregulated in response to the presence of sub-inhibitory levels of 
clindamycin in the growth medium. 
The magnitude of change of the statistically upregulated genes ranges from 1.20-fold to 
6.75-fold (mean 1.93-, median 1.77-fold), and the fold-change of downregulated genes ranges 
from 1.29- to 3.50-fold (mean 2.07-, median 1.96-fold). Selected genes are detailed below, and 
the remainder are inspected in Section 8.5. For clarity CD gene numbers have been omitted 
from the text, but all genes are detailed in Tables 7.10 and 7.11. Selected gene sets are 
illustrated in Figure 4.41 in addition to figures in other sections. 
Genes encoding all 30S and 50S ribosomal proteins are on average upregulated 1.66-folds, 
although only two significantly so (Section 4.8i, Figure 4.47). On average all conjugative 
transposon proteins are downregulated 1.41-folds, although only six are significantly repressed 
(Section 4.8vii, Figure 4.58). mreB2s, mreO (Figure 4.32A: Amoxicillin) and mreBl (rod 
shape-determining proteins) are all upregulated; and all seven annotated chemotaxis proteins are 
upregulated, by an average of 1.95-fold, but only one significantly so (Figure 4.33A: 
Amoxicillin). All seven tcdB (toxin B) reporter probes are downregulated, by an average of 
1.70-fold, but only CD0660b significantly so (Section 4.8ii, Figure 4.48). 
Gene clusters containing opuCC and opuCA5 (glycine/betaine/carnitine/choline ABC transporter 
substrate-binding protein and ATP-binding protein) (Figure 4.41 A); grdGS and grdFF (sarcosine 
reductase complex component B a- and ß subunits) (Figure 4.41B); and grdD$, grdC, grdBS, 
grdA$, grdE$ (glycine/sarcosine/betaine reductase complex component A, component B a-, B- 
and y-subunits, and component C a- and ß-subunits), trxA1 and trxB2 (thioredoxin and 
thioredoxin reductase), and grdJ (putative glycine reductase complex component) 
(Figure 4.41C) are all downregulated. Glycine-betaine can act as an osmoprotectant, and is 
derived from choline (Kappes et al. 1999). 
$ not significantly regulated 
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Phosphotransferase system (PTS) components show a general downregulation trend - fifty-four 
are over 1.5-fold downregulated$ (seven significantly) whereas only eleven are 1.5-fold 
upregulated$ (one significantly) (Section 4.8iii, Figure 4.40A). Thefab gene cluster encoding 
fatty acid synthesis proteins is co-ordinately upregulated by an average of 1.65-folds, four genes 
significantly (Figure 4.9B: Heat; Figure 4.42). 
s not significantly regulated 
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Figure 4.40 
Acid Alkali Aero Amox Clind Metro 
Cd630 genes with significantly altered expression during growth in the 
presence of clindamycin 
Cultures of Cd630 were grown to late logarithmic phase in the presence ("Clind") or absence 
(control) of 50gg/ml clindamycin. RNA was extracted from triplicate cultures and competitive 
DNA/RNA hybridisations were carried out. Spot intensities were determined and the resultant 
gene ratios were filtered by ANOVA using a 1% confidence level. The behaviour of this gene 
set after all tested stresses is shown. For an explanation of GeneSpringTM graph interpretation, 
see Figure 4.2. 
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Figure 4.41 Responses of genes clusters encoding glycine-betaine related proteins 
GeneSpringTM graphs illustrating the change in expression after stress of the c'00900-1 (A), 
cD1740-1 (B) and CD2348-57 (C) gene clusters. These encode a glycine/betaine/carnitine/ 
choline ABC transporter (A) and glycine/sarcosine/betaine reductase complex subunits (B and 
Q. The lines are coloured by the relative level of gene expression after growth in the presence of 
clindamycin. Diagrammatic representations of these gene clusters are depicted below each graph 
with significantly regulated genes shown 
in bold: vertical black lines represent stop codons. 
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Figure 4.42 Fatty acid synthesis pathway 
Reactions in the straight chain fatty acid synthesis pathway are detailed. Protein names are 
shown in green and their enzyme descriptions are shown in dark blue; cofactors are shown in 
ore\. Enzymes with significantly upregulated transcripts are boxed in red; those with over 
1.5-fold but statistically insignificant upregulation are boxed in orange. 
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Microarray analysis of the responses of C. difficile 630 to the presence of 
metronidazole 
In order to investigate the responses of C. docile to antibiotic exposure, Cd630 was grown to 
late logarithmic phase in the presence of 150ng/ml metronidazole, the maximal concentration of 
antibiotic that allows relatively normal growth rate. RNA was then extracted and subjected to 
microarray analysis. ANOVA tests using a 1% confidence level (but no multiple testing 
correction) were then used to identify genes with statistically altered expression. Eight genes 
are determined to be significantly upregulated and twelve significantly downregulated in 
response to the presence of subinhibitory levels of metronidazole in the growth medium 
(Figure 4.43, Table 7.12). 
The magnitude of change of the statistically upregulated genes ranges from 1.31-fold to 
1.94-fold (mean 1.83-, median 1.59-fold), and the fold-change of downregulated genes ranges 
from 1.40- to 1.73-fold (mean 1.54-, median 1.63-fold). These genes are detailed below, and 
although CD gene numbers have been omitted from the text for clarity all genes are detailed in 
Table 7.12. Selected gene sets are illustrated in Figure 4.44 in addition to figures in other 
sections. 
ftsH2 (cell division protein) and a putative sigma-54 interacting transcription antiterminator 
gene are upregulated whereas a putative signalling protein gene is downregulated. A putative 
phage anti-repressor gene is upregulated, as are the majority of phage proteins; whereas a 
conjugative transposon membrane protein gene and xis (excisionase) are downregulated, which 
appears to be typical of transposon-related genes during growth in metronidazole 
(Section 4.8vii). 
rnJB (electron transport complex protein), prsA (ribose-phosphate pyrophosphokinase) and ntpD 
(V-type sodium ATP synthase subunit D) are upregulated. garK (glycerate kinase), bg1F (PTS 
system, ß-glucoside-specific IIabc component), and genes encoding a putative ketopantoate 
reductase, a putative phophosugar aldolase and a putative pilin/general secretion pathway 
protein are downregulated. 
All five genes of the potABCDs operon (spermidine/putrescine ABC transporter) are 
upregulated, but only potA significantly. On this occasion, speADEB$ does not seem to be 
s not significantly regulated 
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co-ordinately regulated and remains relatively unchanged (Figure 4.11: Heat), but metK 
(S-adenosylmethionine synthetase) is upregulated. JhuC and fhuG$ (putative ferrichrome ABC 
transporter, ATP-binding protein and permease protein) are downregulated, but not the adjacent 
fhuB$ and fhuD$ (putative ferrichrome ABC transporter, permease protein and substrate-binding 
protein) (Figure 4.44). Genes encoding three conserved hypothetical proteins are also 
downregulated. 
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Figure 4.43 Cd630 genes with significantly altered expression during growth in the 
presence of metronidazole 
Cultures of Cd630 were grown to late logarithmic phase in the presence ("Metro") or absence 
(control) of 150ng/ml metronidazole. RNA was extracted from triplicate cultures and 
competitive DNA/RNA hybridisations were carried out. Spot intensities were determined and 
the resultant gene ratios were filtered by ANOVA using a I% confidence level. The behaviour 
of this gene set after all tested stresses is shown. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 4.44 Responses of the fhu gene cluster 
GeneSpringTM graph illustrating the change in expression after stress of the jhu gene cluster. 
This gene cluster encodes a ferrichrome ABC transporter. The lines are coloured by the relative 
level of gene expression after growth in the presence of metronidazole. A diagrammatic 
representation of this gene cluster within the genome is depicted below the graph. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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4.7 Genes with significantly altered expression after multiple stresses 
Although each gene set is interesting and informative in isolation, much more information can 
be gleaned from comparison of the different gene lists and the associated pathways. 
The genes with statistically changing expression after acid shock overlaps significantly with 
those changing after heat shock. Ten of the twelve common genes are from the four major heat 
shock operons (Figures 4.4 and 4.5: Heat), plus a probable protease (also upregulated after 
alkali shock) and bcp (putative thiol peroxidase, bacterioferritin comigratory protein), which is 
downregulated after heat shock but upregulated after both acid and oxygen shock. 
Acid shock and oxygen shock regulated genes also overlap significantly, although no obvious 
pattern is discernable. In each case bcp, thrS (threonyl-tRNA synthetase), cls (cardiolipin 
synthetase), a putative glyoxalase, a putative membrane protein and a conserved hypothetical 
protein are upregulated whilst a putative surface-anchored membrane protein is downregulated. 
Genes regulated after heat shock overlap significantly with upregulated genes after both 
amoxicillin exposure and clindamycin exposure, although distinct gene sets are involved in 
these overlaps. Both heat shock and amoxicillin exposure significantly upregulate htpG (heat 
shock chaperone protein), pmi (mannose-6-phosphate isomerase), potC (putative spermidine/ 
putrescine ABC transporter permease protein) and genes encoding a phosphotransferase system 
IIabc component and a putative exported protein. ftsH2 (cell division protein), rpsU (30S 
ribosomal protein S21), cafA (ribonuclease g), thrB (homoserine kinase) and genes encoding a 
putative hydantoinase, a putative choline sulphatase and a conserved hypothetical protein are 
upregulated after growth in the presence of amoxicillin but downregulated by heat shock. 
Heat shock and clindamycin exposure both significantly upregulate htpG and genes encoding a 
putative N-acetylmuramoyl-L-alanine amidase, a putative hydantoinase and a hypothetical 
protein; whereas genes encoding an RRF2-family transcriptional regulator, a putative phage 
regulatory protein, a putative hydantoinase, plsX (fatty acid/phospholipid synthesis protein), a 
putative metallo-ß-lactamase superfamily protein, two putative membrane proteins and a 
conserved hypothetical protein are upregulated by the presence of clindamycin but 
downregulated after heat shock. 
The genes regulated by growth in the presence of amoxicillin and clindamycin also significantly 
overlap with each other. htpG, mreBl (rod shape-determining protein) and genes encoding a 
putative transcriptional regulator, a putative RNA-binding protein, a putative RNA/single- 
stranded DNA exonuclease, a putative guanosine 
3', 5'-bis-pyrophosphate (ppGpp) synthesis/ 
degradation protein and a two-component response regulator are upregulated by the presence of 
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both antibiotics. cdd4 (putative lantibiotic ABC transporter ATP-binding protein) and an ABC 
transporter permease protein gene are also both upregulated, as are genes encoding two 
tellurium resistance proteins, a putative 5-nitroimidazole reductase, Pmi (mannose-6-phosphate 
isomerase), a putative acetyltransferase, a putative penicillin-binding protein repressor, PpiB 
(peptidyl-prolyl cis-trans isomerase) and a NUDIX-family hydrolase. acpP (acyl carrier 
protein, ACP), fabF (3-oxoacyl-ACP synthase II) and fabD (malonyl CoA-ACP transacylase) of 
the fatty acid biosynthesis pathway are all upregulated after growth in the presence of both 
antibiotics, as are genes encoding a putative membrane protein, two putative exported proteins, 
two conserved hypothetical proteins and a hypothetical protein. Downregulated in both 
conditions are a putative phage protein, a putative phage tail fibre protein, an ABC transporter 
ATP-binding protein, a putative membrane protein and a two-component sensor histidine 
kinase. 
Genes downregulated by growth in the presence of clindamycin and metronidazole significantly 
overlap, sharing bg1F (PTS ß-glucoside-specific Ilabc component), garK (glycerate kinase) and 
two conserved hypothetical proteins, however complete gene lists created after neither growth 
in the presence of metronidazole nor alkali shock overlap significantly with and list of genes 
with statistically altered expression after any other stress. Interestingly, despite no significant 
overlap, the regulation of genes after alkali shock and growth in the presence of amoxicillin 
appear to correlate (see for example the colouring in Figure 4.19) - it would be interesting to 
determine whether addition of amoxicillin alters the pH of the media. 
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4.8 Behaviour of functional gene sets of Cd630 after stress 
It may be informative to analyse the expression of defined genes of Cd630 that are involved in 
specific pathways of cell metabolism or virulence. In the following section, regulation trends of 
functional gene groupings are examined. In contrast to the preceding sections, the magnitude of 
change of expression is primarily discussed, and where a change is significant it is noted. 
i Protein synthesis 
Ribosomal proteins 
Transcript levels for some ribosomal proteins are affected by every stress investigated 
(Figure 4.47). Many lie within one large gene cluster in the genome, CD0059-CD0099 
(Figure 4.46). Almost all of both the 30S and SOS genes are strongly upregulated by growth in 
the presence of amoxicillin, on average by a factor of 3.69E and 3.80E respectively. Although 
the amoxicillin gene list is the only one to statistically overlap with the 30S and SOS genes, 
these are also generally upregulated by growth on the presence of clindamycin (on average 
1.66- and 1.67-fold) and metronidazole (1.89- and 1.91-fold), and by acid shock (1.48- and 
1.42-fold), alkali shock (1.38- and 1.35-fold) and oxygen shock (1.24- and 1.30-fold). 
tRNÄ smthetases 
Overall, tRNA synthetases show a slight upregulation trend after acid shock, oxygen shock and 
exposure to all three antibiotics, although in each case there is a complete range of up and down 
regulation (Figure 4.45). The most noticeable upregulation trend is after growth in the presence 
of amoxicillin, with thirteen significantly upregulated tRNA synthetase genes (including 
asparaginyl- and tryptophanyl-synthetases which are also significantly upregulated after heat 
shock). Threonyl-tRNA synthetase is significantly upregulated after both acid shock and 
oxygen shock. 
ii Toxins 
Large clostridial toxins 
The production of toxins in response to stress could be relevant in a clinical setting. tcdC, a 
negative regulator of the toxin locus, is slightly upregulated after heat shock and growth in the 
presence of amoxicillin, showing a tendency towards upregulation in all of the stresses tested, 
implying a general negative regulation of toxin production after stress (Figure 4.48C). Multiple 
probes on the microarray represent tcdB; these are downregulated by an average of 2.08- and 
F statistically significant overlap between gene 
lists 
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1.70-fold respectively by growth in the presence of amoxicillin and clindamyciri , and are also 
slightly downregulated by both oxygen shock and growth in the presence of metronidazole 
(Figure 4.48B). tcdR, encoding a putative positive regulator of the toxin locus, is down- 
regulated after heat shock, oxygen shock and growth in the presence of all three antibiotics 
tested; and WE, encoding a putative holin, is downregulated after acid shock and growth in the 
presence of amoxicillin (Figure 4.48D). In contrast, tcdA, which is also represented by multiple 
probes on the microarray, is on average slightly downregulated by heat shock and slightly 
upregulated by pH shock and growth in the presence of clindamycin but is not dramatically 
affected by any stress (Figure 4.48A). 
Binary toxin 
The binary toxin genes are only present in Cd630 as pseudogenes, truncated and with multiple 
frameshifts and in-frame stop codons observed. However, both cdtA and cdtB probes are 
upregulated by growth in the presence of clindamycin by an average of 2.31-fold and 
downregulated 1.60-fold by alkali shock, although not significantly (Figure 4.49). 
iii Phosphotransferase systems (PTS) 
There are one hundred and eight phosphotransferase system (PTS) components annotated in the 
C. diJcile 630 genome (Figure 4.50A). The majority of PTS genes seem to be relatively 
unchanging after heat shock, although there are some highly upregulated"* and downregulated40 
genes; there is a similar situation of no net change after pH shock. A greater proportion of 
genes seem to be downregulated after oxygen shock (32.4% are 1.5-fold downregulated** whilst 
only 6.5% are 1.5-fold upregulated) and growth in the presence of amoxicillin (63.0% 1.5-fold 
downregulated, 9.26% upregulated*0), clindamycin (50.0% 1.5-fold downregulated7 , 10.2% 
upregulated) and metronidazole (5.56% 1.5-fold downregulated, 0.93% upregulated). 
iv ABC transporters 
There are two hundred and twenty nine annotated ABC transporter components within the 
Cd630 genome, and after every stress tested some are highly regulated (Figure 4.50B). ABC 
transporter component genes are upregulated 1.35-fold on average after alkali shock4 , 1.27-fold 
after amoxicillin exposure (ten are significantly upregulated and four downregulated), and 
1.22-fold after clindamycin exposure (however seven are significantly downregulated whilst 
only four are significantly upregulated). Although there is no net change after other stresses 
some genes are significantly regulated: eight components are significantly upregulated and four 
downregulated after heat shock; two downregulated after acid shock; one up- and two 
* one probe/gene significant 
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downregulated after oxygen shock; and one up- and one downregulated after growth in the 
presence of metronidazole. Interestingly, many genes change in the same fashion after alkali 
shock, oxygen shock and growth in the presence of both amoxicillin and clindamycin, as 
evidenced by the similar colouring patterns in Figure 4.50B. Some of these transporters are 
discussed below in reference to antimicrobial resistance. 
v Two-component systems 
There are fifty-one two-component sensor histidine kinases encoded within the Cd630 genome, 
and fifty-four response regulators. Once again, some genes are highly regulated after every 
stress investigated, although there is no average change after any stress (Figure 4.51). Few two- 
component genes are significantly regulated though: only heat shock (two upregulated), oxygen 
shock (two upregulated and one downregulated), and growth in the presence of amoxicillin (one 
upregulated and three downregulated) and clindamycin (two upregulated and one 
downregulated) produce any statistically relevant changes. Some of these signal transducers are 
discussed below in reference to antimicrobial resistance. 
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Figure 4.45 Responses of genes encoding tRNA synthetases 
GeneSpringTM graphs illustrating the change in expression after stress of all tRNA synthetase 
genes in the Cd630 genome. The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. 
These genes are not generally clustered 
within the genome. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.46 Responses of the transcription and translation genome region 
GeneSpringTM graphs illustrating the change in expression after stress of the ('1)0059-99 gene cluster, 
encoding many ribosomal proteins. The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. A diagrammatic representation of the gene 
cluster CD0059-99 within the genome is depicted below, with 50S genes (rpl and rpm) depicted in 
dark red, 30S genes (rps) in blue, and other translation-related genes in black. Transcription-related 
genes are shown in green, and secretion pathway proteins in purple. Unrelated genes are shown in 
grey. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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ýý Acid Alkali Aero Amox Clind Metro Figure 4.47 Responses of 30S and 50S ribosomal protein genes 
GeneSpringTM graphs illustrating the change in expression after stress of all 30S (A) and 
50S (B) genes within the genome. The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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Figure 4.48 Responses of the PaLoc 
GeneSpringTM graphs illustrating the change in expression after stress of the PaLoc locus 
diagrammed below. This incorporates tcdA (A) and icdB (B), encoding the large clostridial 
toxins; their regulators tcdC (C) and tcdR (D); and tcdE (D). The graph Iines are coloured by 
the relative level of gene expression after growth in the presence of amoxicillin. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.49 Responses of the binary toxin pseudogenes 
GeneSpringTM graphs illustrating the change in expression after stress of the cdt binary toxin 
genes. The graph lines are coloured by the relative level of gene expression after growth in the 
presence of amoxicillin. A diagrammatic representation of the cdt locus is shown below the 
graphs: vertical red lines represent frameshift mutations and black lines represent stop codons. 
For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.50 Responses of PTS and ABC transporter component genes 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding 
phosphotransferase system (PTS) components (A) and ABC transporters components (B). The 
graph lines are coloured by the relative level of gene expression after oxygen shock (A) or 
growth in the presence of amoxicillin (B). For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 4.51 Responses of genes encoding two-component systems 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding two- 
component system proteins. The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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vi Antimicrobial resistance genes 
Antibiotic resistance 
tetM, which imparts tetracycline resistance, is situated on conjugative transposon 3 (ConTn3, 
Tn5397) and is strongly downregulated after heat shock (2.09-fold), strongly upregulated after 
growth in the presence of amoxicillin (2.63-fold), and slightly upregulated after pH shock, 
oxygen shock and clindamycin exposure (average 1.58-fold) (Figure 4.52A). 
Two copies of erm(B) are present within Tn. 398, the erythromycin resistance mobilisable 
non-conjugative element. erm(B) encodes an rRNA adenine N-6-methyltransferase, which 
methylates the 23S ribosomal RNA of the 50S ribosomal subunit thereby preventing binding of 
macrolide, lincosamide and streptogramin B antibiotics (Arthur et al. 1987). Both genes are 
most strongly upregulated by growth in the presence of amoxicillin but also upregulated by all 
other stresses (erm(B)1 significantly so after alkali shock) except heat shock, which causes a 
slight downregulation (Figure 4.52B). Streptogramin A acyltransferase (sat, CD2226) is not 
affected by any stress tested (Figure 4.52C). 
There are four genes in the Cd630 genome that encode proteins incorporating the PF04892 
VanZ domain, which imparts teicoplanin resistance. CD1240 and CD2015 are downregulated by 
growth in the presence of antibiotics, CD2520 is downregulated after heat shock and upregulated 
after growth in the presence of amoxicillin and metronidazole, and CD2160 is downregulated 
after oxygen shock and upregulated after growth in the presence of clindamycin and 
metronidazole (Figure 4.52D). 
The VanG vancomycin resistance gene cluster of Enterococcus faecalis encodes a two- 
component system, a serine racemase and a D-ala-D-ser carboxypeptidase among other products. 
A gene cluster in Cd630 encodes VanR, VanS (two-component response regulator and sensor 
histidine kinase), VanG (putative D-alanine: D-alanine ligase, putative vancomycin/teicoplanin 
A-type resistance protein), a putative D-alanyl-D-alanine carboxypeptidase (featuring PF02557 
VanY), and VanTG (serine/alanine racemase). vanG, vanY, and vanTG appear to be 
co-ordinately downregulated after growth in the presence of all three antibiotics, whereas vanR 
is upregulated after oxygen shock* and downregulated after growth in the presence of 
clindamycin and metronidazole, and vanS is upregulated after oxygen shock and growth in 
amoxicillin and clindamycin (Figure 4.52E). 
In Streptococcus pneumoniae the VncRS two-component system and the VexP ABC transporter 
are involved with the induction and export of a small peptide responsible for triggering autolysis 
in response to the presence of antibiotics (Novak et al. 2000). In Cd630, genes encoding a 
* one probe/gene significant 
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putative exported protein, a putative iron-sulphur binding membrane protein and a small 150 bp 
open reading frame encoding a conserved hypothetical protein' lie directly upstream of vexPi, 
vexP2 and vexP3, and vncR and vncS are directly downstream. vexPl-3 and the upstream genes 
(Figure 4.52F, blue) are generally downregulated after pH shock and growth in the presence of 
antibiotics (the putative iron-sulphur binding membrane protein is significantly repressed after 
clindamycin, as is vexPi after amoxicillin), but vncRS are not affected by any stress tested 
(Figure 4.52F, purple). 
Two genes in Cd630 encode proteins that incorporate the PF00144 ß-lactamase domain and are 
annotated as putative penicillin-binding proteins. cwp20 (which is represented by two probes) is 
downregulated by heat shock' and acid shock and upregulated by growth in the presence of 
amoxicillin and clindamycin (Figure 4.53A, purple). CD3196, encoding the other putative 
penicillin-binding protein, is downregulated by heat and oxygen shock and by growth in the 
presence of a amoxicillin and clindamycin (Figure 4.53A, blue); and CDO458, encoding a 
putative ß-lactamase, is downregulated by clindamycin but strongly induced by the presence of 
amoxicilliri (Figure 4.53A, red). A pair of genes, blal (penicillinase repressor) and blaR 
(putative ß-lactamase-inducing penicillin-binding protein), are adjacent in the genome and are 
relatively unaffected by all stresses tested (Figure 4.53B). 
Daunorubicin and nogalamycin are DNA-binding drugs commonly used in cancer 
chemotherapy (Kapur et al. 1999). Specific ABC transporters in C. dicile encode resistance 
to these drugs. snorO (putative nogalamycin resistance protein) is downregulated by oxygen 
shock and growth in the presence of amoxicillin, whilst both putative daunorubicin-specific 
ABC transporter ATP binding protein genes (CD0456 and CD1604) are downregulated by 
oxygen shock and growth in the presence of antibiotics; only CD0456 is also downregulated by 
pH shock (Figure 4.53C). Genes encoding a putative antibiotic resistance ABC transporter ATP 
binding protein gene (CD2593) is 6.75-fold upregulated by clindamycin but unaffected by all 
other stresses; and an antibiotic resistance ATP-binding/permease protein (CD1472) appears to 
be downregulated by growth in the presence of antibiotics and upregulated by heat shock, 
although the signal is not very trustworthy (Figure 4.53D). 
Genes encoding a putative glycosyltransferase with similarity to a Streptomyces macrolide 
glycosyltransferase (CD3119), and a conserved hypothetical protein with similarity to a 
Streptomyces macrotetrolide resistance protein (CD0635) are both downregulated by oxygen 
shock and exposure to antibiotics (Figure 4.53E). 
not represented on the microarray 
one probe/gene significant 
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Lantibiotic resistance 
uppPl and uppP2 encode undecaprenyl-diphosphatases incorporating the PF02673 bacitracin 
resistance protein (BacA) domain. Signal from the microarray is weak for both proteins, but 
uppP2 seems to be downregulated by amoxicillin exposure (Figure 4.54A). Elsewhere, four 
gene clusters encode a two-component system with similarity to Bacillus lichenifomensis 
BacRS and ABC transporter components with similarity to B. lichenifomensis BcrAB and 
B. subtilis BceAB bacitracin export ABC transporters. CD0368-3 (situated on ConTnl), 
CD0643-6, CD0820-4, and CD109S-9 seem to be generally downregulated on average after 
oxygen shock and growth in the presence of antibiotics (Figure 4.54B-E). CD0367 (sensor 
histidine kinase) is significantly downregulated after amoxicillin and clindamycin and CDO368 
(response regulator) is significantly upregulated after heat shock. However, CDO822 (ATP 
binding protein) does not give any signal on the microarray, and CD0823 (permease) is 
upregulated after exposure to antibiotics (Figure 4.54D). 
Genes encoding the putative subtilin lantibiotic ABC transporter SpaEFG and the adjacent 
SpaRK subtilin biosynthesis two-component system seem to be generally downregulated after 
oxygen shock and growth in the presence of antibiotics (Figure 4.55A). Two other gene clusters 
encoding genes similar to B. subtilis spaEFG and spaRK are found in Cd630. CD1349-52 ABC 
transporter genes are downregulated after oxygen shock and growth in the presence of 
amoxicillin or clindamycin, but the adjacent two-component sensor histidine kinase is only 
downregulated after heat shock (Figure 4.55B). CD0483-9 is co-ordinately downregulated after 
growth in the presence of the antibiotics tested, but only the ABC transporter components are 
downregulated by alkali and oxygen shock (Figure 4.55C). Elsewhere in the genome a spaR 
homologue (CD3320) is slightly downregulated after each stress tested, and a spaT homologue 
(CDO161) is downregulated after acid shock and growth in the presence of amoxicillin and 
clindamycin (Figure 4.55D). 
The cdd2-4 gene cluster (putative lantibiotic ABC transporter) does not seem to be 
co-ordinately regulated, although cdd4 is significantly upregulated after growth with amoxicillin 
or clindamycin (Figure 4.55E). 
Resistance to other chemicals 
The PF01554 MATE (multi-antimicrobial extrusion) domain functions as a drug/sodium 
antiporter (Brown et al. 1999). There are fifteen genes in the Cd630 genome encoding proteins 
with two MATE domains. On average, these are downregulated 1.37-fold after amoxicillin 
exposure and also show a slight downwards trend after heat shock", oxygen shock and growth 
in the presence of clindamycin and metronidazole (Figure 4.56A). 
0 one probe/gene significant 
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There are four other multidrug efflux pumps annotated in the genome: CD3198 and CD1809 are 
downregulated by heat shock, oxygen shock and exposure to antibiotics (only CD1809 after 
metronidazole exposure); CD2407 and CD2408 are relatively unaffected by any of the stresses 
tested, with the exception that CD2407 is slightly upregulated by alkali shock and CD2408 is 
slightly downregulated by acid shock and exposure to metronidazole (Figure 4.56B). CD0488, 
encoding a quaternary ammonium compound-resistance protein incorporating the PF00893 
small multidrug resistance domain, is slightly upregulated by atmospheric exposure and by 
growth in the presence of amoxicillin; whilst CD0984, encoding a putative membrane protein 
with homology to a C. tetani putative small multi-drug export protein, is slightly downregulated 
by heat and acid shock (Figure 4.56C). 
There are five tellurium resistance proteins on the Cd630 genome that incorporate the PF02342 
TerD bacterial stress protein domain, in addition to another putative tellurium resistance protein. 
Two of these are located adjacently in the genome (CD1799 and CD1800); and the other three 
are in a gene cluster (CD1634-9, Figure 4.33B) also including two other proteins with similarity 
to C. tetani putative tellurium resistance proteins, and a putative tellurite resistance protein, 
incorporating PF05816 TeIA toxic anion resistance domain. A putative toxic anion resistance 
protein also containing PF05816 (CD2336), and a putative transporter with similarity to E. coli 
tellurite resistance protein TehA (CD3019) are also encoded within the genome. Both tellurium 
(Figure 4.57A) and tellurite (Figure 4.57B) resistance proteins are upregulated after growth in 
the presence of amoxicillin4 and clindamyciri by an average of 2.30- and 1.69-fold respectively 
and also after alkali shock by 1.37-fold on average. A gene encoding a conserved hypothetical 
protein containing PF06838 aluminium resistance domain (CD1973) is slightly upregulated by 
atmospheric exposure (Figure 4.57C); whilst three genes encoding proteins with PF00403 heavy 
metal-associated domain (CD0313, CD1132 and CD2115) are all upregulated by acid shock but 
otherwise divergently regulated (CD1132 is significantly upregulated by clindamycin) (Figure 
4.57D). CD1695, encoding a putative arsenical pump membrane protein, is not significantly 
regulated after any stress tested, but shows a downward trend after heat shock (Figure 4.57E). 
An NADP-dependent 7-a-hydroxysteroid dehydrogenase (CDO065) can convert bile acids to 
secondary bile metabolites, and the osmoprotectant ABC transporter (CD3215-6) is thought to 
be involved in protection from these toxic products. A probable transporter with similarity to a 
Lactobacillus acidophilus putative bile salt transporter is also found (CD3312). The steroid 
dehydrogenase is not particularly affected by any stress tested, whilst the osmoprotectant ABC 
transporter (see also Figure 4.11B: Heat) is strongly co-ordinately downregulated by heat 
shock" and also downregulated by amoxicillin , clindamycin and alkali shock. The putative 
bile salt transporter is downregulated by growth in the presence of all three antibiotics tested 
(Figure 4.57F). 
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Figure 4.52 Responses of genes encoding proteins responsible for antibiotic resistance 
GeneSpringTM graphs illustrating the change in expression after stress of tetM (tetracycline) (A), errn(B) 
(erythromycin) (B), PF04892 VanZ (teicoplanin) (C), and sat (streptogramin A) (D) genes, and gene 
clusters encoding putative vancomycin resistance two-component systems and ABC transporters vanRS 
and vanGTG (E), and vncRS and vexP (F). The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. Diagrammatic representations of relevant gene 
clusters are shown below the graphs (van and vexP at 70% scale). For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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Figure 4.53 Responses of genes encoding proteins responsible for antibiotic resistance 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding 
ß-lactamases (A), ß-lactamase repressor (b/aR) and inducer (b/al) (B), daunorubicin and 
nogalamycin resistance specific- (C) and other antibiotic resistance- (D) ABC transporter 
components, and macrolide and macrotetralide resistance proteins (E). The graph lines are 
coloured by the relative level of gene expression after growth in the presence of amoxicillin 
(A and B) or clindamycin (C, D and E). A diagrammatic representation of b/aIR within the 
genome is shown below its graph, other gene sets are not clustered in the Cd630 genome. For 
an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.54 Responses of bacitracin lantibiotic resistance genes 
GeneSpringTM graphs illustrating the change in expression after stress of bacitracin lantibiotic 
resistance genes uppP (A), CD0368-3 (B), CD0643-6 (C), CD0820-4 (D) and ('1)1095-9(E). The 
graph lines are coloured by the relative level of gene expression after growth in the presence of 
amoxicillin. Diagrammatic representations of gene clusters within the genome are shown below the 
graphs (CD0368-3 at 80% scale), uppPl and uppP2 are not clustered 
in the U630 genome. For an 
explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 4.55 Responses of subtilin and other lantibiotic resistance genes 
GeneSpringTM graphs illustrating the change in expression after stress of subtilin (antibiotic 
resistance genes spaFEG and spark (A); their homologues CD1349-52 (B), CD0486-3 (C) and 
cDO161 and cD3320 (D); and lantibiotic resistance genes cdd (E). The graph lines are coloured by 
the relative level of gene expression after growth in the presence of amoxicillin. Diagrammatic 
representations of gene clusters within the genome are shown 
below the graphs. For an explanation 
of GeneSpringTM graph interpretation, see 
Figure 4.2. 
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Figure 4.56 Responses of genes encoding multidrug resistance proteins 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding 
PF01554 MATE domain sodium-drug antiporters (A); multidrug efflux pumps (B); and small 
multidrug resistance proteins (C). The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. These genes are not clustered within the 
genome. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.57 Responses of genes encoding chemical resistance proteins 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding 
proteins conferring resistance to tellurium (A); tellurite (B); aluminium (C); heavy metals (D); 
arsenic (E) and bile salts (F). The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. These genes are not generally clustered 
within the genome, although a tellurium/tellurite related cluster is shown. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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vii Foreign DNA 
Conjugative transposons 
There are several regions of the genome that look likely to have external origins. Seven 
conjugative transposons (ConTn) and a conjugative transposon remnant can be identified in 
Cd630, and on average their genes are downregulated by oxygen shock and by all three 
antibiotics (genes regulated by clindamycin show a significant overlap), but are not affected by 
heat shock or pH shock (Figure 4.58). 
There are four Tn916-like elements in Cd630: ConTnl, ConTn3 (Tn5397), ConTn6 and 
ConTn7. ConTnl genes are strongly co-ordinately downregulated after growth in the presence 
of both amoxicilliri * and clindamycin'* , in each case with the exception of the two 5' genes 
int-tn (integrase) and xis (excisionase) (Figure 4.58A). ConTn3 (Tn5397) genes are most 
strongly co-ordinately downregulated after oxygen shock and growth in the presence of 
amoxicillin *, with the exception of tetM (conjugative transposon tetracycline resistance protein) 
and orJ9 (putative conjugative transposon regulatory protein), which are upregulated after these 
stresses (Figure 4.58B). As orf9 is a repressor of the conjugative transposon, this gene's 
opposing expression pattern is not unexpected. ConTn6 seems to be regulated in two opposing 
gene sets, which correspond to closely clustered genes within the transposon. CD3326-7 and 
CD3330-4 are generally upregulated after amoxicillin exposure* and alkali shock, slightly 
increased after oxygen shock and clindamyciri and metronidazole exposure, and slightly 
downregulated after heat shock; whereas cD3328-9 and CD3335-48 are generally 
downregulated after oxygen shock and amoxicillin and clindamycin exposure, slightly 
decreased after oxygen shock and metronidazole exposure, and slightly upregulated after heat 
shock (Figure 4.58C). ConTn7 genes are co-ordinately downregulated after oxygen shock* and 
exposure to all three antibiotics (clindamyciri *), with the exception of CD3373-7 (encoding a 
putative transcriptional regulator, a putative membrane protein and magnesium transporting 
ATPase components MgtA, MgtB and MgtC), which is upregulated after exposure to 
amoxicillin (Figure 4.58D). 
Cd630 has two Enterococcus faecalis Tn1549-like conjugative transposons - ConTn2 and 
ConTn5 - which appear to be regulated in very similar fashions. The genes of both transposons 
appear on average to be downregulated most noticeably after amoxicillin 
' and clindamycin'' 
exposure, and to a lesser degree after oxygen shock, metronidazole exposure and alkali shock; 
and are slightly upregulated after heat shock'. Exceptions to this are CDO422 and CD0404-5 of 
one probe/gene significant 
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ConTn2 and CD1864 and CD1867-8 of ConTn5, which are upregulated after oxygen shock and 
exposure to all three antibiotics (Figures 4.58E and F). 
ConTn4 has Tn1549-like conjugative functions and Tn916-like regulatory functions. Its genes 
are strongly co-ordinately downregulated after amoxicillin and clindamycin exposure, and also 
downregulated after alkali shock, oxygen shock and growth in the presence of metronidazole 
(Figure 4.58G). The conjugative transposon remnant is far less co-ordinately regulated, but also 
seems to fit the downregulation trend of conjugative transposon genes after alkali shock, oxygen 
shock and all three antibiotics (Figure 4.58H). 
Prophages 
There are two very similar prophages in the Cd630 genome. The genes of both prophage 1 and 
prophage 2 are strongly upregulated after growth in the presence of metronidazole (on average 
2.34- and 2.45-fold respectively) and strongly downregulated after growth with amoxicillin3' 
(1.40- and 1.65-fold). There is also a trend towards upregulation after heat shock" and towards 
downregulation after all other stresses (alkali shock'', oxygen shock" and clindamycin'') 
(Figures 4.59A and B). There are also two small putative prophages in the genome. CD1359-79 
shows a similar induction pattern to prophages 1 and 2, showing upregulation after heat shock 
and exposure to metronidazole and downregulation after all other stresses (clindamycin ), 
particularly amoxicillin**. However, CD3147-56 does not seem to vary substantially after any 
stress (Figures 4.59C and D). 
Other elements 
The genes of Tn5398, the erythromycin resistance mobilisable non-conjugative element, appear 
to be co-ordinately downregulated in response to heat shock and upregulated after all other 
stresses, particularly alkali shock** and growth in the presence of amoxicillinP. The exception 
to this is CD2001-3, encoding two conserved hypothetical proteins and the EffD putative efflux 
pump, which are downregulated (CD2002 clindamycin) or relatively unaffected by all stresses 
(Figure 4.59E). The skin (sigK intervening sequence) element, which is excised before 
sporulation, does not appear to be co-ordinately regulated after any stress tested (Figure 4.59F). 
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Figure 4.58 Responses of conjugative transposons 
GeneSpringTM graphs illustrating the change in expression after stress of Tn916-like 
ConTnl (A), ConTn3 (B), ConTn6 (C) and ConTn7 (D); Tn1549-like ConTn2 (E) and 
ConTn5 (F); ConTn4 (G) and the conjugative transposon remnant (H). The graph lines are 
coloured by the relative level of gene expression after growth in the presence of amoxicillin. 
For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.59 Responses of prophages and other foreign elements 
GeneSpringTM graphs illustrating the change in expression after stress of the genes of 
prophage I (A), prophage 2 (B), two putative prophages (C and D); Erythromycin resistance 
mobilisable non-conjugative element (E) and sigK intervening element skin (F). The graph 
lines are coloured by the relative level of gene expression after growth in the presence of 
metronidazole (A to D), growth in the presence of amoxicillin (E) or heat shock (F). For an 
explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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viii Extracellular structures 
Flagella 
The flagellar genes are located in one cluster in the genome, comprising thirty-five flagellar 
genes and only nine others (Figure 4.60). The flagellar proteins appear to be co-ordinately 
upregulated after growth in the presence of amoxicillinE and clindamycin by at least 1.56- and 
1.61-fold respectively (average 2.98- and 2.34-fold), and are also. 1.46-fold upregulated on 
average after alkali shock, although not all genes are affected. Interestingly, although the 
average change is approximately nil in these stresses, those genes that are slightly 
downregulated after heat shock are those observed to be slightly upregulated after acid and 
oxygen shock**, and vice versa, as shown by the colouring trends in Figure 4.60. 
Type IV pilus 
There are two gene clusters encoding type IV pilus proteins in the Cd630 genome, in addition to 
a fimbrial protein (pilin) and a putative pilin/general secretion pathway protein elsewhere in the 
genome. There appears to be no overall pattern of regulation of pilus-related genes after any of 
the stresses tested (Figure 4.61), although a putative exported protein in the cluster is 
significantly upregulated after atmospheric exposure and the putative pilin/general secretion 
pathway protein is significantly downregulated by growth in the presence of metronidazole. 
ix Secretion apparatus 
Components of the sec protein cotranslational secretory system can be identified in Cd630: 
secA1, secA2, secE and secY preprotein translocase subunits and a putative protein translocase 
subunit. secA1 is slightly upregulated by amoxicillin, downregulated by heat shock and acid 
shock, and relatively unaffected by all other stresses; whereas all other subunits are 
co-ordinately upregulated after exposure to amoxicillin, alkali shock, oxygen shock and growth 
in the presence of clindamycin and metronidazole. There is also another putative preprotein 
translocase annotated in the genome that is similarly upregulated after oxygen shock and 
exposure to antibiotics but is downregulated by pH shock (Figure 4.62A). In contrast, the signal 
peptidases, which work in concert with the sec machinery, are not particularly affected by any 
stress investigated (Figure 4.62B). 
x Cell wall biosynthesis 
Peptidoglvcan 
N-acetylglucosamine (GIcNAc) and N-acetylmuramic acid (MurNAc) are converted into 
peptidoglycan in a long series of reactions including incorporation of D-glutamine and D-alanyl- 
F statistically significant overlap - 12/40 flagellar genes significantly upregulated 
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D-alanine (Figure 4.31). Genes encoding this pathway are primarily named mur, and are 
co-ordinately upregulated after exposure to antibiotics, particularly amoxicillin 
(Figure 4.63A). Genes encoding the formation of UDP-GIcNAc (glmS, CD0119, glmt%) and 
D-glutamine (Figure 4.30B) are also upregulated after exposure to amoxicillin, but dd1B 
(D-alanine-D-alanine ligase B), responsible for generation of the peptidoglycan component 
D-alanyl-D-alanine, is downregulated. 
Secondary cell wall polymers 
Secondary cell wall polymers, including teichoic acids and teichuronic acids, are highly 
negatively charged polymers that make up 10-60% of the cell wall (reviewed in Schaffer & 
Messner 2005). Teichoic acid consists of glycerol or ribitol linked by phosphodiester bridges, 
and modifying enzymes can be identified in the Cd630 genome. ditA and dltC (D-alanine- 
poly(phosphoribitol) ligase subunits: D-alanine-activating enzyme and D-alanyl carrier protein) 
are present in the genome in a gene cluster with dltD (putative D-alanine transferase) and 
dltB (D-alanyl transferase) and are responsible for the addition of D-alanine to secondary 
cell wall polymers thereby masking their negative charge (Perego et al. 1995). A putative 
CDP-glycerol-polyglycerophosphate glycerophosphotransferase is responsible for the 
elongation of teichoic acid, and a putative cell wall teichoic acid glycosylation protein and a 
putative minor teichoic acid biosynthesis protein are also present in Cd630. Genes encoding all 
of these proteins are upregulated after amoxicilliri `, whilst only the dlt cluster is upregulated 
after heat shock* (Figure 4.63B). 
xi Cell wall proteins (CWPs) 
There are twenty-nine genes in the C. dicile 630 genome encoding proteins predicted to 
incorporate three copies of the PF04122 cell-wall-binding domain 2, named CWPs (cell wall 
proteins). These are named using the prefix cwp and were discussed in detail in Chapter 3. 
cwp22 also incorporates seven tandem copies of another cell wall binding domain, PF01473, 
which is also found in the repeat regions of tcdA and tcdB. Thirteen CWP genes are found in 
one genome region, CD2767-2801, which also encodes many cell wall synthesis proteins (Figure 
4.64). On average, all PF04122-encoding genes are upregulated by growth in the presence of 
ampicillin (2.27-fold), clindamycin (1.54-fold) and metronidazole (1.35-fold), but after all other 
stresses they are relatively unchanging. Each paralogue is represented on the microarray by one 
probe for the PF04122 cell-wall binding domain and a second for the unique domain, if present. 
sipA, cwp2, cwp66 (cwp3), cwp84 (cwp4), cwp6 and cwp22 all show similar induction patterns 
across all stresses, with strongest induction after growth in the presence of amoxicillin 
(cwp2`*, cwp4*, cwp6*), lesser upregulation after growth in the presence of clindamycin and 
0 one probe/gene significant 
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metronidazole, and perhaps an upwards trend after alkali shock and a downwards trend after 
heat shock (Figure 4.65A-F). A similar pattern of upregulation after amoxicilliri and down- 
regulation after heat shock is observed for cwp7 (Figure 4.66A); and cwp20 is downregulated 
after heat shock* and slightly upregulated after growth in both amoxicillin and clindamycin 
(Figure 4.66B). cwp27 is downregulated after growth with amoxicillin (Figure 4.66C); and 
cwp2l is upregulated after growth in the presence of clindamycin' (Figure 4.66D). 
cwp18 is upregulated after both oxygen shock and growth in amoxicillin whereas cwp10 is 
upregulated after oxygen shock" and growth in amoxicillin and is also downregulated after 
acid shock (Figures 4.66E and F). cwp23 is downregulated after heat shock, and cwp8 is 
upregulated after heat shock" and downregulated after growth in the presence of clindamycin` 
and amoxicillin (Figures 4.67A and B). cwp24 is downregulated after heat shock and 
upregulated after alkali shock, and cwp19 is downregulated after heat shock and upregulated 
after alkali shock* and growth with amoxicillin (Figures 4.67C and D). cwp13 is upregulated 
after both acid shock* and alkali shock (Figure 4.67E). 
Expression of all other paralogues is relatively unchanging, including that of cwpV (cwp15) 
(Figure 4.67F), which is the focus of Chapter 3. 
xii Extracellular matrix binding domains 
Several extracellular matrix-binding proteins can be identified within the C. docile 630 
genome. CD3831, encoding a putative surface-anchored membrane protein incorporating the 
PF05737 collagen binding domain, is downregulated after acid shock, oxygen shock' and 
growth in the presence of all three antibiotics (Figure 4.68A). CD2592, encoding a fibronectin 
binding protein, is downregulated by heat shock but relatively unaffected by other stresses 
(Figure 4.68B). CD2797 encodes a putative exported protein that incorporates PF00041 
fibronectin type III domain, which can bind to heparin and DNA, and also PF00754 F5/8 type C 
domain, which is found in blood coagulation factors V and VIII, and may therefore be involved 
in binding to the extracellular milieu. CD2797 is upregulated by exposure to atmospheric 
oxygen' and downregulated by acid shock, but is relatively unaffected by other stresses 
(Figure 4.68C). CD3145, encoding a putative serine-aspartate-rich surface anchored fibrinogen- 
binding protein, is upregulated by amoxicillin and possibly oxygen shock (Figure 4.68D). 
There are two proteins encoded in the Cd630 genome that incorporate the PF01471 putative 
peptidoglycan-binding domain. CDOSSI encodes a putative pre-pro-spore-cortex-lytic enzyme 
(putative spore peptidoglycan hydrolase) and is upregulated by acid shock and downregulated 
by exposure to antibiotics; whilst CD2388 encodes a putative peptidoglycan-binding/hydrolysing 
protein and is upregulated by alkali shock and perhaps exposure to amoxicillin and clindamycin. 
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Figure 4.60 Responses of the flagellar gene cluster 
GeneSpringTM graph illustrating the change in expression after stress of the C1)0226-72 gene 
cluster, primarily encoding flagellar proteins. The graph lines are coloured by the relative level of 
gene expression after growth in the presence of amoxicillin. A diagrammatic representation of 
the gene cluster CD0226-73 within the genome is depicted below the graph, with flagellar genes 
depicted in black and unrelated genes shown in grey. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 4.61 Responses of type IV pili genes 
GeneSpringTM graph illustrating the change in expression after stress of the type IV pili genes. 
The graph lines are coloured by the relative level of gene expression after growth in the 
presence of amoxicillin. A diagrammatic representation of the two type IV pili gene clusters 
within the genome, CD3297-0 and CD3513-03, are depicted below the graph at 75% scale. For 
an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.62 Responses of the sec secretory system and sip signal peptidase genes 
GeneSpringTM graphs illustrating the change in expression after stress of the sec secretory 
system and sip signal peptidase genes. The graph lines are coloured by the relative level of gene 
expression after growth in the presence of amoxicillin. These genes do not lie in clusters within 
the genome. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 4.63 Responses of cell wall biosynthesis genes 
GeneSpringTM graphS illustrating the change in expression after stress of the peptidoglycan (A) 
and teichoic acid (B) biosynthesis genes. The graph lines are coloured by the relative level of 
gene expression after growth in the presence of amoxicillin (A) or heat shock (B). A 
diagrammatic representation of the dlt gene cluster, linked to teichoic acid modification, is 
shown below the graph. A peptidoglycan biosynthesis gene cluster can be seen in Figure 4.29A. 
Other genes represented here are not clustered within the genome. Relevant pathways can be 
seen in Figures 4.30 and 4.3 1. For an explanation of GeneSpringTM graph interpretation, see 
Figure 4.2. 
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Figure 4.64 Responses of the cell wall associated gene cluster 
GeneSpringTM graph illustrating the change in expression after stress of the cell all associated 
gene cluster, (7)2767-2801. Graph lines are coloured by the relative level of gene expression 
after growth in the presence of amoxicillin. A diagrammatic representation of the gene cluster 
within the Cd630 genome is shown below the graph. CWPs are shown in blue and cell wall 
biosynthesis proteins in black. Genes encoding translocasc subunits are shown in green; and 
other cell wall associated proteins, membrane proteins and conserved hypothetical proteins are 
shown in purple. For an explanation of GeneSpring'M graph interpretation, see figure 4.2. 
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Figure 4.65 Responses of CWP genes slpA, cwp2, cwp66, cwp84, cwp6 and cwp22 
GeneSpringTM graphs illustrating the change in expression after stress of CWP (cell wall protein) 
genes slpA (A), cwp2 (B), cwp66 (C), cwp84 (D), cwp6 (E) and cwp22 (F). Graph lines are 
coloured by the relative level of gene expression after growth in the presence of arnoxicillin. 
CWPs are detailed in Section 3.1. For an explanation of GeneSpringTM graph interpretation, see 
Figure 4.2. * represents one significantly regulated probe. 
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Figure 4.66 Responses of CWP genes cwp7, cwp20, cwp27, cwp2l, cwplO and cwpl8 
GeneSpringTM graphs illustrating the change in expression after stress of CWP (cell wall protein) 
genes cwp7 (A), cwp20 (B), cwp27 (C), cwp2l (D), cwp10 (E) and cwp18 (F). Graph lines are 
coloured by the relative level of gene expression as indicated by underlining. CWPs are detailed 
in Section 3.1. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
" represents one significantly regulated probe. 
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Figure 4.67 Responses of CWP genes cwp23, cwp8, cwp19, cwp24, cwp13 and cwp V 
GeneSpringTM graphs illustrating the change in expression after stress of CWP (cell wall protein) 
genes cwp23 (A), cwp8 (B), cwp19 (C), cwp24 (D), cwp13 (E) and cwpV(F). Graph lines are 
coloured by the relative level of gene expression as indicated by underlining. CWPs are detailed 
in Section 3.1. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
" represents one significantly regulated probe. 
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Figure 4.68 Responses of genes encoding extracellular matrix binding proteins 
GeneSpringTM graphs illustrating the change in expression after stress of collagen binding 
CD2831 (A), fibronectin binding CD2592 (B) and CD2797 (C), fibrinogen binding CD3145 (D), 
and peptidoglycan binding CD0551 and C'D2388 (E). Graph lines are coloured by the relative 
level of gene expression as indicated by underlining. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. * represents one significantly regulated probe. 
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4.9 Discussion 
Microarray analysis 
Microarray has been used in this study to elucidate the transcriptional responses of U630 to a 
variety of stresses. While this approach can give a global overview of bacterial expression, it 
does have limitations. Hybridisation levels are not directly related to prevalence of nucleic acid 
due to a number of factors including probe length, affinity and concentration. In order to negate 
these potential confounding factors, data is analysed as a ratio of hybridisation relative to a 
constant background of genomic DNA hybridisation. This does, however, result in such high 
hybridisation competition against rare transcripts that it is possible that they may not be 
detected: microarray analysis using competitive RNA/DNA hybridisation is not a particularly 
sensitive transcript detection technique. An unfortunate outcome of this is that potentially very 
interesting genes such as transcription factors that are only transcribed at very low levels are 
often below the detection limits of this system. 
Where possible, MAVI analysis was used to convert data from multiple slide scans at increasing 
sensitivities into a single data set, allowing meaningful spot fluorescence quantification over a 
far greater intensity range and reducing the loss of information for weakly hybridising spots. 
The heat shock and antibiotic exposure microarrays were analysed in this fashion, however pH 
and oxygen microarray slides tended to have a lower Cy5 (RNA) fluorescence intensity; 
multiple scans were therefore not possible as the slides needed to be scanned at close to 
maximum sensitivity for basic data collection. As the RNA for these experiments was 
processed as one batch, it is possible that the purification was not as efficient as expected. It 
may be that either a higher proportion of rRNA or tRNA and therefore a lower concentration of 
mRNA per µg total RNA was isolated; or that a contaminant, such as residual ethanol, was 
introduced that partially inhibited the reverse transcription and Cy5 labelling process. 
Due to the quality control measures used, the hybridisation data from many spots was discarded 
during analysis. This is to be expected in any microarray data set, and it is not reasonable to 
expect a complete data set for every probe under every condition using microarray analysis. 
This underscores the necessity for sufficient biological and technical repetitions in order to 
generate enough data to produce meaningful results. In this study, biological triplicates and 
technical duplicates were analysed. These six independent hybridisations per test condition, in 
addition to the internal duplicate spots within each hybridisation, potentially result in intensity 
, 
data for up to twelve spots per probe per condition. 
Microarray analysis evaluates expression at the level of total mRNA, which is a net result of the 
relative transcription rate and mRNA stability. A constant signal may be due to high turnover 
(equally rapid production and breakdown), or a static transcript population. As microarray only 
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measures the prevalence of mRNA, no direct conclusion can be drawn as to the actual 
transcription rate of any gene product. In addition, protein prevalence will be affected by 
translational efficiency and protein stability; and protein activity may be further modulated by 
post-translational modifications or by cellular location. 
Overall, however, microarray is the most straightforward method of analysing a cell 
population's response profile in a global manner. The data in this study was normalised using 
the overall intensity of the hybridisation on each slide. This assumes that the total RNA level in 
the cell remains constant even after shock. However, evidence has been presented that global 
RNA levels can change with stress, and that this affects the statistical detection of significant 
changes in expression level (van de Peppel et al. 2003). In the absence of any other satisfactory 
normalisation technique, it was not possible to estimate the contribution of such changes to the 
results presented here. 
Overall, seven hundred and eight genes (out of three thousand, six hundred and seventy-nine in 
the Cd630 genome) are found to be statistically regulated after at least one stress tested. 
Responses of C. difficile to shock 
Microarray analysis of the transcriptome was used to analyse the responses of Cd630 to heat 
shock, pH shock (acid and alkali) and atmospheric shock. As expected, heat shock most 
strongly upregulated the transcript levels of the conserved bacterial heat shock operons 
regulated by HrcA and CtsR. An exception to this generalisation is that the level of cipP was 
not observed to increase after heat shock, as occurs in B. subtilis (Petersohn et al. 2001). In 
un-stressed B. subtilis, the tetradecameric C1pP protease is present in 1200 copies, and can bind 
two C1pC hexamers which are present in 250 copies: therefore C1pP is present in almost 10-fold 
excess (Gerth et al. 2004). If this ratio also occurs in C. dii facile, then there is sufficient C1pP 
present to prevent this being the limiting factor even after the c1pC induction seen, assuming 
equivalent translation rates. c1pP1 in Cd630 is found in an operon with clpX, known not to be 
induced by heat shock in B. subtilis (Gerth et al. 2004; Frees et al. 2007). The heat shock 
operons are also strongly upregulated after acid shock of Cd630, as has been previously 
described in other species (Guerzoni et al. 2001; Petersohn et al. 2001). 
Heat shock is also expected to upregulate the sigB-rsbV-rsbW operon, but this was not observed 
in these microarray hybridisations. This may be explained due to the time point examined: 
sigB in B. subtilis is observed to be maximally induced three minutes after the onset of heat 
shock, and the degree of upregulation is greatly reduced after ten and twenty minutes of heat 
shock (Helmann et al. 2001). Nonetheless, some components of the B. subtilis aB regulon are 
also observed to be upregulated in Cd630. 
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Choline is a precursor of the osmoprotectant glycine-betaine, and the opuB choline-specific 
osmoprotectant ABC transporter (Kappes et al. 1999) has been previously shown to be 
upregulated by heat shock (Helmann et al. 2001; Price et al. 2001). However, the only 
osmoprotectant ABC transporter components significantly regulated in this study were strongly 
downregulated after heat shock (CD3215-6). The majority of the components of the grd 
glycine/sarcosine/betaine reductase complex are upregulated, although none significantly so. 
The app operon was previously found to be upregulated after heat shock in B. subtilis (Helmann 
et al. 2001). In this study, the app gene cluster was found to be unaffected by heat shock, but 
the opp gene cluster of C. docile was found to upregulated. In B. subtilis these operons, 
encoding oligopeptide ABC transporters, are functionally interchangeable in enabling B. subtilis 
to sporulate efficiently (Koide & Hoch 1994). 
Cardiolipin synthase was also found to be upregulated by heat shock in previous studies on 
B. subtilis (Petersohn et al. 2001; Price et al. 2001), and was upregulated 1.54-fold after heat 
shock in C. docile, although not significantly so. Cardiolipin synthase was also significantly 
upregulated after both acid and oxygen shocks. 
Teichoic acid synthesis was upregulated by heat shock in B. subtilis (Price et al. 2001), and in 
C. di cile the balance of expression of the genes encoding incorporation of D-alanine into cell 
wall polymers after heat shock appears to be shifted from peptidoglycan synthesis to teichoic 
acid synthesis (Section 8.2). 
The significance of the repression of straight chain fatty acid biosynthesis pathways by heat 
shock is not known. It is possible that this is due to a shift in cell membrane composition at the 
elevated temperatures, however no alternative fatty acid pathway (for example branched chain 
synthesis) was observed to be upregulated. This phenomenon has also been observed after 
severe heat shock in E. coli K12 and 01571. Similarly, the significance of the induction of the 
genes encoding the pyrimidine synthesis pathway is not known. 
In B. subtilis, the alkali shock response is mediated by the RNA polymerase alternative sigma 
factor sigma W (SigW, aW) (Wiegert et al. 2001). However, BLASTP searching of the Cd630 
and Cd20352 published genome sequences reveals that there is no close homologue of aW in 
C. difficile. Similarities between the responses of C. dif cile and B. subtilis can still be noted. 
The histidine synthesis pathway has previously been detected to be upregulated after alkaline 
shock (Wiegert et al. 2001), as was observed in this study. Tellurite and tellurium resistance 
proteins are upregulated in B. subtilis (Petersohn et al. 2001; Wiegert et al. 2001), and are 
1 Martin Goldberg, personal communication 
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upregulated by an average of 1.37-fold by alkali shock in this study, although none significantly 
so. However the expected induction of Na+/H+ antiporters and multidrug efflux proteins was 
not observed, and neither was any evidence of phosphate starvation, as predicted by Hombaek 
et al (2004). 
Of particular interest are the protein complex subunits and metabolic pathways that are 
co-ordinately regulated, especially those regulated in response to more than one stress. 
Interestingly, the fld gene cluster, encoding phenyllactate dehydrogenase components (Dickert 
et al. 2000; Kim et al. 2005b), was induced by both acid and alkali shocks, as were a number of 
oxidoreductases and electron transport proteins. 
The gene clusters speADEB and potABCD, encoding the spermidine synthesis pathway and 
ABC transporter respectively, are both strongly upregulated in response to heat shock and alkali 
shock. Spermidine is a polyamine involved in various cellular processes, and is linked to 
abiotic stress resistance in apple and pear fruit trees (Wen et al. 2007) and peroxide resistance in 
mouse fibroblasts (Rider et al. 2007). The Pot ABC transporter is known to be surface 
associated in Streptococcus pneumoniae (Shah et al. 2006) and may contribute to virulence in a 
murine sepsis model (Ware et al. 2006). 
One possible confounding factor in this study of the response to pH shock in that in addition to 
the changing pH of the medium, the salt concentration was also increased. In fact, the alkali- 
induced a"' regulon is also reported to be induced by salt stress (Petersohn et al. 2001). 
However, BHI medium itself comprises 85mM NaCI, and only 17mM HCl and 37mM NaOH 
were added. In contrast, 4% NaCl (685mM) was used for induction of experimental salt stress 
(Petersohn et al. 2001). 
The response of C. docile, a strict anaerobe, to atmospheric exposure is very interesting. A 
large number of presumably protective oxidoreductases and electron transport components are 
induced, implying that C. dWIcile does in fact have some mechanisms for tolerance of limited 
atmospheric conditions. The low level of culturability of atmospherically exposed cultures 
suggests that Cd630 is substantially damaged by this level of oxygen exposure, however these 
observed responses may allow it to improve survival, if not growth, in microaerophilic 
environments. The gut is not strictly anaerobic, and either C. dicile must grow and survive in 
strictly anaerobic niches or it must be capable of tolerating microaerophilic conditions. It is 
known that C. diicfle does not tolerate presence of any oxygen in vitro. 
The induction of cold shock proteins in this experiment suggests that temperature shift caused 
by exposure to the atmosphere (22°C) in comparison to the growth temperature 
(37°C) may 
have been a confounding factor. However, in comparison to the cold shock response of 
B. subtilis (Kaan et a!. 2002), osmoprotectant 
ABC transporters and purine synthesis genes were 
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not induced by atmospheric shock treatment, nor were biosynthesis pathways repressed, 
although ribosomal protein genes were slightly induced. 
In addition to the upregulation of redox proteins, a large number of conserved hypothetical 
proteins are induced by exposure to the atmosphere, revealing that many of the response 
mechanisms of C. difficile to oxygen exposure are currently highly uncharacterised. The 
conserved nature of these proteins implies that these responses to oxidising conditions may also 
be found in other organisms, and could represent shared survival mechanisms. 
It would be interesting to compare the data generated in this study with the expression profiles 
after growth under stressful conditions, as opposed to shock treatment. C. docile is capable of 
growth at 42°C, and in a pH range of pH 5.4 to pH 9.2. This comparison would elucidate which 
responses are due to the rapid change in conditions and which are adaptive responses necessary 
for long-term survival under the given stress. We found difficulty, however, in keeping pH 
conditions stable in the reducing anaerobic atmosphere of the cabinet (10% C02,10% H2, 
80% N2). 
Responses of C. difficile to the presence of antibiotics 
Microarray analysis of the transcriptome was used to analyse the responses of Cd630 to growth 
in the presence of subinhibitory concentrations of antibiotics. Amoxicillin works by inhibiting 
cell wall synthesis; clindamycin by inhibiting protein translation; and metronidazole by 
inhibiting DNA synthesis. 
In this study metronidazole caused only a very small change in the transcription patterns of 
Cd630; few genes are significantly regulated. This may be explained because C. docile is 
highly sensitive to the effects of metronidazole, and a very low concentration had to be used in 
order for Cd630 to be able to grow normally. 
Some unique responses are observed after metronidazole treatment though. In particular, 
metronidazole increases levels of prophage transcript. It would be interesting to investigate 
whether this increase corresponds to prophage excision and mature phage production. This 
could be achieved by utilising outward facing primers at each end of the prophage within the 
genome, in conjunction with PCR amplification of DNA from cells and/or supernatant of 
growing cultures. No product would be obtained from genomic DNA; in contrast excised, 
circularised phage DNA would be amplified. 
The transcriptional profiles of Cd630 are similar after growth in the presence of amoxicillin and 
clindamycin, as can be seen by the consistent colouring of these panels in Figures 4.28 and 4.40. 
This similarity between classes of genes regulated by protein synthesis inhibitors and RNA, 
DNA, or cell wall-synthesis inhibitors has also been observed in B. subtilis (Lin et al. 2005). 
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It is interesting to note that growth in the presence of all three antibiotics tested, particularly 
amoxicillin and clindamycin, raised the transcription levels of most ribosomal proteins, and also 
the majority of tRNA synthetases. This phenomenon has also been observed after antibiotic 
shock of B. subtilis using protein synthesis inhibitors (Lin et al. 2005). Some transcription and 
translation inhibiting antibiotics have previously been reported to suppress the production of 
ppGpp (Lund & Kjeldgaard 1972; Muto et al. 1975), which is the mediator of the stringent 
response. A putative guanosine 3', 5'-bis-pyrophosphate (ppGpp) synthesis/degradation protein 
is significantly upregulated after growth in the presence of both amoxicillin and clindamycin, 
and could possible be responsible for the degradation of ppGpp. ppGpp would cause repression 
of ribosomal protein expression, and it is possible that this derepression is responsible for the 
observed increase in ribosomal protein transcripts. 
Many cell wall biosynthetic enzymes and related proteins are upregulated by antibiotics, 
particularly amoxicillin. This is consistent with the mechanism of action of amoxicillin, which 
mimics D-alanyl-D-alanine and disrupts proper cell wall synthesis by acylating penicillin- 
binding proteins (reviewed in Macheboeuf et al. 2006). All penicillin-binding proteins are 
either up- or down-regulated by growth in the presence of amoxicillin, and it is possible that 
C. dWIcile downregulates the targets with highest affinity for amoxicillin, and upregulates all 
alternative pathways. A cell-wall stimulon has recently been described for Staphylococcus 
aureus (Utaida et al. 2003), which may be upregulated in vancomycin intermediate resistance 
strains (McAleese et al. 2006). Comparison between this regulon and those genes regulated in 
this study reveals some overlap, although some genes have disparate regulation, and many 
S. aureus genes are not identified in C. docile. 
Components of the Sec protein export machinery are also generally upregulated by antibiotics, 
particularly amoxicillin, as are many other surface-associated and excreted proteins. Many 
CWP transcripts are seen to be upregulated; antibiotic upregulation of slpA, cwp66, and cwp84 
in C. difficile has been demonstrated previously, although the level of regulation varies between 
strains and antibiotics'. Taken together with the upregulation of cell wall biosynthetic 
components, it is tempting to speculate that perhaps C. dicile is capable of producing a thicker 
or denser cell wall as a physical barrier to antibiotic penetration, as has been reported to confer 
intermediate vancomycin resistance (reviewed in Appelbaum & Bozdogan 2004), although this 
phenomenon has not been previously observed in C. dicile in response to antibiotics. 
Both amoxicillin and clindamycin induce production of flagellar transcripts and those encoding 
other chemotaxis-related proteins. This implies that cellular motility is increased in the 
presence of these antibiotics. Gut mucus of animals and humans serves as a chemoattractant 
Cecile Deneve, Anne Collignon, personal communication 
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for C. difficile, and chemotactic motility correlated positively with the relative virulence of the 
strains examined in a hamster model (Borriello 1998). Motility could allow the bacterium to 
escape from an antibiotic down a concentration gradient, or to move towards higher nutrient 
concentrations. 
As C. difficile is known to be able to transfer DNA to and from other gut organisms (Hachler et 
al. 1987a; Spigaglia et al. 2005), transfer of antibiotic genes is of real clinical concern. Both 
amoxicillin and clindamycin generally repress transcription of conjugative transposons, and if 
this observation is also true in vivo they may reduce the chances of C. docile transmitting 
antibiotic resistances to other gut microflora. 
The regulation of toxin genes by various stresses may have clinical relevance. tcdB transcript 
appears to be repressed by clindamycin and amoxicillin, and both tcdR and tcdE by only 
amoxicillin. Antibiotics are not known to regulate toxin expression in vitro, although in 
complex gut flora cultures antibiotic administration may lead to toxin production due to 
disruption of colonisation resistance and C. dicile overgrowth (Freeman et al. 2003; Pultz & 
Donskey 2005). The upregulation of the binary toxin pseudogenes after growth in the presence 
of clindamycin, and the downregulation after alkali shock, is intriguing. In Cd630, these genes 
are truncated and disrupted by numerous frameshift and nonsense mutations, so binary toxin 
cannot be produced. However, it is possible that the same regulatory mechanisms are shared in 
other C. difficile strains with functional cdt genes, in which case these observations may be 
valuable. 
The aromatic amino acid synthesis pathway leading to the production of phenylpyruvate (a 
precursor of phenylalanine, tryptophan and tyrosine) is upregulated by growth in the presence of 
amoxicillin. Interestingly, components of the glycolysis and pentose phosphate pathways 
leading to the synthesis of both phosphoenolpyruvate and D-erythrose-4-phosphate, the aromatic 
amino acid precursors, are also upregulated. 
The opuA glycine/betaine ABC transporter has been previously shown to be upregulated by 
erythromycin shock (Lin et al. 2005); glycine-betaine can act as an osmoprotectant, and is 
derived from choline (Kappes et al. 1999). However, in this study the opuC glycine/betaine/ 
carnitine/choline ABC transporter and the glycine/sarcosine/betaine reductase complex are 
downregulated by the presence of antibiotics. 
In contrast to the response to heat shock, both accADCB and the fab gene cluster (fapR, p1sX, 
fabHKDG, acpP, fabF), encoding the fatty acid biosynthesis pathway, are strongly upregulated 
by growth in the presence of amoxicillin and also slightly upregulated by the presence of both 
clindamycin and metronidazole 
(Figures 4.7: Heat and 4.30). Similar to the response observed 
after alkali shock, hisK and the hisZGCBHAFI gene cluster (Figures 4.20A: Alkali and 4.21) are 
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both upregulated after amoxicillin exposure, whereas NO is not, implying the upregulation of 
the histidine synthesis pathway as far as the generation of histidinol. 
The gene clusters speADEB and potABCD, encoding the spermidine synthesis pathway and 
ABC transporter respectively, are both strongly upregulated in response to heat shock and alkali 
shock, and also by exposure to amoxicillin. Spermidine is a polyamine involved in various 
cellular processes. It is interesting to note that exogenous spermidine has been observed to 
increase the sensitivity of many bacteria to antibiotics (Kwon & Lu 2007), although in 
Pseudomonas aeruginosa exogenous spermidine increases sensitivity to ß-lactam antibiotics, 
chloramphenicol, nalidixic acid, and trimethoprim (Kwon & Lu 2006b) but induces resistance to 
cationic peptide, aminoglycoside, and quinolone antibiotics (Kwon & Lu 2006a). 
Overall, the presence of subinhibitory antibiotic in the growth medium evokes a response in the 
transcriptional profile of C. diJcile. Responses are broadly similar between antibiotics with 
disparate mechanisms of action, and to which Cd630 is both resistant and susceptible. The 
responses of Cd630 to shock appear to be more specific to the type of shock, and many of the 
observed responses would be expected given the known adaptation and survival responses in 
other species. 
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Chapter 5: Discussion 
5.1 The responses of C. difftcile to stress 
C. diJcile is an escalating nosocomial and community-acquired problem, causing considerable 
morbidity and mortality. Both the incidence and the severity of C. dfýcile-associated disease 
(CDAD) are reported to be increasing. In order to target C. diJcile within the host, it will be 
necessary to elucidate the survival mechanisms necessary for colonisation and pathogenesis. It 
is hoped that investigation of the responses of C. docile to general stresses will prove useful in 
revealing possible adaptation and resistance mechanisms in vivo. In this study, we have used 
microarray analysis to determine the proportional changes in the entire transcriptome in 
response to various stresses. 
Examination of the responses of C. di cile to heat shock reveals that C. docile shares the 
widely conserved general stress response, characterised by the strong induction of the classic 
heat shock proteins. As in other organisms, this regulon is also upregulated by acid shock. 
Although the aB stress response is shared with other organisms, the precise regulon is distinct 
between species, and therefore further classification is still necessary. Heat shock also induces 
many potential operons and metabolic pathways; the co-ordinately regulated behaviour 
observed in this study may aid in subsequent operon classification. The study of the response of 
the C. docile vegetative cell to acid shock may have direct relevance to CDAD precipitated by 
acid suppressants; in these patients gastric pH can rise above pH 5, and we have shown 
vegetative C. dWcile to be able to tolerate this. 
The response of C. dicile, reported to be a strict anaerobe, to atmospheric exposure is 
fascinating. Although cell viability is lost upon this treatment, consistent upregulation of the 
transcripts of many redox and electron transport proteins is observed. This reveals that 
C. docile does have some survival mechanisms for aerobic or oxidising conditions, which may 
allow it to survive or even proliferate in the microaerophilic conditions prevalent in much of the 
gut. It would be interesting to compare this response with that to the presence of an oxidising 
agent, for example hydrogen peroxide, in the medium, either as a growth condition or a shock 
treatment. The large number of conserved hypothetical proteins affected by atmospheric 
exposure only serves to underline how little is understood of the basic biology of C. docile. 
Antibiotics are the primary precipitating agents for CDAD, and therefore the response of 
C. dicile to growth in the presence of antibiotics was investigated. Metronidazole is a strong 
inhibitor of C. dfJcile, and therefore in order to obtain a relatively normal growth curve an 
extremely low drug concentration had to be used. Very 
few genes were regulated by the 
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presence of metronidazole in the growth medium, and it is likely that metronidazole was diluted 
out of effective concentration. The implication that C. difcile does not invoke any protective 
mechanisms at sub-inhibitory concentrations of metronidazole suggests that evolution of 
resistance is unlikely; any detected C. docile metronidazole resistance is probably due to 
horizontal gene transfer as there are no basic survival strategies currently present, at least in 
Cd630. 
Amoxicillin and clindamycin, both common predisposing agents for CDAD, were also 
examined. Despite their dissimilar modes of action, these drugs resulted in similar expression 
profiles, although the specific genes determined to be significantly changing were largely 
separate in each case. Both antibiotics resulted in a general increase in transcripts related to 
transcription and translation. It is possible that this has led to a distortion in the results: 10µg of 
total RNA is hybridised to the slide and then the signals are normalised to the average spot 
intensity of the slide. A change in the balance of mRNA to other cellular RNA (tRNA, rRNA) 
may therefore affect hybridisation patterns. It is hoped that this confounding effect was 
minimal, as we are not able to control for it. 
Both amoxicillin and clindamycin upregulated membrane and cell wall related enzymes, which 
could affect cell permeability to the drug, and also the flagellar locus, which could potentially 
enable bacterial escape down an antibiotic concentration gradient. The physiological effects of 
these transcriptional changes would be interesting to investigate. 
In an organism such as C. diJcile that is not already well studied, microarray analysis can only 
ever hope to highlight those genes that may merit further investigation and characterisation. It 
is hoped that the data produced in this project will be used to enable directed investigation into 
the expression of particular genes under conditions more closely mimicking those in the gut. 
Global studies such as microarray analysis need a large amount of raw material, and this would 
be very difficult to isolate from natural conditions. Studies of specific in vitro responses, such 
as that presented here, should aid in the prediction of genes that may play a role in disease and 
C. difficile survival and therefore allow targeted research in vivo. 
5.2 CwpV, a phase variable cell wall protein of C. difftcile 
It is unfortunate that we have not been able to characterise a function of the type I CwpV 
repeats. We have demonstrated that they are not involved in adhesion to Hep2, Vero or human 
red blood cells. It is possible that the repeats are involved in adhesion to other mammalian cells 
or products and that they show no affinity to these cell lines because they do not express the 
mammalian binding partner. It would be informative to assay for adhesion to a wide range of 
extracellular matrix or mucus components. 
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The detection of the cwp V gene in every C. difJlcile strain tested (83 strains, including the data 
of Stabler et al. ) suggests that cwp V may play an essential role in C. docile biology. However, 
three observations would argue to bring this into doubt. The lack of expression of CwpV in the 
pathogenic (but laboratory adapted) strain Cdl demonstrates that at least in vitro growth is 
possible without CwpV; the constant expression level and phase variability of CwpV expression 
demonstrates that neither continuous nor inducible expression of CwpV is necessary for growth; 
and the lack of homology between the C-terminal domains of CwpV-types suggests that they do 
not impart the same function. Characterisation of both the cwp V gene sequence of type III 
strains and the functional role of the type I and type II CwpV repeats will be necessary to 
determine whether the C-terminal regions of CwpV confer a conserved function despite their 
unrelated sequences and predicted structures. Testing of other ribotype 001 strains will be 
necessary to determine whether CwpV expression is frequently disrupted in pathogenic strains, 
or whether the Cdl (R8366) strain held in this laboratory has developed the observed mutation 
disrupting cwpV expression since it was isolated. 
The phase variability of CwpV expression is extremely interesting. We do not know of any 
reports of other phase variable proteins in C. docile. Fimbriae are regulated by DNA inversion 
in many organisms, and other surface enzymes and glycoproteins are regulated in this way in 
Bacteroides. In these cases, inversion is mediated by either a tyrosine or serine site-specific 
recombinase. A similar mechanism can be envisioned for CwpV in C. difcile. Further 
investigation of the putative site-specific recombinases in the Cd630 genome will be necessary 
to determine which of these proteins is/are responsible for the observed switching. Moreover, 
DNA inversion can be affected by the external environment in other species: Proteus mirabilis 
fimbrial promoters were found to be completely "off' after growth on agar, in mixed 
orientations during growth in broth, and completely "on" in vivo (Zhao et al. 1997). 
Determination of the orientation of the CwpV promoter in in vivo models will reveal whether a 
potential contribution to pathogenesis is feasible. 
The discovery of DNA-inversion controlled protein expression in C. docile invites further 
investigations as to whether this mechanism is also employed for other C. diff: cile proteins; the 
identification of phase variability in CwpV brings out the intriguing possibility of phase 
variation in other CWPs. BLAST searching of the inverted repeats against the C. dicile does 
not reveal any other opposing pairs of this sequence, however this does not rule out alternative 
inverted repeats controlling expression of other CWPs. We have carried out a global search for 
inverted repeats in the Cd630 genome using EINVERTED, in collaboration with our 
bioinformatics department, but this has not yet been fully analysed. Candidate inverted repeats 
can be identified in the upstream regions of cwp5, cwpll, cwpl4, cwpl9, cwpl7, cwp2l, cwp24 
and cwp84. 
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5.3 Conclusions 
In this study we have demonstrated the application of microarray technology to investigate the 
transcriptional stress responses of C. docile. It is hoped that the data generated here will 
facilitate the determination of C. docile survival and proliferation factors in the context of 
pathogenicity. We have also demonstrated that cwpV, encoding one of a family of putative cell- 
wall associated proteins, is present in all strains of C. difficile and that at least three cwpV types 
exist. We have shown type I CwpV to be surface expressed on a subset of cells and we believe 
all cwpV"types to be subject to phase variation. This is the first report in C. dicile of 
regulation of gene expression by DNA inversion. 
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Gene Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
1 CD2022 1.72E-06 + 6.20 hypothetical protein 
2 cD2021 3.54E-06 + 11.17 hypothetical protein 
3 CD0194 groEL 5.93E-06 + 6.79 60 kDa chaperonin 
4 CD0436 6.30E-06 + 5.52 putative recombinase 
5 cD0549 6.72E-06 + 2.51 putative exported protein 
6 CD0890 speE 1.36E-05 + 3.35 spermidine synthase 
7 CD2020 cIpB 2.17E-05 + 9.17 chaperone 
8 cD2927 2.41E-05 + 4.23 putative phage DNA-binding protein 
9 cD2463 hrcA 2.45E-05 + 7.70 heat-inducible transcription repressor 
10 CD1023 2.80E-05 + 2.79 putative transcriptional regulator 
11 JD2460 dnaJ 2.80E-05 + 3.82 chaperone protein 
12 CD2826 2.80E-05 + 2.29 
putative oxidoreductase (FAD-binding 
domain) 
13 CL-)2461 dnaK 13.31E-05 + 5.60 chaperone protein 
14 CD3578 3.31E-05 + 4.11 putative resolvase 
15 cD2849 6.01E-05 + 2.05 
putative bifunctional protein: phosphono- 
acetaldehyde phosphonohydrolase; 
2-aminoethylphosphonate: pyruvate 
aminotransferase 
16 cD3273 feoA3 6.01 E-05 + 2.24 putative ferrous Iron transport protein A 
17 cD0888 speA 9.74E-05 + 2.79 arginine decarboxylase 
18 CD1026 potC 9.74E-05 + 3.84 
putative spermidine/putrescine ABC 
transporter, permease protein 
1,9 co0193 groES 1.09E-04 + 8.26 10 kDa chaperonin 
20 CD2242 1.35E-04 + 2.31 conserved hypothetical protein 
21 CD2928 1.44E-04 + 4.84 hypothetical phage protein 
22 CD2023 1.48E-04 + 3.06 GntR-famil transcriptional regulator 
23 cDO025 1.92E-04 + 3.99 putative ATP: guanido phosphotransferase 
24 CD0621 2.26E-04 + 3.69 hypothetical protein 
25 CD1027 potD 2.34E-04 + 4.58 spermidine/putrescine 
ABC transporter, 
substrate-binding lipoprotein 
26 CD2462 grpE 2.34E-04 + 7.96 heat shock protein 
27 CD3284 2.71E-04 + 2.67 probable protease 
28 CDO891 speB 2.73E-04 + 2.25 putative agmatinase 
29 cD2848 4.80E-04 + 2.66 conserved hypothetical protein 
30 cD2825 5.75E-04 + 1.85 putative flavodoxin 
31 CD0195 8.53E-04 + 3.03 putative membrane protein 
32 cD3589 pyrAA1 9.60E-04 + 1.90 
carbamoyl-phosphate synthase, pyrimidine- 
specific, small chain 
33 CD1025 potB 1.06E-03 + 2.97 
spermidine/putrescine ABC transporter, 
ermease protein 
34 cD2024 1.22E-03 + 2.80 ABC transporter, ATP-bindin protein 
35 cD2464 hemN 1.41E-03 + 2.91 
oxygen-independent coproporphyrinogen Ill 
oxidase 
36 cD2173 1.42E-03 + 2.02 putative peptidase 
37 CDO147 1.64E-03 + 2.21 putative membrane protein 
38 cD0024 1.73E-03 + 3.23 putative DNA repair protein 
39 cDO186 D pyr 1.81E 03 + 2.09 
dihydroorotate dehydrogenase, catalytic 
subunit 
40 CD2852 ditB 1.86E-03 + 2.03 D-alanyl transferase 
41 cv3274 feoB3 1.87E-03 + 1.87 putative ferrous iron transport protein B 
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n P-value +/- ChaFold nge 
Gene Product 
42 cD2262 1.98E-03 + 2,14 probable proton-dependent oligopeptide transporter 
43 cr2491 mi 2.56E-03 + 1.82 mannose-6-phosphate isomerase 
44 cD2799 2.56E-03 + 2.28 putative cell surface protein 
45 cD2071 2.91E-03 + 1.79 conserved hypothetical protein 
46 CD1186 3.02E-03 + 1,76 putative sigma-54 
dependent transcriptional 
regulator 
47 cD3603 3.36E-03 + 2.00 putative exported phosphoesterase 
48 cD3140 3.38E-03 + 1.98 putative membrane protein 
49 cD2810 3.62E-03 + 1.50 putative membrane protein 
50 cD3591 pyrAA2 3.79E-03 + 1.97 
carbamoyl-phosphate synthase, pyrimidine- 
specific, small chain 
51 cD0438 3.82E-03 + 2.05 putative exported protein 
52 cD1264 4.45E-03 + 1.68 hypothetical protein 
53 cD0320 4.69E-03 + 1.93 two-component response regulator 
54 cD2072 4.69E-03 + 2,01 putative neutral protease putative transposase 
55 cD0026 cl C 4.79E-03 + 3.07 ATP-dependent Cip protease 
56 cD0187 pyrE 4.87E-03 + 2.68 orotate phosphoribosyltransferase 
57 cD3246 4.87E-03 + 2.98 putative surface protein 
58 cD3588 pyrAB1 5.07E-03 + 1.83 carbamoyl-phosphate 
synthase, pyrimidine- 
specific, large chain 
59 cD2799 5.40E-03 + 2.26 putative cell surface protein 
60 cD3590 pyrAB2 5.62E-03 + 2.46 carbamoyl-phosphate synthase, 
pyrimidine- 
specific, large chain 
61 CD2328 5.95E-03 + 2.46 putative sigma-54 
Interacting transcription 
antiterminator 
62 cD0995 serA 7.32E-03 + 2,91 putative D-3-phosphoglycerate deh dro enase 
63 cD2819 7.39E-03 + 1.60 putative amino acid racemase 
64 CD1245 8.17E-03 + 1.72 putative membrane protein 
65 cD2410 ppdK 8.57E-03 + 2.16 pyruvate, phosphate dikinase 
66 cD1262 rnhB 9.15E-03 + 2.03 ribonuclease HII 
67 7D-0531 9.67E-03 + 1.80 DeoR-family transcriptional regulator 
68 cD2494 se/B 9.67E-03 + 1.56 selenoc steine-s ecific elongation factor 
69 CD2261 9.81 E-03 + 2.07 peptidase 
70 000327 cbiO 1.12E-02 + 1.73 cobalt ABC transporter, ATP-binding protein 
71 CD0996 1.12E-02 + 3.05 conserved hypothetical protein 
72 cD2245 asnS 1.14E-02 + 1.94 asparaginyl-tRNA synthetase 
73 cDO185 pyrK 1.22E-02 + 1.99 
dihydroorotate dehydrogenase electron transfer 
subunit 
74 CD0349 CD0348 1.27E-02 + 1.47 conserved hypothetical protein (seudo ene 
75 cD0837 1.32E-02 + 2.12 putative reductase 
76 c03647 1.32E-02 + 1.44 PTS system, Ila component 
77 cD1263 1.39E-02 + 1.82 putative FMN-dependent dehydrogenase 
78 cD0858 1.40E-02 + 1.57 putative transcription antiterminator seudo ene 
7g cD3370 1.40E-02 + 2.39 putative conjugative transposon recombinase 
80 c00839 1.56E-02 + 2.14 
putative membrane-associated CAAX amino 
terminal protease 
81 cD3088 1.87E-021 1+ 2.98 putative cellobiose- hos hate degrading protein 
Table 7.1 Genes with statistically upregulated expression after heat shock ... 
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Gene Product 
82 cD0039 acoL 1.90E-02 + 2.13 
E3 component of acetoin dehydrogenase enzyme 
system (dihydrolipoyl dehydrogenase) 
83 cD2595 pyrR 2.09E-02 + 1.93 
PyrR bifunctional protein: pyrimidine operon 
regulatory protein; uracil phosphoribosyl- 
transferase 
84 CD1024 potA 2.26E-02 + 2.47 
spermidine/putrescine ABC transporter, 
ATP-binding protein 
85 cD3089 2.45E-02 + 2.58 PTS system, Ilabc component 
86 cD2500 argH 2.65E-02 + 1.58 argininosuccinate lyase 
87 co0035 2.67E-02 + 1.84 transcriptional regulator 
88 -FD-2675 2.67E-02 + 1.47 I LysR-family transcriptional regulator 
89 Co0037 acoB 2.77E-02 + 2.08 
acetoin: 2,6-dichlorophenolindophenol 
oxidoreductase subunit 
90 Co0642 2.77E-02 + 4.09 putative transcriptional regulator 
91 CD2466 2.93E-02 + 1.70 putative poly(A) polymerase 
92 co1041 addA 2.95E-02 + 1.63 ATP-dependent nuclease subunit A 
93 cD2158 gabT 2.95E-02 + 2.05 4-aminobutyrate aminotransferase 
94 CD2761 3.02E-02 + 1.50 putative N-acetylmuramo I-L-alanine amidase 
95 cD1417 3.08E-02 + 1.84 putative ATP-binding protein 
96 CD3446 ceIM 3.08E-02 + 1.81 endoglucanase 
97 co0036 acoA 3.17E-02 + 2.16 
acetoin: 2,6-dichlorophenolindophenol 
oxidoreductase a subunit 
98 cD1721 3.17E-02 + 1.53 conserved hypothetical protein 
99 cD3453 agaA 3.21 E-02 + 1.49 N-acet lglucosamine-6- hos hate deacetylase 
100 co0216 3.22E-02 + 2.06 transposase 
101 co1611 3.59E-02 + 2.55 putative exported protein 
102 CD0273 htpG 3.72E-02 + 2.09 chaperone protein (heat shock protein) 
103 cD1828 ftsH1 3.80E-02 + 2.10 cell division protein 
104 Co0184 pyrB 3.88E-02 + 2.02 aspartate carbamo ltransferase catalytic chain 
105 co0022 3.90E-02 + 1.76 putative translation elongation factor 
106 co0368 3.94E-02 + 1.59 two-component system, response regulator 
107 Co0123 murA 4.05E-02 + 1.41 
UDP-N-acetylglucosamine 
I -carbox in ltransferase 1 
108 Co0994 4.16E-02 + 2.05 putative aminotransferase 
109 cD2857 4.16E-02 + 1.64 putative hydrolase 
110 7D1504 4.25E-02 + 1.88 ABC transporter, ATP-binding protein 
111 cD0279 4.76E-02 + 1.95 conserved hypothetical rotein 
112 cD2172 4.93E-02 + 1.96 probable amino-acid 
ABC transporter, 
ATP-binding protein 
113 co3299 4.94E-02 + 1.37 probable transporter 
114 cD1243 4.99E-02 + 2.22 putative membrane protein 
Table 7.1 Genes with statistically upregulated expression after heat shock 
Logarithmic phase Cd630 were subjected to 42°C heat shock for 15 min and then RNA was 
extracted. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures (30°C). Statistically regulated genes were identified by an ANOVA 
test with 5% cut-off using Benjamini-Hochberg multiple testing correction. Regulated genes 
also statistically significant when Bonferroni correction was used are shown 
in bold italic text. 
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Gene Commo 
name 
n P-value +1- ChFold ange 
Gene Product 
cD3066 x lR 3.54E-06 - 3.49 lose repressor 
CD3215 2.34E-04 - 4.63 
putative osmoprotectant acid ABC 
transporter, ATP-binding protein 
cD3254 3.84E-04 - 2.08 putative serine protease 
cD2665 4.35E-04 - 3.00 raC-family transcriptional regulator 
CD3037 4.44E-04 - 2.07 putative regulatory protein 
CD3027 crr 6.34E-04 - 2.56 PTS system, glucose-specific Ila component 
CD2459 gicK 1.16E-03 - 1.83 glucokinase 
CD1411 1.29E-03 - 2.05 conserved hypothetical protein 
CD2664 murE 1.41E-03 - 2.95 
putative UDP-N-acetylmuramoylalanyl- 
D-glutamate-2,6-diaminopimelate ligase 
cD1158 1.42E-03 - 1.51 radical SAM-superfarnity protein 
cD2017 1.77E-03 - 2.09 putative phage regulatory protein 
cD2124 1.77E-03 - 2.17 putative transporter 
cD3651 1.86E-03 - 1.72 
putative metallo-f3-lactamase superfamily 
protein 
cD3028 1.98E-03 - 2.21 putative phosphosugar isomerase 
cD1396 2.13E-03 - 2.26 putative amino acid amidase 
cD3216 2.56E-03 3.49 putative osmoprotectant 
ABC transporter, 
substrate-binding/permease protein 
cD2345 2.91E-03 2.21 L sR-famil regulatory protein 
cD3138 3.02E-03 - 2.06 transcription antiterminator 
cD2830 3.13E-03 1.93 putative exported protein 
CD1469 3.26E-03 - 2.03 putative penicillin-binding protein 
cD0212 3.49E-03 - 2.28 putative choline sulfatase 
CD2458 3.49E-03 - 1.80 probable transporter 
CD2119 thrB 3.59E-03 - 1.82 homoserine kinase 
CD3660 3.75E-03 - 1.38 utative membrane protein 
cD1178 pIsX 3.82E-03 - 1.75 fatty acid/ hos holi id synthesis protein 
CD0211 IicC 4.39E-03 - 2.57 CTP: phosphocholine c tid lyltransferase 
cD0868 5.95E-03 - 1.77 conserved hypothetical protein 
CD0993 5.95E-03 - 3.22 putative thioesterase 
CD3487 rho 6.08E-03 - 18.53 transcription termination factor Rho 
cD2588 gmk 6.25E-03 - 1.74 guanylate kinase 
cD1720 CD1718 8.17E-03 - 1.82 putative hydantoinase 
CD2057 8.57E-03 - 1.62 conserved hypothetical protein 
cD1410 9.67E-03 - 1.94 putative hydrolase 
CD1822 bcp 9.67E-03 - 1.80 
putative thiol peroxidase (bacterioferritin 
comi rato rotem 
cD2063 9.67E-03 - 2.21 putative membrane protein 
cD2151 9.67E-03 - 2.07 putative membrane protein 
cD2344 9.67E-03 - 1.64 putative membrane protein 
cD3030 ma1X 9.88E-03 - 3.16 
PTS system, maltose and glucose-specific llbc 
component 
CD0716 coos 1.00E-02 - 1.51 
putative bifunctional protein: carbon monoxide 
dehydrogenase; acetyl-CoA synthase 
CD2753 1.04E-02 - 1.55 putative signaling protein 
CDO701 1.12E-02 - 1.53 conserved hypothetical protein 
CD0394 IdhA 1.14E-02 - 1.87 D-lactate dehydrogenase 
Table 7.2 Genes with statistically downregulated expression after heat shock ... 
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Gene 
Commo 
name 
n P-value +1- ChFold ange 
Gene Product 
43 cD1944 1.17E-02 - 1.45 conserved hypothetical protein 
44 CD1968 1.24E-02 - 1.77 putative membrane protein 
45 CD3136 bgIA3 1.31 E-02 - 2.34 6- hos ho- -glucosidase 
46 cD3253 folC 1.34E-02 - 1.49 putative folylpolyglutamate synthase 
47 CD1278 1.39E-02 - 1.84 RRF2-family transcriptional regulator 
48 CD1506 1.40E-02 - 1.68 putative drug/sodium anti porters 
49 CD0853 o pB 1.46E-02 - 1.85 oligo e tide ABC transporter, permease protein 
50 CD0199 1.54E-02 - 1.54 putative membrane-associated nucleotidase 
51 CD3568 veg 1.77E-02 - 2.04 conserved hypothetical protein 
52 CD1559 1.78E-02 - 1.53 conserved hypothetical protein 
53 CD3354 1.87E-02 - 1.62 conserved hypothetical protein 
54 cD3187 tdcF 2.07E-02 - 1.81 putative regulatory endoribonuclease 
55 cD1214 spoOA 2.09E-02 - 1.53 stage 0 sporulation protein A 
56 CD0879 2.11 E-02 1.60 putative carbohydrate kinase 
57 CD0854 oppC 2.15E-02 - 1.62 oligo e tide ABC transporter, permease protein 
58 CD1718 2.15E-02 - 1.70 putative hydantoinase 
59 cD2165 2.19E-02 - 1.44 conserved hypothetical protein 
60 co3042 2.20E-02 1.60 putative membrane protein 
61 CD1414 2.26E-02 - 1.67 putative radical SAM-superfamily protein 
62 CD2539 rnz 2.36E-02 - 1.52 ribonuclease Z 
63 CD0054 th X 2.39E-02 - 1.78 putative th mid late synthase 
64 CD1277 2.60E-02 " 1.45 putative acetyltransferase 
65 cD1159 2.67E-02 - 1.48 conserved hypothetical protein 
66 co1160 cafA 2.67E-02 - 1.36 ribonuclease g 
67 co2610 trpS 2.68E-02 - 1.64 t to han l-tRNA synthetase 
68 CD1594 cysts 2.95E-02 - 1.88 putative 0-acetylserine sulfh d lase 
69 CD3150 2.95E-02 - 1.68 conserved hypothetical protein 
70 CD2446 rpsU 3.21 E-02 - 1.69 30S ribosomal protein S21 
71 CD3559 ftsH2 3.21 E-02 - 1.45 cell division protein 
72 cD0202 3.24E-02 - 1.63 conserved hypothetical protein 
73 c_2377 3.29E-02 - 1.62 NUDIX-family protein 
74 CD1747 add 3.49E-02 - 1.35 adenosine deaminase 
75 CD2589 3.72E-02 - 1.64 conserved hypothetical protein 
76 CD0545 3.80E-02 - 1.49 putative lipoprotein 
77 CD1541 3.89E-02 - 1.75 putative drug/sodium anti porter 
78 cD2250 3.90E-02 - 1.34 putative membrane protein 
79 CD2310 cspD 3.90E-02 - 2.36 cold shock protein 
80 CD3031 3.92E-02 - 2.19 transcription antiterminator 
81 6D2667 ptsG 4.01 E-02 - 2.55 PTS system, glucose-specific llbc component 
82 CD3067 4.07E-02 - 2.06 PTS system, Ila component 
83 CD3332 4.07E-02 - 1.52 TetR-family transcriptional regulator 
84 cD1538 4.16E-02 - 1.50 putative signaling protein 
85 cD0056 4.18E-02 - 1.42 conserved hypothetical protein 
86 cD3197 4.25E-02 - 1.85 MerR-family transcriptional regulator 
87 cD1404 4.44E-02 - 1.58 putative oli oe tide transporter 
88 CD1779 4.44E-02 - 1.63 conserved hypothetical protein 
89 cD2590 da F 4.54E-02 - 1.56 diaminopimelate epimerase 
90 
91 
CD3272 
cD0709 
4.62E-02 
4.68E-02 
- 
- 
1.35 
1.39 
putative membrane protein 
putative DNA mismatch repair protein 
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Gene Commo 
name 
n P-value +1- ChaFold nge 
Gene Product 
92 cD0562 4.69E-02 - 1.59 putative endonuclease 
93 CD0712 4.71 E-02 - 1.75 hypothetical protein 
94 CD3147 4.72E-02 - 1.47 putative DNA-methyltransferase 
95 cD1408 ddIB 4.76E-02 - 4.70 D-alanine-D-alanine li ase B 
96 cD3477 4.83E-02 - 1.36 putative cytidine and deox c id late deaminase 
97 CD1803 4.86E-02 - 1.65 putative cell surface protein 
98 CD1690 trxA1 4.97E-02 - 1.86 thioredoxin 
Table 7.2 Genes with statistically downregulated expression after heat shock 
Logarithmic phase Cd630 were subjected to 42°C heat shock for 15 min and then RNA was 
extracted. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures (30°C). Statistically regulated genes were identified by an 
ANOVA test with 5% cut-off using Benjamini-Hochberg multiple testing correction. Regulated 
genes also statistically significant when Bonferroni correction was used are shown in bold italic 
text. 
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Appendix I- Microarray tables - Acid shock 
A Gene C 
name 
n P-value +/- ChFold ange 
Gene Product 
I CD1590 5.94E-07 + 6.06 putative membrane protein 
2 CD2462 rE 1.40E-05 + 3.12 heat shock protein 
3 cD2021 2.73E-05 + 6.59 1 hypothetkal protein 
4 CD1796 3.47E-05 + 2.05 putative nitrite and sulfite reductase subunit 
5 cD2022 8.76E-05 + 7.33 hypothetical protein 
6 CD2020 cl B 9.62E-05 + 4.54 chaperone 
7 CD3284 1.54E-04 + 6.92 probable protease 
8 cD0025 1.69E-04 + 5.34 putative ATP: uanido phosphotransferase 
9 cDO193 groES 1.86E-04 + 3.12 10 kDa chaperonin 
10 cD2461 dnaK 4.74E-04 + 2.71 chaperone protein 
11 CD0024 5.97E-04 + 5.59 putative DNA repair protein 
12 cD0825 rbr 9.85E-04 + 6.14 rubrerythrin 
13 CD0192 c/s 1.30E-03 + 1.88 cardioli in synthetase 
14 CD0400 etfB1 2.12E-03 + 1.93 electron transfer flavoprotein -subunit 
15 CDO026 CI PC 2.72E-03 + 4.19 ATP-dependent Clp protease 
16 cD0574 thrS 3.18E-03 + 1.85 threonyl-tRNA synthetase 
17 cD1943 3.28E-03 + 2.63 conserved hypothetical protein 
18 cD0027 radA 3.32E-03 + 2.06 DNA repair protein 
19 CD1184 fabF 3.33E-03 + 1.41 3-oxoac l- ac l-carrier- rotein synthase II 
20 cD1822 bcp 3.35E-03 + 2.13 Putative thiol peroxidase 
(bacterioferritin 
comi rato protein) 
21 CDO194 roEL 4.55E-03 + 2.36 60 kDa chaperonin 
22 CD3610 4.58E-03 + 2.01 putative glyoxalase 
23 cD0398 fldC 5.16E-03 + 2.05 R-phenyllactate dehydratase small subunit 
24 CD1692 7.41 E-03 + 2.17 
ER-family 
transcriptional regulator 
B Gene Commo 
name 
n P-value +1- Chold Gene Product 
1 cD1573 4.07E-04 - 100.00 putative transcriptional regulator 
2 cD2831 4.27E-03 - 1.27 putative surface-anchored membrane protein 
3 Co1927 4.43E-03 - 1.67 i 
ABC transporter, ATP-binding protein 
(pseudogene) 
4 CD0999 5.09E-03 - 99.92 ABC transporter, substrate-binding lipoprotei 
5 CD2668 IicT 7.51 E-03 - 2.17 putative transcription antiterminator 
Table 7.3 Genes with statistically altered expression after acid shock 
Logarithmic phase Cd630 were subjected to acidic pH shock for 15 min and then RNA was 
extracted. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically upregulated (A) and downregulated (B) genes were 
identified by an ANOVA test with 1% cut-off using no multiple testing correction. Regulated 
genes also statistically significant using a 5% cut-off and Benjamini-Hochberg multiple testing 
correction are shown in bold italic text. 
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Appendix I- Microarray tables - Alkali shock upregulation 
Gene Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
1 cD2767 6.78E-04 + 1.73 putative cell surface protein 
2 c02172 1.08E-03 + 2.14 probable amino-acid 
ABC transporter, 
ATP-binding protein 
3 cD1027 potD 1.30E-03 + 5.02 spermidine/putrescine 
ABC transporter, 
substrate-binding lipoprotein 
4 cD3036 1.82E-03 + 1.66 proton-de endent oli oe tide transporter 
5 CD2174 2.04E-03 + 3.36 probable amino-acid 
ABC transporter, 
substrate-binding protein 
6 cD1161 rp/U 2.06E-03 + 2.01 50S ribosomal protein L21 
7 CD2173 2.12E-03 + 1.68 putative peptidase 
8 CD2547 2.31 E-03 + 1.59 conserved hypothetical protein 
9 CD1838 aroK 2.34E-03 + 8.26 shikimate kinase 
10 cD2363 2.53E-03 + 1.75 hypothetical protein 
11 CD0524 3.08E-03 + 1.35 putative peptidase 
12 cD3662 ssb 3.25E-03 + 2.01 single-strand binding protein 
13 CD1453 3.44E-03 + 1.79 
putative chorismate biosynthesis-related protein: 
phospho-2-dehydro-3-deoxyheptonate aldolase 
and chorismate mutase 
14 cD2010 erm(B)1 3.49E-03 + 1.88 rRNA adenine 
N-6-methyltransferase 
(erythromycin resistance protein) 
15 cD0064 rpIL 3.71 E-03 + 2.10 50S ribosomal protein L7/L12 
16 CD2473 rpsT 4.95E-03 + 2.17 30S ribosomal protein S20 
17 CD1304 5.20E-03 + 2.45 putative mannosyl-glycoprotein 
endo-ß-N-acetylglucosam idase 
18 CD2193 5.25E-03 + 2.57 putative cell surface protein 
19 co2783 5.53E-03 + 2.01 putative gl cos ltransferase 
20 cD0400 etfB1 5.54E-03 + 1.88 electron transfer flavoprotein -subunit 
21 CD2801 5.69E-03 + 1.77 putative protein translocase subunit 
22 CD2367 5.75E-03 + 1.84 putative permease 
23 cD0889 speD 5.90E-03 + 1.84 S-adenosylmethionine decarboxylase proenzyme 
24 cD0891 speB 6.12E-03 + 2.41 putative agmatinase 
25 cD3284 7.29E-03 + 1.94 probable protease 
26 CD1550 hisB 7.39E-03 + 4.53 imidazole I cerol- hos hate dehydratase 
27 cD0874 7.44E-03 + 1.92 ABC transporter, ATP-binding protein 
28 CD2005 7.89E-03 + 1.78 conserved hypothetical protein 
29 CDO737 hisK 8.65E-03 + 1.81 putative histidinol phosphatase 
30 cD1751 8.67E-03 + 4060 putative cell surface-associated cysteine protease 
31 cD0890 speE 8.78E-03 + 3.93 s ermidine synthase 
32 cD0198 guaA 9.33E-03 + 1.50 GMP synthase lutamine-h drol in 
33 cD1548 hisG 9.86E-03 + 3.40 putative ATP hos horibos ltransferase 
Table 7.4 Genes with statistically upregulated expression after alkali shock 
Logarithmic phase Cd630 were subjected to alkaline pH shock for 15 min and then RNA was 
extracted. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically regulated genes were identified by an ANOVA test 
with 1% cut-off using no multiple testing correction. 
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Appendix I- Microarray tables - Alkali shock downregulation 
Gene 
- r 
name 
ommon P-value +l- 
Fold 
Change Gene Product 
1 co2597 IspA 8.91 E-04 - 1.99 lipoprotein signal peptidase 
2 co0370 1.67E-03 - 43.1 putative transcriptional regulator 
3 co2451 2.59E-03 - 94.44 probable ATP-dependent helicase 
4 cD3066 xyIR 3.94E-03 - 1.37 xylose repressor 
5 cD0969 4.95E-03 - 2.37 hypothetical phage protein 
6 cD0966 5.89E-03 - 1.95 putative phage tail fiber protein 
7 CD1796 7.90E-03 - 1.40 putative nitrite and sulfite reductase subunit 
8 Co2890 8.07E-03 - 1.71 hypothetical phage protein 
9 Co0384 8.78E-03 - 28.9 con u ative transposon protein 
0 TcoO140 9.52E-03 - 7.68 putative peptidase 
Table 7.5 Genes with statistically downregulated expression after alkali shock 
Logarithmic phase Cd630 were subjected to alkaline pH shock for 15 min and then RNA was 
extracted. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically regulated genes were identified by an ANOVA test 
with I% cut-off using no multiple testing correction. 
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Appendix 1- Microarray tables - Oxygen shock upreguºation 
Gene Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
I cD0703 8.64E-07 + 3.64 protease 
2 CD1822 bcp 1.76E-06 + 2.61 putative thiol peroxidase (bacterioferritin 
com/ rato protein) 
3 cD2476 1.25EE05 + 4.25 conserved hypothetical protein 
4 cD2797 1.41E-05 + 2.09 putative exported protein 
5 CD0580 gapN 3.40E-05 + 2.63 NADP-dependent g/yceraldehyde-3- hoshate deh dro enase 
6 CD0053 4.18E-05 + Z72 conserved hypothetical protein 
7 CD0565 nth 4.88E-05 + 2.15 endonuclease l/l 
8 cD2993 7.83E-051 + 2.76 conserved hypothetical protein 
9 cD3467 at C 1.23E-04 + 2.05 TP s nthase e chain (partial) 
10 cD3610 1.28E-04 + 2.16 putative glyoxalase 
11 CD1943 1.39E-04 + 2.34 conserved hypothetical protein 
12 CD2796 1.55E-04 + 1.90 putative cell surface protein 
13 cD1157 norV 1.70E-04 + 2.39 putative anaerobic nitric oxide reductase flavorubredoxin 
14 cD3271 1.73E-04 + 4.10 h othetical protein 
15 CD1463 1.93E-04 + 3.10 putative membrane protein 
16 cD1690 trxA1 2.09E-04 + 2.44 thioredoxin 
17 cD0561 2.32E-04 + 2.10 putative aldo/keto reductase 
18 CD1622 2.41E-04 + 1.75 putative lipoprotein 
19 cD1125 2.60E-04 + 4.79 nitroreductase-family protein 
20 cD3324 2.88E-04 + 3.04 conserved hypothetical protein 
21 cD0726 3.05E-04 + 2.24 putative carbon monoxide dehydrogenase/ 
acetyl-CoA synthase complex, a subunit 
22 CD1897 3.23E-04 + 2.91 hypothetical protein 
23 CD2603 3.49E-04 + 1.67 putative response regulator 
24 CD3040 4.33E-04 + 2.51 conserved hypothetical protein 
25 cD1778 4.41 E-04 + 1.70 conserved hypothetical protein 
26 cD0351 4.87E-04 + 2.99 hypothetical protein 
27 CD1526 pyrC 4.91 E-04 + 1.37 dihydroorotase 
28 cD0176 5.38E-04 + 2.50 putative oxidoreductase, NAD/FAD binding 
subunit 
29 cD2117 trxB2 5.99E-04 + 3.06 t hioredoxin reductase 
30 cD0350 6.21 E-04 + 2.08 conserved hypothetical protein 
31 cD0675 6.31 E-04 + 1.61 putative acetyltransferase 
32 CD3408 6.71 E-04 T + 1.52 utative DNA mismatch repair protein 
33 CD2046 6.94E-04 + 4.58 h ypothetical protein 
34 
- 
CD2064 7.47E-04 + 3.12 h ypothetical protein T5 73 1.03E-03 + 1.73 utative membrane protein 
36 cD3609 1.03E-03 + 3.45 h ypothetical protein 
37 CD3614 1.26E-03 + 3.05 c onserved hypothetical protein 
38 cD0228 fliN 1.50E-03 + 2.21 fl agellar motor switch protein 
39 cD1485 1.60E-03 + 3.14 c onserved hypothetical protein 
40 CD1624 vanR 1.63E-03 + 1.84 t wo-component response regulator 
41 CD3272 1.73E-03 + 1.49 p utative membrane protein 
42 cD3039 1.77E-03 + 2.01 c onserved hypothetical protein 
43 CD3473 atpE 1.78E-03 + 1.54 A TP synthase C chain 
CD 1576 1.82E-03 + 1.50 p utative arylesterase L 
CD1200 1 . 94E-03 + 
2.83 c onserved h othetical protein 
46 cD05661 
_I 
2 
. 30E-03 + 1.89 p utative RNA meth lase 
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Gene Commo 
name 
n P-value +- ChFold ange 
Gene Product 
47 cD2006 2.41 E-03 + 1.87 putative topoisomerase (partial) 
48 cD0147 2.44E-03 + 1.67 putative membrane protein 
49 CD2057 2.47E-03 + 1.80 conserved hypothetical protein 
50 cD2478 2.53E-03 + 1.86 metallo ß-lactamase superfarnily lipoprotein 
51 CD3307 2.86E-03 + 1.60 putative phosphoesterase 
52 CD0710 2.92E-03 + 2.24 putative membrane protein 
53 CD3311 2.92E-03 + 2.65 conserved hypothetical protein 
54 CD3310 3.06E-03 + 2.38 putative D-isomer specific 2-hydroxyacid deh dro enase 
55 cD1341 exoA 3.08E-03 + 1.89 putative exodeoxyribonuclease 
56 CD3409 hprK 3.10E-03 + 1.51 HPr(Ser) kinase/ hos ho lase 
57 cD3042 3.19E-03 + 1.44 putative membrane protein 
58 cD2195 3.25E-03 + 1.92 ferritin 
59 CD1738 3.55E-03 + 802.63 two-component sensor histidine kinase 
60 cD2310 cspD 3.61 E-03 + 2.34 cold shock protein 
61 CD1694 3.83E-03 + 1.54 hypothetical protein 
62 CD1222 xerD1 3.83E-03 + 1.48 putative tyrosine recombinase 
63 co2048 4.04E-03 + 1.38 RpiR-famil transcriptional regulator 
64 co1524 4.11 E-03 + 2.87 putative rubrerythrin 
65 CD0729 gcvH 4.13E-03 + 1.96 putative gl cine cleavage system H protein 
66 CD1201 nusB 4.33E-03 + 1.74 N utilisation substance protein B 
67 cD1623 4.41 E-03 + 2.72 putative nitric oxide reductase flavoprotein 
68 co1944 4.45E-03 + 1.57 conserved hypothetical protein 
69 CD3410 uvrC 4.60E-03 + 1.93 excinuclease ABC subunit C 
70 cD3308 r ph 4.80E-03 + 1.57 ribonuclease Ph 
71 co2165 4.89E-03 + 1.40 conserved hypothetical protein 
72 cD1062 acpP 5.39E-03 + 1.94 ac l carrier protein 
73 cD1818 ispH 5.59E-03 + 1.86 
I putative 4-hydroxy-3-methylbut-2-enyl 
diphosphate reductase 
74 cD2691 hpt 5.69E-03 + 1.74 putative hos horibos ltransferase 
75 co3291 5.86E-03 + 1.87 putative exported protein 
76 CD1590 6.28E-03 + 1.49 utative membrane protein 
77 CD1055 etfB2 6.62E-03 + 3.61 electron transfer flavoprotein -subunit 
78 CD1821 tlpB 6.75E-03 + 1506.98 transposase-like protein B 
79 cD3038 6.90E-03 + 4.94 conserved hypothetical protein 
80 cD1691 trxB1 6.93E-03 + 2.44 thioredoxin reductase 
81 CD2067 6.96E-03 + 1.92 putative exported protein 
82 cD0560 nfo 6.99E-03 + 2.11 endonuclease IV 
83 CD1571 tipA 7.36E-03 + 1.36 trans osase-like protein A 
84 cD0229 flgM 7.47E-03 + 1.63 
l negative regulator of flagellin synthesis 
(anti-sigma-D factor 
85 cD0733 7.73E-03 + 1.80 putative biotin/li oate- rotein ligase 
86 -co-2761 8.08E-03 + 1.44 putative N-acet lmuramo I-L-alanine amidase 
87 cD0574 thrS 8.20E-03 + 1.92 threon l-tRNA s nthetase 
88 CD1779 8.32E-03 + 1.57 conserved hypothetical protein 
89 cD0704 8.52E-03 + 2.16 putative hos hoh drolase 
90 CD0694 8.65E-03 + 1.61 TetR-farnily transcriptional regulator 
91 CD1679 8.77E-03 + 1.54 utative flavodoxin 
92 cD2365 8.91 E-03 + 1.70 s 
putative sulfonate ABC transporter, 
olute-binding lipoprotein 
93 co1478 feoA1 9.13E-03 + 2.17 putative ferrous iron transport protein A 
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Gene Commo 
name 
n P-value +1- ChaFold nge 
Gene Product 
94 CD1459 9.24E-03 + 1.89 putative 5-nitroimidazole reductase 
95 cDO192 cis 9.27E-03 + 1.58 cardiolipin synthetase 
96, CD2796 9.36E-03 + 1.76 putative cell surface protein 
97 CD0175 9.91 E-03 + 1.81 putative oxidoreductase, electron transfer subunit 
98 CD1163 rpmA 9.97E-03 + 1.75 50S ribosomal protein L27 
Table 7.6 Genes with statistically upregulated expression after oxygen shock 
Logarithmic phase Cd630 were exposed to atmospheric oxygen and then incubated for a further 
10 min before RNA was extracted. Competitive RNA-DNA microarrays were carried out, and 
gene expression was compared to control cultures. Statistically regulated genes were identified 
by an ANOVA test with 1% cut-off using no multiple testing correction. Regulated genes also 
statistically significant using a 5% cut-off and Benjamini-Hochberg multiple testing correction 
are shown in bold italic text. 
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Appendix 1- Microarray tables - Oxygen shock downregulation 
Gene Commo 
name 
n P-value +I- ChFold ange 
Gene Product 
1 CD3180 pbuX 9.19E-04 - 1.93 xanthine permease 
2 cD2469 spoliP 1.49E-03 - 1.59 putative stage II sporulation protein P 
3 CD2285 1.62E-03 - 1.83 GntR-family transcriptional regulator 
4 CD3200 2.35E-03 - 1.61 putative ABC transporter, permease protein 
5 CD3182 2.93E-03 - 2.06 o-aminoac lase 
6 cD0948 3.19E-03 - 1.50 putative phage major capsid protein 
7 CD1698 ribA 3.93E-03 - 1.46 riboflavin biosynthesis protein 
8 cD2865 4.08E-03 - 2.27 putative bacterioferritin 
9 CD2732 4.12E-03 - 1.71 putative sigma-54-interacting regulatory protein 
10 cD1508 4.16E-03 - 2.04 putative iron-sulfur cluster-binding protein 
11 CD3620 4.60E-03 - 1.20 hypothetical protein 
12 cD0529 4.93E-03 - 2.07 putative membrane protein 
13 cD1297 5.56E-03 - 1.48 putative membrane protein 
14 E0391 5.56E-03 - 1.61 asparagine synthetase glutamine-h drol sing 
15 003116 bglF 6.07E-03 - 1.63 
PTS system, ß-glucoside-specific Ilabc 
component 
16 cD0388 bglP 6.31 E-03 - 1.86 
PTS system, ß-glucoside-specific Ilabc 
component 
17 cD0424 6.54E-03 - 1.81 putative single-strand binding protein 
18 cD1258 7.39E-03 - 1.40 putative GTPase 
19 co0301 rbsA 7.68E-03 - 2.15 ribose ABC transporter, ATP-binding protein 
20 CD2727 7.89E-03 - 1.29 putative membrane protein 
21 cD0935 7.89E-03 - 1.59 phage modification meth lase 
22 CD2831 8.69E-03 - 1.48 putative surface-anchored membrane protein 
23 cD3191 8.83E-03 - 1.40 putative oxidoreductase 
24 cD 3310 rbfA 9.04E-03 - 1.57 ribosome-binding factor A 
25 CD3371 9.64E-03 - 2.04 conjugative transposon protein 
26 co2570 9.80E-03 - 1.46 -component sensor histidine kinase 
Table 7.7 Genes with statistically downregulated expression after oxygen shock 
Logarithmic phase Cd630 were exposed to atmospheric oxygen and then incubated for a further 
10 min before RNA was extracted. Competitive RNA-DNA microarrays were carried out, and 
gene expression was compared to control cultures. Statistically regulated genes were identified 
by an ANOVA test with 1% cut-off using no multiple testing correction. 
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Gene Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
1 CD0099 rp/Q 7.41E-04 + 2.73 50S ribosomal protein L17 
2 CD0458 2.88E-03 + 11.70 putative -lactamase 
3 CD0085 rpsH 3.39E-03 + 5.54 30S ribosomal protein S8 
4 CD0072 rpsJ 3.39E-03 + 4.35 30S ribosomal protein S10 
5 cD2791 3.39E-03 + 3.28 putative S-layer protein precursor 
6 CD3666 3.39E-03 + 3.05 conserved hypothetical protein 
7 cD2368 3.39E-03 + 3.45 hypothetical protein 
8 CD3495 3.39E-03 + 2.63 putative RNA-binding protein 
9 CD1800 3.39E-03 + 2.01 tellurium resistance protein 
10 CD0073 r /C 3.39E-03 + 6.01 50S ribosomal protein L3 
11 CD0063 rplJ 3.39E-03 + 4.89 50S ribosomal protein L10 
12 CD0075 rp1W 3.39E-03 + 3.76 50S ribosomal protein L23 
13 co1765 3.39E-03 + 1.97 Nudix-family h drolase 
14 CDO130 metK 3.39E-03 + 2.25 S-adenosylmethionine synthetase 
15 CD0127 mreB1 3.39E-03 + 2.62 rod shape-determining protein 
16 003099 3.39E-03 + 2.52 putative amidohydrolase 
17 CD0095 rpsM 3.39E-03 + 4.46 30S ribosomal protein S13 
18 CD0345 3.39E-03 + 1.84 putative guanosine 3', 5'-bis-pyrophosphate (ppGpp) synthesis/degradation protein 
19 cD0266 fliA 3.39E-03 + 2.50 RNA polymerase sigma factor for flagellar operon 
20 CD0198 guaA 3.39E-03 + 2.59 GMP synthase lutamine-h drol sin 
21 cD1291 dacF 3.39E-03 + 1.53 D-alanyl-D-alanine carboxypeptidase (penicillin-binding protein) 
22 cD0078 rp/V 3.39E-03 + 4.37 50S ribosomal protein L22 
23 CD1683 3.39E-03 + 3.73 putative membrane protein 
24 CD0090 secY 3.39E-03 + 4.54 pre rotein translocase SecY subunit 
25 CD3041 pepl 3.39E-03 + 1.78 proline imino e tidase 
26 CD 1143 maf 3.39E-03 + 4.43 septum formation protein 
27 cD0086 rplF 3.39E-03 + 4.51 50S ribosomal protein L6 
28 CD0091 adk 3.59E-03 + 5.33 adenylate kinase 
29 co0093 3.97E-03 + 4.73 putative ribosomal protein 
30 co0743 3.98E-03 + 2.81 DeoR-family transcriptional regulator 
31 CD0083 r /X 3.98E-03 + 4.57 50S ribosomal protein L24 
32 co0082 rpIN 4.15E-03 + 5.03 50S ribosomal protein L14 
33 CD1684 4.15E-03 + 3.63 radical SAM-superfamily protein 
34 cD1768 4.15E-03 + 2.61 putative membrane protein 
35 CD0062 rp/A 4.15E-03 + 4.20 50S ribosomal protein L1 
36 cD0675 4.15E-03 + 2.04 putative acetyltransferase 
37 cD1144 radC 4.35E-03 + 5.24 DNA repair protein 
38 CD0096 rpsK 4.37E-03 + 4.98 30S ribosomal protein S11 
39 cD1838 aroK 4.75E-03 + 2.83 shikimate kinase 
40 CD0069 rpsG 4.75E-03 + 4.78 30S ribosomal protein S7 
41 cD0737 hisK 4.78E-03 + 4.13 putative histidinol phosphatase 
42 cD3479 upp 4.86E-03 + 3.17 uracil hos horibos ltransferase 
43 CD2550 4.86E-03 + 2.70 
1p putative sugar transporter, substrate-binding 
rotein 
44 c03665 4.94E-03 + 3.40 c onserved hypothetical protein 
45 CD0333 ppaC 4.98E-03 + 2.29 
manganese-dependent inorganic 
ro hos hatase 
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46 CD0269 5.07E-03 + 2.64 putative flagellar basal-body rod protein 
47 cD0074 rpID 5.42E-03 + 5.26 50S ribosomal protein L4 
48 CD0088 rpsE 5.42E-03 + 4.67 30S ribosomal protein S5 
49 CD0263 flhA 5.42E-03 + 2.43 flagellar export protein 
50 CD0738 5.42E-03 + 2.66 putative exported protein 
51 CDO080 rpIP 5.42E-03 + 4.32 50S ribosomal protein L16 
52 CD2053 lysA 5.42E-03 + 2.12 diamino imelate decarboxylase 
53 cD3498 spoVB 5.42E-03 + 2.07 stage V sporulation protein B 
54 CD0561 5.49E-03 + 1.68 putative aldo/keto reductase 
55 CD2722 5.49E-03 + 3.58 two-component response regulator 
56 CD2787 cwp84 5.49E-03 + 2.69 putative cell surface-associated cysteine protease 
57 CD3173 pgK 5.49E-03 + 2.70 phosphogl cerate kinase 
58 cD3172 t iA 5.49E-03 + 2.77 triose hos hate isomerase 
59 CD1279 iscS2 5.49E-03 + 2.37 cysteine desulphurase 
60 CD1722 5.49E-03 + 4.39 putative transcriptional regulator 
61 cD2495 seIA 5.49E-03 + 1.69 
L-seryl-tRNA(Sec) selenium transferase 
(selenocysteinyl-tRNA(Sec) synthase) 
62 CD1183 acpP 5.49E-03 + 2.94 ac I carrier protein 
63 CDO084 rp/E 5.70E-03 + 4.84 50S ribosomal protein L5 
64 cD1177 fapR 5.70E-03 + 3.26 
DeoR-family transcriptional regulator (fatty acid 
and phospholipid biosynthesis regulator) 
65 cD3355 5.70E-03 + 1.66 putative nitroreductase 
66 Co1124 5.70E-03 + 1.99 h pothetical protein 
67 Co3669 5.70E-03 + 2.12 putative exported protein 
68 CD0098 rpoA 5.70E-03 + 3.37 DNA-directed RNA polymerase a chain 
69 CD0986 5.70E-03 + 2.35 putative 30S ribosomal protein SI 
70 CD0087 rpIR 5.70E-03 + 3.13 50S ribosomal protein L18 
71 ED3483 5.70E-03 + 1.92 putative zinc transporter 
72 CD1937 accD 5.71 E-03 + 2.74 acetyl-coenzyme 
A carboxylase carboxyl 
transferase subunit 
73 7D3662 ssb 5.88E-03 + 4.78 single-strand binding protein 
74 CD2322 tkt 5.89E-03 + 3.53 transketolase 
75 CD3398 5.89E-03 + 1.84 putative 
DNA repair protein (nucleotide 
ro hos hatase 
76 cD2736 6.05E-03 + 1.84 LysR-family transcriptional regulator 
77 CD1953 6.05E-03 + 2.34 conserved hypothetical protein 
78 CD2068 6.05E-03 + 2.31 ABC transporter, ATP-binding protein 
79 CD3659 6.11 E-03 + 1.88 putative RNA/single-stranded DNA exonuclease 
80 CD0061 rpIK 6.11 E-03 + 4.86 50S ribosomal protein L11 
81 cD2618 6.18E-03 + 2.67 isoleucyl-tRNA synthetase 
82 002654 mraY 6.18E-03 + 1.88 
phospho-N-acetylmuramoyl-pentapeptide- 
transferase 
83 CD2670 appF 6.18E-03 + 2.85 oli oe tide ABC transporter, ATP-binding protein 
84 Co1682 iunH 6.18E-03 + 3.55 inosine-uridine preferring nucleoside hydrolase 
85 CDO076 rplB 6.18E-03 + 4.40 50S ribosomal protein L2 
86 CD1147 6.18E-03 + 3.40 putative membrane protein 
87 CD1153 mgsA 6.18E-03 + 2.26 meth I oxal synthase 
8 CD0873 6.18E-03 + 2.86 ABC transporter, substrate-binding lipoprotein 
gg CD0066 rpoB 6.18E-03 + 2.60 DNA-directed RNA polymerase chain 
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90 CD2367 6.19E-03 + 2.42 putative permease 
91 cDO077 rpsS 6.19E-03 + 5.22 30S ribosomal protein S19 
92 cD3677 jag 6.19E-03 + 2.83 S ollIJ-associated protein 
93 CDO081 rpsQ 6.19E-03 + 3.60 30S ribosomal protein S17 
94 CD1181 fabD 6.19E-03 + 4.14 malonyl CoA-ac l carrier protein transacylase 
95 cD2491 mi 6.19E-03 + 1.74 mannose-6- hos hate isomerase 
96 CD0549 6.21 E-03 + 2.57 putative exported protein 
97 co0067 rpoC 6.21 E-03 + 2.98 DNA-directed RNA polymerase P' chain 
98 CD3527 6.21 E-03 + 1.80 putative iron ABC transporter, ATP-binding protein 
99 cD2715 gtaB 6.55E-03 + 1.89 UTP lucose-1-phosphate urid I ltransferase 
100 CD3497 6.68E-03 + 3.02 
putative bifunctional protein: tetrapyrrole 
(corrin/porphyrin) methylase; nucleoside 
tri hos hate ro hos hoh drolase 
101 CD1527 6.89E-03 + 2.56 ABC transporter, permease protein 
102 cD1494 6.89E-03 + 2.94 putative transcriptional regulator 
103 co0068 rpsL 6.89E-03 + 4.11 30S ribosomal protein S12 
104 cD3170 eno 6.96E-03 + 5.00 enolase 
105 cD0097 rpsD 7.00E-03 + 4.65 30S ribosomal protein S4 
106 cD2662 7.00E-03 + 1.65 putative GTP-binding protein 
107 CD2791 7.00E-03 + 3.21 putative S-layer protein precursor 
108 cD3171 gpml 7.00E-03 + 3.12 
2,3-bisphosphoglycerate-independent 
phosphoglycerate mutase 
109 cD1975 miaA 7.00E-03 + 2.11 tRNA A -isopenten I ro hos hate transferase 
110 cD1496 7.00E-03 + 2.59 putative exported protein 
111 co0071 NO 7.00E-03 + 4.62 elongation factor TU 
112 CD1145 mreB2 7.12E-03 + 4.76 rod shape-determining protein 
113 CD3089 7.14E-03 + 1.74 PTS system, Ilabc component 
114 CD1251 ftsY 7.14E-03 + 3.95 putative signal recognition particle 
115 cD3514 prsA 7.21 E-03 + 2.08 ribose-phosphate p ro hos hokinase 
116 652726 gl A 7.21 E-03 + 3.13 putative serine h drox meth ltransferase 
117 C7D3661 7.21 E-03 + 2.04 conserved hypothetical protein 
118 CD1176 7.21 E-03 + 3.62 conserved hypothetical protein 
119 CD1054 bcd2 7.21 E-03 + 2.31 butyryl-CoA dehydrogenase 
120 cD1459 7.21 E-03 + 2.06 putative 5-nitroimidazole reductase 
121 co1547 hisZ 7.21 E-03 + 2.13 Putative 
ATP phosphoribosyltransferase 
regulatory subunit 
122 CD2655 murF 7.33E-03 + 1.97 
UDP-N-acetylmuramoyl-tripeptide-D-alanyl- 
o-alanine ligase 
123 CD0029 7.42E-03 + 2.33 utative membrane protein 
124 CD0059 secE 7.42E-03 + 2.46 preprotein translocase SecE subunit 
125 cD1836 pheA 7.42E-03 + 2.77 
P-protein: chorismate mutase; prephenate 
deh dratase 
126 col 152 mrdB 7.42E-03 + 2.06 rod shape-determining protein rod shape- determinin protein 
127 
128 
CDO706 
cD0547 
7.42E-03 
7.42E-03 
+ 
+ 
2.21 
1.91 
utative reductase 
putative penicillin-binding rotein repressor 
129 CD0729 gcvH 7.53E-03 + 1.54 putative glycine cleavage system H protein 
130 CD0403 fba 7.53E-03 + 1.94 putative fructose-bisphosphate aldolase 
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I CD1026 potC 7.53E-03 + 3.36 putative sperm id ine/putrescine ABC transporter, permease protein 
z cD1497 7.55E-03 + 2.58 hypothetical protein 
3 CD2673 appB 7.59E-03 + 1.87 oli oe tide ABC transporter, permease protein 
t CD0258 flL 7.59E-03 + 3.09 flagellar basal body-associated protein 
5 cD1184 fabF 7.59E-03 + 4.15 3-oxoac l- ac l-carrier- rotein synthase II 
3 CD1282 alaS 7.62E-03 + 3.71 putative alanyl-tRNA synthetase 
r" cD2119 thrB 7.62E-03 + 1.67 homoserine kinase 
3 cD2547 7.62E-03 + 2.34 conserved hypothetical protein 
) cD0331 ppiB 7.65E-03 + 1.77 e tid l-roll cis-trans isomerase 
CD1156 7.90E-03 + 2.83 putative exported protein 
co3496 hupA 7.90E-03 + 3.12 DNA-bind in protein HU 
CD2362 7.90E-03 + 1.98 putative aliphatic sulfonates ABC transporter, 
permease protein (pseudogene) 
CD3471 atpH 7.91 E-03 + 2.95 ATP synthase subunit b 
CD0548 7.91 E-03 + 1.88 putative penicillin-binding protein 
CD1720 cD1718 7.91 E-03 + 2.15 putative h dantoinase 
CD1151 minE 7.91 E-03 + 2.47 cell division topological specificity factor 
cD2695 asnA 7.91 E-03 + 1.64 aspartate-ammonia ligase 
{ cD0422 7.91 E-03 + 1.66 conserved hypothetical protein 
cD2028 racX 7.91 E-03 + 1.51 probable amino acid racemase 
cD0230 8.06E-03 + 2.05 putative flagellar biosynthesis protein 
CD1837 aroE 8.08E-03 + 2.70 shikimate deh dro enase 
CD2853 ditA 8.08E-03 + 1.98 D-alanine-poly(phosphoribitol) ligase subunit 1 (D-alanine-activating enzyme) 
CD2360 8.08E-03 + 2.05 h othetical protein 
cD2366 8.08E-03 + 2.52 putative exported protein 
CD2613 8.16E-03 + 3.37 probable peptidase 
cD1939 acc6 8.18E-03 + 2.06 biotin carboxyl carrier protein of acetyl-CoA 
carbox lase 
cD2067 8.18E-03 + 1.66 putative exported protein 
CDO104 
co3306 
r IM 
fig 
8.18E-03 
8.18E-03 
+ 
+ 
2.32 
3.23 
50S ribosomal protein L13 
trig er factor 
CD0273 htpG 8.23E-03 + 3.05 chaperone protein (heat shock protein) 
cD0248 fliF 8.23E-03 + 2.88 I flagellar Wring protein 
CD3480 rpiB2 8.26E-03 + 2.74 ribose-5- hosphate isomerase 2 
cD0667 cdd4 8.35E-03 + 2.26 
1 putative lantibiotic ABC transporter, ATP-binding 
protein 
cD2006 CD2006A 8.37E-03 + 3.08 conserved plasmid h othetical protein 
cD1896 8.40E-03 + 2.05 putative lipoprotein 
cD2784 8.40E-03 + 2.50 putative cell surface protein 
cD2792 secA2 8.40E-03 + 3.08 pre protein translocase SecA subunit 
701160 cafA 8.40E-03 + 1.66 ribonuclease g 
CD3515 g/mU 8.40E-03 + 1.46 
bifunctional protein: UDP-N- acetylglucosamine 
pyrophosphorylase; glucosamine-1-phosphate 
N-acetyltransferase 
CD1148 8.40E-03 + 3.27 putative penicillin-binding protein 
cD2058 8.40E-03 + 1.90 putative exported protein 
CD2776 8.40E-03 + 1.71 p utative glycosyl transferase 
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173 cD0265 fleN 8.40E-03 + 2.35 flagellar number regulator 
174 cD3394 ykF 8.40E-03 + 2.70 pyruvate kinase 
175 cD2319 rpe 8.63E-03 + 1.87 putative ribulose- hos hate 3-epimerase 
176 cD3407 hymC 8.63E-03 + 1.81 putative iron-only h dro enase, catalytic subunit 
177 cD0758 pifA 8.63E-03 + 2.16 p ruvate formate-lyase activating enzyme 
178 cD2220 8.63E-03 + 1.62 putative cAMP-binding regulatory protein 
179 CD3174 gapB 8.65E-03 + 4.05 gl ceraldeh e-3-phosp hate deh dro enase 2 
180 CDO736 8.65E-03 + 2.85 hypothetical protein 
181 cD2330 xpt 8.65E-03 + 2.50 xanthine phosphoribosyltransferase 
182 cD0212 8.65E-03 + 1.76 putative choline sulfatase 
183 cD1944 8.65E-03 + 1.99 conserved hypothetical protein 
184 cD2149 8.65E-03 + 3.67 putative exported protein 
185 cD1728 8.68E-03 + 3.00 conserved hypothetical protein 
186 cD0710 8.71 E-03 + 3.16 putative membrane protein 
187 cD2008 8.77E-03 + 3.30 putative plasmid replication protein 
188 cD2446 rpsU 8.86E-03 + 3.28 30S ribosomal protein S21 
189 cD0271 MN 8.86E-03 + 2.05 putative flagellar motor switch protein 
190 cD2561 8.86E-03 + 2.27 putative phosphatase 
191 cD2004 effR 8.86E-03 + 2.22 hypothetical protein 
192 cD0781 8.86E-03 + 1.83 penicillin-binding protein 
193 cD0003 8.86E-03 + 1.99 putative RNA-binding mediating protein 
194 CD1945 8.86E-03 + 1.74 putative gl oxalase 
195 cD0726 8.86E-03 + 2.03 putative carbon monoxide dehydrogenase/ 
acetyl-CoA synthase complex, a subunit 
196 cD2783 8.87E-03 + 2.87 putative gl cos ltransferase 
197 cD2781 mviN 8.97E-03 + 1.39 
. 
putative transmembrane virulence factor MviN 
family rotein 
198 CD3472 atpF 8.97E-03 + 2.62 ATP synthase B chain 
199 cD1639 8.97E-03 + 2.64 putative tellurite resistance protein 
200 CD0270 
- 
flits 8.97E-03 + 2.32 putative flagellar motor switch protein 
201 2549 FD 8.97E-03 + 1.74 putative sugar transporter, permease protein 
202 CD3091 treA 8.97E-03 + 1.75 trehalose-6- hos hate hydrolase 
203 CD2713 8.99E-03 + 2.12 cell surface rotein 
204 cD3559 ftsH2 8.99E-03 + 1.51 cell division protein 
205 cD0744 9.05E-03 + 2.77 putative chemotaxis protein 
206 cD0244 9.13E-03 + 2.37 putative 
CDP-glycerol: poly(glycerophosphate) 
glycerol-phosphotransferase 
207 CD3333 9.13E-03 + 2.05 conserved hypothetical protein 
208 CD2269 9.13E-03 + 2.68 PTS s stem, llbc component 
209 CD0239 fliC 9.13E-03 + 4.25 flagellin subunit 
210 cD0733 9.17E-03 + 2.88 putative biotin/li oate- rotein ligase 
211 CD3607 9.17E-03 + 1.73 conserved hypothetical protein 
212 CD1289 9.17E-03 + 2.09 metallo -lactamase su erfamil protein 
213 cD3678 spo111J 9.18E-03 + 2.16 putative sporulation membrane protein 
214 co2631 9.18E-03 + 1.50 p utative membrane protein 
215 C01180 fabK 9.18E-03 + 4.01 t rans-2-enoyl-ACP reductase 
216 cD1634 9.18E-03 + 2.81 t ellurium resistance protein 
217 cD2153 9.18E-03 + 2.43 c onserved hypothetical protein 
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218 cD2713 9.24E-03 + 2.65 cell surface protein 
219 CD1637 9.24E-03 + 2.93 putative calcium-transporting ATPase 
220 cD0262 MR 9.34E-03 + 2.13 flagellar export protein 
221 cD0711 argS 9.34E-03 + 3.81 ar in l-tRNA s nthetase 
222 CD1209 recN 9.39E-03 + 1.76 DNA repair protein 
223 CD0254 flgD 9.48E-03 + 2.73 putative basal-body rod modification protein 
224 cD3227 dapD 9.66E-03 + 1.87 
2,3,4,5-tetrahydropyrid ine-2,6-d icarboxylate 
N-succinyltransferase 
225 CD2653 murD 9.71 E-03 + 2.40 
UDP-N-acetylmuramoylalanine-D-glutamate 
ligase 
226 cD2626 9.81 E-03 + 3.05 conserved hypothetical protein 
227 CD3397 9.90E-03 + 2.31 conserved hypothetical protein 
228 cD1833 aroB 9.90E-03 + 2.70 3-deh dro uinate synthase 
229 CD1191 fbp 9.92E-03 + 1.85 putative fructose-1,6-bis hos hatase 
230 CD1635 9.92E-03 + 3.14 tellurium resistance protein 
Table 7.8 Genes with statistically upregulated expression after growth in the presence 
of amoxicillin 
Cd630 were grown in the presence of amoxicillin and RNA was extracted at mid-logarithmic 
phase. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically regulated genes were identified by an ANOVA test 
with 1% cut-off using Benjamini-Hochberg multiple testing correction. Regulated genes also 
statistically significant using a 1% cut-off and Bonferroni multiple testing correction are shown 
in bold italic text. 
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Gene Commo 
name 
n P-value +/- ChFold ange 
Gene Product 
I CD1873 vexP1 3.39E-03 - 3.43 ABC transporter, permease protein 
2 CD2399 3.39E-03 - 2.75 hypothetical protein 
3 cD1363 3.39E-03 - 3.61 putative phage protein 
4 cD2642 sigG 4.20E-03 - 3.12 RNA polymerase sigma-G factor 
5 cD2657 5.49E-03 - 2.51 putative membrane protein 
6 cD2429 5.49E-03 - 2.56 putative oxidoreductase subunit 
7 CD0624 6.18E-03 - 4.02 putative phage-related regulatory protein 
8 cD0367 6.55E-03 - 1.94 two-component system, sensor histidine kinase 
9 CD1848 7.21 E-03 - 2.98 putative conjugative transposon protein 
10 co0598 cotJC1 7.21 E-03 - 3.35 putative spore-coat protein 
11 CD2078 7.35E-03 - 4.65 putative amidohydrolase 
12 cD2629 s oIVA 7.35E-03 - 1.75 stage IV sporulation protein A 
13 CD3364 7.53E-03 - 2.73 ABC transporter, ATP-binding protein 
14 co3117 bg/G 8.08E-03 - 1.64 
putative ß-glucoside bgl operon transcription 
antiterminator 
15 cD0359 8.37E-03 - 1.99 
conjugative transposon conserved hypothetical 
protein 
16 cD2325 gatC 8.37E-03 - 2.40 PTS system, galactitol-specific lic component 
17 cD1604 8.37E-03 - 2.69 ABC transporter, ATP-binding protein 
18 cD1364 8.40E-03 - 2.95 putative phage protein 
19 cD0311 8.63E-03 - 2.22 hypothetical protein 
20 cD0467 8.63E-03 - 1.78 putative hydrolase 
21 cDO502 orf16 8.63E-03 - 2.44 
conjugative transposon ATP/GTP-binding 
protein 
22 cD1743 8.65E-03 - 5.03 two-component response regulator 
23 cD3077 8.68E-03 - 1.87 phosphosugar-binding transcriptional regulator 
24 FD0298 rbsR 8.73E-03 - 1.95 putative ribose operon repressor 
25 cD2304 8.86E-03 - 2.41 putative regulatory protein 
26 CD1658 gcvPB 8.86E-03 - 1.96 I cine cleavage system P protein 
27 CD0503 8.97E-03 - 2.87 conjugative transposon membrane protein 
28 CD2469 s oliP 8.97E-03 - 2.05 putative stage 11 sporulation protein P 
29 CD1117 9.13E-03 - 2.95 conserved hypothetical protein 
30 CD3216 9.18E-03 - 2.55 
putative osmoprotectant ABC transporter, 
substrate-bind in / ermease protein 
31 CD0956 9.34E-03 - 3.34 phage protein 
32 CD2898 9.66E-03 - 2.78 putative phage tail fiber protein 
33 cD2938 9.73E-03 - 1.50 hypothetical phage protein 
34 CD2839 9.97E-03 - 2.20 putative two-component system, kinase 
Table 7.9 Genes with statistically downregulated expression after growth in the 
presence of amoxicillin 
Cd630 were grown in the presence of amoxicillin and RNA was extracted at mid-logarithmic 
phase. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically regulated genes were identified by an ANOVA test 
with 1% cut-off using Benjamini-Hochberg multiple testing correction. Regulated genes also 
statistically significant using a 1% cut-off and Bonferroni multiple testing correction are shown 
in bold italic text. 
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9 
5 
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26 
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CD1765 1.50E-05 + 2.03 Nudix-famil hydrolase 
CD1545 1.65E-04 + 2.02 conserved hypothetical protein 
CD2110 fsaB 2.93E-04 + 1.77 fructose-6-phosphate aldolase 2 
cD2179 4.99E-04 + 1.85 putative oxidoreductase, molybdopterin-binding subunit 
CD2593 6.91 E-04 + 6.75 putative antibiotic resistance 
ABC transporter, 
ATP-binding protein 
CD3192 8.53E-04 + 1.66 putative cell surface protein 
CD0331 ppiB 1.26E-03 + 1.44 pe tidyl-prol l cis-trans isomerase 
CD0547 1.38E-03 + 1.64 putative penicillin-binding protein repressor 
cD3659 1.51 E-03 + 1.70 putative RNA/single-stranded DNA exonuclease 
001711 1.85E-03 + 2.36 conserved hypothetical protein 
c02136 uppS 1.85E-03 + 2.07 undecaprenyl pyrophosphate synthetase 
t CD1378 1.86E-03 + 2.08 putative phage regulatory protein 
f CD1644 1.95E-03 + 1.87 putative transcriptional regulator 
s CD2060 2.00E-03 + 1.47 conserved hypothetical protein 
CD 1722 2.03E-03 + 3.30 putative transcriptional regulator 
C52529 2.29E-03 + 1.67 conserved hypothetical protein 
003609 2.42E-03 + 2.48 hypothetical protein 
cD0667 cdd4 2.45E-03 + 1.53 putative 
lantibiotic ABC transporter, ATP-binding 
protein 
cD3333 2.66E-03 + 1.60 conserved hypothetical protein 
CD2761 2.71 E-03 + 1.52 putative N-acetylmuramoyl-L-alanine amidase 
CD2067 2.72E-03 + 1.64 putative exported protein 
CDO127 mreB1 3.02E-03 + 1.69 rod sha e-determining protein 
CD3661 3.09E-03 + 1.81 conserved hypothetical protein 
CD1286 3.61 E-03 + 1.43 conserved hypothetical protein 
CD0540 3.73E-03 + 2.37 chemotaxis protein 
cD2017 3.91 E-03 + 1.93 putative phage regulatory protein 
c02383 3.95E-03 + 1.73 putative sigma-54 interacting regulatory protein 
CD1868 4.03E-03 + 1.76 conjugative transposon conserved hypothetical rotein 
000705 4.24E-03 + 1.69 putative DNA repair protein 
CD2063 4.38E-03 + 1.30 putative membrane protein 
_01718 4.86E-03 + 1.65 putative h dantoinase 
CD1355 cspB 4.94E-03 + 1.75 putative cold shock protein 
CD3495 5.09E-03 + 2.12 putative RNA-bindin protein 
CD0392 5.23E-03 + 2.59 Radical SAM-superfamily protein 
CD3660 5.70E-03 + 1.74 putative membrane protein 
CD 1782 5.79E-03 + 1.93 two component response regulator 
CD2435 recO 5.94E-03 + 1.64 DNA repair protein 
CD3206 6.00E-03 + 1.61 putative membrane rotein 
co1147 6.07E-03 + 1.69 putative membrane protein 
CD 1181 fabD 6.09E-03 + 1.77 malonyl CoA-acyl carrier protein transacylase 
CD1200 6.13E-03 + 2.11 conserved hypothetical protein 
CD0345 6.16E-03 + 1.65 s 
putative guanosine 3', 5'-bis-pyrophosphate (ppGpp) 
ynthesis/degradation protein 
cD1663 guaD 6.18E-03 + 1.72 g uanine deaminase 
CD1183 acpP 6.22E-03 + 1.97 a cl carrier protein 
Table 7.10 Genes with statistically upregulated expression after growth with clindamycfn ... 
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Gene Commo 
name 
n P-value +l- ChaFold nge 
Gene Product 
45 CD2176 6.29E-03 + 2.59 probable amino-acid 
ABC transporter, permease 
protein 
46 
, CD1527 
6.29E-03 + 2.23 ABC transporter, permease protein 
47 CD3651 6.30E-03 + 1.46 putative metal lo- -lactamase superfamily protein 
48 CD1557 6.72E-03 + 1.82 putative peptidyl-prolyl isomerase 
49 CD0675 6.82E-03 + 1.38 putative acetyltransferase 
50 CD2209 6.84E-03 + 3.08 putative GTP-binding protein 
51 CD1178 pIsX 6.94E-03 + 1.41 fatty acid/phospholipid synthesis protein 
52 CD1278 6.99E-03 + 1.57 RRF2-farnily transcriptional regulator 
53 cD0686 rpml 7.17E-03 + 1.33 50S ribosomal protein L35 
54 cD1132 7.21 E-03 + 2.15 putative heavy-metal binding protein 
55 cD1635 7.23E-03 + 1.92 tellurium resistance protein 
56 002722 7.43E-03 + 1.97 two-component response regulator 
57 CD3658 rp/l 7.67E-03 + 1.87 50S ribosomal protein L9 
58 CD1800 7.83E-03 + 1.71 tellurium resistance protein 
59 cD2491 pmi 7.95E-03 + 1.55 mannose-6- hos hate isomerase 
60 002880 licA 8.04E-03 + 1.79 PTS system, lichenan-specific Ila component 
61 FD1459 8.26E-03 + 2.17 putative 5-nitroimidazole reductase 
2 001184 fabF 8.49E-03 + 1.91 3-oxoac I- ac I-carrier- rotein synthase 11 
63 CD1497 8.51 E-03 + 1.84 hypothetical protein 
64 002052 8.75E-03 + 1.66 putative lipoprotein 
65 CD2623 8.78E-03 + 2.15 putative alanine racemase 
66 001129 coaE 8.87E-03 + 1.27 putative de hos ho-CoA kinase 
67 CD3669 8.88E-03 + 1.95 putative exported protein 
68 CD0621 9.13E-03 + 1.74 hypothetical protein 
69 CD0679 9.29E-03 + 1.47 conserved hypothetical protein 
70 CDO273 htpG 9.48E-03 + 2.12 chaperone protein (heat shock protein) 
71 003667 9.48E-03 + 2.54 conserved hypothetical protein 
72 CD2123 9.67E-03 + 1.20 putative multi rotein-com lex assembly protein 
73 CD0658 cdul 9.86E-03 + 3.60 putative regulatory protein 
74 000701 9.89E-03 + 1.52 conserved hypothetical protein 
Table 7.10 Genes with statistically upregulated expression after growth in the presence 
of clindamycin 
Cd630 were grown in the presence of clindamycin and RNA was extracted at mid-logarithmic 
phase. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically regulated genes were identified by an ANOVA test 
with 1% cut-off using no multiple testing correction. 
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Gene Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
1 cD1849 6.53E-04 - 3.28 putative conjugal transfer protein 
2 CD1371 8.20E-04 - 1.71 phage protein 
3 CD0416 1.01E-03 - 2.10 utative exported protein 
4 cD3116 bglF 1.07E-03 - 1.38 PTS system, ß-glucoside-specific Ilabc component 
5 CD0891 s eB 1.39E-03 - 1.32 putative agmatinase 
6 cD2472 1.64E-03 - 1.45 conserved hypothetical protein 
7 CD0288 2.05E-03 - 2.06 PTS system, 11c component 
8 CD2815 2.37E-03 - 1.63 hypothetical protein 
9 cD3096 ascB1 2.57E-03 - 1.95 6- hos ho- - lucosidase 
10 CD0660 foxB 2.73E-03 - 1.80 toxin B 
11 'FD-2645 2.87E-03 - 1.95 putative extracellular solute-binding protein 
12 cD1604 2.88E-03 - 2.83 ABC transporter, ATP-binding protein 
13 CD0605 3.44E-03 - 1.41 conserved hypothetical protein 
14 CD0754 Phil 3.53E-03 - 1.59 putative thiamine biosynthesis protein 
15 CD2002 3.54E-03 - 2.08 conserved hypothetical protein 
16 CD2282 3.65E-03 - 1.53 PTS system, llbc component 
17 CD0933 4.00E-03 - 2.89 hypothetical phage protein 
18 CD2349 grdC 4.27E-03 - 1.82 
glycine/sarcosine/betaine reductase complex 
component C subunit 
19 cD3051 4.34E-03 - 1.59 conserved hypothetical protein 
20 CD0803 4.52E-03 - 2.26 putative ac l-CoA deh dro enase 
21 CD3612 CD3611 4.68E-03 - 1.66 
putative multidrug resistance protein 
seudo ene 
22 cD2681 4.85E-03 - 1.65 putative calcium-chelating exported protein 
23 cD2949 5.24E-03 - 1.61 putative phage repressor 
24 CD3242 prdB 5.35E-03 - 2.19 proline reductase 
25 cD3101 5.52E-03 - 1.79 PTS system, llbc component 
26 CD3257 5.68E-03 - 1.47 putative polysaccharide deacetylase 
27 CD1872 5.74E-03 - 2.38 putative iron-sulfur-binding membrane protein 
28 CD2096 5.91 E-03 - 1.81 conserved hypothetical protein 
29 CD0557 5.96E-03 - 1.35 putative phosphoribulokinase/uridine kinase 
30 CD0367 6.06E-03 - 1.96 two-component system, sensor histidine kinase 
31 cD2677 ctfA 6.08E-03 - 2.25 butyrate-acetoacetate CoA-transferase subunit A 
32 CD0200 6.14E-03 - 2.20 LysR-family transcriptional regulator (partial) 
33 cD2799 6.35E-03 - 1.34 putative cell surface protein 
34 CD0205 6.41 E-03 - 1.66 putative transcription antiterminator 
35 CD2785 6.52E-03 - 1.38 putative membrane protein 
36 D26-57 6.52E-03 - 1.95 putative membrane protein 
37 CD0901 opuCC 6.54E-03 - 1.29 
glycine/betaine/carnitine/choline ABC transporter, 
substrate-binding protein 
38 CD2898 6.55E-03 - 1.81 putative phage tail fiber protein 
39 cD2312 modB 6.69E-03 - 1.98 ABC transporter, permease protein 
40 cD0932 6.97E-03 - 2.55 hypothetical phage protein 
41 cD0417 6.99E-03 - 2.06 putative membrane protein 
42 cD1854 7.37E-03 - 2.76 
putative conjugative transposon membrane 
exported protein 
43 CDO040 7.65E-03 - 2.01 putative transcription antiterminator 
44 CDO764 sr1A 7.65E-03 - 3.50 
PTS system, glucitol/sorbitol-specific IIc2 
component 
Table 7.11 Genes with statistically downregulated expression alter growth with clindamycin ... 
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Gene Commo 
name 
n P-value +l- ChaFold nge 
Gene Product 
45 CD3396 dnaE 7.69E-03 - 1.33 DNA oI erase III a subunit 
46 CD1343 glnA 7.77E-03 - 2.73 glutamine synthetase 
47 cD0625 7.81 E-03 - 2.52 putative phage-related regulatory protein 
48 cD1862 7.91 E-03 - 2.05 
putative conjugative transposon DNA 
recombination protein 
49 CD1845 7.93E-03 - 2.38 putative membrane protein (partial) 
50 CD1906 8.10E-03 - 2.95 hypothetical protein 
51 CD2201 8.64E-03 - 2.48 lactose permease putative sugar transporter 
52 cD2085 dpaLl 8.65E-03 - 1.70 diaminopropionate ammonia-lyase 
53 CD0780 8.69E-03 - 2.55 conserved hypothetical protein 
54 CD1851 8.70E-03 - 3.18 
putative conjugal transfer protein 
(putative single-stranded dna binding protein) 
55 cD1363 8.79E-03 - 1.62 putative phage protein 
56 CD3443 8.84E-03 - 1.96 PTS system, Ilc component 
57 CD2465 8.94E-03 - 1.88 amino acid transporter 
58 CD1894 8.99E-03 - 1.87 putative plasmid-related protein 
59 CD0358 9.05E-03 - 2.84 , 
conjugative transposon conserved hypothetical 
protein 
60 CD3200 9.21 E-03 - 2.57 putative ABC transporter, permease protein 
61 CD2356 trxB3 9.42E-03 - 1.91 thioredoxin reductase 
62 CD3416 9.45E-03 - 2.78 ABC transporter, permease protein 
63 CD3415 9.49E-03 - 2.28 ABC transporter, permease protein 
64 cD3392 9.54E-03 - 3.17 putative collagen-binding surface protein 
65 CD3084 garK 9.65E-03 - 1.71 glycerate kinase 
66 CD3085 9.77E-03 - 2.12 putative I cos l hydrolase 
67 CD0380 9.79E-03 - 2.76 conjugative transposon protein 
68 CD3388 9.80E-03 - 2.27 
putative conjugative transposon replication 
initiation factor 
69 D06-28 9.94E-03 - 2.13 putative membrane protein 
Table 7.11 Genes with statistically downregulated expression after growth to the 
presence of clindamycin 
Cd630 were grown in the presence of clindamycin and RNA was extracted at mid-logarithmic 
phase. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically regulated genes were identified by an ANOVA test 
with 1% cut-off using no multiple testing correction. 
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A Gene 
Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
1 co1024 potA 2.35E-03 + 1.94 
spermidine/putrescine ABC transporter, 
ATP-binding protein 
2 CD3514 prsA 3.19E-03 + 1.52 ribose-phosphate ro hos hokinase 
3 CD3559 ftsH2 4.27E-03 + 1.38 cell division protein 
4 cD2954 ntpD 6.52E-03 + 1.84 V-type sodium ATP synthase subunit D 
5 CDO130 metK 8.60E-03 + 1.34 S-adenosylmethionine synthetase 
6 co1142 rnfB 8.79E-03 + 1.72 electron transport complex protein 
7 cD2948 9.32E-03 + 3.59 utative phage anti-repressor 
8 co2328 9.98E-03 + 1.31 putative sigma-54 
interacting transcription 
antiterminator 
B Gene 
Commo 
name 
n P-value +/- ChaFold nge 
Gene Product 
1 CD0503 9.91 E-04 - 1.40 conjugative transposon membrane protein 
2 CD3116 bglF 1.67E-03 - 1.45 PTS system, - lucoside-s ecific Ilabc component 
3 co3365 3.63E-03 - 1.28 putative signaling protein 
4 CD2305 3.79E-03 - 1.42 putative pilin/general secretion pathway protein 
5 cD2096 4.18E-03 - 1.84 conserved hypothetical protein 
6 CD3084 garK 4.27E-03 - 1.60 glycerate kinase 
7 cD3106 4.63E-03 - 1.66 putative phopho-sugar aldolase 
8 cD3150 4.98E-03 - 1.30 conserved hypothetical protein 
9 CD0188 7.30E-03 - 1.41 putative ketopantoate reductase 
10 cD1092 xis 8.82E-03 - 1.98 excisionase 
11 cD2875 fhuC 9.64E-03 - 1.40 
putative ferrichrome ABC transporter, ATP-binding 
protein 
12 CD0605 9.67E-03 - 1.73 conserved hypothetical protein 
Table 7.12 Genes with statistically altered expression after growth in the presence of 
metronidazole 
Cd630 were grown in the presence of metronidazole and RNA was extracted at mid-logarithmic 
phase. Competitive RNA-DNA microarrays were carried out, and gene expression was 
compared to control cultures. Statistically upregulated (A) and downregulated (B) genes were 
identified by an ANOVA test with 1% cut-off using no multiple testing correction. 
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Chapter 8- Further microarray data - Heat shock 
8.1 Rationale 
The statistical lists generated from microarray analysis after each stress are shown in Tables 7.1 
to 7.12 in Appendix 1 (Chapter 7). Interesting genes and gene sets within each list have been 
picked out and are detailed in Sections 4.3 to 4.6, and genes in the lists that have not been 
discussed earlier are examined here. For clarity, CD gene numbers have been omitted from the 
text. Selected gene sets are illustrated in figures that incorporate expression graphs exported 
from GeneSpringTM, and a diagrammatic representation of the genes within the genome where 
appropriate. See Section 4.2 for an explanation of the presentation of results. 
8.2 Microarray analysis of the responses of C. difficile 630 to heat shock 
RNA was extracted from heat shocked (42°C 15 min) or control (30°C 15 min) logarithmic 
cultures of C. difcile 630 and subjected to microarray analysis. Genes with statistically altered 
expression between control and heat shocked cultures were then identified using ANOVA tests 
with a 5% confidence level and the Benjamini-Hochberg multiple testing correction: one 
hundred and fourteen genes were determined to be upregulated and ninety-eight determined to 
be downregulated (Figure 4.3; Tables 7.1 and 7.2). Selected genes were discussed in 
Section 4.3, whilst others are detailed below. For clarity CD numbers have been omitted, but all 
genes are detailed in Tables 7.1 and 7.2. Selected gene sets are illustrated in Figures 8.1 to 8.3. 
Transcriptional regulators that are increased at the mRNA level after heat shock are single 
representatives of each of the GntR-, DeoR- and LysR-family transcriptional regulators, and a 
putative sigma-54 dependent transcriptional regulator. In contrast individual representatives of 
the LysR-, MerR-, AraC-, RRF2- and TetR-family transcriptional regulators and xy1R (xylose 
repressor) are downregulated. Genes encoding SpoOA (stage 0 sporulation protein A), TdcF 
(putative regulatory endoribonuclease), a putative regulatory protein, two putative signalling 
proteins, Rho (transcription termination factor) and two transcription antiterminators are also 
downregulated, whereas genes encoding two putative transcriptional regulators, a putative 
sigma-54 interacting transcription antiterminator and a putative poly(A) polymerase are 
upregulated. Additionally, seiB (selenocysteine-specific elongation 
factor), a putative 
translation elongation factor gene, and asnS (asparaginyl-tRNA synthetase) are upregulated 
whilst trpS (tryptophanyl-tRNA synthetase) is downregulated. rpsU (a 30S ribosomal protein) 
is significantly downregulated, and while no other genes encoding ribosomal-protein genes are 
significantly reduced, genes encoding all 
30S and 50S proteins are downregulated by an average 
of 1.3-fold (Section 4.8i). 
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rnhB (ribonuclease HID, addA (ATP-dependent nuclease subunit A) and a putative resolvase 
gene are upregulated, whilst rnz (ribonuclease Z), cafA (ribonuclease G), a putative 
endonuclease gene and a putative membrane-associated nucleotidase gene are downregulated. 
add (adenosine deaminase) and a putative cytidine/deoxycytidylate deaminase gene are also 
downregulated, in addition to genes encoding a putative DNA mismatch repair protein and a 
putative DNA-methyltransferase. 
Genes encoding a putative conjugative transposon recombinase, a putative recombinase and two 
putative transposases are upregulated, whilst most conjugative transposons genes are relatively 
unaffected (Section 4.8vii). A potential operon encoding a putative phage DNA-binding protein 
and hypothetical phage protein are also upregulated, and a putative phage regulatory protein 
gene is downregulated, but the majority of phage genes are relatively unchanging 
(Section 4.8vii). 
A gene cluster encoding a putative oxidoreductase FAD-binding domain, a putative flavodoxin 
and a putative MarR-family regulatory proteins is upregulated (Figure 8.1A). Genes encoding a 
putative FMN-dependent dehydrogenase and a putative reductase are also upregulated, however 
trxAl (a thioredoxin) is downregulated. Effects on genes encoding other enzymes affecting 
oxidation state of their substrate include upregulation of sed (putative D-3-phosphoglycerate 
dehydrogenase) and downregulation of IdhA (D-lactate dehydrogenase), cooS (putative 
bifunctional carbon monoxide dehydrogenase/acetyl-CoA synthase) and bcp (putative thiol 
peroxidase, bacterioferritin comigratory protein). 
Upregulated transferase genes encode a putative aminotransferase, GabT (4-aminobutyrate 
aminotransferase) and a putative bifunctional protein (phosphonoacetaldehyde phosphono- 
hydrolase and 2-aminoethylphosphonate: pyruvate aminotransferase), whereas a putative 
acetyltransferase gene is downregulated. 
Cell-wall biosynthesis genes murA (UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1) 
and a putative N-acetylmuramoyl-L-alanine amidase gene are upregulated; and murE (putative 
UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase) is downregulatcd, 
whereas all other mur genese are relatively unchanging 
(Figure 4.29B: Amoxicillin). d1iAs, 
dltC (D-alanine-poly(phosphoribitol) ligase subunits 1 and 2), dUtB (D-alanyl transferase) and 
dltDI (putative D-alanine transferase) lie in a gene cluster which is co-ordinately upregulated by 
an average of 1.95-fold (Figure 
8.1B), and are responsible for the addition of D-alanine to 
secondary cell wall polymers thereby masking 
their negative charge (Perego et a!. 1995). ddIB 
$ not significantly regulated 
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(D-alanine-D-alanine ligase B), which links D-alanine to the mur associated peptidoglycan 
synthesis pathway and is located elsewhere in the genome, is downregulated. Both CD0244$ 
and CD2810$, encoding CDP-glycerol: poly(glycerophosphate) glycerophosphotransferases, are 
also downregulated. Taken together this implies a general downregulation of cell wall 
components in conjunction with increased cell surface charge neutrality. ce1M (endoglucanase) 
and a putative cellobiose-phosphate degrading gene are also upregulated. Both probes 
representing cwp8 (PF04122 putative cell surface protein) are upregulated, whereas cwp23" 
(PF04122 putative cell surface protein) and cwp20# (PF04122 putative cell surface ß-lactamase) 
are downregulated. 
Overall, genes involved in cell division and cell shape show no consistent pattern (Figure 4.32B: 
Amoxicillin). For example, genes encoding the cell division proteins ftsHl, ftsH2 and ftsZa are 
upregulated, downregulated and unchanging respectively. Two two-component response 
regulator genes, but not their adjacent sensor histidine kinases, are upregulated. 
Significantly upregulated ABC transport components include genes encoding the ATP-binding 
proteins of a cobalt- (cbiO), a probable amino acid-, and three other ABC transporters. 
A potential operon of feoA3 and feoB3 (putative ferrous iron transport proteins A and B) is 
co-ordinately upregulated (Figure 8.2A); and a probable proton-dependent oligopeptide 
transporter gene is upregulated whilst a putative oligopeptide transporter gene is downregulated. 
Two putative drug/sodium antiporter genes are downregulated; and three putative transporter 
genes are significantly regulated - one up and two down. 
crr and ptsG are the two-components of the glucose-specific phosphotransferase system (PTS), 
and are both significantly downregulated after heat shock. crr is present in a gene cluster with 
ma1X (PTS maltose and glucose-specific Ilbc component), mali5 (putative bifunctional protein: 
repressor, cystathionine ß-lyase) and a putative phosphosugar isomerase gene, which seem to be 
co-ordinately downregulated by, on average, 1.85-fold (Figure 8.2B). One other non-specific 
PTS IIa component is also downregulated; whereas a PTS IIa and a PTS Ilabc component are 
upregulated. 
Other effects of heat shock on genes encoding phosphosugar-modifying enzymes include 
upregulation of glcK (glucokinase), bglA3 (6-phospho-ß-glucosidase) and a putative 
carbohydrate kinase gene. pm! (mannose-6-phosphate isomerase), agaA (N-acetylglucosamine- 
" only one probe/gene significant 
$ not significantly regulated 
I 
337 
Chapter 8- Further microarray data - Heat shock 
6-phosphate deacetylase), ppdK (pyruvate phosphate dikinase), and thrB (homoserine kinase) 
are also downregulated. 
thyX (putative thymidylate synthase), fo1C (putative folylpolyglutamate synthase), and genes 
encoding two radical-SAM superfamily proteins are also downregulated, while a putative amino 
acid racemase gene and argH (argininosuccinate lyase) are upregulated. A putative operon 
consisting of licC (CTP: phosphocholine cytidylyltransferase) and a putative choline sulphatase 
gene is co-ordinately downregulated (Figure 8.3A); as is a gene cluster consisting of dapF 
(diaminopimelate epimerase), rpoZ' (DNA-directed RNA polymerase omega chain), a 
conserved hypothetical protein, gmk (guanylate kinase) and coaBCS (coenzyme A biosynthesis 
bifunctional protein) (Figure 8.3B). 
Downregulated hydrolases include genes encoding a putative thioesterase, a putative amino acid 
amidase, CysM (putative O-acetylserine sulfhydrylase), a NUDIX-family protein (nucleoside 
diphosphate hydrolysing), a putative hydrolase, and both probes representing parts of a split- 
gene putative hydantoinase; whilst another putative hydrolase gene and a putative exported 
phosphoesterase gene are downregulated. A putative metallo-ß-lactamase superfamily protein 
gene is downregulated. Genes encoding a peptidase, a probable protease, a putative peptidase, a 
putative neutral protease and a putative membrane-associated CAAX amino terminal protease 
are upregulated while a putative serine protease gene is downregulated. 
Also upregulated are genes encoding six putative membrane proteins, three putative exported 
proteins, seven conserved hypothetical proteins and two hypothetical proteins. Downregulated 
are genes encoding eight putative membrane proteins, a putative lipoprotein, a putative cell 
surface protein, a putative exported protein, fourteen conserved hypothetical proteins and a 
hypothetical protein. 
1 not represented on the microarray 
$ not significantly regulated 
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Figure 8.1 Responses of gene clusters encoding flavoproteins and teichoic acid 
synthase enzymes 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
a putative oxidoreductase FAD-binding domain, a putative flavodoxin and a putative MarR- 
family regulatory protein (A) and the d1tCBAD gene cluster, encoding poly(phosphoribitol) 
teichoic acid modification proteins (B). The lines are coloured by the relative level of gene 
expression after heat shock. Diagrammatic representations of these gene clusters within the 
genome are depicted below the graphs, with significantly regulated genes shown in bold. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.2 Responses of gene clusters encoding iron and maltose transport proteins 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
putative ferrous iron transport proteins 
A and B (A); and maltose modification enzymes and 
maltose/glucose specific phosphotransferase system components (B). The lines are coloured by 
the relative level of gene expression after heat shock. Diagrammatic representations of these 
gene clusters within the genome are 
depicted below the graphs with significantly regulated 
genes shown in bold. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.3 Responses of gene clusters encoding choline-related proteins and various 
enzymes 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
CTP: phosphocholine cytidylyltransferase and a putative choline sulphatase (A); and the 
enzymes diaminopimelate epimerase, DNA-directed RNA polymerase omega chain, a 
conserved hypothetical protein, guanylate kinase and coenzyme A biosynthesis bifunctional 
protein (B). The lines are coloured by the relative level of gene expression after heat shock. 
Diagrammatic representations of these gene clusters within the genome are depicted below the 
graphs with significantly regulated genes shown in bold. For an explanation of GeneSpringTM 
graph interpretation, see Figure 
4.2. 
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8.3 Microarray analysis of the responses of C. difficile 630 to exposure to 
atmospheric oxygen 
RNA was extracted from oxygen shocked or control logarithmic cultures of C. difficile 630 and 
subjected to microarray analysis. Genes with statistically altered expression between control 
and heat shocked cultures were then identified using ANOVA tests with a 1% confidence level 
but no multiple testing correction: ninety-eight genes are determined to be upregulated and 
twenty-six downregulated after oxygen shock (Figure 4.19, Tables 7.6 and 7.7). Selected genes 
were examined in Section 4.5, and the remainder are detailed below. For clarity, CD numbers 
have been omitted, but all genes are detailed in Tables 7.6 and 7.7. Selected genes are 
illustrated in Figures 8.4 to 8.6, in addition to figures in previous sections. 
Genes encoding an RpiR-family- and a TetR-family transcriptional regulator are upregulated, 
whereas genes encoding a GntR-family transcriptional regulator, a putative sigma-54-interacting 
regulatory protein and spolP (putative stage II sporulation protein P) are downregulated. 
nusB (N utilisation substance protein B- an antiterminator necessary for rRNA biosynthesis) is 
upregulated, as is rpmA (50S ribosomal protein L27); both 30S and 50S ribosomal proteins 
show a trend towards upregulation (Section 4.8i). rbfA (ribosome-binding factor A) is 
downregulated and thrS (threonyl-tRNA synthetase) is upregulated. rph (ribonuclease Ph) and 
the adjacent putative phosphoesterase gene are co-ordinately upregulated (Figure 8.4), as are a 
putative RNA methylase gene, nth (endonuclease III) and nfo (endonuclease IV). exo. 4 
(putative exodeoxyribonuclease), a putative DNA mismatch repair protein gene and a partial 
putative topoisomerase gene are upregulated; whereas a putative single-strand binding protein 
gene is downregulated. 
vanR and adjacent vanSs (two-component response regulator and sensor histidine kinase), which 
in other species are responsible for glycopeptide (vancomycin) resistance, are upregulated 
(Figure 4.52E: Gene sets). Genes encoding another two-component sensor histidine kinase and 
response regulators pair, a two-component sensor histidine kinase (but not its pair) and a 
putative response regulator are also upregulated. 
Genes encoding a putative phage major capsid protein, a phage modification methylase and a 
conjugative transposon protein are downregulated, whereas tlpA (transposase-like protein A), 
one tlpB (transposase-like protein 
B) and xerDl (putative tyrosine recombinase) are 
upregulated, however foreign DNA as a whole shows no consistent trend (Section 4.8vii). 
$ not significantly regulated 
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Both f iN (flagellar motor switch protein) and flgM (negative regulator of flagellin synthesis: 
anti-sigma-D factor) are upregulated, whereas most flagellar genes are not affected 
(Section 4.8viii). Also upregulated are a putative N-acetylmuramoyl-L-alanine amidase gene 
and both indicators for cwp10 (PF01422 putative cell surface protein). 
Histidine-containing protein (HPr) participates in the phosphotransferase system (PTS) and is 
phosphorylated at a regulatory serine by HPr kinase (HprK) to repress the activity of several 
catabolic genes. hprK is upregulated after oxygen shock of C. docile, together with the 
adjacent uvrC (excinuclease ABC subunit Q. bg1F and bglP (PTS ß-glucoside-specific IIabc 
components) are downregulated, and all bgl genest are downregulated by an average of 
1.23-fold (Figure 8.5A). All genes encoding glucitol/sorbitol specific PTS componentsf are 
downregulated by an average of 1.33-fold (Figure 8.5B). Of 108 annotated genes encoding PTS 
components, thirty-five are 1.5-fold reduceds whereas only seven are 1.5-fold increased$ after 
oxygen shock (Section 4.8iii). 
Effects on other transporter components by exposure to aerobic conditions include induction of 
a putative sulphonate ABC transporter solute-binding lipoprotein gene and downregulation of 
rbsA (ribose ABC transporter ATP-binding protein), a putative ABC transporter permease 
protein gene and pbuX (xanthine permease). 
gcvH (putative glycine cleavage system H protein) is upregulated whereas gcvPBS is 
downregulated. acpP (acyl carrier protein) is upregulated whilst the rest of the fatty acid 
biosynthesis genes are relatively unaffected (Figure 4.9: Heat). pyrC (dihydroorotase) is 
upregulated while other pyr genes are relatively unchanging (Figure 4.7: Heat). gapN 
(NADP-dependent glyceraldehyde-3 -phosphate dehydrogenase), ispH (putative 4-hydroxy- 
3-methylbut-2-enyl diphosphate reductase), and genes encoding a putative aldo/keto reductase, 
a nitroreductase-family protein and a putative 5-nitroimidazole reductase are upregulated. 
Other upregulated genes encoding enzymes include those encoding a putative biotin/lipoate- 
protein ligase, Hpt (putative phosphoribosyltransferase), a putative acetyltransferase, a metallo- 
p-lactamase superfamily lipoprotein, and a putative arylesterase. Genes encoding a glutamine- 
hydrolysing asparagine synthetase, a putative GTPase, and a D-aminoacylase, a putative 
glyoxalase, a protease and a putative phosphohydrolase are also upregulated. 
A pair of genes encoding a putative D-isomer specific 2-hydroxyacid dehydrogenase and a 
conserved hypothetical protein is co-ordinately upregulated (Figure 8.6A), as are a clusters 
$ not significantly regulated 
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encoding three conserved hypothetical proteins (Figure 8.6B); a conserved hypothetical protein 
and a hypothetical protein (Figure 8.6C); and a hypothetical protein and a putative membrane 
protein (Figure 8.6D). 
Also upregulated are genes encoding a putative lipoprotein, six putative membrane proteins, 
three putative exported proteins, thirteen conserved hypothetical proteins and five hypothetical 
proteins. Genes encoding three putative membrane proteins, a putative surface-anchored 
membrane protein and a hypothetical protein are downregulated. 
0 
CD3307 rph 
Figure 8.4 Responses of the gene cluster encoding ribonuclease Ph 
GeneSpringTM graph illustrating the change in expression after stress of gene clusters encoding 
ribonuclease Ph and the adjacent putative phosphoesterase gene. The lines are coloured by the 
relative level of gene expression after oxygen shock. A diagrammatic representation of this 
gene cluster within the genome is depicted below the graph with significantly regulated genes 
shown in bold. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
344 
Heat Acid Alkali Aero Amox Clind Metro 
Chapter 8- Further microarray data - Oxygen shock 
A' 
o. 
Heat Acid Alkali Aero Amox Clind Metro 
bglP bg1A bglG 
bglA2 - bglF ' bglG 
B 
Iý 
I 1\1--N 
0.1 
Heat Acid Alkali Aero Amox Clind Metro 
CD0762 srlM srlA sr1E sr1E' sr/B srlD 
sr/E sr1A 
Figure 8.5 Responses of gene clusters encoding ß-glucoside and glucitol/sorbitol 
phosphotransferase system components 
GeneSpringTM graphs illustrating the change in expression after stress of bgl genes encoding 
phosphotransferase system (PTS) ß-glucoside-specific Ilabc components, 6-phospho-ß- 
glucosidases and their transcription anti-terminators (A) and srl genes encoding glucitol/sorbitol 
specific PTS components and a sorbitol-6-phosphate 2-dehydrogenase (B). The lines are coloured 
by the relative level of gene expression after oxygen shock. Diagrammatic representations of 
relevant gene clusters within the genome are depicted below the graphs with significantly regulated 
genes shown in bold. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.6 Responses of gene clusters encoding conserved hypothetical proteins 
GeneSpringTM graphs illustrating the change in expression after stress of selected gene clusters 
genes encoding conserved hypothetical proteins (A-D). The lines are coloured by the relative 
level of gene expression after oxygen shock. Diagrammatic representations of these gene 
clusters within the genome are depicted below the graphs with significantly regulated genes 
shown in bold. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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8.4 Microarray analysis of the responses of C. difficile to the presence of 
amoxicillin 
C. dicile 630 was grown in the presence or absence of 1 µg/ml amoxicillin, and then RNA was 
extracted and subjected to microarray analysis. Genes with statistically altered expression 
between control and antibiotic-exposed cultures were then identified using ANOVA tests with a 
1% confidence level and Benjamini-Hochberg multiple testing correction: two hundred and 
thirty genes are determined to be upregulated and twenty-four are downregulated. (Figure 4.28, 
Tables 7.8 and 7.9). Selected genes were examined in Section 4.6, and the remainder are 
detailed below. For clarity, CD numbers have been omitted, but all genes are detailed in Tables 
7.8 and 7.9. Selected gene sets are illustrated in Figures 8.7 to 8.13, in addition to figures in 
previous sections. 
Statistically upregulated genes in the genome region CD0059-CD0099 (Section 4.8i) are rpoB, 
rpoC and rpoA (DNA-directed RNA polymerase ß, ß' and a chains); rplK, rp1A, rp1J, rplC, 
rplD, rplW, rplB, rplV, rp1P, rp1N, rplX, rp1E, rplF, rp1R and rplQ (50S ribosomal proteins L11, 
L1, L10, L3, L4, L23, L2, L22, L16, L14, L24, L5, L6, L18 and L17); rpsL, rpsG, rpsJ, rpsS, 
rpsQ, rpsH, rpsE, rpsM, rpsK and rpsD (30S ribosomal proteins S12, S7, S 10, S19, S17, S8, S5, 
S 13, S 11 and S4); secE and secY (preprotein translocase subunits); tuJB (elongation factor TU), 
adk (adenylate kinase) and a putative ribosomal protein gene. rp1M (50S ribosomal protein 
L13), rpsU (30S ribosomal protein S21), a putative 30S ribosomal protein Si gene and secA2 
(preprotein translocase SecA subunit), all located elsewhere in the genome, are also 
significantly upregulated. A gene cluster containing dnaCS (dnaB, replicative DNA helicase), 
rplls (50S ribosomal protein L9) and genes encoding a putative RNA/single-stranded DNA 
exonuclease, a putative membrane proteins and a conserved hypothetical protein is also 
co-ordinately upregulated (Figure 8.7A). selA (fdhA, selenocysteinyl-tRNA(Sec) synthase), 
alaS (putative alanyl-tRNA synthetase), argS (arginyl-tRNA synthetase), an isoleucyl-tRNA 
synthetase, and trpX (miaA, tRNA A2-isopentenylpyrophosphate transferase) are all upregulated; 
overall, genes encoding tRNA-associated proteins are upregulated 1.81-fold (Section 4.8i). 
Genes encoding a DeoR-family-, a LysR-family- and two putative transcriptional regulators are 
upregulated; whilst rbsR (putative ribose operon repressor) and a phosphosugar-binding 
transcriptional regulator gene are downregulated. spoliP (putative stage II sporulation 
protein P), spoIIIG (sigG, RNA polymerase sigma-G factor) and spoIVA (stage IV sporulation 
protein A) are downregulated; whereas a gene cluster encoding a putative RNA-binding protein, 
$ not significantly regulated 
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HupA (DNA-binding protein HU), a putative bifunctional protein (tetrapyrrole 
(corrin/porphyrin) methylase; nucleoside triphosphate pyrophosphohydrolase) and SpoVB 
(SpoIIIF, stage V sporulation protein B) is co-ordinately upregulated (Figure 8.8A). spoIIIJ 
(oxaAl, putative sporulation membrane protein) and the adjacent jag (SpoIIIJ-associated 
protein) are also upregulated, but the majority of spoIII genes are downregulated (Figure 8.8B). 
Also upregulated are cafA (mg, ribonuclease g), a putative RNA-binding mediating protein 
gene, ssb (single-strand binding protein), recN (DNA repair protein) and a putative nucleotide 
pyrophosphatase (DNA repair protein). htpG (heat shock chaperone protein) is also 
upregulated, as is groELS/groES$ (Figure 4.4: Heat), but the other heat-shock related operons are 
not greatly affected. tig (trigger factor), ppiB (peptidyl-prolyl cis-trans isomerase), racX 
(probable amino acid racemase), pepl (pip, proline iminopeptidase) and genes encoding a 
probable peptidase and a putative amidohydrolase are statistically upregulated during growth in 
the presence of amoxicillin, whilst another putative amidohydrolase is downregulated. 
A two-component system sensor histidine kinases and response regulator pair is upregulated 
(Figure 8.9A), whereas a gene cluster encoding another two-component response regulators and 
sensor histidine kinase pair, a hypothetical proteins and a putative transcriptional regulators are 
downregulated (Figure 8.9B). A putative two-component sensor histidine kinase and a two- 
component response regulator not adjacent in the genome are also downregulated. 
Most foreign DNA is downregulated during exposure to amoxicillin: conjugative transposon 
genes by an average of 1.26-fold and phage genes by 1.53-fold (Section 4.8vii). Significantly 
downregulated conjugative transposon genes encode a putative cAMP-binding regulatory 
protein, an ATP/GTP-binding protein, a membrane protein, a conserved hypothetical protein 
and another protein. Genes encoding a putative phage-related regulatory protein, a putative 
phage tail fibre protein, a phage protein, two putative phage proteins and a hypothetical phage 
protein are downregulated, as is a putative regulatory protein present on a mobile element. 
A putative chemotaxis protein is -significantly upregulated, and chemotaxis proteins are 
generally upregulated 1.20-fold (Figure 4.33B: Amoxicillin). Statistically upregulated genes in 
the region of the genome from CD0226-CD0272, which contains primarily flagellar genes 
(Section 4.8viii), areliA (RNA polymerase sigma factor for flagellar operon), fleN (flagellar 
number regulator), a putative flagellar biosynthesis protein gene, fliC (flagellin subunit), fliF 
(M-ring protein), a putative flagellar basal-body rod protein gene, flgD (putative basal-body rod 
modification protein), fliL (basal body-associated protein), fliM, fiN (putative flagellar motor 
s not significantly regulated 
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switch proteins), liR/flhB, flhA (export proteins), and a putative CDP-glycerol: polyglycero- 
phosphate glycerophosphotransferase teichoic acid synthase gene. 
A gene cluster containing upp (uracil phosphoribosyltransferase), rpiB2 (ribose-5 -phosphate 
isomerase 2) and genes encoding a low molecular weight protein-tyrosine-phosphatases, a 
putative zinc transporter and a conserved hypothetical proteins is upregulated (Figure 8.10), as 
are pmi (mannose-6-phosphate isomerase) and treA (treC, trehalose-6-phosphate hydrolase). 
pykF (pyruvate kinase), a putative phosphatase gene, a putative guanosine 3', 5'-bis- 
pyrophosphate (ppGpp) synthesis gene and thrB (homoserine kinase) are all upregulated, as are 
hisK (putative histidinol phosphatase), hisZ (putative ATP phosphoribosyltransferase regulatory 
subunit), and xpt (xanthine phosphoribosyltransferase). Also upregulated are dapD (2,3,4,5- 
tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase), glyA (putative serine hydroxy- 
methyltransferase), a putative acetyltransferase gene and gluM (gcaD, bifunctional protein: 
glucosamine-l-phosphate N-acetyltransferase; UDP-N-acetylglucosamine pyrophosphorylase), 
as are prsA (ribose-phosphate pyrophosphokinase) and ppaC (manganese-dependent inorganic 
pyrophosphatase). 
The putative glycine cleavage system gcvH (H protein) is upregulated, but gcvPB (P protein) is 
downregulated. A gene cluster containing gatAs, gatB$ and gatC (PTS galactitol-specific IIa, 
Ilb and rIc components) is co-ordinately downregulated, together with the adjacent gatD 
(putative galactitol-1-phosphate 5-dehydrogenase) (Figure 8.11A). Genes encoding a PTS habe 
component and a Ilbc component are upregulated, as is a gene cluster encoding a conserved 
hypothetical protein, two putative sugar transporter permease proteins# and a putative sugar 
transporter substrate-binding protein (Figure 8.1113). 
Five unnamed ABC transporter gene clusters are upregulated and two downregulated, although 
in each case the change in only one gene is statistically significant: a putative osmoprotectant 
substrate-binding/permease protein (Figure 4.11B: Heat), a substrate-binding lipoprotein, a 
permease protein, an ATP-binding protein and a putative iron-specific ATP-binding protein are 
upregulated (Figure 8.12A-D); and two ATP-binding proteins are downregulated 
(Figure 8.12E-F). 
cdd4 (putative lantibiotic ABC transporter ATP-binding protein) is upregulated, but the adjacent 
cdd2 and cdd3 (permease and substrate- binding proteins) are not (Figure 4.55E: Gene sets). 
vexPi (permease protein), vexP2$ and vexP3$ (encoding the VexP ABC transporter) are 
S not significantly regulated 
# only one probe/gene significant 
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Figure 8.7 Responses of gene clusters encoding nucleic acid related proteins and 
UNP-glucose related proteins 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
the replicative DNA helicase, a ribosomal protein, a putative exonuclease, a putative membrane 
protein and a conserved hypothetical protein 
(A); and UTP-glucose-l-phosphate uridylyl- 
transferase, UDP-glucose 4-epimerase and a PF04122 cell wall protein (CWP) (B). 'I'hc lines 
are coloured by the relative 
level of gene expression after growth in the presence of amoxicillin. 
Diagrammatic representations of these gene clusters within the genome are depicted below the 
graphs. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.8 Responses of spoIII genes 
GeneSpringTM graphs illustrating the change in expression after stress of a gene cluster 
encoding a putative RNA-binding protein, DNA-binding protein H, a bifunctional tetrapyrrole 
(corrin/porphyrin) methylase/nucleoside triphosphate pyrophosphohyd ro lase, and stage V 
sporulation protein B (SpollIF) (A); and all spoil! genes (B). The lines are coloured by the 
relative level of gene expression after growth in the presence of arnoxicillin. Diagrammatic 
representations of relevant gene clusters within the genome are depicted below the graphs with 
significantly regulated genes shown in bold. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 8.9 Responses of gene clusters encoding two-component system protein pairs 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
a two-component system sensor kinase and response regulator pair (A); a two-component pair 
plus a hypothetical protein and a putative transcriptional regulator (B); and a two-component 
pair plus a putative lipoprotein and tRNA pseudouridine synthase 2 (C). The lines are coloured 
by the relative level of gene expression after growth in the presence of amoxicillin. 
Diagrammatic representations of these gene clusters within the genome are depicted below the 
graphs with significantly regulated genes shown in bold. For an explanation of GeneSpringTM 
graph interpretation, see Figure 4.2. 
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Figure 8.10 Responses of a gene cluster encoding ribose-phosphate related proteins 
GeneSpringTM graphs illustrating the change in expression after stress of a gene cluster 
encoding uracil phosphoribosyltransferase, ribose-5-phosphate isomerase 2, a low molecular 
weight protein-tyrosine-phosphatase, a putative zinc transporter and a conserved hypothetical 
protein. The lines are coloured by the relative level of gene expression after growth in the 
presence of amoxicillin. A diagrammatic representation of this gene clusters within the genome 
is depicted below the graph with significantly regulated genes shown in bold. For an 
explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.11 Responses of gene clusters encoding sugar transport systems 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
phosphotransferase system galactitol-specific Ila, IIb and He components (gut) (A), and 
conserved hypothetical protein, two putative sugar transporter permease proteins" and a putative 
sugar transporter substrate-binding protein (B). The lines are coloured by the relative level of 
gene expression after growth in the presence of amoxicillin. Diagrammatic representations of 
these gene clusters within the genome are depicted below the graphs with significantly regulated 
genes shown in bold. For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
only one probe/gene significantly regulated 
355 
Chapter 8- Further microarray data - Amoxicillin 
A B 
0 
C' 
o. 
E 
D 
a -ý I1 
01 
Heat Acid Alkali Aero Amox Clind Metro Heat Acid Alkali Aero Amox Clind Metro 
cv2068 CD3525 rL)3526 CD3S27 
=ý'ý ýý ýýýýýýýý 
010.1 
Heat Acid Alkali Aero Amox Clind Metro Heat Acid Alkali Aero Amox Clind Metro 
CD1603 CD1604 CD1605 CD3362 ('1)3363 w3364 
Figure 8.12 Responses of gene clusters encoding ABC transporters 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
ABC transporter components (A-F); components represented in D are putatively iron-specific. 
The lines are coloured by the relative level of gene expression after growth in the presence of 
amoxicillin. Diagrammatic representations of these gene clusters within the genome, all shown 
at 70% scale, are depicted below the graphs with significantly regulated genes shown in bold. 
For an explanation of GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.13 Responses of other co-regulated gene clusters 
GeneSpringTM graphs illustrating the change in expression after stress of gene clusters encoding 
a putative glyoxalase and a conserved hypothetical protein (A); inosine-uridine preferring 
nucleoside hydrolase, a radical SAM-superfamily protein and a putative membrane protein (11); 
and three conserved hypothetical proteins (C). The lines are coloured by the relative level of 
gene expression after growth in the presence of amoxicillin. 
Diagrammatic representations of 
these gene clusters within the genome are depicted 
below the graphs with significantly regulated 
genes shown in bold. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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co-ordinately downregulated, together with upstream genes encoding a putative exported 
protein and a putative iron-sulphur binding membrane protein, however prevalence of the 
downstream vncRS two-component system transcripts remain unchanged (Figure 4.52F: Gene 
sets). 
bcd2 (butyryl-CoA dehydrogenase), hymC (putative iron-only hydrogenase catalytic subunit) 
and genes encoding a putative carbon monoxide dehydrogenase/acetyl-CoA synthase complex 
a-subunit, a putative 5-nitroimidazole reductase, a putative aldo/keto reductase, a putative 
nitroreductase and a putative reductase are all upregulated, whereas a putative oxidoreductase 
subunit is downregulated. 
bg1G (putative ß-glucoside bgl operon transcription antiterminator) is downregulated, as are 
most bgl genes (Figure 8.5A: Oxygen). A putative GTP-binding protein gene and guaA 
(glutamine-hydrolysing GMP synthase) are upregulated, as is a NUDIX-family hydrolase, 
whereas a putative hydrolase is downregulated. IysA (diaminopimelate decarboxylase), iscS2 
(cysteine desulphurase), a putative choline sulphatase, asnA (aspartate-ammonia ligase), a 
putative biotin/lipoate-protein ligase, a putative hydantoinase, plfA (pyruvate formate-lyase 
activating enzyme) and a metallo-ß-lactamase superfamily protein gene are all upregulated. 
Also upregulated is a gene cluster encoding a putative glyoxalase and a conserved hypothetical 
protein (Figure 8.13A); and one incorporating iunH (inosine-uridine preferring nucleoside 
hydrolase) and genes encoding a radical SAM-superfamily protein and a putative membrane 
protein (Figure 8.13B). A gene cluster encoding three conserved hypothetical proteins is 
upregulated (only two genes significantly) (Figure 8.13C); as are genes encoding four putative 
membrane proteins, a putative lipoprotein, eight putative exported proteins, nine conserved 
hypothetical proteins and three hypothetical proteins; whilst genes encoding a putative 
membrane protein, a conserved hypothetical protein and two hypothetical proteins are 
downregulated. 
$ not significantly regulated 
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8.5 Microarray analysis of the responses of C. diffcile to the presence of 
clindamycin 
C. docile 630 was grown in the presence or absence of I tg/ml amoxicillin, and then RNA was 
extracted and subjected to microarray analysis. Genes with statistically altered expression 
between control and antibiotic-exposed cultures were then identified by ANOVA tests using a 
1% confidence level but no multiple testing correction: seventy-four genes were determined to 
be upregulated and sixty-nine are downregulated in response to the presence of sub-inhibitory 
levels of clindamycin in the growth medium (Figure 4.40; Tables 7.10 and 7.11). Selected 
genes were examined in Section 4.6, and the remainder are detailed below. For clarity, CD 
numbers have been omitted, but all genes are detailed in Tables 7.10 and 7.11. Selected genes 
are illustrated in Figures 8.14 to 8.16, in addition to figures in previous sections. 
Upregulated regulatory factors include genes encoding an RRF2- family transcriptional 
regulator, two putative transcriptional regulators, a putative sigma-54 interacting regulatory 
protein and Cdul (putative regulatory protein) and genes encoding two putative transcription 
antiterminators and a partial LysR-family transcriptional regulator are downregulated. Genes 
encoding RecO (DNA repair protein), a putative DNA repair protein, a putative RNA/single- 
stranded DNA exonuclease, a putative RNA-binding protein and a putative phosphoribulo- 
kinase/uridine kinase are upregulated. A gene cluster incorporating dnaC$ (replicative DNA 
helicase), rpll (50S ribosomal protein L9), and genes encoding a putative RNA/single-stranded 
DNA exonuclease, a putative membrane protein and a conserved hypothetical protein 
is co-ordinately upregulated (Figure 8.7A: Amoxicillin), as is dnaE (po1C, DNA polymerase III 
a-subunit). rpml (50S ribosomal protein L35) is also significantly upregulated; genes encoding 
all 30S and 50S ribosomal proteins are on average upregulated 1.66-fold (Section 4.8i). 
A gene cluster encoding a putative lipoproteins, a two-component sensor histidine kinases and 
response regulator, and TruA2s (tRNA pseudouridine synthase 2) is co-ordinately upregulated 
(Figure 8.9C: Amoxicillin); as is another two-component response regulator and sensor 
histidine kinases pair (Figure 8.9A: Amoxicillin); whereas a gene cluster encoding another two- 
component response regulators and sensor histidine kinase pair, a hypothetical proteins and a 
putative transcriptional regulators is downregulated (Figure 8.9B: Amoxicillin). 
Both htpG (heat shock chaperone protein) and cspB (putative cold shock protein) are induced by 
the presence of clindamycin. Foreign DNA is generally downregulated: genes encoding a phage 
protein, two hypothetical phage proteins, a putative phage protein and a putative phage tail fibre 
protein are significantly reduced. Two putative phage regulatory proteins are upregulated and a 
$ not significantly regulated 
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putative phage repressor and a putative phage-related regulatory protein are downregulated. 
Putative conjugative transposon genes encoding a DNA recombination protein, a membrane 
exported protein, a replication initiation factor, two conserved hypothetical proteins and another 
conjugative transposon protein are downregulated; as are two putative conjugal transfer proteins 
(one putative single-stranded DNA binding protein). On average, all conjugative transposon 
proteins are downregulated 1.41-fold (Section 4.8vii). 
Genes encoding possible resistance proteins are generally upregulated, including genes for a 
putative metallo-ß-lactamase superfamily protein, a putative penicillin-binding protein 
repressor, a putative heavy-metal binding protein and two tellurium resistance proteins, whereas 
a putative calcium-chelating exported protein gene, a putative extracellular solute-binding 
protein gene and a putative multidrug resistance protein pseudogene are downregulated. cdd4 
(putative lantibiotic ABC transporter ATP-binding protein) and a putative antibiotic resistance 
ABC transporter ATP-binding protein gene are upregulated. 
Other regulated transporter components include upregulation of an ABC transporter permease 
protein gene and a probable amino acid ABC transporter permease protein gene; and 
downregulation of genes encoding an ABC transporter ATP-binding protein, ModB (ABC 
transporter permease protein), a putative ABC transporter permease protein, an amino acid 
transporter and a lactose permease putative sugar transporter. Also downregulated is a gene 
cluster encoding an ABC transporter solute-binding proteins, two permease proteins and an 
ATP-binding proteins (Figure 8.14A). 
Phosphotransferase system (PTS) components show a general downregulation trend: fifty-four 
are over 1.5-fold downregulated whereas only eleven are 1.5-fold upregulated (Section 4.8iii). 
bg1F (ß-glucoside-specific habe component), srlA (gutA, glucitol/sorbitol-specific IIc2 
component) and genes encoding two Ilbc components and two IIc components are significantly 
downregulated; whereas licA (ce1C, lichenan-specific Ha component) is upregulated. 
garK (glycerate kinase) is downregulated whilst coaE (putative dephospho-CoA kinase), uppS 
(undecaprenyl pyrophosphate synthetase) and a putative guanosine 3', 5'-bis-pyrophosphate 
(ppGpp) synthesis/degradation protein gene are upregulated. Genes encoding a putative 
oxidoreductase molybdopterin-binding subunit and a putative 5-nitroimidazole reductase are 
upregulated; and prdB (proline reductase), a putative iron-sulphur-binding membrane protein 
gene and a putative acyl-CoA dehydrogenase are downregulated. 
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The fab gene cluster encoding fatty acid synthesis proteins is co-ordinately upregulated by an 
average of 1.65-fold (Figure 4.9B: Heat), but only acpP (acyl carrier protein), fabD (malonyl 
CoA-ACP transacylase), fabF (3-oxoacyl-ACP synthase II), and plsX (fatty acid/phospholipid 
synthesis protein) significantly so. ascBS, ascBl and ascB2$ (6-phospho-ß-glucosidases) are all 
downregulated (Figure 8.14B); as are dpaLl and dpaL2s (diaminopropionate ammonia-lyases) 
(Figure 8.15A). guaAs (glutamine-hydrolysing GMP synthase), guaB$ (inosine-5'-mono- 
phosphate dehydrogenase), and guaD (guanine deaminase) are all upregulated (Figure 8.15B); 
whilst speAs, speDs, speEs and speB are downregulated (Figure 4.11A: Heat). A gene cluster 
incorporating th1A2$ (putative acetyl-CoA acetyltransferase), ctfA and c fBs (butyrate- 
acetoacetate CoA-transferase subunits A and B) and bdhA (D-p-hydroxybutyrate 
dehydrogenase) is co-ordinately downregulated (Figure 8.16). 
pm! (mannose-6-phosphate isomerase), ppiB (peptidyl-prolyl cis-trans isomerase) and genes 
encoding a putative peptidyl-prolyl isomerase and a putative alanine racemase are upregulated; 
as are fsaB (fructose-6-phosphate aldolase 2), and genes encoding a NUDIX-family hydrolase, a 
putative hydantoinase, a putative N-acetylmuramoyl-L-alanine amidase and a radical SAM- 
superfamily protein. glnA (glutamine synthetase), thil (putative thiamine biosynthesis protein), 
and genes encoding a putative glycosyl hydrolase, a putative polysaccharide deacetylase and a 
putative acetyltransferase are downregulated. Genes encoding a putative GTP-binding protein 
and a putative multiprotein-complex assembly protein are upregulated and genes encoding a 
putative plasmid-related protein and a putative collagen-binding surface protein are 
downregulated. 
Two putative cell surface proteins containing PF04122 domains are regulated, although 
significantly only for one probe out of two each: cwp21 upregulated and cwp8 downregulated 
(Figures 4.66D and 5.57B: Gene sets). Also downregulated are genes encoding a putative 
export protein, five putative membrane proteins, two hypothetical proteins and six conserved 
hypothetical proteins. Upregulated genes include those encoding a putative lipoprotein, three 
putative membrane proteins, two putative exported proteins, three hypothetical proteins and ten 
conserved hypothetical proteins. 
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Figure 8.14 Responses of gene clusters encoding an ABC transporter and AscB 
6-phospho-ß-glucosidases 
GeneSpringTM graphs illustrating the change in expression after stress of a gene cluster 
encoding ABC transporter components (A); and genes encoding AscB 6-phospho-ß- 
glucosidases (B). The lines are coloured by the relative level of gene expression after growth in 
the presence of clindamycin. Diagrammatic representations of these gene clusters within the 
genome are depicted below the graphs with significantly regulated genes shown in bold. ; genes 
not represented in the GeneSpringTM graph are shown in grey. For an explanation of 
GeneSpringTM graph interpretation, see Figure 4.2. 
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Figure 8.15 Responses of gene clusters encoding diaminopropionate ammonia-lyases 
and guanine-related proteins 
GeneSpringTM graphs illustrating the change in expression after stress of genes encoding 
diaminopropionate ammonia-lyases (A); and glutamine-hydrolysing GMP synthase, inosine- 
5'-monophosphate dehydrogenase, and guanine deaminase (B). The lines are coloured by the 
relative level of gene expression after growth in the presence of clindamycin. Diagrammatic 
representations of these genes within the genome are depicted below the graphs with 
significantly regulated genes shown in bold. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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Figure 8.16 Responses of gene clusters encoding butyrate and acetyl-CoA related 
proteins 
GeneSpringTM graphs illustrating the change in expression after stress of a gene cluster 
encoding putative acetyl-CoA acetyltransferase, butyrate-acetoacetate CoA-transferase 
subunits A and B), and D-ß-hydroxybutyrate dehydrogenase. The lines are coloured by the 
relative level of gene expression after growth in the presence of clindamycin. A diagrammatic 
representation of the gene cluster within the genome is depicted below the graph with 
significantly regulated genes shown in bold. For an explanation of GeneSpringTM graph 
interpretation, see Figure 4.2. 
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